id	sid	tid	token	lemma	pos
admet-3030	1	1	topical	topical	ADJ
admet-3030	1	2	composite	composite	ADJ
admet-3030	1	3	hydrogel	hydrogel	NOUN
admet-3030	1	4	incorporating	incorporate	VERB
admet-3030	1	5	human	human	ADJ
admet-3030	1	6	amniotic	amniotic	ADJ
admet-3030	1	7	membrane	membrane	NOUN
admet-3030	1	8	and	and	CCONJ
admet-3030	1	9	spidroin	spidroin	NOUN
admet-3030	1	10	for	for	ADP
admet-3030	1	11	the	the	DET
admet-3030	1	12	treatment	treatment	NOUN
admet-3030	1	13	of	of	ADP
admet-3030	1	14	chronic	chronic	ADJ
admet-3030	1	15	wounds	wound	NOUN
admet-3030	1	16	in	in	ADP
admet-3030	1	17	diabetes	diabetes	NOUN
admet-3030	1	18	mellitus	mellitus	PROPN
admet-3030	1	19	doi	doi	PROPN
admet-3030	1	20	:	:	PUNCT
admet-3030	1	21	http://dx.doi.org/10.5599/admet.3030	http://dx.doi.org/10.5599/admet.3030	X
admet-3030	1	22	1	1	NUM
admet-3030	1	23	admet	admet	X
admet-3030	1	24	&	&	CCONJ
admet-3030	1	25	dmpk	dmpk	PROPN
admet-3030	1	26	00(0	00(0	PROPN
admet-3030	1	27	)	)	PUNCT
admet-3030	1	28	(	(	PUNCT
admet-3030	1	29	2025	2025	NUM
admet-3030	1	30	)	)	PUNCT
admet-3030	1	31	3030	3030	NUM
admet-3030	1	32	;	;	PUNCT
admet-3030	1	33	doi	doi	NOUN
admet-3030	1	34	:	:	PUNCT
admet-3030	1	35	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	1	36	open	open	ADJ
admet-3030	1	37	access	access	NOUN
admet-3030	1	38	:	:	PUNCT
admet-3030	1	39	issn	issn	PROPN
admet-3030	1	40	:	:	PUNCT
admet-3030	1	41	1848	1848	NUM
admet-3030	1	42	-	-	SYM
admet-3030	1	43	7718	7718	NUM
admet-3030	1	44	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index	http://www.pub.iapchem.org/ojs/index.ph-p/admet/index	PROPN
admet-3030	1	45	review	review	NOUN
admet-3030	1	46	paper	paper	NOUN
admet-3030	1	47	precision	precision	NOUN
admet-3030	1	48	therapeutics	therapeutic	NOUN
admet-3030	1	49	in	in	ADP
admet-3030	1	50	non	non	ADJ
admet-3030	1	51	-	-	ADJ
admet-3030	1	52	scarring	scarring	ADJ
admet-3030	1	53	alopecia	alopecia	NOUN
admet-3030	1	54	:	:	PUNCT
admet-3030	1	55	a	a	DET
admet-3030	1	56	systemic	systemic	ADJ
admet-3030	1	57	genomic	genomic	NOUN
admet-3030	1	58	and	and	CCONJ
admet-3030	1	59	pathway	pathway	NOUN
admet-3030	1	60	-	-	PUNCT
admet-3030	1	61	based	base	VERB
admet-3030	1	62	framework	framework	NOUN
admet-3030	1	63	for	for	ADP
admet-3030	1	64	targeted	target	VERB
admet-3030	1	65	interventions	intervention	NOUN
admet-3030	1	66	rinky	rinky	ADJ
admet-3030	1	67	kapoor1	kapoor1	NOUN
admet-3030	1	68	,	,	PUNCT
admet-3030	1	69	depti	depti	PROPN
admet-3030	1	70	bellani2	bellani2	NOUN
admet-3030	1	71	,	,	PUNCT
admet-3030	1	72	raji	raji	PROPN
admet-3030	1	73	patil2	patil2	PROPN
admet-3030	1	74	,	,	PUNCT
admet-3030	1	75	debalina	debalina	PROPN
admet-3030	1	76	bose3	bose3	PROPN
admet-3030	1	77	,	,	PUNCT
admet-3030	1	78	madhuri	madhuri	PROPN
admet-3030	1	79	pola3	pola3	PROPN
admet-3030	1	80	,	,	PUNCT
admet-3030	1	81	prashant	prashant	PROPN
admet-3030	1	82	anilkumar	anilkumar	PROPN
admet-3030	1	83	singh2	singh2	PROPN
admet-3030	1	84	,	,	PUNCT
admet-3030	1	85	mamata	mamata	PROPN
admet-3030	1	86	mishra3	mishra3	PROPN
admet-3030	1	87	and	and	CCONJ
admet-3030	1	88	debraj	debraj	PROPN
admet-3030	1	89	shome4	shome4	PROPN
admet-3030	1	90	,	,	PUNCT
admet-3030	1	91	*	*	PROPN
admet-3030	1	92	1department	1department	NUM
admet-3030	1	93	of	of	ADP
admet-3030	1	94	dermatology	dermatology	NOUN
admet-3030	1	95	,	,	PUNCT
admet-3030	1	96	cosmetic	cosmetic	ADJ
admet-3030	1	97	dermatology	dermatology	NOUN
admet-3030	1	98	&	&	CCONJ
admet-3030	1	99	dermato	dermato	PROPN
admet-3030	1	100	-	-	PUNCT
admet-3030	1	101	surgery	surgery	NOUN
admet-3030	1	102	,	,	PUNCT
admet-3030	1	103	the	the	DET
admet-3030	1	104	esthetic	esthetic	ADJ
admet-3030	1	105	clinics	clinic	NOUN
admet-3030	1	106	,	,	PUNCT
admet-3030	1	107	mumbai	mumbai	PROPN
admet-3030	1	108	,	,	PUNCT
admet-3030	1	109	maharashtra	maharashtra	PROPN
admet-3030	1	110	,	,	PUNCT
admet-3030	1	111	india	india	PROPN
admet-3030	1	112	2department	2department	PROPN
admet-3030	1	113	of	of	ADP
admet-3030	1	114	medical	medical	ADJ
admet-3030	1	115	affairs	affair	NOUN
admet-3030	1	116	,	,	PUNCT
admet-3030	1	117	esthetic	esthetic	ADJ
admet-3030	1	118	creations	creation	NOUN
admet-3030	1	119	international	international	PROPN
admet-3030	1	120	pvt	pvt	PROPN
admet-3030	1	121	.	.	PROPN
admet-3030	1	122	ltd	ltd	PROPN
admet-3030	1	123	.	.	PROPN
admet-3030	2	1	(	(	PUNCT
admet-3030	2	2	ecipl	ecipl	PROPN
admet-3030	2	3	)	)	PUNCT
admet-3030	2	4	,	,	PUNCT
admet-3030	2	5	mumbai	mumbai	PROPN
admet-3030	2	6	,	,	PUNCT
admet-3030	2	7	maharashtra	maharashtra	PROPN
admet-3030	2	8	,	,	PUNCT
admet-3030	2	9	india	india	PROPN
admet-3030	2	10	3department	3department	PROPN
admet-3030	2	11	of	of	ADP
admet-3030	2	12	research	research	NOUN
admet-3030	2	13	,	,	PUNCT
admet-3030	2	14	the	the	DET
admet-3030	2	15	esthetic	esthetic	ADJ
admet-3030	2	16	clinics	clinic	NOUN
admet-3030	2	17	clinical	clinical	ADJ
admet-3030	2	18	research	research	NOUN
admet-3030	2	19	organization	organization	NOUN
admet-3030	2	20	(	(	PUNCT
admet-3030	2	21	teccro	teccro	NOUN
admet-3030	2	22	)	)	PUNCT
admet-3030	2	23	,	,	PUNCT
admet-3030	2	24	mumbai	mumbai	PROPN
admet-3030	2	25	,	,	PUNCT
admet-3030	2	26	maharashtra	maharashtra	PROPN
admet-3030	2	27	,	,	PUNCT
admet-3030	2	28	india	india	PROPN
admet-3030	2	29	4department	4department	NUM
admet-3030	2	30	of	of	ADP
admet-3030	2	31	facial	facial	ADJ
admet-3030	2	32	plastic	plastic	NOUN
admet-3030	2	33	surgery	surgery	NOUN
admet-3030	2	34	&	&	CCONJ
admet-3030	2	35	facial	facial	ADJ
admet-3030	2	36	cosmetic	cosmetic	ADJ
admet-3030	2	37	surgery	surgery	NOUN
admet-3030	2	38	,	,	PUNCT
admet-3030	2	39	the	the	DET
admet-3030	2	40	esthetic	esthetic	ADJ
admet-3030	2	41	clinics	clinic	NOUN
admet-3030	2	42	,	,	PUNCT
admet-3030	2	43	mumbai	mumbai	PROPN
admet-3030	2	44	,	,	PUNCT
admet-3030	2	45	maharashtra	maharashtra	PROPN
admet-3030	2	46	,	,	PUNCT
admet-3030	2	47	india	india	PROPN
admet-3030	2	48	*	*	PUNCT
admet-3030	2	49	corresponding	correspond	VERB
admet-3030	2	50	author	author	NOUN
admet-3030	2	51	:	:	PUNCT
admet-3030	2	52	e	e	NOUN
admet-3030	2	53	-	-	NOUN
admet-3030	2	54	mail	mail	NOUN
admet-3030	2	55	:	:	PUNCT
admet-3030	2	56	debraj.shome@theestheticclinics.com	debraj.shome@theestheticclinics.com	X
admet-3030	2	57	received	receive	VERB
admet-3030	2	58	:	:	PUNCT
admet-3030	2	59	october	october	PROPN
admet-3030	2	60	1	1	NUM
admet-3030	2	61	,	,	PUNCT
admet-3030	2	62	2025	2025	NUM
admet-3030	2	63	;	;	PUNCT
admet-3030	2	64	revised	revise	VERB
admet-3030	2	65	:	:	PUNCT
admet-3030	2	66	december	december	PROPN
admet-3030	2	67	9	9	NUM
admet-3030	2	68	,	,	PUNCT
admet-3030	2	69	2025	2025	NUM
admet-3030	2	70	;	;	PUNCT
admet-3030	2	71	published	publish	VERB
admet-3030	2	72	:	:	PUNCT
admet-3030	2	73	december	december	PROPN
admet-3030	2	74	16	16	NUM
admet-3030	2	75	,	,	PUNCT
admet-3030	2	76	2025	2025	NUM
admet-3030	2	77	abstract	abstract	ADJ
admet-3030	2	78	background	background	NOUN
admet-3030	2	79	and	and	CCONJ
admet-3030	2	80	purpose	purpose	NOUN
admet-3030	2	81	:	:	PUNCT
admet-3030	2	82	non	non	ADJ
admet-3030	2	83	-	-	ADJ
admet-3030	2	84	scarring	scarring	ADJ
admet-3030	2	85	alopecia	alopecia	NOUN
admet-3030	2	86	,	,	PUNCT
admet-3030	2	87	principally	principally	ADV
admet-3030	2	88	androgenetic	androgenetic	ADJ
admet-3030	2	89	alopecia	alopecia	NOUN
admet-3030	2	90	and	and	CCONJ
admet-3030	2	91	alopecia	alopecia	NOUN
admet-3030	2	92	areata	areata	NOUN
admet-3030	2	93	is	be	AUX
admet-3030	2	94	highly	highly	ADV
admet-3030	2	95	prevalent	prevalent	ADJ
admet-3030	2	96	and	and	CCONJ
admet-3030	2	97	psychologically	psychologically	ADV
admet-3030	2	98	burdensome	burdensome	ADJ
admet-3030	2	99	;	;	PUNCT
admet-3030	2	100	androgenetic	androgenetic	ADJ
admet-3030	2	101	alopecia	alopecia	NOUN
admet-3030	2	102	is	be	AUX
admet-3030	2	103	androgen	androgen	NOUN
admet-3030	2	104	-	-	PUNCT
admet-3030	2	105	driven	drive	VERB
admet-3030	2	106	,	,	PUNCT
admet-3030	2	107	whereas	whereas	SCONJ
admet-3030	2	108	alopecia	alopecia	NOUN
admet-3030	2	109	areata	areata	NOUN
admet-3030	2	110	is	be	AUX
admet-3030	2	111	autoimmune	autoimmune	ADJ
admet-3030	2	112	.	.	PUNCT
admet-3030	3	1	this	this	DET
admet-3030	3	2	review	review	NOUN
admet-3030	3	3	synthesizes	synthesize	VERB
admet-3030	3	4	genetic	genetic	ADJ
admet-3030	3	5	architecture	architecture	NOUN
admet-3030	3	6	and	and	CCONJ
admet-3030	3	7	pathway	pathway	NOUN
admet-3030	3	8	biology	biology	NOUN
admet-3030	3	9	to	to	PART
admet-3030	3	10	outline	outline	VERB
admet-3030	3	11	a	a	DET
admet-3030	3	12	precision	precision	NOUN
admet-3030	3	13	framework	framework	NOUN
admet-3030	3	14	for	for	ADP
admet-3030	3	15	targeted	target	VERB
admet-3030	3	16	interventions	intervention	NOUN
admet-3030	3	17	.	.	PUNCT
admet-3030	4	1	experimental	experimental	ADJ
admet-3030	4	2	approach	approach	NOUN
admet-3030	4	3	:	:	PUNCT
admet-3030	4	4	we	we	PRON
admet-3030	4	5	reviewed	review	VERB
admet-3030	4	6	full	full	ADJ
admet-3030	4	7	-	-	PUNCT
admet-3030	4	8	text	text	NOUN
admet-3030	4	9	studies	study	NOUN
admet-3030	4	10	from	from	ADP
admet-3030	4	11	the	the	DET
admet-3030	4	12	past	past	ADJ
admet-3030	4	13	decade	decade	NOUN
admet-3030	4	14	across	across	ADP
admet-3030	4	15	pubmed	pubmed	PROPN
admet-3030	4	16	,	,	PUNCT
admet-3030	4	17	web	web	NOUN
admet-3030	4	18	of	of	ADP
admet-3030	4	19	science	science	NOUN
admet-3030	4	20	and	and	CCONJ
admet-3030	4	21	google	google	PROPN
admet-3030	4	22	scholar	scholar	NOUN
admet-3030	4	23	,	,	PUNCT
admet-3030	4	24	applying	apply	VERB
admet-3030	4	25	explicit	explicit	ADJ
admet-3030	4	26	inclusion	inclusion	NOUN
admet-3030	4	27	/	/	SYM
admet-3030	4	28	exclusion	exclusion	NOUN
admet-3030	4	29	criteria	criterion	NOUN
admet-3030	4	30	;	;	PUNCT
admet-3030	4	31	emphasis	emphasis	NOUN
admet-3030	4	32	was	be	AUX
admet-3030	4	33	placed	place	VERB
admet-3030	4	34	on	on	ADP
admet-3030	4	35	genome	genome	NOUN
admet-3030	4	36	wide	wide	ADJ
admet-3030	4	37	association	association	NOUN
admet-3030	4	38	studies	study	NOUN
admet-3030	4	39	and	and	CCONJ
admet-3030	4	40	next	next	ADJ
admet-3030	4	41	generation	generation	NOUN
admet-3030	4	42	sequencing	sequence	VERB
admet-3030	4	43	findings	finding	NOUN
admet-3030	4	44	,	,	PUNCT
admet-3030	4	45	immune	immune	ADJ
admet-3030	4	46	and	and	CCONJ
admet-3030	4	47	androgen	androgen	NOUN
admet-3030	4	48	-	-	PUNCT
admet-3030	4	49	axis	axis	NOUN
admet-3030	4	50	biology	biology	NOUN
admet-3030	4	51	,	,	PUNCT
admet-3030	4	52	environmental	environmental	ADJ
admet-3030	4	53	modifiers	modifier	NOUN
admet-3030	4	54	,	,	PUNCT
admet-3030	4	55	and	and	CCONJ
admet-3030	4	56	therapeutic	therapeutic	ADJ
admet-3030	4	57	evidence	evidence	NOUN
admet-3030	4	58	(	(	PUNCT
admet-3030	4	59	conventional	conventional	ADJ
admet-3030	4	60	,	,	PUNCT
admet-3030	4	61	targeted	target	VERB
admet-3030	4	62	,	,	PUNCT
admet-3030	4	63	and	and	CCONJ
admet-3030	4	64	regenerative	regenerative	ADJ
admet-3030	4	65	)	)	PUNCT
admet-3030	4	66	,	,	PUNCT
admet-3030	4	67	alongside	alongside	ADP
admet-3030	4	68	artificial	artificial	ADJ
admet-3030	4	69	intelligence	intelligence	NOUN
admet-3030	4	70	-	-	PUNCT
admet-3030	4	71	enabled	enable	VERB
admet-3030	4	72	diagnostics	diagnostic	NOUN
admet-3030	4	73	.	.	PUNCT
admet-3030	5	1	key	key	ADJ
admet-3030	5	2	results	result	NOUN
admet-3030	5	3	:	:	PUNCT
admet-3030	5	4	androgenetic	androgenetic	ADJ
admet-3030	5	5	alopecia	alopecia	NOUN
admet-3030	5	6	risk	risk	NOUN
admet-3030	5	7	converges	converge	VERB
admet-3030	5	8	on	on	ADP
admet-3030	5	9	androgen	androgen	NOUN
admet-3030	5	10	-	-	PUNCT
admet-3030	5	11	receptor	receptor	NOUN
admet-3030	5	12	signalling	signal	VERB
admet-3030	5	13	and	and	CCONJ
admet-3030	5	14	related	related	ADJ
admet-3030	5	15	loci	locus	NOUN
admet-3030	5	16	,	,	PUNCT
admet-3030	5	17	with	with	ADP
admet-3030	5	18	perifollicular	perifollicular	ADJ
admet-3030	5	19	inflammation	inflammation	NOUN
admet-3030	5	20	and	and	CCONJ
admet-3030	5	21	oxidative	oxidative	ADJ
admet-3030	5	22	stress	stress	NOUN
admet-3030	5	23	as	as	ADP
admet-3030	5	24	modifiers	modifier	NOUN
admet-3030	5	25	;	;	PUNCT
admet-3030	5	26	finasteride	finasteride	ADV
admet-3030	5	27	remains	remain	VERB
admet-3030	5	28	a	a	DET
admet-3030	5	29	cornerstone	cornerstone	NOUN
admet-3030	5	30	therapy	therapy	NOUN
admet-3030	5	31	.	.	PUNCT
admet-3030	6	1	alopecia	alopecia	NOUN
admet-3030	6	2	areata	areata	PROPN
admet-3030	6	3	reflects	reflect	VERB
admet-3030	6	4	polygenic	polygenic	ADJ
admet-3030	6	5	immune	immune	ADJ
admet-3030	6	6	dysregulation	dysregulation	NOUN
admet-3030	6	7	(	(	PUNCT
admet-3030	6	8	e.g.	e.g.	ADV
admet-3030	6	9	human	human	ADJ
admet-3030	6	10	leukocyte	leukocyte	NOUN
admet-3030	6	11	antigen	antigen	NOUN
admet-3030	6	12	/	/	SYM
admet-3030	6	13	cytokine	cytokine	NOUN
admet-3030	6	14	axes	axis	NOUN
admet-3030	6	15	)	)	PUNCT
admet-3030	6	16	with	with	ADP
admet-3030	6	17	janus	janus	PROPN
admet-3030	6	18	kinase	kinase	PROPN
admet-3030	6	19	-	-	PUNCT
admet-3030	6	20	pathway	pathway	NOUN
admet-3030	6	21	inhibition	inhibition	NOUN
admet-3030	6	22	yielding	yield	VERB
admet-3030	6	23	robust	robust	ADJ
admet-3030	6	24	regrowth	regrowth	NOUN
admet-3030	6	25	;	;	PUNCT
admet-3030	6	26	across	across	ADP
admet-3030	6	27	phenotypes	phenotype	NOUN
admet-3030	6	28	,	,	PUNCT
admet-3030	6	29	wingless	wingless	NOUN
admet-3030	6	30	-	-	PUNCT
admet-3030	6	31	related	relate	VERB
admet-3030	6	32	integration	integration	NOUN
admet-3030	6	33	sit	sit	VERB
admet-3030	6	34	/	/	SYM
admet-3030	6	35	β	β	NOUN
admet-3030	6	36	-	-	NOUN
admet-3030	6	37	catenin	catenin	ADJ
admet-3030	6	38	and	and	CCONJ
admet-3030	6	39	stem	stem	NOUN
admet-3030	6	40	-cell	-cell	NOUN
admet-3030	6	41	programs	program	NOUN
admet-3030	6	42	are	be	AUX
admet-3030	6	43	central	central	ADJ
admet-3030	6	44	targets	target	NOUN
admet-3030	6	45	.	.	PUNCT
admet-3030	7	1	regenerative	regenerative	ADJ
admet-3030	7	2	options	option	NOUN
admet-3030	7	3	(	(	PUNCT
admet-3030	7	4	protein	protein	NOUN
admet-3030	7	5	rich	rich	ADJ
admet-3030	7	6	plasma	plasma	NOUN
admet-3030	7	7	,	,	PUNCT
admet-3030	7	8	stem	stem	NOUN
admet-3030	7	9	-	-	PUNCT
admet-3030	7	10	cell	cell	NOUN
admet-3030	7	11	/	/	SYM
admet-3030	7	12	exosome	exosome	NOUN
admet-3030	7	13	approaches	approach	NOUN
admet-3030	7	14	)	)	PUNCT
admet-3030	7	15	and	and	CCONJ
admet-3030	7	16	artificial	artificial	ADJ
admet-3030	7	17	intelligence	intelligence	NOUN
admet-3030	7	18	-	-	PUNCT
admet-3030	7	19	assisted	assist	VERB
admet-3030	7	20	stratification	stratification	NOUN
admet-3030	7	21	are	be	AUX
admet-3030	7	22	emerging	emerge	VERB
admet-3030	7	23	adjuncts	adjunct	NOUN
admet-3030	7	24	.	.	PUNCT
admet-3030	8	1	conclusion	conclusion	NOUN
admet-3030	8	2	:	:	PUNCT
admet-3030	8	3	a	a	DET
admet-3030	8	4	pathway	pathway	NOUN
admet-3030	8	5	-	-	PUNCT
admet-3030	8	6	guided	guide	VERB
admet-3030	8	7	,	,	PUNCT
admet-3030	8	8	genotype	genotype	NOUN
admet-3030	8	9	and	and	CCONJ
admet-3030	8	10	phenotype	phenotype	NOUN
admet-3030	8	11	-	-	PUNCT
admet-3030	8	12	informed	inform	VERB
admet-3030	8	13	strategy	strategy	NOUN
admet-3030	8	14	,	,	PUNCT
admet-3030	8	15	targeting	target	VERB
admet-3030	8	16	the	the	DET
admet-3030	8	17	androgen	androgen	NOUN
admet-3030	8	18	axis	axis	NOUN
admet-3030	8	19	for	for	ADP
admet-3030	8	20	androgenetic	androgenetic	ADJ
admet-3030	8	21	alopecia	alopecia	NOUN
admet-3030	8	22	,	,	PUNCT
admet-3030	8	23	immune	immune	ADJ
admet-3030	8	24	circuits	circuit	NOUN
admet-3030	8	25	for	for	ADP
admet-3030	8	26	alopecia	alopecia	NOUN
admet-3030	8	27	areata	areata	NOUN
admet-3030	8	28	,	,	PUNCT
admet-3030	8	29	and	and	CCONJ
admet-3030	8	30	adding	add	VERB
admet-3030	8	31	regenerative	regenerative	ADJ
admet-3030	8	32	or	or	CCONJ
admet-3030	8	33	microenvironmental	microenvironmental	ADJ
admet-3030	8	34	therapies	therapy	NOUN
admet-3030	8	35	where	where	SCONJ
admet-3030	8	36	indicatedpromises	indicatedpromise	NOUN
admet-3030	8	37	earlier	early	ADV
admet-3030	8	38	diagnosis	diagnosis	NOUN
admet-3030	8	39	and	and	CCONJ
admet-3030	8	40	more	more	ADV
admet-3030	8	41	durable	durable	ADJ
admet-3030	8	42	,	,	PUNCT
admet-3030	8	43	individualized	individualized	ADJ
admet-3030	8	44	outcomes	outcome	NOUN
admet-3030	8	45	,	,	PUNCT
admet-3030	8	46	especially	especially	ADV
admet-3030	8	47	as	as	SCONJ
admet-3030	8	48	genome	genome	NOUN
admet-3030	8	49	-	-	PUNCT
admet-3030	8	50	wide	wide	ADJ
admet-3030	8	51	association	association	NOUN
admet-3030	8	52	study	study	NOUN
admet-3030	8	53	/	/	SYM
admet-3030	8	54	next	next	ADJ
admet-3030	8	55	-	-	PUNCT
admet-3030	8	56	generation	generation	NOUN
admet-3030	8	57	sequencing	sequencing	NOUN
admet-3030	8	58	and	and	CCONJ
admet-3030	8	59	artificial	artificial	ADJ
admet-3030	8	60	intelligence	intelligence	NOUN
admet-3030	8	61	tools	tool	NOUN
admet-3030	8	62	are	be	AUX
admet-3030	8	63	integrated	integrate	VERB
admet-3030	8	64	into	into	ADP
admet-3030	8	65	care	care	NOUN
admet-3030	8	66	.	.	PUNCT
admet-3030	9	1	©	©	PROPN
admet-3030	9	2	2025	2025	NUM
admet-3030	9	3	by	by	ADP
admet-3030	9	4	the	the	DET
admet-3030	9	5	authors	author	NOUN
admet-3030	9	6	.	.	PUNCT
admet-3030	10	1	this	this	DET
admet-3030	10	2	article	article	NOUN
admet-3030	10	3	is	be	AUX
admet-3030	10	4	an	an	DET
admet-3030	10	5	open	open	ADJ
admet-3030	10	6	-	-	PUNCT
admet-3030	10	7	access	access	NOUN
admet-3030	10	8	article	article	NOUN
admet-3030	10	9	distributed	distribute	VERB
admet-3030	10	10	under	under	ADP
admet-3030	10	11	the	the	DET
admet-3030	10	12	terms	term	NOUN
admet-3030	10	13	and	and	CCONJ
admet-3030	10	14	conditions	condition	NOUN
admet-3030	10	15	of	of	ADP
admet-3030	10	16	the	the	DET
admet-3030	10	17	creative	creative	ADJ
admet-3030	10	18	commons	common	NOUN
admet-3030	10	19	attribution	attribution	NOUN
admet-3030	10	20	license	license	NOUN
admet-3030	10	21	(	(	PUNCT
admet-3030	10	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-3030	10	23	)	)	PUNCT
admet-3030	10	24	.	.	PUNCT
admet-3030	11	1	keywords	keyword	VERB
admet-3030	11	2	androgenetic	androgenetic	ADJ
admet-3030	11	3	alopecia	alopecia	NOUN
admet-3030	11	4	;	;	PUNCT
admet-3030	11	5	alopecia	alopecia	NOUN
admet-3030	11	6	areata	areata	NOUN
admet-3030	11	7	;	;	PUNCT
admet-3030	11	8	genome	genome	NOUN
admet-3030	11	9	-	-	PUNCT
admet-3030	11	10	wide	wide	ADJ
admet-3030	11	11	association	association	NOUN
admet-3030	11	12	studies	study	NOUN
admet-3030	11	13	and	and	CCONJ
admet-3030	11	14	next	next	ADJ
admet-3030	11	15	-	-	PUNCT
admet-3030	11	16	generation	generation	NOUN
admet-3030	11	17	sequencing	sequencing	NOUN
admet-3030	11	18	;	;	PUNCT
admet-3030	11	19	wingless	wingless	NOUN
admet-3030	11	20	-	-	PUNCT
admet-3030	11	21	related	relate	VERB
admet-3030	11	22	integration	integration	NOUN
admet-3030	11	23	sit	sit	VERB
admet-3030	11	24	/	/	SYM
admet-3030	11	25	beta	beta	NOUN
admet-3030	11	26	-	-	PUNCT
admet-3030	11	27	catenin	catenin	NOUN
admet-3030	11	28	signalling	signal	VERB
admet-3030	11	29	pathway	pathway	NOUN
admet-3030	11	30	;	;	PUNCT
admet-3030	11	31	janus	janus	PROPN
admet-3030	11	32	kinase	kinase	PROPN
admet-3030	11	33	-	-	PUNCT
admet-3030	11	34	signal	signal	NOUN
admet-3030	11	35	transducer	transducer	NOUN
admet-3030	11	36	and	and	CCONJ
admet-3030	11	37	activator	activator	NOUN
admet-3030	11	38	of	of	ADP
admet-3030	11	39	transcription	transcription	NOUN
admet-3030	11	40	pathway	pathway	NOUN
admet-3030	11	41	;	;	PUNCT
admet-3030	11	42	artificial	artificial	ADJ
admet-3030	11	43	intelligence	intelligence	NOUN
admet-3030	11	44	introduction	introduction	NOUN
admet-3030	11	45	alopecia	alopecia	NOUN
admet-3030	11	46	is	be	AUX
admet-3030	11	47	a	a	DET
admet-3030	11	48	genetic	genetic	ADJ
admet-3030	11	49	disorder	disorder	NOUN
admet-3030	11	50	,	,	PUNCT
admet-3030	11	51	often	often	ADV
admet-3030	11	52	referred	refer	VERB
admet-3030	11	53	to	to	ADP
admet-3030	11	54	as	as	ADP
admet-3030	11	55	a	a	DET
admet-3030	11	56	hair	hair	NOUN
admet-3030	11	57	loss	loss	NOUN
admet-3030	11	58	condition	condition	NOUN
admet-3030	11	59	,	,	PUNCT
admet-3030	11	60	which	which	PRON
admet-3030	11	61	affects	affect	VERB
admet-3030	11	62	2.1	2.1	NUM
admet-3030	11	63	%	%	NOUN
admet-3030	11	64	of	of	ADP
admet-3030	11	65	people	people	NOUN
admet-3030	11	66	across	across	ADP
admet-3030	11	67	the	the	DET
admet-3030	11	68	world	world	NOUN
admet-3030	12	1	[	[	X
admet-3030	12	2	1	1	NUM
admet-3030	12	3	]	]	PUNCT
admet-3030	12	4	.	.	PUNCT
admet-3030	13	1	based	base	VERB
admet-3030	13	2	on	on	ADP
admet-3030	13	3	its	its	PRON
admet-3030	13	4	nature	nature	NOUN
admet-3030	13	5	of	of	ADP
admet-3030	13	6	reversibility	reversibility	NOUN
admet-3030	13	7	,	,	PUNCT
admet-3030	13	8	alopecia	alopecia	NOUN
admet-3030	13	9	is	be	AUX
admet-3030	13	10	further	far	ADV
admet-3030	13	11	classified	classify	VERB
admet-3030	13	12	into	into	ADP
admet-3030	13	13	scarring	scarring	NOUN
admet-3030	13	14	and	and	CCONJ
admet-3030	13	15	nonhttp://dx.doi.org/10.5599/admet.3030	nonhttp://dx.doi.org/10.5599/admet.3030	NUM
admet-3030	13	16	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	13	17	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	PROPN
admet-3030	13	18	mailto:debraj.shome@theestheticclinics.com	mailto:debraj.shome@theestheticclinics.com	PROPN
admet-3030	13	19	https://www.google.com/search?sca_esv=e4f071505be2a160&rlz=1c1chbd_enin1175in1175&q=wingless-related+integration+site&sa=x&ved=2ahukewi5korojairaxvyswwghufbe0sqgk4qegqiarae&biw=1517&bih=703&dpr=0.9&mstk=autexfduv8bafdkzk3asg9mghmubwby_2edpdebpmcbjk4v7xbhye9ephqeghyaj2g5xmipdka5tn0jkd2xkr5muelujplglt3kq68icxs94qexw4hdawgk37jcvcfzsqqrxax4jgqrcymb0i-n8rvsq9dd0l2gwkecokjnvsrazpxxtpgvnqogsidpx9v3uaqtd2gz0&csui=3	https://www.google.com/search?sca_esv=e4f071505be2a160&rlz=1c1chbd_enin1175in1175&q=wingless-related+integration+site&sa=x&ved=2ahukewi5korojairaxvyswwghufbe0sqgk4qegqiarae&biw=1517&bih=703&dpr=0.9&mstk=autexfduv8bafdkzk3asg9mghmubwby_2edpdebpmcbjk4v7xbhye9ephqeghyaj2g5xmipdka5tn0jkd2xkr5muelujplglt3kq68icxs94qexw4hdawgk37jcvcfzsqqrxax4jgqrcymb0i-n8rvsq9dd0l2gwkecokjnvsrazpxxtpgvnqogsidpx9v3uaqtd2gz0&csui=3	VERB
admet-3030	13	20	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-3030	13	21	https://www.google.com/search?sca_esv=e4f071505be2a160&rlz=1c1chbd_enin1175in1175&q=wingless-related+integration+site&sa=x&ved=2ahukewi5korojairaxvyswwghufbe0sqgk4qegqiarae&biw=1517&bih=703&dpr=0.9&mstk=autexfduv8bafdkzk3asg9mghmubwby_2edpdebpmcbjk4v7xbhye9ephqeghyaj2g5xmipdka5tn0jkd2xkr5muelujplglt3kq68icxs94qexw4hdawgk37jcvcfzsqqrxax4jgqrcymb0i-n8rvsq9dd0l2gwkecokjnvsrazpxxtpgvnqogsidpx9v3uaqtd2gz0&csui=3	https://www.google.com/search?sca_esv=e4f071505be2a160&rlz=1c1chbd_enin1175in1175&q=wingless-related+integration+site&sa=x&ved=2ahukewi5korojairaxvyswwghufbe0sqgk4qegqiarae&biw=1517&bih=703&dpr=0.9&mstk=autexfduv8bafdkzk3asg9mghmubwby_2edpdebpmcbjk4v7xbhye9ephqeghyaj2g5xmipdka5tn0jkd2xkr5muelujplglt3kq68icxs94qexw4hdawgk37jcvcfzsqqrxax4jgqrcymb0i-n8rvsq9dd0l2gwkecokjnvsrazpxxtpgvnqogsidpx9v3uaqtd2gz0&csui=3	VERB
admet-3030	13	22	https://orcid.org/0009-0002-2443-878x	https://orcid.org/0009-0002-2443-878x	PROPN
admet-3030	13	23	https://orcid.org/0000-0003-1045-9758	https://orcid.org/0000-0003-1045-9758	PROPN
admet-3030	13	24	https://orcid.org/0009-0003-2725-7578	https://orcid.org/0009-0003-2725-7578	PROPN
admet-3030	13	25	https://orcid.org/0009-0005-0350-3839	https://orcid.org/0009-0005-0350-3839	PROPN
admet-3030	13	26	https://orcid.org/0000-0003-3959-0223	https://orcid.org/0000-0003-3959-0223	PROPN
admet-3030	14	1	https://orcid.org/0009-0006-0427-6866	https://orcid.org/0009-0006-0427-6866	PROPN
admet-3030	14	2	https://orcid.org/0000-0003-3797-7133	https://orcid.org/0000-0003-3797-7133	PROPN
admet-3030	14	3	https://orcid.org/0009-0007-8026-4629	https://orcid.org/0009-0007-8026-4629	PROPN
admet-3030	14	4	r.	r.	PROPN
admet-3030	14	5	kapoor	kapoor	PROPN
admet-3030	14	6	et	et	PROPN
admet-3030	14	7	al	al	PROPN
admet-3030	14	8	.	.	PROPN
admet-3030	14	9	admet	admet	PROPN
admet-3030	14	10	&	&	CCONJ
admet-3030	14	11	dmpk	dmpk	PROPN
admet-3030	14	12	00(0	00(0	PROPN
admet-3030	14	13	)	)	PUNCT
admet-3030	14	14	(	(	PUNCT
admet-3030	14	15	2025	2025	NUM
admet-3030	14	16	)	)	PUNCT
admet-3030	14	17	3030	3030	NUM
admet-3030	14	18	2	2	NUM
admet-3030	14	19	scarring	scar	VERB
admet-3030	14	20	alopecia	alopecia	NOUN
admet-3030	14	21	.	.	PUNCT
admet-3030	15	1	scarring	scar	VERB
admet-3030	15	2	alopecia	alopecia	NOUN
admet-3030	15	3	results	result	NOUN
admet-3030	15	4	in	in	ADP
admet-3030	15	5	the	the	DET
admet-3030	15	6	permanent	permanent	ADJ
admet-3030	15	7	loss	loss	NOUN
admet-3030	15	8	of	of	ADP
admet-3030	15	9	hair	hair	NOUN
admet-3030	15	10	because	because	SCONJ
admet-3030	15	11	of	of	ADP
admet-3030	15	12	irreversible	irreversible	ADJ
admet-3030	15	13	damage	damage	NOUN
admet-3030	15	14	to	to	ADP
admet-3030	15	15	the	the	DET
admet-3030	15	16	hair	hair	NOUN
admet-3030	15	17	follicles	follicle	NOUN
admet-3030	15	18	,	,	PUNCT
admet-3030	15	19	while	while	SCONJ
admet-3030	15	20	in	in	ADP
admet-3030	15	21	non	non	ADJ
admet-3030	15	22	-	-	ADJ
admet-3030	15	23	scarring	scarring	ADJ
admet-3030	15	24	alopecia	alopecia	NOUN
admet-3030	15	25	,	,	PUNCT
admet-3030	15	26	the	the	DET
admet-3030	15	27	hair	hair	NOUN
admet-3030	15	28	follicles	follicle	NOUN
admet-3030	15	29	remain	remain	VERB
admet-3030	15	30	intact	intact	ADJ
admet-3030	15	31	,	,	PUNCT
admet-3030	15	32	and	and	CCONJ
admet-3030	15	33	proper	proper	ADJ
admet-3030	15	34	treatment	treatment	NOUN
admet-3030	15	35	based	base	VERB
admet-3030	15	36	on	on	ADP
admet-3030	15	37	the	the	DET
admet-3030	15	38	cause	cause	NOUN
admet-3030	15	39	results	result	NOUN
admet-3030	15	40	in	in	ADP
admet-3030	15	41	hair	hair	NOUN
admet-3030	15	42	re	re	NOUN
admet-3030	15	43	-	-	NOUN
admet-3030	15	44	growth	growth	NOUN
admet-3030	15	45	[	[	X
admet-3030	15	46	2	2	NUM
admet-3030	15	47	]	]	PUNCT
admet-3030	15	48	.	.	PUNCT
admet-3030	16	1	of	of	ADP
admet-3030	16	2	the	the	DET
admet-3030	16	3	various	various	ADJ
admet-3030	16	4	kinds	kind	NOUN
admet-3030	16	5	of	of	ADP
admet-3030	16	6	non	non	ADJ
admet-3030	16	7	-	-	ADJ
admet-3030	16	8	scarring	scarring	ADJ
admet-3030	16	9	alopecia	alopecia	NOUN
admet-3030	16	10	,	,	PUNCT
admet-3030	16	11	the	the	DET
admet-3030	16	12	most	most	ADV
admet-3030	16	13	popular	popular	ADJ
admet-3030	16	14	non	non	ADJ
admet-3030	16	15	-	-	ADJ
admet-3030	16	16	scarring	scar	VERB
admet-3030	16	17	alopecia	alopecia	NOUN
admet-3030	16	18	are	be	AUX
admet-3030	16	19	androgenetic	androgenetic	ADJ
admet-3030	16	20	alopecia	alopecia	NOUN
admet-3030	16	21	(	(	PUNCT
admet-3030	16	22	aga	aga	NOUN
admet-3030	16	23	)	)	PUNCT
admet-3030	16	24	and	and	CCONJ
admet-3030	16	25	alopecia	alopecia	NOUN
admet-3030	16	26	areata	areata	ADJ
admet-3030	16	27	(	(	PUNCT
admet-3030	16	28	aa	aa	NOUN
admet-3030	16	29	)	)	PUNCT
admet-3030	17	1	[	[	X
admet-3030	17	2	3	3	NUM
admet-3030	17	3	]	]	PUNCT
admet-3030	17	4	.	.	PUNCT
admet-3030	18	1	maleor	maleor	PROPN
admet-3030	18	2	female	female	ADJ
admet-3030	18	3	-	-	PUNCT
admet-3030	18	4	pattern	pattern	NOUN
admet-3030	18	5	baldness	baldness	NOUN
admet-3030	18	6	is	be	AUX
admet-3030	18	7	the	the	DET
admet-3030	18	8	most	most	ADV
admet-3030	18	9	prominent	prominent	ADJ
admet-3030	18	10	characteristic	characteristic	NOUN
admet-3030	18	11	of	of	ADP
admet-3030	18	12	aga	aga	NOUN
admet-3030	18	13	,	,	PUNCT
admet-3030	18	14	driven	drive	VERB
admet-3030	18	15	by	by	ADP
admet-3030	18	16	androgenic	androgenic	ADJ
admet-3030	18	17	effects	effect	NOUN
admet-3030	18	18	at	at	ADP
admet-3030	18	19	the	the	DET
admet-3030	18	20	genetic	genetic	ADJ
admet-3030	18	21	level	level	NOUN
admet-3030	18	22	,	,	PUNCT
admet-3030	18	23	in	in	ADP
admet-3030	18	24	which	which	PRON
admet-3030	18	25	the	the	DET
admet-3030	18	26	anagen	anagen	NOUN
admet-3030	18	27	phase	phase	NOUN
admet-3030	18	28	is	be	AUX
admet-3030	18	29	shortened	shorten	VERB
admet-3030	18	30	,	,	PUNCT
admet-3030	18	31	leading	lead	VERB
admet-3030	18	32	to	to	ADP
admet-3030	18	33	follicular	follicular	ADJ
admet-3030	18	34	shrinkage	shrinkage	NOUN
admet-3030	18	35	[	[	X
admet-3030	18	36	4	4	NUM
admet-3030	18	37	]	]	PUNCT
admet-3030	18	38	.	.	PUNCT
admet-3030	19	1	it	it	PRON
admet-3030	19	2	was	be	AUX
admet-3030	19	3	reported	report	VERB
admet-3030	19	4	from	from	ADP
admet-3030	19	5	various	various	ADJ
admet-3030	19	6	studies	study	NOUN
admet-3030	19	7	that	that	SCONJ
admet-3030	19	8	nearly	nearly	ADV
admet-3030	19	9	74.8	74.8	NUM
admet-3030	19	10	%	%	NOUN
admet-3030	19	11	of	of	ADP
admet-3030	19	12	men	man	NOUN
admet-3030	19	13	and	and	CCONJ
admet-3030	19	14	40	40	NUM
admet-3030	19	15	%	%	NOUN
admet-3030	19	16	of	of	ADP
admet-3030	19	17	women	woman	NOUN
admet-3030	19	18	will	will	AUX
admet-3030	19	19	experience	experience	VERB
admet-3030	19	20	this	this	DET
admet-3030	19	21	condition	condition	NOUN
admet-3030	19	22	in	in	ADP
admet-3030	19	23	their	their	PRON
admet-3030	19	24	lifetimes	lifetime	NOUN
admet-3030	19	25	.	.	PUNCT
admet-3030	20	1	unlike	unlike	ADP
admet-3030	20	2	aga	aga	PROPN
admet-3030	20	3	,	,	PUNCT
admet-3030	20	4	which	which	PRON
admet-3030	20	5	is	be	AUX
admet-3030	20	6	caused	cause	VERB
admet-3030	20	7	by	by	ADP
admet-3030	20	8	androgens	androgen	NOUN
admet-3030	20	9	,	,	PUNCT
admet-3030	20	10	alopecia	alopecia	NOUN
admet-3030	20	11	areata	areata	NOUN
admet-3030	20	12	is	be	AUX
admet-3030	20	13	an	an	DET
admet-3030	20	14	autoimmune	autoimmune	ADJ
admet-3030	20	15	condition	condition	NOUN
admet-3030	20	16	in	in	ADP
admet-3030	20	17	which	which	PRON
admet-3030	20	18	the	the	DET
admet-3030	20	19	immune	immune	ADJ
admet-3030	20	20	system	system	NOUN
admet-3030	20	21	attacks	attack	VERB
admet-3030	20	22	the	the	DET
admet-3030	20	23	hair	hair	NOUN
admet-3030	20	24	follicles	follicle	NOUN
admet-3030	20	25	,	,	PUNCT
admet-3030	20	26	causing	cause	VERB
admet-3030	20	27	patches	patch	NOUN
admet-3030	20	28	[	[	X
admet-3030	20	29	5	5	NUM
admet-3030	20	30	]	]	PUNCT
admet-3030	20	31	.	.	PUNCT
admet-3030	21	1	the	the	DET
admet-3030	21	2	exact	exact	ADJ
admet-3030	21	3	cause	cause	NOUN
admet-3030	21	4	of	of	ADP
admet-3030	21	5	aa	aa	NOUN
admet-3030	21	6	remains	remain	VERB
admet-3030	21	7	unclear	unclear	ADJ
admet-3030	21	8	;	;	PUNCT
admet-3030	21	9	however	however	ADV
admet-3030	21	10	,	,	PUNCT
admet-3030	21	11	environmental	environmental	ADJ
admet-3030	21	12	factors	factor	NOUN
admet-3030	21	13	,	,	PUNCT
admet-3030	21	14	along	along	ADP
admet-3030	21	15	with	with	ADP
admet-3030	21	16	weakened	weakened	ADJ
admet-3030	21	17	immunity	immunity	NOUN
admet-3030	21	18	,	,	PUNCT
admet-3030	21	19	contribute	contribute	VERB
admet-3030	21	20	to	to	ADP
admet-3030	21	21	hair	hair	NOUN
admet-3030	21	22	loss	loss	NOUN
admet-3030	21	23	.	.	PUNCT
admet-3030	22	1	aa	aa	NOUN
admet-3030	22	2	is	be	AUX
admet-3030	22	3	most	most	ADV
admet-3030	22	4	commonly	commonly	ADV
admet-3030	22	5	observed	observe	VERB
admet-3030	22	6	in	in	ADP
admet-3030	22	7	youngsters	youngster	NOUN
admet-3030	22	8	and	and	CCONJ
admet-3030	22	9	has	have	VERB
admet-3030	22	10	a	a	DET
admet-3030	22	11	significant	significant	ADJ
admet-3030	22	12	impact	impact	NOUN
admet-3030	22	13	on	on	ADP
admet-3030	22	14	their	their	PRON
admet-3030	22	15	physical	physical	ADJ
admet-3030	22	16	appearance	appearance	NOUN
admet-3030	22	17	,	,	PUNCT
admet-3030	22	18	a	a	DET
admet-3030	22	19	major	major	ADJ
admet-3030	22	20	factor	factor	NOUN
admet-3030	22	21	accounting	account	VERB
admet-3030	22	22	for	for	ADP
admet-3030	22	23	both	both	CCONJ
admet-3030	22	24	emotional	emotional	ADJ
admet-3030	22	25	distress	distress	NOUN
admet-3030	22	26	and	and	CCONJ
admet-3030	22	27	psychological	psychological	ADJ
admet-3030	22	28	problems	problem	NOUN
admet-3030	22	29	[	[	X
admet-3030	22	30	6	6	NUM
admet-3030	22	31	]	]	PUNCT
admet-3030	22	32	.	.	PUNCT
admet-3030	23	1	in	in	ADP
admet-3030	23	2	-	-	PUNCT
admet-3030	23	3	depth	depth	NOUN
admet-3030	23	4	research	research	NOUN
admet-3030	23	5	into	into	ADP
admet-3030	23	6	the	the	DET
admet-3030	23	7	genetic	genetic	ADJ
admet-3030	23	8	factors	factor	NOUN
admet-3030	23	9	underlying	underlie	VERB
admet-3030	23	10	non	non	ADJ
admet-3030	23	11	-	-	ADJ
admet-3030	23	12	scarring	scar	VERB
admet-3030	23	13	alopecia	alopecia	NOUN
admet-3030	23	14	will	will	AUX
admet-3030	23	15	help	help	VERB
admet-3030	23	16	tailor	tailor	VERB
admet-3030	23	17	targeted	target	VERB
admet-3030	23	18	therapies	therapy	NOUN
admet-3030	23	19	for	for	ADP
admet-3030	23	20	hair	hair	NOUN
admet-3030	23	21	regrowth	regrowth	NOUN
admet-3030	23	22	.	.	PUNCT
admet-3030	24	1	the	the	DET
admet-3030	24	2	literature	literature	NOUN
admet-3030	24	3	indicates	indicate	VERB
admet-3030	24	4	that	that	SCONJ
admet-3030	24	5	aa	aa	PROPN
admet-3030	24	6	is	be	AUX
admet-3030	24	7	caused	cause	VERB
admet-3030	24	8	by	by	ADP
admet-3030	24	9	deregulation	deregulation	NOUN
admet-3030	24	10	of	of	ADP
admet-3030	24	11	human	human	ADJ
admet-3030	24	12	leukocyte	leukocyte	NOUN
admet-3030	24	13	antigen	antigen	NOUN
admet-3030	24	14	(	(	PUNCT
admet-3030	24	15	hla	hla	NOUN
admet-3030	24	16	)	)	PUNCT
admet-3030	24	17	genes	gene	NOUN
admet-3030	24	18	,	,	PUNCT
admet-3030	24	19	changes	change	NOUN
admet-3030	24	20	in	in	ADP
admet-3030	24	21	cytokine	cytokine	ADJ
admet-3030	24	22	production	production	NOUN
admet-3030	24	23	,	,	PUNCT
admet-3030	24	24	or	or	CCONJ
admet-3030	24	25	t	t	NOUN
admet-3030	24	26	-	-	PUNCT
admet-3030	24	27	cell	cell	NOUN
admet-3030	24	28	activation	activation	NOUN
admet-3030	24	29	,	,	PUNCT
admet-3030	24	30	leading	lead	VERB
admet-3030	24	31	to	to	ADP
admet-3030	24	32	follicular	follicular	ADJ
admet-3030	24	33	damage	damage	NOUN
admet-3030	24	34	[	[	X
admet-3030	24	35	7	7	NUM
admet-3030	24	36	]	]	PUNCT
admet-3030	24	37	.	.	PUNCT
admet-3030	25	1	researchers	researcher	NOUN
admet-3030	25	2	are	be	AUX
admet-3030	25	3	focusing	focus	VERB
admet-3030	25	4	on	on	ADP
admet-3030	25	5	targeting	target	VERB
admet-3030	25	6	the	the	DET
admet-3030	25	7	janus	janus	PROPN
admet-3030	25	8	kinase	kinase	PROPN
admet-3030	25	9	pathways	pathway	NOUN
admet-3030	25	10	as	as	ADP
admet-3030	25	11	a	a	DET
admet-3030	25	12	tailored	tailor	VERB
admet-3030	25	13	solution	solution	NOUN
admet-3030	25	14	to	to	PART
admet-3030	25	15	treat	treat	VERB
admet-3030	25	16	individuals	individual	NOUN
admet-3030	25	17	with	with	ADP
admet-3030	25	18	aa	aa	NOUN
admet-3030	25	19	[	[	X
admet-3030	25	20	8	8	NUM
admet-3030	25	21	]	]	PUNCT
admet-3030	25	22	.	.	PUNCT
admet-3030	26	1	this	this	PRON
admet-3030	26	2	will	will	AUX
admet-3030	26	3	be	be	AUX
admet-3030	26	4	one	one	NUM
admet-3030	26	5	of	of	ADP
admet-3030	26	6	the	the	DET
admet-3030	26	7	safest	safe	ADJ
admet-3030	26	8	and	and	CCONJ
admet-3030	26	9	most	most	ADV
admet-3030	26	10	promising	promising	ADJ
admet-3030	26	11	approaches	approach	NOUN
admet-3030	26	12	to	to	ADP
admet-3030	26	13	using	use	VERB
admet-3030	26	14	corticosteroids	corticosteroid	NOUN
admet-3030	26	15	to	to	PART
admet-3030	26	16	promote	promote	VERB
admet-3030	26	17	hair	hair	NOUN
admet-3030	26	18	regrowth	regrowth	NOUN
admet-3030	26	19	.	.	PUNCT
admet-3030	27	1	genetic	genetic	ADJ
admet-3030	27	2	variations	variation	NOUN
admet-3030	27	3	in	in	ADP
admet-3030	27	4	androgen	androgen	NOUN
admet-3030	27	5	receptors	receptor	NOUN
admet-3030	27	6	have	have	AUX
admet-3030	27	7	led	lead	VERB
admet-3030	27	8	to	to	ADP
admet-3030	27	9	aga	aga	PROPN
admet-3030	27	10	.	.	PUNCT
admet-3030	28	1	these	these	DET
admet-3030	28	2	biomarkers	biomarker	NOUN
admet-3030	28	3	can	can	AUX
admet-3030	28	4	be	be	AUX
admet-3030	28	5	used	use	VERB
admet-3030	28	6	to	to	PART
admet-3030	28	7	diagnose	diagnose	VERB
admet-3030	28	8	and	and	CCONJ
admet-3030	28	9	treat	treat	VERB
admet-3030	28	10	aga	aga	PROPN
admet-3030	28	11	.	.	PUNCT
admet-3030	29	1	among	among	ADP
admet-3030	29	2	the	the	DET
admet-3030	29	3	available	available	ADJ
admet-3030	29	4	medications	medication	NOUN
admet-3030	29	5	,	,	PUNCT
admet-3030	29	6	finasteride	finasteride	ADV
admet-3030	29	7	is	be	AUX
admet-3030	29	8	the	the	DET
admet-3030	29	9	most	most	ADV
admet-3030	29	10	commonly	commonly	ADV
admet-3030	29	11	prescribed	prescribe	VERB
admet-3030	29	12	for	for	ADP
admet-3030	29	13	aga	aga	NOUN
admet-3030	29	14	[	[	X
admet-3030	29	15	9	9	NUM
admet-3030	29	16	]	]	PUNCT
admet-3030	29	17	.	.	PUNCT
admet-3030	30	1	even	even	ADV
admet-3030	30	2	though	though	SCONJ
admet-3030	30	3	various	various	ADJ
admet-3030	30	4	genetic	genetic	ADJ
admet-3030	30	5	factors	factor	NOUN
admet-3030	30	6	contribute	contribute	VERB
admet-3030	30	7	to	to	ADP
admet-3030	30	8	hair	hair	NOUN
admet-3030	30	9	loss	loss	NOUN
admet-3030	30	10	,	,	PUNCT
admet-3030	30	11	it	it	PRON
admet-3030	30	12	is	be	AUX
admet-3030	30	13	attributed	attribute	VERB
admet-3030	30	14	to	to	ADP
admet-3030	30	15	the	the	DET
admet-3030	30	16	combined	combine	VERB
admet-3030	30	17	effects	effect	NOUN
admet-3030	30	18	of	of	ADP
admet-3030	30	19	medications	medication	NOUN
admet-3030	30	20	,	,	PUNCT
admet-3030	30	21	nutrition	nutrition	NOUN
admet-3030	30	22	,	,	PUNCT
admet-3030	30	23	and	and	CCONJ
admet-3030	30	24	environmental	environmental	ADJ
admet-3030	30	25	factors	factor	NOUN
admet-3030	30	26	.	.	PUNCT
admet-3030	31	1	some	some	DET
admet-3030	31	2	molecular	molecular	ADJ
admet-3030	31	3	signalling	signal	VERB
admet-3030	31	4	pathways	pathway	NOUN
admet-3030	31	5	that	that	PRON
admet-3030	31	6	can	can	AUX
admet-3030	31	7	be	be	AUX
admet-3030	31	8	targeted	target	VERB
admet-3030	31	9	for	for	ADP
admet-3030	31	10	hair	hair	NOUN
admet-3030	31	11	growth	growth	NOUN
admet-3030	31	12	include	include	VERB
admet-3030	31	13	wnt	wnt	NOUN
admet-3030	31	14	signalling	signal	VERB
admet-3030	31	15	pathway	pathway	NOUN
admet-3030	31	16	factors	factor	NOUN
admet-3030	31	17	,	,	PUNCT
admet-3030	31	18	hair	hair	NOUN
admet-3030	31	19	follicle	follicle	NOUN
admet-3030	31	20	stem	stem	NOUN
admet-3030	31	21	cell	cell	NOUN
admet-3030	31	22	regulation	regulation	NOUN
admet-3030	31	23	pathways	pathway	NOUN
admet-3030	31	24	,	,	PUNCT
admet-3030	31	25	etc	etc	X
admet-3030	31	26	.	.	X
admet-3030	32	1	[	[	X
admet-3030	32	2	10	10	NUM
admet-3030	32	3	]	]	PUNCT
admet-3030	32	4	.	.	PUNCT
admet-3030	33	1	technological	technological	ADJ
admet-3030	33	2	advances	advance	NOUN
admet-3030	33	3	,	,	PUNCT
admet-3030	33	4	such	such	ADJ
admet-3030	33	5	as	as	ADP
admet-3030	33	6	genetic	genetic	ADJ
admet-3030	33	7	screening	screening	NOUN
admet-3030	33	8	,	,	PUNCT
admet-3030	33	9	the	the	DET
admet-3030	33	10	integration	integration	NOUN
admet-3030	33	11	of	of	ADP
admet-3030	33	12	artificial	artificial	ADJ
admet-3030	33	13	intelligence	intelligence	NOUN
admet-3030	33	14	(	(	PUNCT
admet-3030	33	15	ai	ai	NOUN
admet-3030	33	16	)	)	PUNCT
admet-3030	33	17	,	,	PUNCT
admet-3030	33	18	and	and	CCONJ
admet-3030	33	19	precision	precision	NOUN
admet-3030	33	20	medicine	medicine	NOUN
admet-3030	33	21	,	,	PUNCT
admet-3030	33	22	will	will	AUX
admet-3030	33	23	enable	enable	VERB
admet-3030	33	24	individualized	individualized	ADJ
admet-3030	33	25	treatment	treatment	NOUN
admet-3030	33	26	for	for	ADP
admet-3030	33	27	the	the	DET
admet-3030	33	28	management	management	NOUN
admet-3030	33	29	of	of	ADP
admet-3030	33	30	non	non	ADJ
admet-3030	33	31	-	-	ADJ
admet-3030	33	32	scarring	scar	VERB
admet-3030	33	33	alopecia	alopecia	NOUN
admet-3030	33	34	[	[	X
admet-3030	33	35	11	11	NUM
admet-3030	33	36	]	]	PUNCT
admet-3030	33	37	.	.	PUNCT
admet-3030	34	1	the	the	DET
admet-3030	34	2	present	present	ADJ
admet-3030	34	3	study	study	NOUN
admet-3030	34	4	explores	explore	NOUN
admet-3030	34	5	in	in	ADP
admet-3030	34	6	detail	detail	NOUN
admet-3030	34	7	the	the	DET
admet-3030	34	8	understanding	understand	VERB
admet-3030	34	9	mechanisms	mechanism	NOUN
admet-3030	34	10	of	of	ADP
admet-3030	34	11	various	various	ADJ
admet-3030	34	12	genetic	genetic	ADJ
admet-3030	34	13	markers	marker	NOUN
admet-3030	34	14	,	,	PUNCT
admet-3030	34	15	associated	associated	ADJ
admet-3030	34	16	pathways	pathway	NOUN
admet-3030	34	17	,	,	PUNCT
admet-3030	34	18	psychological	psychological	ADJ
admet-3030	34	19	impact	impact	NOUN
admet-3030	34	20	,	,	PUNCT
admet-3030	34	21	and	and	CCONJ
admet-3030	34	22	tailored	tailor	VERB
admet-3030	34	23	therapies	therapy	NOUN
admet-3030	34	24	for	for	ADP
admet-3030	34	25	curing	cure	VERB
admet-3030	34	26	non	non	ADJ
admet-3030	34	27	-	-	ADJ
admet-3030	34	28	scarring	scarring	ADJ
admet-3030	34	29	androgenic	androgenic	ADJ
admet-3030	34	30	alopecia	alopecia	NOUN
admet-3030	34	31	.	.	PUNCT
admet-3030	35	1	genetic	genetic	ADJ
admet-3030	35	2	basis	basis	NOUN
admet-3030	35	3	for	for	ADP
admet-3030	35	4	the	the	DET
admet-3030	35	5	non	non	ADJ
admet-3030	35	6	-	-	ADJ
admet-3030	35	7	scarring	scar	VERB
admet-3030	35	8	alopecia	alopecia	NOUN
admet-3030	35	9	search	search	NOUN
admet-3030	35	10	strategy	strategy	NOUN
admet-3030	35	11	articles	article	NOUN
admet-3030	35	12	related	relate	VERB
admet-3030	35	13	to	to	ADP
admet-3030	35	14	non	non	ADJ
admet-3030	35	15	-	-	ADJ
admet-3030	35	16	scarring	scarring	ADJ
admet-3030	35	17	alopecia	alopecia	NOUN
admet-3030	35	18	,	,	PUNCT
admet-3030	35	19	genetic	genetic	ADJ
admet-3030	35	20	and	and	CCONJ
admet-3030	35	21	molecular	molecular	ADJ
admet-3030	35	22	pathways	pathway	NOUN
admet-3030	35	23	,	,	PUNCT
admet-3030	35	24	and	and	CCONJ
admet-3030	35	25	associated	associated	ADJ
admet-3030	35	26	treatment	treatment	NOUN
admet-3030	35	27	papers	paper	NOUN
admet-3030	35	28	are	be	AUX
admet-3030	35	29	retrieved	retrieve	VERB
admet-3030	35	30	from	from	ADP
admet-3030	35	31	databases	database	NOUN
admet-3030	35	32	such	such	ADJ
admet-3030	35	33	as	as	ADP
admet-3030	35	34	pubmed	pubmed	PROPN
admet-3030	35	35	,	,	PUNCT
admet-3030	35	36	web	web	NOUN
admet-3030	35	37	of	of	ADP
admet-3030	35	38	science	science	NOUN
admet-3030	35	39	,	,	PUNCT
admet-3030	35	40	and	and	CCONJ
admet-3030	35	41	google	google	PROPN
admet-3030	35	42	scholar	scholar	NOUN
admet-3030	35	43	.	.	PUNCT
admet-3030	36	1	the	the	DET
admet-3030	36	2	keywords	keyword	NOUN
admet-3030	36	3	used	use	VERB
admet-3030	36	4	for	for	ADP
admet-3030	36	5	the	the	DET
admet-3030	36	6	identification	identification	NOUN
admet-3030	36	7	of	of	ADP
admet-3030	36	8	the	the	DET
admet-3030	36	9	relevant	relevant	ADJ
admet-3030	36	10	papers	paper	NOUN
admet-3030	36	11	are	be	AUX
admet-3030	36	12	“	"	PUNCT
admet-3030	36	13	alopecia	alopecia	NOUN
admet-3030	36	14	”	"	PUNCT
admet-3030	36	15	,	,	PUNCT
admet-3030	36	16	“	"	PUNCT
admet-3030	36	17	hair	hair	NOUN
admet-3030	36	18	loss	loss	NOUN
admet-3030	36	19	”	"	PUNCT
admet-3030	36	20	,	,	PUNCT
admet-3030	36	21	“	"	PUNCT
admet-3030	36	22	hair	hair	NOUN
admet-3030	36	23	regrowth	regrowth	NOUN
admet-3030	36	24	”	"	PUNCT
admet-3030	36	25	,	,	PUNCT
admet-3030	36	26	“	"	PUNCT
admet-3030	36	27	tailored	tailor	VERB
admet-3030	36	28	treatments	treatment	NOUN
admet-3030	36	29	”	"	PUNCT
admet-3030	36	30	,	,	PUNCT
admet-3030	36	31	“	"	PUNCT
admet-3030	36	32	technology	technology	NOUN
admet-3030	36	33	”	"	PUNCT
admet-3030	36	34	,	,	PUNCT
admet-3030	36	35	“	"	PUNCT
admet-3030	36	36	traditional	traditional	ADJ
admet-3030	36	37	methods	method	NOUN
admet-3030	36	38	”	"	PUNCT
admet-3030	36	39	,	,	PUNCT
admet-3030	36	40	“	"	PUNCT
admet-3030	36	41	genetic	genetic	ADJ
admet-3030	36	42	markers	marker	NOUN
admet-3030	36	43	”	"	PUNCT
admet-3030	36	44	,	,	PUNCT
admet-3030	36	45	“	"	PUNCT
admet-3030	36	46	molecular	molecular	ADJ
admet-3030	36	47	pathway	pathway	NOUN
admet-3030	36	48	signalling	signal	VERB
admet-3030	36	49	”	"	PUNCT
admet-3030	36	50	and	and	CCONJ
admet-3030	36	51	“	"	PUNCT
admet-3030	36	52	herbal	herbal	ADJ
admet-3030	36	53	therapies	therapy	NOUN
admet-3030	36	54	”	"	PUNCT
admet-3030	36	55	.	.	PUNCT
admet-3030	37	1	to	to	PART
admet-3030	37	2	understand	understand	VERB
admet-3030	37	3	molecular	molecular	ADJ
admet-3030	37	4	data	datum	NOUN
admet-3030	37	5	analysis	analysis	NOUN
admet-3030	37	6	,	,	PUNCT
admet-3030	37	7	some	some	DET
admet-3030	37	8	studies	study	NOUN
admet-3030	37	9	on	on	ADP
admet-3030	37	10	microarrays	microarray	NOUN
admet-3030	37	11	and	and	CCONJ
admet-3030	37	12	gene	gene	NOUN
admet-3030	37	13	expression	expression	NOUN
admet-3030	37	14	profiling	profiling	NOUN
admet-3030	37	15	in	in	ADP
admet-3030	37	16	non	non	ADJ
admet-3030	37	17	-	-	ADJ
admet-3030	37	18	scarring	scar	VERB
admet-3030	37	19	alopecia	alopecia	NOUN
admet-3030	37	20	were	be	AUX
admet-3030	37	21	also	also	ADV
admet-3030	37	22	utilised	utilise	VERB
admet-3030	37	23	.	.	PUNCT
admet-3030	38	1	inclusion	inclusion	NOUN
admet-3030	38	2	and	and	CCONJ
admet-3030	38	3	exclusion	exclusion	NOUN
admet-3030	38	4	criteria	criterion	NOUN
admet-3030	38	5	studies	study	NOUN
admet-3030	38	6	on	on	ADP
admet-3030	38	7	alopecia	alopecia	NOUN
admet-3030	38	8	,	,	PUNCT
admet-3030	38	9	specifically	specifically	ADV
admet-3030	38	10	non	non	ADJ
admet-3030	38	11	-	-	ADJ
admet-3030	38	12	scarring	scarring	ADJ
admet-3030	38	13	alopecia	alopecia	NOUN
admet-3030	38	14	,	,	PUNCT
admet-3030	38	15	are	be	AUX
admet-3030	38	16	considered	consider	VERB
admet-3030	38	17	.	.	PUNCT
admet-3030	39	1	there	there	PRON
admet-3030	39	2	are	be	VERB
admet-3030	39	3	a	a	DET
admet-3030	39	4	few	few	ADJ
admet-3030	39	5	studies	study	NOUN
admet-3030	39	6	related	relate	VERB
admet-3030	39	7	to	to	ADP
admet-3030	39	8	randomised	randomise	VERB
admet-3030	39	9	controlled	control	VERB
admet-3030	39	10	trials	trial	NOUN
admet-3030	39	11	,	,	PUNCT
admet-3030	39	12	case	case	NOUN
admet-3030	39	13	studies	study	NOUN
admet-3030	39	14	,	,	PUNCT
admet-3030	39	15	and	and	CCONJ
admet-3030	39	16	quantitative	quantitative	ADJ
admet-3030	39	17	studies	study	NOUN
admet-3030	39	18	.	.	PUNCT
admet-3030	40	1	the	the	DET
admet-3030	40	2	articles	article	NOUN
admet-3030	40	3	that	that	PRON
admet-3030	40	4	are	be	AUX
admet-3030	40	5	full	full	ADJ
admet-3030	40	6	-	-	PUNCT
admet-3030	40	7	length	length	NOUN
admet-3030	40	8	and	and	CCONJ
admet-3030	40	9	freely	freely	ADV
admet-3030	40	10	available	available	ADJ
admet-3030	40	11	in	in	ADP
admet-3030	40	12	the	the	DET
admet-3030	40	13	above	above	ADJ
admet-3030	40	14	database	database	NOUN
admet-3030	40	15	were	be	AUX
admet-3030	40	16	chosen	choose	VERB
admet-3030	40	17	for	for	ADP
admet-3030	40	18	this	this	DET
admet-3030	40	19	study	study	NOUN
admet-3030	40	20	.	.	PUNCT
admet-3030	41	1	articles	article	NOUN
admet-3030	41	2	from	from	ADP
admet-3030	41	3	the	the	DET
admet-3030	41	4	past	past	ADJ
admet-3030	41	5	10	10	NUM
admet-3030	41	6	years	year	NOUN
admet-3030	41	7	were	be	AUX
admet-3030	41	8	collected	collect	VERB
admet-3030	41	9	,	,	PUNCT
admet-3030	41	10	and	and	CCONJ
admet-3030	41	11	further	further	ADJ
admet-3030	41	12	analysis	analysis	NOUN
admet-3030	41	13	was	be	AUX
admet-3030	41	14	conducted	conduct	VERB
admet-3030	41	15	.	.	PUNCT
admet-3030	42	1	studies	study	NOUN
admet-3030	42	2	older	old	ADJ
admet-3030	42	3	than	than	ADP
admet-3030	42	4	10	10	NUM
admet-3030	42	5	years	year	NOUN
admet-3030	42	6	were	be	AUX
admet-3030	42	7	excluded	exclude	VERB
admet-3030	42	8	.	.	PUNCT
admet-3030	43	1	studies	study	NOUN
admet-3030	43	2	of	of	ADP
admet-3030	43	3	hair	hair	NOUN
admet-3030	43	4	loss	loss	NOUN
admet-3030	43	5	without	without	ADP
admet-3030	43	6	significant	significant	ADJ
admet-3030	43	7	details	detail	NOUN
admet-3030	43	8	on	on	ADP
admet-3030	43	9	non	non	ADJ
admet-3030	43	10	-	-	ADJ
admet-3030	43	11	scarring	scar	VERB
admet-3030	43	12	alopecia	alopecia	NOUN
admet-3030	43	13	were	be	AUX
admet-3030	43	14	excluded	exclude	VERB
admet-3030	43	15	.	.	PUNCT
admet-3030	44	1	studies	study	NOUN
admet-3030	44	2	on	on	ADP
admet-3030	44	3	hair	hair	NOUN
admet-3030	44	4	regrowth	regrowth	NOUN
admet-3030	44	5	supplements	supplement	NOUN
admet-3030	44	6	are	be	AUX
admet-3030	44	7	also	also	ADV
admet-3030	44	8	excluded	exclude	VERB
admet-3030	44	9	.	.	PUNCT
admet-3030	45	1	in	in	ADP
admet-3030	45	2	the	the	DET
admet-3030	45	3	past	past	NOUN
admet-3030	45	4	,	,	PUNCT
admet-3030	45	5	genetic	genetic	ADJ
admet-3030	45	6	analysis	analysis	NOUN
admet-3030	45	7	has	have	AUX
admet-3030	45	8	enabled	enable	VERB
admet-3030	45	9	detailed	detailed	ADJ
admet-3030	45	10	study	study	NOUN
admet-3030	45	11	of	of	ADP
admet-3030	45	12	disease	disease	NOUN
admet-3030	45	13	pathophysiology	pathophysiology	NOUN
admet-3030	45	14	and	and	CCONJ
admet-3030	45	15	helped	help	VERB
admet-3030	45	16	admet	admet	PROPN
admet-3030	45	17	&	&	CCONJ
admet-3030	45	18	dmpk	dmpk	PROPN
admet-3030	45	19	00(0	00(0	PROPN
admet-3030	45	20	)	)	PUNCT
admet-3030	45	21	(	(	PUNCT
admet-3030	45	22	2025	2025	NUM
admet-3030	45	23	)	)	PUNCT
admet-3030	45	24	3030	3030	NUM
admet-3030	45	25	precision	precision	NOUN
admet-3030	45	26	therapeutics	therapeutic	NOUN
admet-3030	45	27	in	in	ADP
admet-3030	45	28	non	non	ADJ
admet-3030	45	29	-	-	ADJ
admet-3030	45	30	scarring	scar	VERB
admet-3030	45	31	alopecia	alopecia	NOUN
admet-3030	45	32	doi	doi	NOUN
admet-3030	45	33	:	:	PUNCT
admet-3030	45	34	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	45	35	3	3	NUM
admet-3030	45	36	tailor	tailor	NOUN
admet-3030	45	37	personalised	personalise	VERB
admet-3030	45	38	treatments	treatment	NOUN
admet-3030	45	39	.	.	PUNCT
admet-3030	46	1	as	as	SCONJ
admet-3030	46	2	the	the	DET
admet-3030	46	3	literature	literature	NOUN
admet-3030	46	4	indicates	indicate	VERB
admet-3030	46	5	that	that	SCONJ
admet-3030	46	6	aa	aa	PROPN
admet-3030	46	7	and	and	CCONJ
admet-3030	46	8	aga	aga	NOUN
admet-3030	46	9	are	be	AUX
admet-3030	46	10	inherited	inherit	VERB
admet-3030	46	11	hair	hair	NOUN
admet-3030	46	12	disorders	disorder	NOUN
admet-3030	47	1	,	,	PUNCT
admet-3030	47	2	genetic	genetic	ADJ
admet-3030	47	3	analysis	analysis	NOUN
admet-3030	47	4	will	will	AUX
admet-3030	47	5	help	help	VERB
admet-3030	47	6	prevent	prevent	VERB
admet-3030	47	7	hair	hair	NOUN
admet-3030	47	8	loss	loss	NOUN
admet-3030	47	9	.	.	PUNCT
admet-3030	48	1	technological	technological	ADJ
admet-3030	48	2	advancements	advancement	NOUN
admet-3030	48	3	have	have	AUX
admet-3030	48	4	provided	provide	VERB
admet-3030	48	5	evidence	evidence	NOUN
admet-3030	48	6	of	of	ADP
admet-3030	48	7	the	the	DET
admet-3030	48	8	genetic	genetic	ADJ
admet-3030	48	9	variants	variant	NOUN
admet-3030	48	10	and	and	CCONJ
admet-3030	48	11	their	their	PRON
admet-3030	48	12	loci	locus	NOUN
admet-3030	48	13	that	that	PRON
admet-3030	48	14	influence	influence	VERB
admet-3030	48	15	the	the	DET
admet-3030	48	16	type	type	NOUN
admet-3030	48	17	of	of	ADP
admet-3030	48	18	alopecia	alopecia	NOUN
admet-3030	48	19	[	[	X
admet-3030	48	20	12	12	NUM
admet-3030	48	21	]	]	PUNCT
admet-3030	48	22	.	.	PUNCT
admet-3030	49	1	single	single	ADJ
admet-3030	49	2	-	-	PUNCT
admet-3030	49	3	gene	gene	NOUN
admet-3030	49	4	-	-	PUNCT
admet-3030	49	5	related	relate	VERB
admet-3030	49	6	alopecia	alopecia	NOUN
admet-3030	49	7	is	be	AUX
admet-3030	49	8	known	know	VERB
admet-3030	49	9	as	as	ADP
admet-3030	49	10	monogenic	monogenic	ADJ
admet-3030	49	11	,	,	PUNCT
admet-3030	49	12	whereas	whereas	SCONJ
admet-3030	49	13	multiple	multiple	ADJ
admet-3030	49	14	-	-	PUNCT
admet-3030	49	15	generelated	generelate	VERB
admet-3030	49	16	alopecia	alopecia	NOUN
admet-3030	49	17	is	be	AUX
admet-3030	49	18	known	know	VERB
admet-3030	49	19	as	as	ADP
admet-3030	49	20	polygenic	polygenic	ADJ
admet-3030	49	21	[	[	X
admet-3030	49	22	13	13	NUM
admet-3030	49	23	]	]	PUNCT
admet-3030	49	24	.	.	PUNCT
admet-3030	50	1	alopecia	alopecia	NOUN
admet-3030	50	2	is	be	AUX
admet-3030	50	3	a	a	DET
admet-3030	50	4	complex	complex	ADJ
admet-3030	50	5	hair	hair	NOUN
admet-3030	50	6	disorder	disorder	NOUN
admet-3030	50	7	that	that	PRON
admet-3030	50	8	can	can	AUX
admet-3030	50	9	be	be	AUX
admet-3030	50	10	triggered	trigger	VERB
admet-3030	50	11	by	by	ADP
admet-3030	50	12	environmental	environmental	ADJ
admet-3030	50	13	factors	factor	NOUN
admet-3030	50	14	in	in	ADP
admet-3030	50	15	addition	addition	NOUN
admet-3030	50	16	to	to	ADP
admet-3030	50	17	genetic	genetic	ADJ
admet-3030	50	18	predisposition	predisposition	NOUN
admet-3030	50	19	[	[	X
admet-3030	50	20	14	14	NUM
admet-3030	50	21	]	]	PUNCT
admet-3030	50	22	.	.	PUNCT
admet-3030	51	1	this	this	PRON
admet-3030	51	2	,	,	PUNCT
admet-3030	51	3	in	in	ADP
admet-3030	51	4	turn	turn	NOUN
admet-3030	51	5	,	,	PUNCT
admet-3030	51	6	will	will	AUX
admet-3030	51	7	affect	affect	VERB
admet-3030	51	8	hair	hair	NOUN
admet-3030	51	9	follicle	follicle	NOUN
admet-3030	51	10	cycling	cycling	NOUN
admet-3030	51	11	,	,	PUNCT
admet-3030	51	12	the	the	DET
admet-3030	51	13	autoimmune	autoimmune	ADJ
admet-3030	51	14	response	response	NOUN
admet-3030	51	15	,	,	PUNCT
admet-3030	51	16	and	and	CCONJ
admet-3030	51	17	hormonal	hormonal	ADJ
admet-3030	51	18	dysregulation	dysregulation	NOUN
admet-3030	51	19	,	,	PUNCT
admet-3030	51	20	thereby	thereby	ADV
admet-3030	51	21	impacting	impact	VERB
admet-3030	51	22	individuals	individual	NOUN
admet-3030	51	23	'	'	PART
admet-3030	51	24	psychological	psychological	ADJ
admet-3030	51	25	health	health	NOUN
admet-3030	51	26	.	.	PUNCT
admet-3030	52	1	some	some	PRON
admet-3030	52	2	of	of	ADP
admet-3030	52	3	the	the	DET
admet-3030	52	4	crucial	crucial	ADJ
admet-3030	52	5	techniques	technique	NOUN
admet-3030	52	6	that	that	PRON
admet-3030	52	7	have	have	AUX
admet-3030	52	8	become	become	VERB
admet-3030	52	9	popular	popular	ADJ
admet-3030	52	10	in	in	ADP
admet-3030	52	11	recent	recent	ADJ
admet-3030	52	12	times	time	NOUN
admet-3030	52	13	include	include	VERB
admet-3030	52	14	genome	genome	NOUN
admet-3030	52	15	wide	wide	ADJ
admet-3030	52	16	association	association	NOUN
admet-3030	52	17	studies	study	NOUN
admet-3030	52	18	(	(	PUNCT
admet-3030	52	19	gwas	gwas	PROPN
admet-3030	52	20	)	)	PUNCT
admet-3030	52	21	and	and	CCONJ
admet-3030	52	22	next	next	ADJ
admet-3030	52	23	-	-	PUNCT
admet-3030	52	24	generation	generation	NOUN
admet-3030	52	25	sequencing	sequencing	NOUN
admet-3030	52	26	(	(	PUNCT
admet-3030	52	27	ngs	ng	NOUN
admet-3030	52	28	)	)	PUNCT
admet-3030	52	29	to	to	PART
admet-3030	52	30	uncover	uncover	VERB
admet-3030	52	31	the	the	DET
admet-3030	52	32	causes	cause	NOUN
admet-3030	52	33	of	of	ADP
admet-3030	52	34	different	different	ADJ
admet-3030	52	35	types	type	NOUN
admet-3030	52	36	of	of	ADP
admet-3030	52	37	nonscarring	nonscarre	VERB
admet-3030	52	38	alopecia	alopecia	NOUN
admet-3030	52	39	[	[	X
admet-3030	52	40	15	15	NUM
admet-3030	52	41	]	]	PUNCT
admet-3030	52	42	.	.	PUNCT
admet-3030	53	1	various	various	ADJ
admet-3030	53	2	researchers	researcher	NOUN
admet-3030	53	3	are	be	AUX
admet-3030	53	4	working	work	VERB
admet-3030	53	5	on	on	ADP
admet-3030	53	6	different	different	ADJ
admet-3030	53	7	aspects	aspect	NOUN
admet-3030	53	8	related	relate	VERB
admet-3030	53	9	to	to	ADP
admet-3030	53	10	immune	immune	ADJ
admet-3030	53	11	changes	change	NOUN
admet-3030	53	12	,	,	PUNCT
admet-3030	53	13	environmental	environmental	ADJ
admet-3030	53	14	impact	impact	NOUN
admet-3030	53	15	,	,	PUNCT
admet-3030	53	16	pre	pre	ADJ
admet-3030	53	17	-	-	ADJ
admet-3030	53	18	existing	existing	ADJ
admet-3030	53	19	disorders	disorder	NOUN
admet-3030	53	20	,	,	PUNCT
admet-3030	53	21	genetic	genetic	ADJ
admet-3030	53	22	analysis	analysis	NOUN
admet-3030	53	23	(	(	PUNCT
admet-3030	53	24	figure	figure	NOUN
admet-3030	53	25	1	1	NUM
admet-3030	53	26	)	)	PUNCT
admet-3030	53	27	,	,	PUNCT
admet-3030	53	28	and	and	CCONJ
admet-3030	53	29	technology	technology	NOUN
admet-3030	53	30	integration	integration	NOUN
admet-3030	53	31	to	to	PART
admet-3030	53	32	identify	identify	VERB
admet-3030	53	33	potential	potential	ADJ
admet-3030	53	34	targets	target	NOUN
admet-3030	53	35	for	for	ADP
admet-3030	53	36	diagnosing	diagnose	VERB
admet-3030	53	37	and	and	CCONJ
admet-3030	53	38	treating	treat	VERB
admet-3030	53	39	non	non	ADJ
admet-3030	53	40	-	-	ADJ
admet-3030	53	41	scarring	scarring	ADJ
admet-3030	53	42	alopecia	alopecia	NOUN
admet-3030	53	43	.	.	PUNCT
admet-3030	54	1	figure	figure	NOUN
admet-3030	54	2	1	1	NUM
admet-3030	54	3	.	.	PUNCT
admet-3030	55	1	causes	cause	NOUN
admet-3030	55	2	of	of	ADP
admet-3030	55	3	alopecia	alopecia	NOUN
admet-3030	55	4	environmental	environmental	ADJ
admet-3030	55	5	and	and	CCONJ
admet-3030	55	6	psychological	psychological	ADJ
admet-3030	55	7	factors	factor	NOUN
admet-3030	55	8	in	in	ADP
admet-3030	55	9	alopecia	alopecia	NOUN
admet-3030	55	10	areata	areata	VERB
admet-3030	55	11	the	the	DET
admet-3030	55	12	most	most	ADV
admet-3030	55	13	common	common	ADJ
admet-3030	55	14	environmental	environmental	ADJ
admet-3030	55	15	factors	factor	NOUN
admet-3030	55	16	that	that	PRON
admet-3030	55	17	trigger	trigger	NOUN
admet-3030	55	18	aga	aga	NOUN
admet-3030	55	19	,	,	PUNCT
admet-3030	55	20	in	in	ADP
admet-3030	55	21	addition	addition	NOUN
admet-3030	55	22	to	to	ADP
admet-3030	55	23	genetic	genetic	ADJ
admet-3030	55	24	changes	change	NOUN
admet-3030	55	25	,	,	PUNCT
admet-3030	55	26	include	include	VERB
admet-3030	55	27	hormonal	hormonal	ADJ
admet-3030	55	28	changes	change	NOUN
admet-3030	55	29	,	,	PUNCT
admet-3030	55	30	pollution	pollution	NOUN
admet-3030	55	31	,	,	PUNCT
admet-3030	55	32	oxidative	oxidative	ADJ
admet-3030	55	33	stress	stress	NOUN
admet-3030	55	34	,	,	PUNCT
admet-3030	55	35	nutritional	nutritional	ADJ
admet-3030	55	36	deficiencies	deficiency	NOUN
admet-3030	55	37	,	,	PUNCT
admet-3030	55	38	sleep	sleep	NOUN
admet-3030	55	39	disturbances	disturbance	NOUN
admet-3030	55	40	,	,	PUNCT
admet-3030	55	41	psychological	psychological	ADJ
admet-3030	55	42	distress	distress	NOUN
admet-3030	55	43	,	,	PUNCT
admet-3030	55	44	smoking	smoking	NOUN
admet-3030	55	45	,	,	PUNCT
admet-3030	55	46	alcohol	alcohol	NOUN
admet-3030	55	47	,	,	PUNCT
admet-3030	55	48	and	and	CCONJ
admet-3030	55	49	exposure	exposure	NOUN
admet-3030	55	50	to	to	ADP
admet-3030	55	51	uv	uv	NOUN
admet-3030	55	52	radiation	radiation	NOUN
admet-3030	55	53	(	(	PUNCT
admet-3030	55	54	figure	figure	NOUN
admet-3030	55	55	2	2	NUM
admet-3030	55	56	)	)	PUNCT
admet-3030	56	1	[	[	X
admet-3030	56	2	16	16	NUM
admet-3030	56	3	]	]	PUNCT
admet-3030	56	4	.	.	PUNCT
admet-3030	57	1	endocrine	endocrine	NOUN
admet-3030	57	2	-	-	PUNCT
admet-3030	57	3	disrupting	disrupt	VERB
admet-3030	57	4	chemicals	chemical	NOUN
admet-3030	57	5	,	,	PUNCT
admet-3030	57	6	such	such	ADJ
admet-3030	57	7	as	as	ADP
admet-3030	57	8	phthalates	phthalate	NOUN
admet-3030	57	9	and	and	CCONJ
admet-3030	57	10	pesticides	pesticide	NOUN
admet-3030	57	11	,	,	PUNCT
admet-3030	57	12	mimic	mimic	ADJ
admet-3030	57	13	androgenic	androgenic	ADJ
admet-3030	57	14	pathways	pathway	NOUN
admet-3030	57	15	,	,	PUNCT
admet-3030	57	16	increasing	increase	VERB
admet-3030	57	17	dihydrotestosterone	dihydrotestosterone	NOUN
admet-3030	57	18	(	(	PUNCT
admet-3030	57	19	dht	dht	NOUN
admet-3030	57	20	)	)	PUNCT
admet-3030	57	21	sensitivity	sensitivity	NOUN
admet-3030	57	22	,	,	PUNCT
admet-3030	57	23	thereby	thereby	ADV
admet-3030	57	24	causing	cause	VERB
admet-3030	57	25	follicular	follicular	ADJ
admet-3030	57	26	miniaturization	miniaturization	NOUN
admet-3030	57	27	,	,	PUNCT
admet-3030	57	28	weak	weak	ADJ
admet-3030	57	29	,	,	PUNCT
admet-3030	57	30	thin	thin	ADJ
admet-3030	57	31	hair	hair	NOUN
admet-3030	57	32	,	,	PUNCT
admet-3030	57	33	and	and	CCONJ
admet-3030	57	34	patterned	pattern	VERB
admet-3030	57	35	baldness	baldness	NOUN
admet-3030	57	36	[	[	X
admet-3030	57	37	17	17	NUM
admet-3030	57	38	]	]	PUNCT
admet-3030	57	39	.	.	PUNCT
admet-3030	58	1	one	one	NUM
admet-3030	58	2	of	of	ADP
admet-3030	58	3	the	the	DET
admet-3030	58	4	most	most	ADV
admet-3030	58	5	commonly	commonly	ADV
admet-3030	58	6	recommended	recommend	VERB
admet-3030	58	7	aga	aga	NOUN
admet-3030	58	8	treatments	treatment	NOUN
admet-3030	58	9	is	be	AUX
admet-3030	58	10	finasteride	finasteride	ADJ
admet-3030	58	11	or	or	CCONJ
admet-3030	58	12	dutasteride	dutasteride	NOUN
admet-3030	58	13	[	[	X
admet-3030	58	14	18	18	NUM
admet-3030	58	15	]	]	PUNCT
admet-3030	58	16	.	.	PUNCT
admet-3030	59	1	smoking	smoking	NOUN
admet-3030	59	2	and	and	CCONJ
admet-3030	59	3	air	air	NOUN
admet-3030	59	4	pollutants	pollutant	NOUN
admet-3030	59	5	generate	generate	VERB
admet-3030	59	6	reactive	reactive	ADJ
admet-3030	59	7	oxygen	oxygen	NOUN
admet-3030	59	8	species	specie	NOUN
admet-3030	59	9	(	(	PUNCT
admet-3030	59	10	ros	ros	PROPN
admet-3030	59	11	)	)	PUNCT
admet-3030	59	12	in	in	ADP
admet-3030	59	13	the	the	DET
admet-3030	59	14	hair	hair	NOUN
admet-3030	59	15	follicles	follicle	NOUN
admet-3030	59	16	and	and	CCONJ
admet-3030	59	17	account	account	VERB
admet-3030	59	18	for	for	ADP
admet-3030	59	19	their	their	PRON
admet-3030	59	20	damage	damage	NOUN
admet-3030	59	21	.	.	PUNCT
admet-3030	60	1	high	high	ADJ
admet-3030	60	2	-	-	PUNCT
admet-3030	60	3	fat	fat	ADJ
admet-3030	60	4	,	,	PUNCT
admet-3030	60	5	high	high	ADJ
admet-3030	60	6	-	-	PUNCT
admet-3030	60	7	sugar	sugar	NOUN
admet-3030	60	8	,	,	PUNCT
admet-3030	60	9	and	and	CCONJ
admet-3030	60	10	low	low	ADJ
admet-3030	60	11	-	-	PUNCT
admet-3030	60	12	protein	protein	NOUN
admet-3030	60	13	and	and	CCONJ
admet-3030	60	14	mineral	mineral	NOUN
admet-3030	60	15	foods	food	NOUN
admet-3030	60	16	increase	increase	VERB
admet-3030	60	17	androgen	androgen	NOUN
admet-3030	60	18	production	production	NOUN
admet-3030	60	19	,	,	PUNCT
admet-3030	60	20	impair	impair	VERB
admet-3030	60	21	follicular	follicular	ADJ
admet-3030	60	22	function	function	NOUN
admet-3030	60	23	,	,	PUNCT
admet-3030	60	24	and	and	CCONJ
admet-3030	60	25	induce	induce	VERB
admet-3030	60	26	follicular	follicular	ADJ
admet-3030	60	27	inflammation	inflammation	NOUN
admet-3030	60	28	,	,	PUNCT
admet-3030	60	29	respectively	respectively	ADV
admet-3030	60	30	.	.	PUNCT
admet-3030	61	1	psychological	psychological	ADJ
admet-3030	61	2	stress	stress	NOUN
admet-3030	61	3	increases	increase	VERB
admet-3030	61	4	cortisol	cortisol	ADJ
admet-3030	61	5	levels	level	NOUN
admet-3030	61	6	,	,	PUNCT
admet-3030	61	7	leading	lead	VERB
admet-3030	61	8	to	to	ADP
admet-3030	61	9	androgen	androgen	NOUN
admet-3030	61	10	sensitivity	sensitivity	NOUN
admet-3030	61	11	and	and	CCONJ
admet-3030	61	12	inflammation	inflammation	NOUN
admet-3030	61	13	.	.	PUNCT
admet-3030	62	1	disturbances	disturbance	NOUN
admet-3030	62	2	in	in	ADP
admet-3030	62	3	the	the	DET
admet-3030	62	4	sleep	sleep	NOUN
admet-3030	62	5	cycle	cycle	NOUN
admet-3030	62	6	affect	affect	VERB
admet-3030	62	7	the	the	DET
admet-3030	62	8	follicular	follicular	ADJ
admet-3030	62	9	cells	cell	NOUN
admet-3030	62	10	'	'	PART
admet-3030	62	11	circadian	circadian	ADJ
admet-3030	62	12	regulation	regulation	NOUN
admet-3030	62	13	.	.	PUNCT
admet-3030	63	1	long	long	ADJ
admet-3030	63	2	-	-	PUNCT
admet-3030	63	3	term	term	NOUN
admet-3030	63	4	exposure	exposure	NOUN
admet-3030	63	5	to	to	ADP
admet-3030	63	6	uv	uv	NOUN
admet-3030	63	7	causes	cause	VERB
admet-3030	63	8	scalp	scalp	NOUN
admet-3030	63	9	inflammation	inflammation	NOUN
admet-3030	63	10	,	,	PUNCT
admet-3030	63	11	follicular	follicular	ADJ
admet-3030	63	12	stem	stem	NOUN
admet-3030	63	13	cells	cell	NOUN
admet-3030	63	14	damage	damage	NOUN
admet-3030	63	15	and	and	CCONJ
admet-3030	63	16	can	can	AUX
admet-3030	63	17	alter	alter	VERB
admet-3030	63	18	the	the	DET
admet-3030	63	19	patterns	pattern	NOUN
admet-3030	63	20	of	of	ADP
admet-3030	63	21	aging	age	VERB
admet-3030	63	22	[	[	X
admet-3030	63	23	19	19	NUM
admet-3030	63	24	]	]	PUNCT
admet-3030	63	25	.	.	PUNCT
admet-3030	64	1	alotiby	alotiby	PROPN
admet-3030	64	2	et	et	PROPN
admet-3030	64	3	al	al	PROPN
admet-3030	64	4	.	.	PUNCT
admet-3030	65	1	[	[	X
admet-3030	65	2	20	20	NUM
admet-3030	65	3	]	]	PUNCT
admet-3030	65	4	presented	present	VERB
admet-3030	65	5	a	a	DET
admet-3030	65	6	case	case	NOUN
admet-3030	65	7	study	study	NOUN
admet-3030	65	8	of	of	ADP
admet-3030	65	9	a	a	DET
admet-3030	65	10	28	28	NUM
admet-3030	65	11	-	-	PUNCT
admet-3030	65	12	year	year	NOUN
admet-3030	65	13	-	-	PUNCT
admet-3030	65	14	old	old	ADJ
admet-3030	65	15	female	female	NOUN
admet-3030	65	16	diagnosed	diagnose	VERB
admet-3030	65	17	with	with	ADP
admet-3030	65	18	aa	aa	PROPN
admet-3030	65	19	,	,	PUNCT
admet-3030	65	20	with	with	ADP
admet-3030	65	21	no	no	DET
admet-3030	65	22	history	history	NOUN
admet-3030	65	23	of	of	ADP
admet-3030	65	24	autoimmune	autoimmune	ADJ
admet-3030	65	25	disorders	disorder	NOUN
admet-3030	65	26	,	,	PUNCT
admet-3030	65	27	whose	whose	DET
admet-3030	65	28	condition	condition	NOUN
admet-3030	65	29	was	be	AUX
admet-3030	65	30	exacerbated	exacerbate	VERB
admet-3030	65	31	by	by	ADP
admet-3030	65	32	emotional	emotional	ADJ
admet-3030	65	33	stress	stress	NOUN
admet-3030	65	34	.	.	PUNCT
admet-3030	66	1	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	PROPN
admet-3030	66	2	r.	r.	PROPN
admet-3030	66	3	kapoor	kapoor	PROPN
admet-3030	66	4	et	et	PROPN
admet-3030	66	5	al	al	PROPN
admet-3030	66	6	.	.	PROPN
admet-3030	66	7	admet	admet	PROPN
admet-3030	66	8	&	&	CCONJ
admet-3030	66	9	dmpk	dmpk	PROPN
admet-3030	66	10	00(0	00(0	PROPN
admet-3030	66	11	)	)	PUNCT
admet-3030	66	12	(	(	PUNCT
admet-3030	66	13	2025	2025	NUM
admet-3030	66	14	)	)	PUNCT
admet-3030	66	15	3030	3030	NUM
admet-3030	66	16	4	4	NUM
admet-3030	66	17	figure	figure	NOUN
admet-3030	66	18	2	2	NUM
admet-3030	66	19	.	.	PUNCT
admet-3030	66	20	impact	impact	NOUN
admet-3030	66	21	of	of	ADP
admet-3030	66	22	environmental	environmental	ADJ
admet-3030	66	23	stressors	stressor	NOUN
admet-3030	66	24	on	on	ADP
admet-3030	66	25	aga	aga	NOUN
admet-3030	66	26	their	their	PRON
admet-3030	66	27	research	research	NOUN
admet-3030	66	28	focused	focus	VERB
admet-3030	66	29	on	on	ADP
admet-3030	66	30	the	the	DET
admet-3030	66	31	role	role	NOUN
admet-3030	66	32	of	of	ADP
admet-3030	66	33	psychological	psychological	ADJ
admet-3030	66	34	distress	distress	NOUN
admet-3030	66	35	as	as	ADP
admet-3030	66	36	an	an	DET
admet-3030	66	37	environmental	environmental	ADJ
admet-3030	66	38	factor	factor	NOUN
admet-3030	66	39	triggering	trigger	VERB
admet-3030	66	40	aa	aa	NOUN
admet-3030	66	41	.	.	PUNCT
admet-3030	67	1	the	the	DET
admet-3030	67	2	researchers	researcher	NOUN
admet-3030	67	3	explored	explore	VERB
admet-3030	67	4	the	the	DET
admet-3030	67	5	combination	combination	NOUN
admet-3030	67	6	of	of	ADP
admet-3030	67	7	minoxidil	minoxidil	ADJ
admet-3030	67	8	treatment	treatment	NOUN
admet-3030	67	9	and	and	CCONJ
admet-3030	67	10	stress	stress	NOUN
admet-3030	67	11	reduction	reduction	NOUN
admet-3030	67	12	techniques	technique	NOUN
admet-3030	67	13	,	,	PUNCT
admet-3030	67	14	which	which	PRON
admet-3030	67	15	resulted	result	VERB
admet-3030	67	16	in	in	ADP
admet-3030	67	17	improved	improved	ADJ
admet-3030	67	18	hair	hair	NOUN
admet-3030	67	19	growth	growth	NOUN
admet-3030	67	20	among	among	ADP
admet-3030	67	21	individuals	individual	NOUN
admet-3030	67	22	suffering	suffer	VERB
admet-3030	67	23	from	from	ADP
admet-3030	67	24	psychological	psychological	ADJ
admet-3030	67	25	distress	distress	NOUN
admet-3030	67	26	.	.	PUNCT
admet-3030	68	1	this	this	PRON
admet-3030	68	2	suggests	suggest	VERB
admet-3030	68	3	that	that	SCONJ
admet-3030	68	4	addressing	address	VERB
admet-3030	68	5	emotional	emotional	ADJ
admet-3030	68	6	well	well	NOUN
admet-3030	68	7	-	-	PUNCT
admet-3030	68	8	being	being	NOUN
admet-3030	68	9	alongside	alongside	ADP
admet-3030	68	10	traditional	traditional	ADJ
admet-3030	68	11	therapies	therapy	NOUN
admet-3030	68	12	can	can	AUX
admet-3030	68	13	improve	improve	VERB
admet-3030	68	14	outcomes	outcome	NOUN
admet-3030	68	15	for	for	ADP
admet-3030	68	16	patients	patient	NOUN
admet-3030	68	17	with	with	ADP
admet-3030	68	18	aa	aa	PROPN
admet-3030	68	19	.	.	PUNCT
admet-3030	69	1	increased	increase	VERB
admet-3030	69	2	stress	stress	NOUN
admet-3030	69	3	activates	activate	VERB
admet-3030	69	4	the	the	DET
admet-3030	69	5	hypothalamic	hypothalamic	ADJ
admet-3030	69	6	-	-	PUNCT
admet-3030	69	7	pituitary	pituitary	ADJ
admet-3030	69	8	-	-	PUNCT
admet-3030	69	9	adrenal	adrenal	ADJ
admet-3030	69	10	(	(	PUNCT
admet-3030	69	11	hpa	hpa	NOUN
admet-3030	69	12	)	)	PUNCT
admet-3030	69	13	axis	axis	NOUN
admet-3030	69	14	,	,	PUNCT
admet-3030	69	15	causing	cause	VERB
admet-3030	69	16	hair	hair	NOUN
admet-3030	69	17	follicle	follicle	NOUN
admet-3030	69	18	damage	damage	NOUN
admet-3030	69	19	.	.	PUNCT
admet-3030	70	1	oxidative	oxidative	ADJ
admet-3030	70	2	stress	stress	NOUN
admet-3030	70	3	is	be	AUX
admet-3030	70	4	the	the	DET
admet-3030	70	5	body	body	NOUN
admet-3030	70	6	’s	’s	PART
admet-3030	70	7	inability	inability	NOUN
admet-3030	70	8	to	to	PART
admet-3030	70	9	neutralise	neutralise	VERB
admet-3030	70	10	the	the	DET
admet-3030	70	11	reactive	reactive	ADJ
admet-3030	70	12	oxygen	oxygen	NOUN
admet-3030	70	13	species	specie	NOUN
admet-3030	70	14	,	,	PUNCT
admet-3030	70	15	which	which	PRON
admet-3030	70	16	in	in	ADP
admet-3030	70	17	turn	turn	NOUN
admet-3030	70	18	accounts	account	VERB
admet-3030	70	19	for	for	SCONJ
admet-3030	70	20	the	the	DET
admet-3030	70	21	hair	hair	NOUN
admet-3030	70	22	follicle	follicle	NOUN
admet-3030	70	23	death	death	NOUN
admet-3030	70	24	and	and	CCONJ
admet-3030	70	25	inflammation	inflammation	NOUN
admet-3030	70	26	.	.	PUNCT
admet-3030	71	1	immune	immune	ADJ
admet-3030	71	2	mechanisms	mechanism	NOUN
admet-3030	71	3	and	and	CCONJ
admet-3030	71	4	inflammatory	inflammatory	ADJ
admet-3030	71	5	pathways	pathway	NOUN
admet-3030	71	6	in	in	ADP
admet-3030	71	7	androgenetic	androgenetic	ADJ
admet-3030	71	8	alopecia	alopecia	NOUN
admet-3030	71	9	and	and	CCONJ
admet-3030	71	10	alopecia	alopecia	NOUN
admet-3030	71	11	areata	areata	ADJ
admet-3030	71	12	aga	aga	NOUN
admet-3030	71	13	is	be	AUX
admet-3030	71	14	primarily	primarily	ADV
admet-3030	71	15	caused	cause	VERB
admet-3030	71	16	by	by	ADP
admet-3030	71	17	the	the	DET
admet-3030	71	18	genetic	genetic	ADJ
admet-3030	71	19	predisposition	predisposition	NOUN
admet-3030	71	20	and	and	CCONJ
admet-3030	71	21	androgen	androgen	NOUN
admet-3030	71	22	metabolism	metabolism	NOUN
admet-3030	71	23	.	.	PUNCT
admet-3030	72	1	recent	recent	ADJ
admet-3030	72	2	research	research	NOUN
admet-3030	72	3	has	have	AUX
admet-3030	72	4	revealed	reveal	VERB
admet-3030	72	5	that	that	SCONJ
admet-3030	72	6	immune	immune	ADJ
admet-3030	72	7	and	and	CCONJ
admet-3030	72	8	inflammatory	inflammatory	ADJ
admet-3030	72	9	pathways	pathway	NOUN
admet-3030	72	10	are	be	AUX
admet-3030	72	11	also	also	ADV
admet-3030	72	12	involved	involve	VERB
admet-3030	72	13	in	in	ADP
admet-3030	72	14	the	the	DET
admet-3030	72	15	progression	progression	NOUN
admet-3030	72	16	of	of	ADP
admet-3030	72	17	aga	aga	NOUN
admet-3030	72	18	(	(	PUNCT
admet-3030	72	19	figure	figure	NOUN
admet-3030	72	20	3	3	NUM
admet-3030	72	21	)	)	PUNCT
admet-3030	72	22	.	.	PUNCT
admet-3030	73	1	perifollicular	perifollicular	ADJ
admet-3030	73	2	inflammation	inflammation	NOUN
admet-3030	73	3	is	be	AUX
admet-3030	73	4	the	the	DET
admet-3030	73	5	most	most	ADV
admet-3030	73	6	commonly	commonly	ADV
admet-3030	73	7	observed	observe	VERB
admet-3030	73	8	finding	finding	NOUN
admet-3030	73	9	in	in	ADP
admet-3030	73	10	biopsies	biopsy	NOUN
admet-3030	73	11	of	of	ADP
admet-3030	73	12	aga	aga	NOUN
admet-3030	73	13	patients	patient	NOUN
admet-3030	73	14	.	.	PUNCT
admet-3030	74	1	the	the	DET
admet-3030	74	2	upregulation	upregulation	NOUN
admet-3030	74	3	of	of	ADP
admet-3030	74	4	pro	pro	ADJ
admet-3030	74	5	-	-	ADJ
admet-3030	74	6	inflammatory	inflammatory	ADJ
admet-3030	74	7	cytokines	cytokine	NOUN
admet-3030	74	8	such	such	ADJ
admet-3030	74	9	as	as	ADP
admet-3030	74	10	il-1α	il-1α	PROPN
admet-3030	74	11	,	,	PUNCT
admet-3030	74	12	il-6	il-6	NUM
admet-3030	74	13	,	,	PUNCT
admet-3030	74	14	and	and	CCONJ
admet-3030	74	15	tnf	tnf	PROPN
admet-3030	74	16	-	-	PUNCT
admet-3030	74	17	α	α	PROPN
admet-3030	74	18	increases	increase	VERB
admet-3030	74	19	baldness	baldness	ADJ
admet-3030	74	20	and	and	CCONJ
admet-3030	74	21	catagenpromoting	catagenpromote	VERB
admet-3030	74	22	effects	effect	NOUN
admet-3030	74	23	.	.	PUNCT
admet-3030	75	1	increased	increase	VERB
admet-3030	75	2	ros	ros	PROPN
admet-3030	75	3	activates	activate	VERB
admet-3030	75	4	the	the	DET
admet-3030	75	5	transcription	transcription	NOUN
admet-3030	75	6	factor	factor	NOUN
admet-3030	75	7	nf	nf	NOUN
admet-3030	75	8	-	-	PUNCT
admet-3030	75	9	κb	κb	NOUN
admet-3030	75	10	,	,	PUNCT
admet-3030	75	11	which	which	PRON
admet-3030	75	12	,	,	PUNCT
admet-3030	75	13	in	in	ADP
admet-3030	75	14	turn	turn	NOUN
admet-3030	75	15	,	,	PUNCT
admet-3030	75	16	causes	cause	VERB
admet-3030	75	17	inflammation	inflammation	NOUN
admet-3030	75	18	.	.	PUNCT
admet-3030	76	1	figure	figure	NOUN
admet-3030	76	2	3	3	NUM
admet-3030	76	3	.	.	NOUN
admet-3030	76	4	immune	immune	ADJ
admet-3030	76	5	pathways	pathway	NOUN
admet-3030	76	6	involved	involve	VERB
admet-3030	76	7	in	in	ADP
admet-3030	76	8	aga	aga	PROPN
admet-3030	76	9	admet	admet	PROPN
admet-3030	76	10	&	&	CCONJ
admet-3030	76	11	dmpk	dmpk	PROPN
admet-3030	76	12	00(0	00(0	PROPN
admet-3030	76	13	)	)	PUNCT
admet-3030	76	14	(	(	PUNCT
admet-3030	76	15	2025	2025	NUM
admet-3030	76	16	)	)	PUNCT
admet-3030	76	17	3030	3030	NUM
admet-3030	76	18	precision	precision	NOUN
admet-3030	76	19	therapeutics	therapeutic	NOUN
admet-3030	76	20	in	in	ADP
admet-3030	76	21	non	non	ADJ
admet-3030	76	22	-	-	ADJ
admet-3030	76	23	scarring	scar	VERB
admet-3030	76	24	alopecia	alopecia	NOUN
admet-3030	76	25	doi	doi	NOUN
admet-3030	76	26	:	:	PUNCT
admet-3030	76	27	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	76	28	5	5	NUM
admet-3030	76	29	the	the	DET
admet-3030	76	30	studies	study	NOUN
admet-3030	76	31	of	of	ADP
admet-3030	76	32	cuevas	cuevas	PROPN
admet-3030	76	33	-	-	PUNCT
admet-3030	76	34	diaz	diaz	PROPN
admet-3030	76	35	duran	duran	PROPN
admet-3030	76	36	et	et	PROPN
admet-3030	76	37	al	al	PROPN
admet-3030	76	38	.	.	PUNCT
admet-3030	77	1	[	[	X
admet-3030	77	2	21	21	NUM
admet-3030	77	3	]	]	PUNCT
admet-3030	77	4	have	have	AUX
admet-3030	77	5	provided	provide	VERB
admet-3030	77	6	evidence	evidence	NOUN
admet-3030	77	7	that	that	SCONJ
admet-3030	77	8	infiltration	infiltration	NOUN
admet-3030	77	9	of	of	ADP
admet-3030	77	10	t	t	NOUN
admet-3030	77	11	cells	cell	NOUN
admet-3030	77	12	and	and	CCONJ
admet-3030	77	13	mast	mast	NOUN
admet-3030	77	14	cells	cell	NOUN
admet-3030	77	15	in	in	ADP
admet-3030	77	16	the	the	DET
admet-3030	77	17	follicular	follicular	ADJ
admet-3030	77	18	areas	area	NOUN
admet-3030	77	19	promotes	promote	VERB
admet-3030	77	20	fibrosis	fibrosis	NOUN
admet-3030	77	21	.	.	PUNCT
admet-3030	78	1	zong	zong	PROPN
admet-3030	78	2	et	et	PROPN
admet-3030	78	3	al	al	PROPN
admet-3030	78	4	.	.	PUNCT
admet-3030	79	1	[	[	X
admet-3030	79	2	22	22	NUM
admet-3030	79	3	]	]	PUNCT
admet-3030	79	4	reported	report	VERB
admet-3030	79	5	that	that	SCONJ
admet-3030	79	6	nlrp3	nlrp3	NOUN
admet-3030	79	7	inflammasome	inflammasome	NOUN
admet-3030	79	8	activation	activation	NOUN
admet-3030	79	9	,	,	PUNCT
admet-3030	79	10	associated	associate	VERB
admet-3030	79	11	with	with	ADP
admet-3030	79	12	the	the	DET
admet-3030	79	13	innate	innate	ADJ
admet-3030	79	14	immunity	immunity	NOUN
admet-3030	79	15	,	,	PUNCT
admet-3030	79	16	causes	cause	VERB
admet-3030	79	17	aga	aga	NOUN
admet-3030	79	18	.	.	PUNCT
admet-3030	80	1	this	this	DET
admet-3030	80	2	process	process	NOUN
admet-3030	80	3	involves	involve	VERB
admet-3030	80	4	the	the	DET
admet-3030	80	5	activation	activation	NOUN
admet-3030	80	6	of	of	ADP
admet-3030	80	7	caspase-1	caspase-1	PROPN
admet-3030	80	8	,	,	PUNCT
admet-3030	80	9	which	which	PRON
admet-3030	80	10	,	,	PUNCT
admet-3030	80	11	in	in	ADP
admet-3030	80	12	turn	turn	NOUN
admet-3030	80	13	,	,	PUNCT
admet-3030	80	14	triggers	trigger	VERB
admet-3030	80	15	inflammatory	inflammatory	ADJ
admet-3030	80	16	pathways	pathway	NOUN
admet-3030	80	17	.	.	PUNCT
admet-3030	81	1	some	some	DET
admet-3030	81	2	microbial	microbial	ADJ
admet-3030	81	3	infections	infection	NOUN
admet-3030	81	4	,	,	PUNCT
admet-3030	81	5	particularly	particularly	ADV
admet-3030	81	6	those	those	PRON
admet-3030	81	7	involving	involve	VERB
admet-3030	81	8	cutibacterium	cutibacterium	ADJ
admet-3030	81	9	spp	spp	NOUN
admet-3030	81	10	.	.	PUNCT
admet-3030	82	1	and	and	CCONJ
admet-3030	82	2	malassezia	malassezia	PROPN
admet-3030	82	3	spp	spp	PROPN
admet-3030	82	4	.	.	PROPN
admet-3030	82	5	,	,	PUNCT
admet-3030	82	6	stimulate	stimulate	VERB
admet-3030	82	7	tlr2	tlr2	PROPN
admet-3030	82	8	and	and	CCONJ
admet-3030	82	9	tlr4	tlr4	NOUN
admet-3030	82	10	,	,	PUNCT
admet-3030	82	11	thereby	thereby	ADV
admet-3030	82	12	activating	activate	VERB
admet-3030	82	13	inflammatory	inflammatory	ADJ
admet-3030	82	14	pathways	pathway	NOUN
admet-3030	82	15	and	and	CCONJ
admet-3030	82	16	inducing	induce	VERB
admet-3030	82	17	the	the	DET
admet-3030	82	18	release	release	NOUN
admet-3030	82	19	of	of	ADP
admet-3030	82	20	inflammatory	inflammatory	ADJ
admet-3030	82	21	cytokines	cytokine	NOUN
admet-3030	82	22	that	that	PRON
admet-3030	82	23	contribute	contribute	VERB
admet-3030	82	24	to	to	ADP
admet-3030	82	25	aga	aga	NOUN
admet-3030	82	26	[	[	X
admet-3030	82	27	23	23	NUM
admet-3030	82	28	]	]	PUNCT
admet-3030	82	29	.	.	PUNCT
admet-3030	83	1	lina	lina	PROPN
admet-3030	83	2	alhanshali	alhanshali	PROPN
admet-3030	83	3	et	et	PROPN
admet-3030	83	4	al	al	PROPN
admet-3030	83	5	.	.	PUNCT
admet-3030	84	1	[	[	X
admet-3030	84	2	1	1	X
admet-3030	84	3	]	]	PUNCT
admet-3030	84	4	provided	provide	VERB
admet-3030	84	5	a	a	DET
admet-3030	84	6	comprehensive	comprehensive	ADJ
admet-3030	84	7	review	review	NOUN
admet-3030	84	8	of	of	ADP
admet-3030	84	9	the	the	DET
admet-3030	84	10	immune	immune	ADJ
admet-3030	84	11	mechanisms	mechanism	NOUN
admet-3030	84	12	underlying	underlie	VERB
admet-3030	84	13	aa	aa	NOUN
admet-3030	84	14	,	,	PUNCT
admet-3030	84	15	particularly	particularly	ADV
admet-3030	84	16	the	the	DET
admet-3030	84	17	downregulation	downregulation	NOUN
admet-3030	84	18	of	of	ADP
admet-3030	84	19	major	major	ADJ
admet-3030	84	20	histocompatibility	histocompatibility	NOUN
admet-3030	84	21	complex	complex	NOUN
admet-3030	84	22	-	-	PUNCT
admet-3030	84	23	i	i	PRON
admet-3030	84	24	(	(	PUNCT
admet-3030	84	25	mhc	mhc	PROPN
admet-3030	84	26	)	)	PUNCT
admet-3030	84	27	,	,	PUNCT
admet-3030	84	28	which	which	PRON
admet-3030	84	29	plays	play	VERB
admet-3030	84	30	a	a	DET
admet-3030	84	31	key	key	ADJ
admet-3030	84	32	role	role	NOUN
admet-3030	84	33	in	in	ADP
admet-3030	84	34	immune	immune	ADJ
admet-3030	84	35	responses	response	NOUN
admet-3030	84	36	.	.	PUNCT
admet-3030	85	1	healthy	healthy	ADJ
admet-3030	85	2	hair	hair	NOUN
admet-3030	85	3	follicles	follicle	VERB
admet-3030	85	4	secrete	secrete	ADJ
admet-3030	85	5	immune	immune	NOUN
admet-3030	85	6	-	-	PUNCT
admet-3030	85	7	privileged	privileged	ADJ
admet-3030	85	8	factors	factor	NOUN
admet-3030	85	9	,	,	PUNCT
admet-3030	85	10	such	such	ADJ
admet-3030	85	11	as	as	ADP
admet-3030	85	12	il-10	il-10	PRON
admet-3030	85	13	,	,	PUNCT
admet-3030	85	14	αmsh	αmsh	PROPN
admet-3030	85	15	,	,	PUNCT
admet-3030	85	16	and	and	CCONJ
admet-3030	85	17	tgfβ1	tgfβ1	PROPN
admet-3030	85	18	,	,	PUNCT
admet-3030	85	19	to	to	PART
admet-3030	85	20	protect	protect	VERB
admet-3030	85	21	against	against	ADP
admet-3030	85	22	autoimmune	autoimmune	ADJ
admet-3030	85	23	attacks	attack	NOUN
admet-3030	85	24	;	;	PUNCT
admet-3030	85	25	however	however	ADV
admet-3030	85	26	,	,	PUNCT
admet-3030	85	27	this	this	DET
admet-3030	85	28	process	process	NOUN
admet-3030	85	29	is	be	AUX
admet-3030	85	30	impaired	impair	VERB
admet-3030	85	31	in	in	ADP
admet-3030	85	32	aa	aa	PROPN
admet-3030	85	33	.	.	PUNCT
admet-3030	86	1	elevated	elevated	ADJ
admet-3030	86	2	interleukin	interleukin	NOUN
admet-3030	86	3	(	(	PUNCT
admet-3030	86	4	il-2	il-2	NUM
admet-3030	86	5	,	,	PUNCT
admet-3030	86	6	il-4	il-4	PRON
admet-3030	86	7	,	,	PUNCT
admet-3030	86	8	il-15	il-15	X
admet-3030	86	9	)	)	PUNCT
admet-3030	86	10	levels	level	NOUN
admet-3030	86	11	have	have	AUX
admet-3030	86	12	been	be	AUX
admet-3030	86	13	observed	observe	VERB
admet-3030	86	14	in	in	ADP
admet-3030	86	15	aa	aa	PROPN
admet-3030	86	16	patients	patient	NOUN
admet-3030	86	17	,	,	PUNCT
admet-3030	86	18	with	with	ADP
admet-3030	86	19	a	a	DET
admet-3030	86	20	subsequent	subsequent	ADJ
admet-3030	86	21	decrease	decrease	NOUN
admet-3030	86	22	after	after	ADP
admet-3030	86	23	treatment	treatment	NOUN
admet-3030	86	24	[	[	X
admet-3030	86	25	1	1	NUM
admet-3030	86	26	]	]	PUNCT
admet-3030	86	27	.	.	PUNCT
admet-3030	87	1	additionally	additionally	ADV
admet-3030	87	2	,	,	PUNCT
admet-3030	87	3	increased	increase	VERB
admet-3030	87	4	expression	expression	NOUN
admet-3030	87	5	of	of	ADP
admet-3030	87	6	toll	toll	NOUN
admet-3030	87	7	-	-	PUNCT
admet-3030	87	8	like	like	ADJ
admet-3030	87	9	receptors	receptor	NOUN
admet-3030	87	10	(	(	PUNCT
admet-3030	87	11	tlr7	tlr7	NOUN
admet-3030	87	12	and	and	CCONJ
admet-3030	87	13	tlr9	tlr9	NOUN
admet-3030	87	14	)	)	PUNCT
admet-3030	87	15	has	have	AUX
admet-3030	87	16	been	be	AUX
admet-3030	87	17	observed	observe	VERB
admet-3030	87	18	in	in	ADP
admet-3030	87	19	aa	aa	PROPN
admet-3030	87	20	patients	patient	NOUN
admet-3030	87	21	,	,	PUNCT
admet-3030	87	22	suggesting	suggest	VERB
admet-3030	87	23	that	that	SCONJ
admet-3030	87	24	targeting	target	VERB
admet-3030	87	25	these	these	DET
admet-3030	87	26	receptors	receptor	NOUN
admet-3030	87	27	could	could	AUX
admet-3030	87	28	mitigate	mitigate	VERB
admet-3030	87	29	disease	disease	NOUN
admet-3030	87	30	severity	severity	NOUN
admet-3030	87	31	.	.	PUNCT
admet-3030	88	1	further	further	ADJ
admet-3030	88	2	research	research	NOUN
admet-3030	88	3	into	into	ADP
admet-3030	88	4	the	the	DET
admet-3030	88	5	genetic	genetic	ADJ
admet-3030	88	6	and	and	CCONJ
admet-3030	88	7	molecular	molecular	ADJ
admet-3030	88	8	mechanisms	mechanism	NOUN
admet-3030	88	9	of	of	ADP
admet-3030	88	10	aa	aa	NOUN
admet-3030	88	11	has	have	AUX
admet-3030	88	12	also	also	ADV
admet-3030	88	13	focused	focus	VERB
admet-3030	88	14	on	on	ADP
admet-3030	88	15	the	the	DET
admet-3030	88	16	role	role	NOUN
admet-3030	88	17	of	of	ADP
admet-3030	88	18	autophagy	autophagy	NOUN
admet-3030	88	19	in	in	ADP
admet-3030	88	20	disease	disease	NOUN
admet-3030	88	21	development	development	NOUN
admet-3030	88	22	.	.	PUNCT
admet-3030	89	1	yi	yi	PROPN
admet-3030	89	2	lin	lin	PROPN
admet-3030	89	3	et	et	PROPN
admet-3030	89	4	al	al	PROPN
admet-3030	89	5	.	.	PUNCT
admet-3030	90	1	[	[	X
admet-3030	90	2	24	24	NUM
admet-3030	90	3	]	]	PUNCT
admet-3030	90	4	demonstrated	demonstrate	VERB
admet-3030	90	5	that	that	SCONJ
admet-3030	90	6	disruption	disruption	NOUN
admet-3030	90	7	of	of	ADP
admet-3030	90	8	the	the	DET
admet-3030	90	9	autophagy	autophagy	ADJ
admet-3030	90	10	mechanism	mechanism	NOUN
admet-3030	90	11	and	and	CCONJ
admet-3030	90	12	accumulation	accumulation	NOUN
admet-3030	90	13	of	of	ADP
admet-3030	90	14	sqstm1	sqstm1	NOUN
admet-3030	90	15	proteins	protein	NOUN
admet-3030	90	16	contribute	contribute	VERB
admet-3030	90	17	to	to	ADP
admet-3030	90	18	aa	aa	NOUN
admet-3030	90	19	,	,	PUNCT
admet-3030	90	20	and	and	CCONJ
admet-3030	90	21	pharmacological	pharmacological	ADJ
admet-3030	90	22	induction	induction	NOUN
admet-3030	90	23	of	of	ADP
admet-3030	90	24	autophagy	autophagy	NOUN
admet-3030	90	25	could	could	AUX
admet-3030	90	26	potentially	potentially	ADV
admet-3030	90	27	prevent	prevent	VERB
admet-3030	90	28	scarring	scarring	NOUN
admet-3030	90	29	in	in	ADP
admet-3030	90	30	affected	affected	ADJ
admet-3030	90	31	individuals	individual	NOUN
admet-3030	90	32	.	.	PUNCT
admet-3030	91	1	the	the	DET
admet-3030	91	2	pathways	pathway	NOUN
admet-3030	91	3	involved	involve	VERB
admet-3030	91	4	in	in	ADP
admet-3030	91	5	non	non	ADJ
admet-3030	91	6	-	-	ADJ
admet-3030	91	7	scarring	scar	VERB
admet-3030	91	8	alopecia	alopecia	NOUN
admet-3030	91	9	were	be	AUX
admet-3030	91	10	tabulated	tabulate	VERB
admet-3030	91	11	in	in	ADP
admet-3030	91	12	table	table	NOUN
admet-3030	91	13	1	1	NUM
admet-3030	91	14	.	.	PUNCT
admet-3030	91	15	table	table	NOUN
admet-3030	91	16	1	1	NUM
admet-3030	91	17	.	.	PUNCT
admet-3030	91	18	pathogenic	pathogenic	ADJ
admet-3030	91	19	pathways	pathway	NOUN
admet-3030	91	20	and	and	CCONJ
admet-3030	91	21	recommendation	recommendation	NOUN
admet-3030	91	22	for	for	ADP
admet-3030	91	23	non	non	ADJ
admet-3030	91	24	-	-	ADJ
admet-3030	91	25	scarring	scar	VERB
admet-3030	91	26	alopecia	alopecia	NOUN
admet-3030	91	27	pathway	pathway	NOUN
admet-3030	91	28	/	/	SYM
admet-3030	91	29	factor	factor	NOUN
admet-3030	91	30	involved	involve	VERB
admet-3030	91	31	recommendation	recommendation	NOUN
admet-3030	91	32	ref	ref	NOUN
admet-3030	91	33	.	.	PUNCT
admet-3030	92	1	immune	immune	ADJ
admet-3030	92	2	factors	factor	NOUN
admet-3030	92	3	forkhead	forkhead	VERB
admet-3030	92	4	box	box	PROPN
admet-3030	92	5	p3	p3	PROPN
admet-3030	92	6	(	(	PUNCT
admet-3030	92	7	foxp3	foxp3	PROPN
admet-3030	92	8	)	)	PUNCT
admet-3030	92	9	,	,	PUNCT
admet-3030	92	10	inducible	inducible	ADJ
admet-3030	92	11	t	t	NOUN
admet-3030	92	12	-	-	PUNCT
admet-3030	92	13	cell	cell	NOUN
admet-3030	92	14	costimulator	costimulator	NOUN
admet-3030	92	15	ligand	ligand	NOUN
admet-3030	92	16	(	(	PUNCT
admet-3030	92	17	icoslg	icoslg	PROPN
admet-3030	92	18	)	)	PUNCT
admet-3030	92	19	,	,	PUNCT
admet-3030	92	20	major	major	ADJ
admet-3030	92	21	histocompatibility	histocompatibility	NOUN
admet-3030	92	22	complex	complex	ADJ
admet-3030	92	23	class	class	NOUN
admet-3030	92	24	i	i	NOUN
admet-3030	92	25	-	-	PUNCT
admet-3030	92	26	related	relate	VERB
admet-3030	92	27	sequence	sequence	NOUN
admet-3030	92	28	a	a	DET
admet-3030	92	29	(	(	PUNCT
admet-3030	92	30	mica	mica	NOUN
admet-3030	92	31	)	)	PUNCT
admet-3030	92	32	,	,	PUNCT
admet-3030	92	33	interleukin	interleukin	NOUN
admet-3030	92	34	7	7	NUM
admet-3030	92	35	receptor	receptor	NOUN
admet-3030	92	36	alpha	alpha	NOUN
admet-3030	92	37	(	(	PUNCT
admet-3030	92	38	il7ra	il7ra	NOUN
admet-3030	92	39	)	)	PUNCT
admet-3030	92	40	,	,	PUNCT
admet-3030	92	41	hla	hla	PROPN
admet-3030	92	42	subtypes	subtype	NOUN
admet-3030	92	43	,	,	PUNCT
admet-3030	92	44	etc	etc	X
admet-3030	92	45	immune	immune	ADJ
admet-3030	92	46	dysregulation	dysregulation	NOUN
admet-3030	92	47	causing	cause	VERB
admet-3030	92	48	aa	aa	NOUN
admet-3030	92	49	,	,	PUNCT
admet-3030	92	50	targeting	target	VERB
admet-3030	92	51	the	the	DET
admet-3030	92	52	inhibitors	inhibitor	NOUN
admet-3030	92	53	for	for	ADP
admet-3030	92	54	these	these	DET
admet-3030	92	55	genes	gene	NOUN
admet-3030	92	56	will	will	AUX
admet-3030	92	57	prevent	prevent	VERB
admet-3030	92	58	aa	aa	NOUN
admet-3030	93	1	[	[	X
admet-3030	93	2	12	12	NUM
admet-3030	93	3	]	]	X
admet-3030	93	4	genetic	genetic	ADJ
admet-3030	93	5	variations	variation	NOUN
admet-3030	93	6	in	in	ADP
admet-3030	93	7	protein	protein	NOUN
admet-3030	93	8	tyrosine	tyrosine	NOUN
admet-3030	93	9	phosphatase	phosphatase	NOUN
admet-3030	93	10	nonreceptor	nonreceptor	ADJ
admet-3030	93	11	type	type	NOUN
admet-3030	93	12	22	22	NUM
admet-3030	93	13	(	(	PUNCT
admet-3030	93	14	ptpn22	ptpn22	NOUN
admet-3030	93	15	)	)	PUNCT
admet-3030	93	16	,	,	PUNCT
admet-3030	93	17	hla	hla	PROPN
admet-3030	93	18	-	-	PUNCT
admet-3030	93	19	drb1	drb1	PROPN
admet-3030	93	20	jak	jak	PROPN
admet-3030	93	21	inhibitors	inhibitor	NOUN
admet-3030	94	1	[	[	X
admet-3030	94	2	12	12	NUM
admet-3030	94	3	]	]	X
admet-3030	94	4	interleukin-13	interleukin-13	PROPN
admet-3030	94	5	(	(	PUNCT
admet-3030	94	6	il-13	il-13	NUM
admet-3030	94	7	)	)	PUNCT
admet-3030	94	8	,	,	PUNCT
admet-3030	94	9	c	c	X
admet-3030	94	10	-	-	PUNCT
admet-3030	94	11	type	type	NOUN
admet-3030	94	12	lectin	lectin	ADJ
admet-3030	94	13	domain	domain	NOUN
admet-3030	94	14	family	family	NOUN
admet-3030	94	15	16	16	NUM
admet-3030	94	16	member	member	NOUN
admet-3030	94	17	a	a	DET
admet-3030	94	18	(	(	PUNCT
admet-3030	94	19	clec16a	clec16a	NOUN
admet-3030	94	20	)	)	PUNCT
admet-3030	94	21	susceptibility	susceptibility	NOUN
admet-3030	94	22	loci	locus	NOUN
admet-3030	94	23	,	,	PUNCT
admet-3030	94	24	cytotoxic	cytotoxic	ADJ
admet-3030	94	25	t	t	NOUN
admet-3030	94	26	-	-	PUNCT
admet-3030	94	27	lymphocyte	lymphocyte	NOUN
admet-3030	94	28	-	-	PUNCT
admet-3030	94	29	associated	associate	VERB
admet-3030	94	30	protein	protein	NOUN
admet-3030	94	31	4	4	NUM
admet-3030	94	32	(	(	PUNCT
admet-3030	94	33	ctla4	ctla4	NOUN
admet-3030	94	34	)	)	PUNCT
admet-3030	94	35	pathways	pathway	NOUN
admet-3030	94	36	exploring	explore	VERB
admet-3030	94	37	ctla4	ctla4	NOUN
admet-3030	94	38	and	and	CCONJ
admet-3030	94	39	t	t	NOUN
admet-3030	94	40	cell	cell	NOUN
admet-3030	94	41	populations	population	NOUN
admet-3030	94	42	for	for	ADP
admet-3030	94	43	aa	aa	NOUN
admet-3030	94	44	treatment	treatment	NOUN
admet-3030	94	45	strategies	strategy	NOUN
admet-3030	94	46	[	[	X
admet-3030	94	47	13	13	NUM
admet-3030	94	48	]	]	X
admet-3030	94	49	environmental	environmental	ADJ
admet-3030	94	50	factorpsychological	factorpsychological	ADJ
admet-3030	94	51	stress	stress	NOUN
admet-3030	94	52	stress	stress	NOUN
admet-3030	94	53	management	management	NOUN
admet-3030	94	54	+	+	CCONJ
admet-3030	94	55	medications	medication	NOUN
admet-3030	95	1	[	[	X
admet-3030	95	2	20	20	NUM
admet-3030	95	3	]	]	PUNCT
admet-3030	95	4	arginine	arginine	NOUN
admet-3030	95	5	deficiencydysregulation	deficiencydysregulation	NOUN
admet-3030	95	6	of	of	ADP
admet-3030	95	7	mechanistic	mechanistic	ADJ
admet-3030	95	8	target	target	NOUN
admet-3030	95	9	of	of	ADP
admet-3030	95	10	rapamycin	rapamycin	NOUN
admet-3030	95	11	(	(	PUNCT
admet-3030	95	12	mtor	mtor	NOUN
admet-3030	95	13	)	)	PUNCT
admet-3030	95	14	pathway	pathway	NOUN
admet-3030	95	15	,	,	PUNCT
admet-3030	95	16	clinical	clinical	ADJ
admet-3030	95	17	intervention	intervention	NOUN
admet-3030	95	18	for	for	ADP
admet-3030	95	19	mtor	mtor	PROPN
admet-3030	95	20	pathway	pathway	NOUN
admet-3030	95	21	alterations	alteration	NOUN
admet-3030	95	22	will	will	AUX
admet-3030	95	23	prevent	prevent	VERB
admet-3030	95	24	aa	aa	NOUN
admet-3030	96	1	[	[	X
admet-3030	96	2	25	25	NUM
admet-3030	96	3	]	]	X
admet-3030	96	4	interleukin-33	interleukin-33	PROPN
admet-3030	96	5	(	(	PUNCT
admet-3030	96	6	il-33	il-33	NUM
admet-3030	96	7	)	)	PUNCT
admet-3030	96	8	as	as	ADP
admet-3030	96	9	a	a	DET
admet-3030	96	10	link	link	NOUN
admet-3030	96	11	between	between	ADP
admet-3030	96	12	asthma	asthma	NOUN
admet-3030	96	13	and	and	CCONJ
admet-3030	96	14	aa	aa	NOUN
admet-3030	96	15	il-33	il-33	VERB
admet-3030	96	16	inhibitors	inhibitor	NOUN
admet-3030	96	17	[	[	X
admet-3030	96	18	26	26	NUM
admet-3030	96	19	]	]	PUNCT
admet-3030	96	20	metabolic	metabolic	NOUN
admet-3030	96	21	profiling	profiling	NOUN
admet-3030	96	22	need	need	NOUN
admet-3030	96	23	to	to	PART
admet-3030	96	24	study	study	VERB
admet-3030	96	25	further	far	ADV
admet-3030	96	26	to	to	PART
admet-3030	96	27	understand	understand	VERB
admet-3030	96	28	interactive	interactive	ADJ
admet-3030	96	29	effects	effect	NOUN
admet-3030	96	30	[	[	X
admet-3030	96	31	26,27	26,27	NUM
admet-3030	96	32	]	]	X
admet-3030	96	33	impact	impact	NOUN
admet-3030	96	34	of	of	ADP
admet-3030	96	35	gut	gut	NOUN
admet-3030	96	36	microbiome	microbiome	NOUN
admet-3030	96	37	and	and	CCONJ
admet-3030	96	38	metabolites	metabolite	NOUN
admet-3030	96	39	in	in	ADP
admet-3030	96	40	-	-	PUNCT
admet-3030	96	41	depth	depth	NOUN
admet-3030	96	42	understanding	understanding	NOUN
admet-3030	96	43	of	of	ADP
admet-3030	96	44	the	the	DET
admet-3030	96	45	gut	gut	NOUN
admet-3030	96	46	microbiome	microbiome	NOUN
admet-3030	96	47	is	be	AUX
admet-3030	96	48	recommended	recommend	VERB
admet-3030	96	49	[	[	X
admet-3030	96	50	28	28	NUM
admet-3030	96	51	]	]	PUNCT
admet-3030	96	52	immune	immune	ADJ
admet-3030	96	53	dysregulation	dysregulation	NOUN
admet-3030	96	54	cluster	cluster	NOUN
admet-3030	96	55	of	of	ADP
admet-3030	96	56	differentiation	differentiation	NOUN
admet-3030	96	57	24	24	NUM
admet-3030	96	58	(	(	PUNCT
admet-3030	96	59	cd24	cd24	PROPN
admet-3030	96	60	)	)	PUNCT
admet-3030	96	61	,	,	PUNCT
admet-3030	96	62	c	c	X
admet-3030	96	63	-	-	PUNCT
admet-3030	96	64	c	c	VERB
admet-3030	96	65	chemokine	chemokine	ADJ
admet-3030	96	66	receptor	receptor	NOUN
admet-3030	96	67	type	type	NOUN
admet-3030	96	68	2	2	NUM
admet-3030	96	69	(	(	PUNCT
admet-3030	96	70	ccr2	ccr2	PROPN
admet-3030	96	71	)	)	PUNCT
admet-3030	96	72	transcriptional	transcriptional	ADJ
admet-3030	96	73	"	"	PUNCT
admet-3030	96	74	hot	hot	ADJ
admet-3030	96	75	spots	spot	NOUN
admet-3030	96	76	"	"	PUNCT
admet-3030	96	77	genetic	genetic	ADJ
admet-3030	96	78	profiling	profiling	NOUN
admet-3030	96	79	+	+	CCONJ
admet-3030	96	80	transcriptional	transcriptional	ADJ
admet-3030	96	81	analysis	analysis	NOUN
admet-3030	96	82	for	for	ADP
admet-3030	96	83	early	early	ADJ
admet-3030	96	84	diagnosis	diagnosis	NOUN
admet-3030	96	85	and	and	CCONJ
admet-3030	96	86	prevention	prevention	NOUN
admet-3030	96	87	of	of	ADP
admet-3030	96	88	aa	aa	NOUN
admet-3030	96	89	[	[	X
admet-3030	96	90	29	29	NUM
admet-3030	96	91	]	]	X
admet-3030	96	92	dysregulated	dysregulated	ADJ
admet-3030	96	93	hair	hair	NOUN
admet-3030	96	94	follicle	follicle	NOUN
admet-3030	96	95	stem	stem	NOUN
admet-3030	96	96	cells	cell	NOUN
admet-3030	96	97	(	(	PUNCT
admet-3030	96	98	hfscs	hfsc	NOUN
admet-3030	96	99	)	)	PUNCT
admet-3030	97	1	+	+	CCONJ
admet-3030	97	2	environmental	environmental	ADJ
admet-3030	97	3	factors	factor	NOUN
admet-3030	97	4	targeting	target	VERB
admet-3030	97	5	hfscs	hfsc	NOUN
admet-3030	97	6	will	will	AUX
admet-3030	97	7	cure	cure	VERB
admet-3030	97	8	non	non	ADJ
admet-3030	97	9	-	-	ADJ
admet-3030	97	10	scarring	scar	VERB
admet-3030	97	11	alopecia	alopecia	NOUN
admet-3030	97	12	[	[	X
admet-3030	97	13	30	30	NUM
admet-3030	97	14	]	]	PUNCT
admet-3030	97	15	decreased	decrease	VERB
admet-3030	97	16	leukocyte	leukocyte	NOUN
admet-3030	97	17	telomere	telomere	NOUN
admet-3030	97	18	length	length	NOUN
admet-3030	97	19	(	(	PUNCT
admet-3030	97	20	ltl	ltl	PROPN
admet-3030	97	21	)	)	PUNCT
admet-3030	97	22	inhibitors	inhibitor	NOUN
admet-3030	97	23	against	against	ADP
admet-3030	97	24	ltl	ltl	PROPN
admet-3030	97	25	prevention	prevention	NOUN
admet-3030	97	26	will	will	AUX
admet-3030	97	27	prevent	prevent	VERB
admet-3030	97	28	aa	aa	NOUN
admet-3030	97	29	[	[	X
admet-3030	97	30	31	31	NUM
admet-3030	97	31	]	]	PUNCT
admet-3030	97	32	immune	immune	ADJ
admet-3030	97	33	dysregulation	dysregulation	NOUN
admet-3030	97	34	-	-	PUNCT
admet-3030	97	35	cd8a	cd8a	PROPN
admet-3030	97	36	,	,	PUNCT
admet-3030	97	37	phosphatidylinositol-4,5bisphosphate	phosphatidylinositol-4,5bisphosphate	VERB
admet-3030	97	38	3	3	NUM
admet-3030	97	39	-	-	PUNCT
admet-3030	97	40	kinase	kinase	NOUN
admet-3030	97	41	catalytic	catalytic	ADJ
admet-3030	97	42	subunit	subunit	NOUN
admet-3030	97	43	gamma	gamma	NOUN
admet-3030	97	44	(	(	PUNCT
admet-3030	97	45	pik3cg	pik3cg	PROPN
admet-3030	97	46	)	)	PUNCT
admet-3030	97	47	,	,	PUNCT
admet-3030	97	48	src	src	PROPN
admet-3030	97	49	kinase	kinase	PROPN
admet-3030	97	50	associated	associate	VERB
admet-3030	97	51	phosphoprotein	phosphoprotein	NOUN
admet-3030	97	52	1	1	NUM
admet-3030	97	53	(	(	PUNCT
admet-3030	97	54	skap1	skap1	NOUN
admet-3030	97	55	)	)	PUNCT
admet-3030	97	56	cluster	cluster	NOUN
admet-3030	97	57	of	of	ADP
admet-3030	97	58	differentiation	differentiation	NOUN
admet-3030	97	59	8	8	NUM
admet-3030	97	60	alpha	alpha	NOUN
admet-3030	97	61	chain	chain	NOUN
admet-3030	97	62	(	(	PUNCT
admet-3030	97	63	cd8a	cd8a	ADJ
admet-3030	97	64	)	)	PUNCT
admet-3030	97	65	and	and	CCONJ
admet-3030	97	66	immune	immune	ADJ
admet-3030	97	67	checkpoint	checkpoint	NOUN
admet-3030	97	68	pathway	pathway	NOUN
admet-3030	97	69	inhibitors	inhibitor	NOUN
admet-3030	97	70	[	[	X
admet-3030	97	71	32	32	NUM
admet-3030	97	72	]	]	PUNCT
admet-3030	97	73	immune	immune	ADJ
admet-3030	97	74	collapse	collapse	NOUN
admet-3030	97	75	-	-	PUNCT
admet-3030	97	76	plasmacytoid	plasmacytoid	NOUN
admet-3030	97	77	dendritic	dendritic	ADJ
admet-3030	97	78	cells	cell	NOUN
admet-3030	97	79	(	(	PUNCT
admet-3030	97	80	pdcs	pdcs	PROPN
admet-3030	97	81	)	)	PUNCT
admet-3030	97	82	,	,	PUNCT
admet-3030	97	83	ifn	ifn	PROPN
admet-3030	97	84	-	-	PUNCT
admet-3030	97	85	γ	γ	X
admet-3030	97	86	clinical	clinical	ADJ
admet-3030	97	87	intervention	intervention	NOUN
admet-3030	97	88	to	to	PART
admet-3030	97	89	pdcs	pdcs	PROPN
admet-3030	97	90	will	will	AUX
admet-3030	97	91	prevent	prevent	VERB
admet-3030	97	92	aa	aa	NOUN
admet-3030	98	1	[	[	X
admet-3030	98	2	33	33	NUM
admet-3030	98	3	]	]	X
admet-3030	98	4	hla	hla	PROPN
admet-3030	98	5	associations	association	NOUN
admet-3030	98	6	and	and	CCONJ
admet-3030	98	7	cytokines	cytokine	NOUN
admet-3030	98	8	(	(	PUNCT
admet-3030	98	9	il-2	il-2	NUM
admet-3030	98	10	,	,	PUNCT
admet-3030	98	11	ifn	ifn	PROPN
admet-3030	98	12	-	-	PUNCT
admet-3030	98	13	γ	γ	NOUN
admet-3030	98	14	,	,	PUNCT
admet-3030	98	15	il-10	il-10	PRON
admet-3030	98	16	,	,	PUNCT
admet-3030	98	17	etc	etc	X
admet-3030	98	18	.	.	X
admet-3030	98	19	)	)	PUNCT
admet-3030	99	1	jak	jak	PROPN
admet-3030	99	2	inhibitors	inhibitor	NOUN
admet-3030	99	3	can	can	AUX
admet-3030	99	4	be	be	AUX
admet-3030	99	5	used	use	VERB
admet-3030	99	6	to	to	PART
admet-3030	99	7	treat	treat	VERB
admet-3030	99	8	aa	aa	NOUN
admet-3030	99	9	[	[	X
admet-3030	99	10	34	34	NUM
admet-3030	99	11	]	]	SYM
admet-3030	99	12	metabolic	metabolic	NOUN
admet-3030	99	13	profiling	profiling	NOUN
admet-3030	99	14	metabolites	metabolite	NOUN
admet-3030	99	15	can	can	AUX
admet-3030	99	16	be	be	AUX
admet-3030	99	17	used	use	VERB
admet-3030	99	18	as	as	ADP
admet-3030	99	19	biomarkers	biomarker	NOUN
admet-3030	99	20	for	for	ADP
admet-3030	99	21	aa	aa	NOUN
admet-3030	99	22	[	[	X
admet-3030	99	23	35	35	NUM
admet-3030	99	24	]	]	PUNCT
admet-3030	99	25	immune	immune	ADJ
admet-3030	99	26	cell	cell	NOUN
admet-3030	99	27	accumulation	accumulation	NOUN
admet-3030	99	28	,	,	PUNCT
admet-3030	99	29	neuroendocrine	neuroendocrine	ADJ
admet-3030	99	30	system	system	NOUN
admet-3030	99	31	disruption	disruption	NOUN
admet-3030	99	32	,	,	PUNCT
admet-3030	99	33	stress	stress	ADJ
admet-3030	99	34	hormones	hormone	NOUN
admet-3030	99	35	neurocrine	neurocrine	VERB
admet-3030	99	36	mediators	mediator	NOUN
admet-3030	100	1	[	[	X
admet-3030	100	2	36	36	NUM
admet-3030	100	3	]	]	PUNCT
admet-3030	100	4	oxidative	oxidative	ADJ
admet-3030	100	5	stress	stress	NOUN
admet-3030	100	6	leading	lead	VERB
admet-3030	100	7	to	to	ADP
admet-3030	100	8	dna	dna	PROPN
admet-3030	100	9	damage	damage	NOUN
admet-3030	100	10	and	and	CCONJ
admet-3030	100	11	antioxidants	antioxidant	NOUN
admet-3030	100	12	vitamin	vitamin	NOUN
admet-3030	100	13	supplementation	supplementation	NOUN
admet-3030	100	14	recommendations	recommendation	NOUN
admet-3030	100	15	[	[	X
admet-3030	100	16	37	37	NUM
admet-3030	100	17	]	]	PUNCT
admet-3030	100	18	dysregulated	dysregulate	VERB
admet-3030	100	19	autophagy	autophagy	ADJ
admet-3030	100	20	autophagy	autophagy	NOUN
admet-3030	100	21	prevention	prevention	NOUN
admet-3030	100	22	will	will	AUX
admet-3030	100	23	prevent	prevent	VERB
admet-3030	100	24	aa	aa	NOUN
admet-3030	101	1	[	[	X
admet-3030	101	2	38	38	NUM
admet-3030	101	3	]	]	PUNCT
admet-3030	101	4	vitamin	vitamin	NOUN
admet-3030	101	5	d	d	NOUN
admet-3030	101	6	deficiency	deficiency	NOUN
admet-3030	101	7	and	and	CCONJ
admet-3030	101	8	zinc	zinc	NOUN
admet-3030	101	9	levels	level	NOUN
admet-3030	101	10	supplements	supplement	NOUN
admet-3030	101	11	for	for	ADP
admet-3030	101	12	vitamin	vitamin	NOUN
admet-3030	101	13	d	d	NOUN
admet-3030	101	14	[	[	X
admet-3030	101	15	39	39	NUM
admet-3030	101	16	]	]	PUNCT
admet-3030	101	17	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	101	18	https://www.google.com/search?q=major+histocompatibility+complex+class+i-related+sequence+a&sca_esv=fc456dddff8b5816&rlz=1c1chbd_enin1175in1175&ei=uwm0aaj6eiwxsemp0b3ssqq&oq=mica+gene+&gs_lp=egxnd3mtd2l6lxnlcnaick1jq0egz2vuzsaqaggemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgsqabiabbikbrigazileaaygaqyiguyhgmycxaagiaegiofgiydmgsqabiabbikbriga0j8ffckavikaxabeagqaqcyac8boahpaaobazitmbgbacgbapgbazgcaqac3ahcagoqabhhgnyegladmamaiaybkayikgcfms4wljggb6sfsgcdmi0xuaftacihazitmsghcoaiaq&sclient=gws-wiz-serp&mstk=autexfcm0swjb5ovsci4leqwiavcsfvodwtasxc7f7jbn1pluzunv4b2ozt5-u82q1mxbnjrjkk6vjxxl25kxdp6jlz0qjdywjd5t5nxxnekovx2p_-7izync9a9ikvtkgzwgqgtzceajzwm5tkdgvlcyzke-y1keew4fknlzsm05syqn1dwtwg5ooj47sj2ey_6vqxbflg0tqzn7rvw7_cuqlwrqza0x6ti25sbxz96tyor1w&csui=3&ved=2ahukewiw8it33qiraxvzugwgha3jijyqgk4qegqiarac	https://www.google.com/search?q=major+histocompatibility+complex+class+i-related+sequence+a&sca_esv=fc456dddff8b5816&rlz=1c1chbd_enin1175in1175&ei=uwm0aaj6eiwxsemp0b3ssqq&oq=mica+gene+&gs_lp=egxnd3mtd2l6lxnlcnaick1jq0egz2vuzsaqaggemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgsqabiabbikbrigazileaaygaqyiguyhgmycxaagiaegiofgiydmgsqabiabbikbriga0j8ffckavikaxabeagqaqcyac8boahpaaobazitmbgbacgbapgbazgcaqac3ahcagoqabhhgnyegladmamaiaybkayikgcfms4wljggb6sfsgcdmi0xuaftacihazitmsghcoaiaq&sclient=gws-wiz-serp&mstk=autexfcm0swjb5ovsci4leqwiavcsfvodwtasxc7f7jbn1pluzunv4b2ozt5-u82q1mxbnjrjkk6vjxxl25kxdp6jlz0qjdywjd5t5nxxnekovx2p_-7izync9a9ikvtkgzwgqgtzceajzwm5tkdgvlcyzke-y1keew4fknlzsm05syqn1dwtwg5ooj47sj2ey_6vqxbflg0tqzn7rvw7_cuqlwrqza0x6ti25sbxz96tyor1w&csui=3&ved=2ahukewiw8it33qiraxvzugwgha3jijyqgk4qegqiarac	PROPN
admet-3030	101	19	https://www.google.com/search?q=major+histocompatibility+complex+class+i-related+sequence+a&sca_esv=fc456dddff8b5816&rlz=1c1chbd_enin1175in1175&ei=uwm0aaj6eiwxsemp0b3ssqq&oq=mica+gene+&gs_lp=egxnd3mtd2l6lxnlcnaick1jq0egz2vuzsaqaggemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgsqabiabbikbrigazileaaygaqyiguyhgmycxaagiaegiofgiydmgsqabiabbikbriga0j8ffckavikaxabeagqaqcyac8boahpaaobazitmbgbacgbapgbazgcaqac3ahcagoqabhhgnyegladmamaiaybkayikgcfms4wljggb6sfsgcdmi0xuaftacihazitmsghcoaiaq&sclient=gws-wiz-serp&mstk=autexfcm0swjb5ovsci4leqwiavcsfvodwtasxc7f7jbn1pluzunv4b2ozt5-u82q1mxbnjrjkk6vjxxl25kxdp6jlz0qjdywjd5t5nxxnekovx2p_-7izync9a9ikvtkgzwgqgtzceajzwm5tkdgvlcyzke-y1keew4fknlzsm05syqn1dwtwg5ooj47sj2ey_6vqxbflg0tqzn7rvw7_cuqlwrqza0x6ti25sbxz96tyor1w&csui=3&ved=2ahukewiw8it33qiraxvzugwgha3jijyqgk4qegqiarac	https://www.google.com/search?q=major+histocompatibility+complex+class+i-related+sequence+a&sca_esv=fc456dddff8b5816&rlz=1c1chbd_enin1175in1175&ei=uwm0aaj6eiwxsemp0b3ssqq&oq=mica+gene+&gs_lp=egxnd3mtd2l6lxnlcnaick1jq0egz2vuzsaqaggemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgsqabiabbikbrigazileaaygaqyiguyhgmycxaagiaegiofgiydmgsqabiabbikbriga0j8ffckavikaxabeagqaqcyac8boahpaaobazitmbgbacgbapgbazgcaqac3ahcagoqabhhgnyegladmamaiaybkayikgcfms4wljggb6sfsgcdmi0xuaftacihazitmsghcoaiaq&sclient=gws-wiz-serp&mstk=autexfcm0swjb5ovsci4leqwiavcsfvodwtasxc7f7jbn1pluzunv4b2ozt5-u82q1mxbnjrjkk6vjxxl25kxdp6jlz0qjdywjd5t5nxxnekovx2p_-7izync9a9ikvtkgzwgqgtzceajzwm5tkdgvlcyzke-y1keew4fknlzsm05syqn1dwtwg5ooj47sj2ey_6vqxbflg0tqzn7rvw7_cuqlwrqza0x6ti25sbxz96tyor1w&csui=3&ved=2ahukewiw8it33qiraxvzugwgha3jijyqgk4qegqiarac	PROPN
admet-3030	101	20	https://www.google.com/search?q=interleukin-13&sca_esv=083f7bdd283a4f59&rlz=1c1chbd_enin1175in1175&sxsrf=ae3tifnb_nyqselsnvvlsqr6eakkdubj4w%3a1765003283793&ei=e9azackommo5nespxqdbmq8&ved=2ahukewjv2nwb4airaxwe2tgghucmheaqgk4qegqiarac&oq=il13+full+form&gs_lp=egxnd3mtd2l6lxnlcnaidklmmtmgznvsbcbmb3jtmgyqabgngb4ycxaagiaegiydgiofmgsqabiabbigaxikbtileaaygaqyhgmyiguycxaagiaegiydgiofmguqabjvbtifeaay7wuycbaagiaegkiemggqabiabbiibeidifdbcvjkdhaceagqaqcyaccboahnaqobazaumrgbdmgbapgbavgbazgcbkacgwpcagoqabiwaxjwbbhhwgineaaygaqysamyqxikbzgdaiggazagcpihbtiums4xoaefclihbtaums4xuafeasihbtitmi4yyacigaga&sclient=gws-wiz-serp&mstk=autexfcsoyphm5uqfhjxatxgfpf-ik6pvcgb1jktm7f8_0u2ozpepf5ghea-aiczvgokagcct1us2al9cwmf2wnvnkpk7cntsudp8jhz7nyjtb4badqdnepduec-roiojzqi9a7uz2uh-u5a43mfcooh8xi27lvo0pvy2w35jqpoc4qxyk8&csui=3	https://www.google.com/search?q=interleukin-13&sca_esv=083f7bdd283a4f59&rlz=1c1chbd_enin1175in1175&sxsrf=ae3tifnb_nyqselsnvvlsqr6eakkdubj4w%3a1765003283793&ei=e9azackommo5nespxqdbmq8&ved=2ahukewjv2nwb4airaxwe2tgghucmheaqgk4qegqiarac&oq=il13+full+form&gs_lp=egxnd3mtd2l6lxnlcnaidklmmtmgznvsbcbmb3jtmgyqabgngb4ycxaagiaegiydgiofmgsqabiabbigaxikbtileaaygaqyhgmyiguycxaagiaegiydgiofmguqabjvbtifeaay7wuycbaagiaegkiemggqabiabbiibeidifdbcvjkdhaceagqaqcyaccboahnaqobazaumrgbdmgbapgbavgbazgcbkacgwpcagoqabiwaxjwbbhhwgineaaygaqysamyqxikbzgdaiggazagcpihbtiums4xoaefclihbtaums4xuafeasihbtitmi4yyacigaga&sclient=gws-wiz-serp&mstk=autexfcsoyphm5uqfhjxatxgfpf-ik6pvcgb1jktm7f8_0u2ozpepf5ghea-aiczvgokagcct1us2al9cwmf2wnvnkpk7cntsudp8jhz7nyjtb4badqdnepduec-roiojzqi9a7uz2uh-u5a43mfcooh8xi27lvo0pvy2w35jqpoc4qxyk8&csui=3	VERB
admet-3030	101	21	https://www.google.com/search?q=cluster+of+differentiation+24&sca_esv=fc456dddff8b5816&rlz=1c1chbd_enin1175in1175&ei=eag0adb6mewrsempgmqp4qe&ved=2ahukewiilfpj46iraxu2xmwghydnjt0qgk4qegqiarab&uact=5&oq=cd24+gene+full+form&gs_lp=egxnd3mtd2l6lxnlcnaie0nemjqgz2vuzsbmdwxsigzvcm0ycbahgkabgmmemggqirigarjdbejskvdnhfjnhhadeagqaqcyaf0goah9bqobazytmbgba8gbapgbavgbazgcbkaclgfcagoqabhhgnyegladmamaiaybkayikgcfmy42ltggb4acsgcdni0xuaebb8ihbtaums4zyacsgagb&sclient=gws-wiz-serp&mstk=autexfdhzdgccg0t0ywgtd93kmjkhfstpnxq6vmfjokzujkrsgkezxtiofcfv_ebyp7ehy2pqhhrr-rnicfe4aburhdeguhlz4ltz2t03rxk-hceokucdfhpzw7w9jxqcq9gcuezjr8ed3clcvim6kia8sygjhc5i4awvxzeltpckfvpqwggul_6qtxieunan9yhplydoopn2_m5sfsnhknry7wi5cmkbbxkfvixf5z-zodoew&csui=3	https://www.google.com/search?q=cluster+of+differentiation+24&sca_esv=fc456dddff8b5816&rlz=1c1chbd_enin1175in1175&ei=eag0adb6mewrsempgmqp4qe&ved=2ahukewiilfpj46iraxu2xmwghydnjt0qgk4qegqiarab&uact=5&oq=cd24+gene+full+form&gs_lp=egxnd3mtd2l6lxnlcnaie0nemjqgz2vuzsbmdwxsigzvcm0ycbahgkabgmmemggqirigarjdbejskvdnhfjnhhadeagqaqcyaf0goah9bqobazytmbgba8gbapgbavgbazgcbkaclgfcagoqabhhgnyegladmamaiaybkayikgcfmy42ltggb4acsgcdni0xuaebb8ihbtaums4zyacsgagb&sclient=gws-wiz-serp&mstk=autexfdhzdgccg0t0ywgtd93kmjkhfstpnxq6vmfjokzujkrsgkezxtiofcfv_ebyp7ehy2pqhhrr-rnicfe4aburhdeguhlz4ltz2t03rxk-hceokucdfhpzw7w9jxqcq9gcuezjr8ed3clcvim6kia8sygjhc5i4awvxzeltpckfvpqwggul_6qtxieunan9yhplydoopn2_m5sfsnhknry7wi5cmkbbxkfvixf5z-zodoew&csui=3	PROPN
admet-3030	101	22	r.	r.	PROPN
admet-3030	101	23	kapoor	kapoor	PROPN
admet-3030	101	24	et	et	PROPN
admet-3030	101	25	al	al	PROPN
admet-3030	101	26	.	.	PROPN
admet-3030	101	27	admet	admet	PROPN
admet-3030	101	28	&	&	CCONJ
admet-3030	101	29	dmpk	dmpk	PROPN
admet-3030	101	30	00(0	00(0	PROPN
admet-3030	101	31	)	)	PUNCT
admet-3030	101	32	(	(	PUNCT
admet-3030	101	33	2025	2025	NUM
admet-3030	101	34	)	)	PUNCT
admet-3030	101	35	3030	3030	NUM
admet-3030	101	36	6	6	NUM
admet-3030	101	37	genetic	genetic	ADJ
admet-3030	101	38	and	and	CCONJ
admet-3030	101	39	molecular	molecular	ADJ
admet-3030	101	40	insights	insight	NOUN
admet-3030	101	41	genetic	genetic	ADJ
admet-3030	101	42	research	research	NOUN
admet-3030	101	43	has	have	AUX
admet-3030	101	44	further	far	ADV
admet-3030	101	45	advanced	advance	VERB
admet-3030	101	46	the	the	DET
admet-3030	101	47	understanding	understanding	NOUN
admet-3030	101	48	of	of	ADP
admet-3030	101	49	aga	aga	NOUN
admet-3030	101	50	and	and	CCONJ
admet-3030	101	51	aa	aa	NOUN
admet-3030	101	52	.	.	PUNCT
admet-3030	102	1	y.	y.	PROPN
admet-3030	102	2	li	li	PROPN
admet-3030	102	3	et	et	PROPN
admet-3030	102	4	al	al	PROPN
admet-3030	102	5	.	.	PUNCT
admet-3030	103	1	[	[	X
admet-3030	103	2	25	25	NUM
admet-3030	103	3	]	]	PUNCT
admet-3030	103	4	explored	explore	VERB
admet-3030	103	5	the	the	DET
admet-3030	103	6	role	role	NOUN
admet-3030	103	7	of	of	ADP
admet-3030	103	8	impaired	impaired	ADJ
admet-3030	103	9	arginine	arginine	NOUN
admet-3030	103	10	metabolism	metabolism	NOUN
admet-3030	103	11	in	in	ADP
admet-3030	103	12	androgenetic	androgenetic	ADJ
admet-3030	103	13	alopecia	alopecia	NOUN
admet-3030	103	14	(	(	PUNCT
admet-3030	103	15	aga	aga	PROPN
admet-3030	103	16	)	)	PUNCT
admet-3030	103	17	,	,	PUNCT
admet-3030	103	18	finding	find	VERB
admet-3030	103	19	that	that	SCONJ
admet-3030	103	20	an	an	DET
admet-3030	103	21	arginine	arginine	NOUN
admet-3030	103	22	deficiency	deficiency	NOUN
admet-3030	103	23	and	and	CCONJ
admet-3030	103	24	increased	increase	VERB
admet-3030	103	25	levels	level	NOUN
admet-3030	103	26	of	of	ADP
admet-3030	103	27	ornithine	ornithine	NOUN
admet-3030	103	28	disrupted	disrupt	VERB
admet-3030	103	29	the	the	DET
admet-3030	103	30	mtor	mtor	PROPN
admet-3030	103	31	pathway	pathway	NOUN
admet-3030	103	32	,	,	PUNCT
admet-3030	103	33	a	a	DET
admet-3030	103	34	key	key	ADJ
admet-3030	103	35	regulator	regulator	NOUN
admet-3030	103	36	of	of	ADP
admet-3030	103	37	hair	hair	NOUN
admet-3030	103	38	follicle	follicle	NOUN
admet-3030	103	39	development	development	NOUN
admet-3030	103	40	.	.	PUNCT
admet-3030	104	1	by	by	ADP
admet-3030	104	2	supplementing	supplement	VERB
admet-3030	104	3	arginine	arginine	NOUN
admet-3030	104	4	and	and	CCONJ
admet-3030	104	5	using	use	VERB
admet-3030	104	6	dietary	dietary	ADJ
admet-3030	104	7	supplements	supplement	NOUN
admet-3030	104	8	,	,	PUNCT
admet-3030	104	9	hair	hair	NOUN
admet-3030	104	10	follicle	follicle	NOUN
admet-3030	104	11	regrowth	regrowth	NOUN
admet-3030	104	12	was	be	AUX
admet-3030	104	13	promoted	promote	VERB
admet-3030	104	14	in	in	ADP
admet-3030	104	15	ex	ex	PRON
admet-3030	104	16	vivo	vivo	ADJ
admet-3030	104	17	experiments	experiment	NOUN
admet-3030	104	18	,	,	PUNCT
admet-3030	104	19	suggesting	suggest	VERB
admet-3030	104	20	that	that	SCONJ
admet-3030	104	21	targeting	target	VERB
admet-3030	104	22	metabolic	metabolic	NOUN
admet-3030	104	23	pathways	pathway	NOUN
admet-3030	104	24	could	could	AUX
admet-3030	104	25	be	be	AUX
admet-3030	104	26	a	a	DET
admet-3030	104	27	therapeutic	therapeutic	ADJ
admet-3030	104	28	strategy	strategy	NOUN
admet-3030	104	29	for	for	ADP
admet-3030	104	30	aga	aga	NOUN
admet-3030	104	31	[	[	X
admet-3030	104	32	40	40	NUM
admet-3030	104	33	]	]	PUNCT
admet-3030	104	34	.	.	PUNCT
admet-3030	105	1	in	in	ADP
admet-3030	105	2	a	a	DET
admet-3030	105	3	broader	broad	ADJ
admet-3030	105	4	genetic	genetic	ADJ
admet-3030	105	5	context	context	NOUN
admet-3030	105	6	,	,	PUNCT
admet-3030	105	7	mendelian	mendelian	ADJ
admet-3030	105	8	randomization	randomization	NOUN
admet-3030	105	9	(	(	PUNCT
admet-3030	105	10	mr	mr	PROPN
admet-3030	105	11	)	)	PUNCT
admet-3030	105	12	studies	study	NOUN
admet-3030	105	13	have	have	AUX
admet-3030	105	14	provided	provide	VERB
admet-3030	105	15	insights	insight	NOUN
admet-3030	105	16	into	into	ADP
admet-3030	105	17	the	the	DET
admet-3030	105	18	genetic	genetic	ADJ
admet-3030	105	19	risk	risk	NOUN
admet-3030	105	20	factors	factor	NOUN
admet-3030	105	21	of	of	ADP
admet-3030	105	22	aa	aa	NOUN
admet-3030	105	23	.	.	PUNCT
admet-3030	106	1	few	few	ADJ
admet-3030	106	2	researchers	researcher	NOUN
admet-3030	106	3	have	have	AUX
admet-3030	106	4	performed	perform	VERB
admet-3030	106	5	mr	mr	PROPN
admet-3030	106	6	and	and	CCONJ
admet-3030	106	7	genome	genome	NOUN
admet-3030	106	8	-	-	PUNCT
admet-3030	106	9	wide	wide	ADJ
admet-3030	106	10	association	association	NOUN
admet-3030	106	11	studies	study	NOUN
admet-3030	106	12	(	(	PUNCT
admet-3030	106	13	gwas	gwas	PROPN
admet-3030	106	14	)	)	PUNCT
admet-3030	106	15	to	to	PART
admet-3030	106	16	investigate	investigate	VERB
admet-3030	106	17	the	the	DET
admet-3030	106	18	relationship	relationship	NOUN
admet-3030	106	19	between	between	ADP
admet-3030	106	20	asthma	asthma	NOUN
admet-3030	106	21	and	and	CCONJ
admet-3030	106	22	aa	aa	NOUN
admet-3030	106	23	,	,	PUNCT
admet-3030	106	24	identifying	identify	VERB
admet-3030	106	25	interleukin	interleukin	NOUN
admet-3030	106	26	il-33	il-33	ADJ
admet-3030	106	27	as	as	ADP
admet-3030	106	28	a	a	DET
admet-3030	106	29	mediator	mediator	NOUN
admet-3030	106	30	[	[	X
admet-3030	106	31	41	41	NUM
admet-3030	106	32	]	]	PUNCT
admet-3030	106	33	.	.	PUNCT
admet-3030	107	1	their	their	PRON
admet-3030	107	2	findings	finding	NOUN
admet-3030	107	3	indicate	indicate	VERB
admet-3030	107	4	that	that	SCONJ
admet-3030	107	5	individuals	individual	NOUN
admet-3030	107	6	with	with	ADP
admet-3030	107	7	asthma	asthma	NOUN
admet-3030	107	8	have	have	VERB
admet-3030	107	9	an	an	DET
admet-3030	107	10	increased	increase	VERB
admet-3030	107	11	risk	risk	NOUN
admet-3030	107	12	of	of	ADP
admet-3030	107	13	developing	develop	VERB
admet-3030	107	14	aa	aa	NOUN
admet-3030	107	15	,	,	PUNCT
admet-3030	107	16	thus	thus	ADV
admet-3030	107	17	highlighting	highlight	VERB
admet-3030	107	18	the	the	DET
admet-3030	107	19	interconnectedness	interconnectedness	NOUN
admet-3030	107	20	of	of	ADP
admet-3030	107	21	immune	immune	NOUN
admet-3030	107	22	-	-	PUNCT
admet-3030	107	23	related	relate	VERB
admet-3030	107	24	diseases	disease	NOUN
admet-3030	107	25	.	.	PUNCT
admet-3030	108	1	additionally	additionally	ADV
admet-3030	108	2	,	,	PUNCT
admet-3030	108	3	yimei	yimei	NOUN
admet-3030	108	4	du	du	PROPN
admet-3030	108	5	et	et	PROPN
admet-3030	108	6	al	al	PROPN
admet-3030	108	7	.	.	PUNCT
admet-3030	109	1	[	[	X
admet-3030	109	2	42	42	NUM
admet-3030	109	3	]	]	PUNCT
admet-3030	109	4	used	use	VERB
admet-3030	109	5	a	a	DET
admet-3030	109	6	two	two	NUM
admet-3030	109	7	-	-	PUNCT
admet-3030	109	8	sample	sample	NOUN
admet-3030	109	9	mr	mr	PROPN
admet-3030	109	10	approach	approach	NOUN
admet-3030	109	11	to	to	PART
admet-3030	109	12	examine	examine	VERB
admet-3030	109	13	the	the	DET
admet-3030	109	14	impact	impact	NOUN
admet-3030	109	15	of	of	ADP
admet-3030	109	16	approximately	approximately	ADV
admet-3030	109	17	452	452	NUM
admet-3030	109	18	metabolites	metabolite	NOUN
admet-3030	109	19	on	on	ADP
admet-3030	109	20	aga	aga	NOUN
admet-3030	109	21	.	.	PUNCT
admet-3030	110	1	their	their	PRON
admet-3030	110	2	analysis	analysis	NOUN
admet-3030	110	3	identified	identify	VERB
admet-3030	110	4	heme	heme	NOUN
admet-3030	110	5	and	and	CCONJ
admet-3030	110	6	2	2	NUM
admet-3030	110	7	-	-	PUNCT
admet-3030	110	8	palmitoyl	palmitoyl	NOUN
admet-3030	110	9	-	-	PUNCT
admet-3030	110	10	glycerophosphocholine	glycerophosphocholine	NOUN
admet-3030	110	11	as	as	ADP
admet-3030	110	12	risk	risk	NOUN
admet-3030	110	13	factors	factor	NOUN
admet-3030	110	14	for	for	ADP
admet-3030	110	15	aga	aga	NOUN
admet-3030	110	16	,	,	PUNCT
admet-3030	110	17	while	while	SCONJ
admet-3030	110	18	scyllo	scyllo	NOUN
admet-3030	110	19	-	-	PUNCT
admet-3030	110	20	inositol	inositol	NOUN
admet-3030	110	21	and	and	CCONJ
admet-3030	110	22	alpha	alpha	NOUN
admet-3030	110	23	-	-	PUNCT
admet-3030	110	24	ketoglutarate	ketoglutarate	PROPN
admet-3030	110	25	were	be	AUX
admet-3030	110	26	found	find	VERB
admet-3030	110	27	to	to	PART
admet-3030	110	28	have	have	VERB
admet-3030	110	29	protective	protective	ADJ
admet-3030	110	30	effects	effect	NOUN
admet-3030	110	31	.	.	PUNCT
admet-3030	111	1	this	this	DET
admet-3030	111	2	study	study	NOUN
admet-3030	111	3	underscores	underscore	VERB
admet-3030	111	4	the	the	DET
admet-3030	111	5	importance	importance	NOUN
admet-3030	111	6	of	of	ADP
admet-3030	111	7	metabolites	metabolite	NOUN
admet-3030	111	8	in	in	ADP
admet-3030	111	9	the	the	DET
admet-3030	111	10	progression	progression	NOUN
admet-3030	111	11	of	of	ADP
admet-3030	111	12	aga	aga	NOUN
admet-3030	111	13	,	,	PUNCT
admet-3030	111	14	further	far	ADV
admet-3030	111	15	suggesting	suggest	VERB
admet-3030	111	16	potential	potential	ADJ
admet-3030	111	17	biomarkers	biomarker	NOUN
admet-3030	111	18	for	for	ADP
admet-3030	111	19	diagnosis	diagnosis	NOUN
admet-3030	111	20	and	and	CCONJ
admet-3030	111	21	treatment	treatment	NOUN
admet-3030	111	22	.	.	PUNCT
admet-3030	112	1	androgenetic	androgenetic	ADJ
admet-3030	112	2	alopecia	alopecia	NOUN
admet-3030	112	3	(	(	PUNCT
admet-3030	112	4	aga	aga	PROPN
admet-3030	112	5	)	)	PUNCT
admet-3030	112	6	is	be	AUX
admet-3030	112	7	a	a	DET
admet-3030	112	8	multifactorial	multifactorial	ADJ
admet-3030	112	9	condition	condition	NOUN
admet-3030	112	10	characterized	characterize	VERB
admet-3030	112	11	by	by	ADP
admet-3030	112	12	progressive	progressive	ADJ
admet-3030	112	13	hair	hair	NOUN
admet-3030	112	14	follicle	follicle	NOUN
admet-3030	112	15	miniaturization	miniaturization	NOUN
admet-3030	112	16	in	in	ADP
admet-3030	112	17	genetically	genetically	ADV
admet-3030	112	18	predisposed	predispose	VERB
admet-3030	112	19	individuals	individual	NOUN
admet-3030	112	20	under	under	ADP
admet-3030	112	21	the	the	DET
admet-3030	112	22	influence	influence	NOUN
admet-3030	112	23	of	of	ADP
admet-3030	112	24	androgens	androgen	NOUN
admet-3030	112	25	.	.	PUNCT
admet-3030	113	1	while	while	SCONJ
admet-3030	113	2	the	the	DET
admet-3030	113	3	role	role	NOUN
admet-3030	113	4	of	of	ADP
admet-3030	113	5	dihydrotestosterone	dihydrotestosterone	NOUN
admet-3030	113	6	(	(	PUNCT
admet-3030	113	7	dht	dht	NOUN
admet-3030	113	8	)	)	PUNCT
admet-3030	113	9	is	be	AUX
admet-3030	113	10	central	central	ADJ
admet-3030	113	11	to	to	ADP
admet-3030	113	12	its	its	PRON
admet-3030	113	13	pathophysiology	pathophysiology	NOUN
admet-3030	113	14	,	,	PUNCT
admet-3030	113	15	mounting	mount	VERB
admet-3030	113	16	evidence	evidence	NOUN
admet-3030	113	17	underscores	underscore	VERB
admet-3030	113	18	a	a	DET
admet-3030	113	19	complex	complex	ADJ
admet-3030	113	20	genetic	genetic	ADJ
admet-3030	113	21	architecture	architecture	NOUN
admet-3030	113	22	involving	involve	VERB
admet-3030	113	23	several	several	ADJ
admet-3030	113	24	key	key	ADJ
admet-3030	113	25	genes	gene	NOUN
admet-3030	113	26	and	and	CCONJ
admet-3030	113	27	signalling	signal	VERB
admet-3030	113	28	pathways	pathway	NOUN
admet-3030	113	29	that	that	PRON
admet-3030	113	30	regulate	regulate	VERB
admet-3030	113	31	follicular	follicular	ADJ
admet-3030	113	32	response	response	NOUN
admet-3030	113	33	to	to	ADP
admet-3030	113	34	androgens	androgens	NOUN
admet-3030	113	35	.	.	PUNCT
admet-3030	114	1	the	the	DET
admet-3030	114	2	androgen	androgen	NOUN
admet-3030	114	3	receptor	receptor	NOUN
admet-3030	114	4	(	(	PUNCT
admet-3030	114	5	ar	ar	NOUN
admet-3030	114	6	)	)	PUNCT
admet-3030	114	7	gene	gene	NOUN
admet-3030	114	8	,	,	PUNCT
admet-3030	114	9	located	locate	VERB
admet-3030	114	10	on	on	ADP
admet-3030	114	11	the	the	DET
admet-3030	114	12	x	x	PUNCT
admet-3030	114	13	chromosome	chromosome	NOUN
admet-3030	114	14	(	(	PUNCT
admet-3030	114	15	xq11	xq11	PROPN
admet-3030	114	16	-	-	PUNCT
admet-3030	114	17	12	12	NUM
admet-3030	114	18	)	)	PUNCT
admet-3030	114	19	,	,	PUNCT
admet-3030	114	20	has	have	AUX
admet-3030	114	21	emerged	emerge	VERB
admet-3030	114	22	as	as	ADP
admet-3030	114	23	a	a	DET
admet-3030	114	24	major	major	ADJ
admet-3030	114	25	genetic	genetic	ADJ
admet-3030	114	26	determinant	determinant	NOUN
admet-3030	114	27	of	of	ADP
admet-3030	114	28	aga	aga	PROPN
admet-3030	114	29	.	.	PUNCT
admet-3030	115	1	hibberts	hibbert	NOUN
admet-3030	115	2	et	et	PROPN
admet-3030	115	3	al	al	PROPN
admet-3030	115	4	.	.	PUNCT
admet-3030	116	1	[	[	X
admet-3030	116	2	30	30	NUM
admet-3030	116	3	]	]	PUNCT
admet-3030	116	4	demonstrated	demonstrate	VERB
admet-3030	116	5	significantly	significantly	ADV
admet-3030	116	6	higher	high	ADJ
admet-3030	116	7	levels	level	NOUN
admet-3030	116	8	of	of	ADP
admet-3030	116	9	ar	ar	NOUN
admet-3030	116	10	expression	expression	NOUN
admet-3030	116	11	in	in	ADP
admet-3030	116	12	dermal	dermal	ADJ
admet-3030	116	13	papilla	papilla	NOUN
admet-3030	116	14	cells	cell	NOUN
admet-3030	116	15	from	from	ADP
admet-3030	116	16	balding	bald	VERB
admet-3030	116	17	scalp	scalp	NOUN
admet-3030	116	18	compared	compare	VERB
admet-3030	116	19	to	to	ADP
admet-3030	116	20	non	non	ADJ
admet-3030	116	21	-	-	ADJ
admet-3030	116	22	balding	balding	ADJ
admet-3030	116	23	regions	region	NOUN
admet-3030	116	24	,	,	PUNCT
admet-3030	116	25	establishing	establish	VERB
admet-3030	116	26	a	a	DET
admet-3030	116	27	functional	functional	ADJ
admet-3030	116	28	link	link	NOUN
admet-3030	116	29	between	between	ADP
admet-3030	116	30	ar	ar	NOUN
admet-3030	116	31	density	density	NOUN
admet-3030	116	32	and	and	CCONJ
admet-3030	116	33	follicular	follicular	ADJ
admet-3030	116	34	sensitivity	sensitivity	NOUN
admet-3030	116	35	to	to	ADP
admet-3030	116	36	androgens	androgens	NOUN
admet-3030	116	37	.	.	PUNCT
admet-3030	117	1	subsequent	subsequent	ADJ
admet-3030	117	2	genetic	genetic	ADJ
admet-3030	117	3	studies	study	NOUN
admet-3030	117	4	identified	identify	VERB
admet-3030	117	5	several	several	ADJ
admet-3030	117	6	single	single	ADJ
admet-3030	117	7	-	-	PUNCT
admet-3030	117	8	nucleotide	nucleotide	NOUN
admet-3030	117	9	polymorphisms	polymorphism	NOUN
admet-3030	117	10	(	(	PUNCT
admet-3030	117	11	snps	snps	PROPN
admet-3030	117	12	)	)	PUNCT
admet-3030	117	13	and	and	CCONJ
admet-3030	117	14	triplet	triplet	NOUN
admet-3030	117	15	-	-	PUNCT
admet-3030	117	16	repeat	repeat	NOUN
admet-3030	117	17	polymorphisms	polymorphism	NOUN
admet-3030	117	18	in	in	ADP
admet-3030	117	19	the	the	DET
admet-3030	117	20	ar	ar	NOUN
admet-3030	117	21	gene	gene	NOUN
admet-3030	117	22	associated	associate	VERB
admet-3030	117	23	with	with	ADP
admet-3030	117	24	early	early	ADJ
admet-3030	117	25	-	-	PUNCT
admet-3030	117	26	onset	onset	NOUN
admet-3030	117	27	aga	aga	NOUN
admet-3030	117	28	.	.	PUNCT
admet-3030	118	1	however	however	ADV
admet-3030	118	2	,	,	PUNCT
admet-3030	118	3	not	not	PART
admet-3030	118	4	all	all	DET
admet-3030	118	5	polymorphisms	polymorphism	NOUN
admet-3030	118	6	exert	exert	VERB
admet-3030	118	7	a	a	DET
admet-3030	118	8	pathogenic	pathogenic	ADJ
admet-3030	118	9	effect	effect	NOUN
admet-3030	118	10	;	;	PUNCT
admet-3030	118	11	for	for	ADP
admet-3030	118	12	instance	instance	NOUN
admet-3030	118	13	,	,	PUNCT
admet-3030	118	14	ellis	ellis	PROPN
admet-3030	118	15	et	et	PROPN
admet-3030	118	16	al	al	PROPN
admet-3030	118	17	.	.	PUNCT
admet-3030	119	1	[	[	X
admet-3030	119	2	43	43	NUM
admet-3030	119	3	]	]	PUNCT
admet-3030	119	4	reported	report	VERB
admet-3030	119	5	that	that	SCONJ
admet-3030	119	6	the	the	DET
admet-3030	119	7	ar	ar	PROPN
admet-3030	119	8	polyglycine	polyglycine	PROPN
admet-3030	119	9	repeat	repeat	NOUN
admet-3030	119	10	variant	variant	NOUN
admet-3030	119	11	does	do	AUX
admet-3030	119	12	not	not	PART
admet-3030	119	13	confer	confer	VERB
admet-3030	119	14	increased	increase	VERB
admet-3030	119	15	susceptibility	susceptibility	NOUN
admet-3030	119	16	.	.	PUNCT
admet-3030	120	1	beyond	beyond	ADP
admet-3030	120	2	ar	ar	PROPN
admet-3030	120	3	,	,	PUNCT
admet-3030	120	4	the	the	DET
admet-3030	120	5	eda2r	eda2r	PROPN
admet-3030	120	6	gene	gene	NOUN
admet-3030	120	7	,	,	PUNCT
admet-3030	120	8	also	also	ADV
admet-3030	120	9	located	locate	VERB
admet-3030	120	10	on	on	ADP
admet-3030	120	11	the	the	DET
admet-3030	120	12	x	x	PUNCT
admet-3030	120	13	chromosome	chromosome	NOUN
admet-3030	120	14	,	,	PUNCT
admet-3030	120	15	has	have	AUX
admet-3030	120	16	been	be	AUX
admet-3030	120	17	implicated	implicate	VERB
admet-3030	120	18	in	in	ADP
admet-3030	120	19	aga	aga	NOUN
admet-3030	120	20	.	.	PUNCT
admet-3030	121	1	prodi	prodi	VERB
admet-3030	121	2	et	et	PROPN
admet-3030	121	3	al	al	PROPN
admet-3030	121	4	.	.	PUNCT
admet-3030	122	1	[	[	X
admet-3030	122	2	44	44	NUM
admet-3030	122	3	]	]	PUNCT
admet-3030	122	4	identified	identify	VERB
admet-3030	122	5	a	a	DET
admet-3030	122	6	strong	strong	ADJ
admet-3030	122	7	association	association	NOUN
admet-3030	122	8	between	between	ADP
admet-3030	122	9	eda2r	eda2r	PROPN
admet-3030	122	10	polymorphisms	polymorphism	NOUN
admet-3030	122	11	and	and	CCONJ
admet-3030	122	12	male	male	ADJ
admet-3030	122	13	pattern	pattern	NOUN
admet-3030	122	14	baldness	baldness	NOUN
admet-3030	122	15	,	,	PUNCT
admet-3030	122	16	potentially	potentially	ADV
admet-3030	122	17	through	through	ADP
admet-3030	122	18	linkage	linkage	NOUN
admet-3030	122	19	disequilibrium	disequilibrium	NOUN
admet-3030	122	20	with	with	ADP
admet-3030	122	21	ar	ar	NOUN
admet-3030	122	22	,	,	PUNCT
admet-3030	122	23	further	far	ADV
admet-3030	122	24	highlighting	highlight	VERB
admet-3030	122	25	the	the	DET
admet-3030	122	26	importance	importance	NOUN
admet-3030	122	27	of	of	ADP
admet-3030	122	28	maternal	maternal	ADJ
admet-3030	122	29	inheritance	inheritance	NOUN
admet-3030	122	30	patterns	pattern	NOUN
admet-3030	122	31	in	in	ADP
admet-3030	122	32	aga	aga	PROPN
admet-3030	122	33	.	.	PUNCT
admet-3030	123	1	genome	genome	NOUN
admet-3030	123	2	-	-	PUNCT
admet-3030	123	3	wide	wide	ADJ
admet-3030	123	4	association	association	NOUN
admet-3030	123	5	studies	study	NOUN
admet-3030	123	6	(	(	PUNCT
admet-3030	123	7	gwas	gwas	PROPN
admet-3030	123	8	)	)	PUNCT
admet-3030	123	9	have	have	AUX
admet-3030	123	10	broadened	broaden	VERB
admet-3030	123	11	our	our	PRON
admet-3030	123	12	understanding	understanding	NOUN
admet-3030	123	13	of	of	ADP
admet-3030	123	14	aga	aga	NOUN
admet-3030	123	15	by	by	ADP
admet-3030	123	16	revealing	reveal	VERB
admet-3030	123	17	additional	additional	ADJ
admet-3030	123	18	risk	risk	NOUN
admet-3030	123	19	loci	locus	NOUN
admet-3030	123	20	.	.	PUNCT
admet-3030	124	1	heilmann	heilmann	PROPN
admet-3030	124	2	et	et	PROPN
admet-3030	124	3	al	al	PROPN
admet-3030	124	4	.	.	PUNCT
admet-3030	125	1	[	[	X
admet-3030	125	2	45	45	NUM
admet-3030	125	3	]	]	PUNCT
admet-3030	125	4	identified	identify	VERB
admet-3030	125	5	four	four	NUM
admet-3030	125	6	significant	significant	ADJ
admet-3030	125	7	loci	locus	NOUN
admet-3030	125	8	at	at	ADP
admet-3030	125	9	2q35	2q35	NUM
admet-3030	125	10	,	,	PUNCT
admet-3030	125	11	3q25.1	3q25.1	NUM
admet-3030	125	12	,	,	PUNCT
admet-3030	125	13	5q33.3	5q33.3	NUM
admet-3030	125	14	and	and	CCONJ
admet-3030	125	15	12p12.1	12p12.1	NUM
admet-3030	125	16	,	,	PUNCT
admet-3030	125	17	implicating	implicate	VERB
admet-3030	125	18	genes	gene	NOUN
admet-3030	125	19	such	such	ADJ
admet-3030	125	20	as	as	ADP
admet-3030	125	21	wnt10a	wnt10a	NOUN
admet-3030	125	22	,	,	PUNCT
admet-3030	125	23	which	which	PRON
admet-3030	125	24	plays	play	VERB
admet-3030	125	25	a	a	DET
admet-3030	125	26	role	role	NOUN
admet-3030	125	27	in	in	ADP
admet-3030	125	28	hair	hair	NOUN
admet-3030	125	29	follicle	follicle	NOUN
admet-3030	125	30	cycling	cycling	NOUN
admet-3030	125	31	and	and	CCONJ
admet-3030	125	32	differentiation	differentiation	NOUN
admet-3030	125	33	.	.	PUNCT
admet-3030	126	1	similarly	similarly	ADV
admet-3030	126	2	,	,	PUNCT
admet-3030	126	3	shimomura	shimomura	NOUN
admet-3030	126	4	et	et	PROPN
admet-3030	126	5	al	al	PROPN
admet-3030	126	6	.	.	PUNCT
admet-3030	127	1	[	[	X
admet-3030	127	2	46	46	NUM
admet-3030	127	3	]	]	PUNCT
admet-3030	127	4	linked	link	VERB
admet-3030	127	5	apcdd1	apcdd1	PROPN
admet-3030	127	6	,	,	PUNCT
admet-3030	127	7	a	a	DET
admet-3030	127	8	known	know	VERB
admet-3030	127	9	wnt	wnt	NOUN
admet-3030	127	10	signalling	signal	VERB
admet-3030	127	11	inhibitor	inhibitor	NOUN
admet-3030	127	12	located	locate	VERB
admet-3030	127	13	at	at	ADP
admet-3030	127	14	18p11.2	18p11.2	NUM
admet-3030	127	15	,	,	PUNCT
admet-3030	127	16	to	to	ADP
admet-3030	127	17	hereditary	hereditary	ADJ
admet-3030	127	18	hair	hair	NOUN
admet-3030	127	19	loss	loss	NOUN
admet-3030	127	20	.	.	PUNCT
admet-3030	128	1	these	these	DET
admet-3030	128	2	findings	finding	NOUN
admet-3030	128	3	support	support	VERB
admet-3030	128	4	the	the	DET
admet-3030	128	5	crucial	crucial	ADJ
admet-3030	128	6	role	role	NOUN
admet-3030	128	7	of	of	ADP
admet-3030	128	8	wnt	wnt	PROPN
admet-3030	128	9	/	/	SYM
admet-3030	128	10	β	β	NOUN
admet-3030	128	11	-	-	ADJ
admet-3030	128	12	catenin	catenin	NOUN
admet-3030	128	13	signalling	signal	VERB
admet-3030	128	14	in	in	ADP
admet-3030	128	15	maintaining	maintain	VERB
admet-3030	128	16	follicular	follicular	ADJ
admet-3030	128	17	integrity	integrity	NOUN
admet-3030	128	18	,	,	PUNCT
admet-3030	128	19	a	a	DET
admet-3030	128	20	hypothesis	hypothesis	NOUN
admet-3030	128	21	reinforced	reinforce	VERB
admet-3030	128	22	by	by	ADP
admet-3030	128	23	leirós	leirós	PROPN
admet-3030	128	24	et	et	PROPN
admet-3030	128	25	al	al	PROPN
admet-3030	128	26	.	.	PUNCT
admet-3030	129	1	[	[	X
admet-3030	129	2	47	47	NUM
admet-3030	129	3	]	]	PUNCT
admet-3030	129	4	,	,	PUNCT
admet-3030	129	5	who	who	PRON
admet-3030	129	6	demonstrated	demonstrate	VERB
admet-3030	129	7	androgen	androgen	NOUN
admet-3030	129	8	-	-	PUNCT
admet-3030	129	9	mediated	mediate	VERB
admet-3030	129	10	suppression	suppression	NOUN
admet-3030	129	11	of	of	ADP
admet-3030	129	12	wnt	wnt	NOUN
admet-3030	129	13	signalling	signal	VERB
admet-3030	129	14	in	in	ADP
admet-3030	129	15	dermal	dermal	ADJ
admet-3030	129	16	papilla	papilla	NOUN
admet-3030	129	17	cells	cell	NOUN
admet-3030	129	18	.	.	PUNCT
admet-3030	130	1	additional	additional	ADJ
admet-3030	130	2	gene	gene	NOUN
admet-3030	130	3	expression	expression	NOUN
admet-3030	130	4	profiling	profiling	NOUN
admet-3030	130	5	studies	study	NOUN
admet-3030	130	6	provide	provide	VERB
admet-3030	130	7	insights	insight	NOUN
admet-3030	130	8	into	into	ADP
admet-3030	130	9	regional	regional	ADJ
admet-3030	130	10	differences	difference	NOUN
admet-3030	130	11	in	in	ADP
admet-3030	130	12	scalp	scalp	NOUN
admet-3030	130	13	gene	gene	NOUN
admet-3030	130	14	activity	activity	NOUN
admet-3030	130	15	.	.	PUNCT
admet-3030	131	1	mirmirani	mirmirani	PROPN
admet-3030	131	2	et	et	PROPN
admet-3030	131	3	al	al	PROPN
admet-3030	131	4	.	.	PUNCT
admet-3030	132	1	[	[	X
admet-3030	132	2	48	48	NUM
admet-3030	132	3	]	]	PUNCT
admet-3030	132	4	identified	identify	VERB
admet-3030	132	5	38	38	NUM
admet-3030	132	6	differentially	differentially	ADV
admet-3030	132	7	expressed	express	VERB
admet-3030	132	8	genes	gene	NOUN
admet-3030	132	9	between	between	ADP
admet-3030	132	10	the	the	DET
admet-3030	132	11	vertex	vertex	NOUN
admet-3030	132	12	and	and	CCONJ
admet-3030	132	13	frontal	frontal	ADJ
admet-3030	132	14	scalp	scalp	NOUN
admet-3030	132	15	in	in	ADP
admet-3030	132	16	aga	aga	NOUN
admet-3030	132	17	patients	patient	NOUN
admet-3030	132	18	,	,	PUNCT
admet-3030	132	19	while	while	SCONJ
admet-3030	132	20	midorikawa	midorikawa	PROPN
admet-3030	132	21	et	et	NOUN
admet-3030	132	22	al	al	PROPN
admet-3030	132	23	.	.	PUNCT
admet-3030	133	1	[	[	X
admet-3030	133	2	49	49	NUM
admet-3030	133	3	]	]	PUNCT
admet-3030	133	4	reported	report	VERB
admet-3030	133	5	a	a	DET
admet-3030	133	6	distinct	distinct	ADJ
admet-3030	133	7	expression	expression	NOUN
admet-3030	133	8	profile	profile	NOUN
admet-3030	133	9	in	in	ADP
admet-3030	133	10	dermal	dermal	ADJ
admet-3030	133	11	papilla	papilla	NOUN
admet-3030	133	12	cells	cell	NOUN
admet-3030	133	13	from	from	ADP
admet-3030	133	14	balding	bald	VERB
admet-3030	133	15	regions	region	NOUN
admet-3030	133	16	.	.	PUNCT
admet-3030	134	1	these	these	DET
admet-3030	134	2	findings	finding	NOUN
admet-3030	134	3	suggest	suggest	VERB
admet-3030	134	4	localized	localized	ADJ
admet-3030	134	5	genetic	genetic	ADJ
admet-3030	134	6	regulation	regulation	NOUN
admet-3030	134	7	in	in	ADP
admet-3030	134	8	response	response	NOUN
admet-3030	134	9	to	to	ADP
admet-3030	134	10	androgen	androgen	NOUN
admet-3030	134	11	exposure	exposure	NOUN
admet-3030	134	12	.	.	PUNCT
admet-3030	135	1	the	the	DET
admet-3030	135	2	role	role	NOUN
admet-3030	135	3	of	of	ADP
admet-3030	135	4	prostaglandin	prostaglandin	VERB
admet-3030	135	5	metabolism	metabolism	NOUN
admet-3030	135	6	has	have	AUX
admet-3030	135	7	also	also	ADV
admet-3030	135	8	garnered	garner	VERB
admet-3030	135	9	interest	interest	NOUN
admet-3030	135	10	.	.	PUNCT
admet-3030	136	1	garza	garza	PROPN
admet-3030	136	2	et	et	PROPN
admet-3030	136	3	al	al	PROPN
admet-3030	136	4	.	.	PUNCT
admet-3030	137	1	[	[	X
admet-3030	137	2	50	50	NUM
admet-3030	137	3	]	]	PUNCT
admet-3030	137	4	found	find	VERB
admet-3030	137	5	elevated	elevated	ADJ
admet-3030	137	6	levels	level	NOUN
admet-3030	137	7	of	of	ADP
admet-3030	137	8	prostaglandin	prostaglandin	NOUN
admet-3030	137	9	d2	d2	NOUN
admet-3030	137	10	(	(	PUNCT
admet-3030	137	11	pgd2	pgd2	PROPN
admet-3030	137	12	)	)	PUNCT
admet-3030	137	13	and	and	CCONJ
admet-3030	137	14	its	its	PRON
admet-3030	137	15	synthesizing	synthesize	VERB
admet-3030	137	16	enzyme	enzyme	NOUN
admet-3030	137	17	pgds	pgds	NOUN
admet-3030	137	18	in	in	ADP
admet-3030	137	19	balding	bald	VERB
admet-3030	137	20	scalp	scalp	NOUN
admet-3030	137	21	regions	region	NOUN
admet-3030	137	22	,	,	PUNCT
admet-3030	137	23	implicating	implicate	VERB
admet-3030	137	24	pgd2	pgd2	PROPN
admet-3030	137	25	as	as	ADP
admet-3030	137	26	an	an	DET
admet-3030	137	27	inhibitor	inhibitor	NOUN
admet-3030	137	28	of	of	ADP
admet-3030	137	29	hair	hair	NOUN
admet-3030	137	30	growth	growth	NOUN
admet-3030	137	31	via	via	ADP
admet-3030	137	32	premature	premature	ADJ
admet-3030	137	33	catagen	catagen	NOUN
admet-3030	137	34	induction	induction	NOUN
admet-3030	137	35	.	.	PUNCT
admet-3030	138	1	however	however	ADV
admet-3030	138	2	,	,	PUNCT
admet-3030	138	3	heilmann	heilmann	PROPN
admet-3030	138	4	et	et	PROPN
admet-3030	138	5	al	al	PROPN
admet-3030	138	6	.	.	PUNCT
admet-3030	139	1	[	[	X
admet-3030	139	2	51	51	NUM
admet-3030	139	3	]	]	PUNCT
admet-3030	139	4	argued	argue	VERB
admet-3030	139	5	against	against	ADP
admet-3030	139	6	a	a	DET
admet-3030	139	7	genetic	genetic	ADJ
admet-3030	139	8	basis	basis	NOUN
admet-3030	139	9	for	for	ADP
admet-3030	139	10	pgd2	pgd2	PROPN
admet-3030	139	11	’s	’s	PART
admet-3030	139	12	involvement	involvement	NOUN
admet-3030	139	13	due	due	ADP
admet-3030	139	14	to	to	ADP
admet-3030	139	15	the	the	DET
admet-3030	139	16	lack	lack	NOUN
admet-3030	139	17	of	of	ADP
admet-3030	139	18	gwas	gwas	PROPN
admet-3030	139	19	association	association	PROPN
admet-3030	139	20	near	near	ADP
admet-3030	139	21	pgds	pgds	PROPN
admet-3030	139	22	loci	loci	PROPN
admet-3030	139	23	.	.	PUNCT
admet-3030	140	1	admet	admet	PROPN
admet-3030	140	2	&	&	CCONJ
admet-3030	140	3	dmpk	dmpk	PROPN
admet-3030	140	4	00(0	00(0	PROPN
admet-3030	140	5	)	)	PUNCT
admet-3030	140	6	(	(	PUNCT
admet-3030	140	7	2025	2025	NUM
admet-3030	140	8	)	)	PUNCT
admet-3030	140	9	3030	3030	NUM
admet-3030	140	10	precision	precision	NOUN
admet-3030	140	11	therapeutics	therapeutic	NOUN
admet-3030	140	12	in	in	ADP
admet-3030	140	13	non	non	ADJ
admet-3030	140	14	-	-	ADJ
admet-3030	140	15	scarring	scar	VERB
admet-3030	140	16	alopecia	alopecia	NOUN
admet-3030	140	17	doi	doi	NOUN
admet-3030	140	18	:	:	PUNCT
admet-3030	140	19	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	140	20	7	7	NUM
admet-3030	140	21	finally	finally	ADV
admet-3030	140	22	,	,	PUNCT
admet-3030	140	23	genetic	genetic	ADJ
admet-3030	140	24	variations	variation	NOUN
admet-3030	140	25	in	in	ADP
admet-3030	140	26	steroid	steroid	NOUN
admet-3030	140	27	5	5	NUM
admet-3030	140	28	alpha	alpha	NOUN
admet-3030	140	29	-	-	PUNCT
admet-3030	140	30	reductase	reductase	NOUN
admet-3030	140	31	1	1	NUM
admet-3030	140	32	(	(	PUNCT
admet-3030	140	33	srd5a1	srd5a1	NOUN
admet-3030	140	34	)	)	PUNCT
admet-3030	140	35	and	and	CCONJ
admet-3030	140	36	steroid	steroid	NOUN
admet-3030	140	37	5	5	NUM
admet-3030	140	38	-	-	PUNCT
admet-3030	140	39	alpha	alpha	NOUN
admet-3030	140	40	-	-	PUNCT
admet-3030	140	41	reductase	reductase	NOUN
admet-3030	140	42	type	type	NOUN
admet-3030	140	43	2	2	NUM
admet-3030	140	44	(	(	PUNCT
admet-3030	140	45	srd5a2	srd5a2	NOUN
admet-3030	140	46	)	)	PUNCT
admet-3030	140	47	,	,	PUNCT
admet-3030	140	48	encoding	encode	VERB
admet-3030	140	49	the	the	DET
admet-3030	140	50	two	two	NUM
admet-3030	140	51	isoforms	isoform	NOUN
admet-3030	140	52	of	of	ADP
admet-3030	140	53	5α	5α	NOUN
admet-3030	140	54	-	-	PUNCT
admet-3030	140	55	reductase	reductase	NOUN
admet-3030	140	56	,	,	PUNCT
admet-3030	140	57	contribute	contribute	VERB
admet-3030	140	58	to	to	ADP
admet-3030	140	59	increased	increase	VERB
admet-3030	140	60	dht	dht	NOUN
admet-3030	140	61	formation	formation	NOUN
admet-3030	140	62	in	in	ADP
admet-3030	140	63	balding	balding	ADJ
admet-3030	140	64	areas	area	NOUN
admet-3030	140	65	,	,	PUNCT
admet-3030	140	66	amplifying	amplify	VERB
admet-3030	140	67	androgenic	androgenic	ADJ
admet-3030	140	68	effects	effect	NOUN
admet-3030	140	69	at	at	ADP
admet-3030	140	70	the	the	DET
admet-3030	140	71	follicular	follicular	ADJ
admet-3030	140	72	level	level	NOUN
admet-3030	140	73	[	[	X
admet-3030	140	74	52,53	52,53	NOUN
admet-3030	140	75	]	]	PUNCT
admet-3030	140	76	.	.	PUNCT
admet-3030	141	1	together	together	ADV
admet-3030	141	2	,	,	PUNCT
admet-3030	141	3	these	these	DET
admet-3030	141	4	findings	finding	NOUN
admet-3030	141	5	demonstrate	demonstrate	VERB
admet-3030	141	6	that	that	SCONJ
admet-3030	141	7	aga	aga	NOUN
admet-3030	141	8	arises	arise	VERB
admet-3030	141	9	from	from	ADP
admet-3030	141	10	a	a	DET
admet-3030	141	11	complex	complex	ADJ
admet-3030	141	12	interplay	interplay	NOUN
admet-3030	141	13	among	among	ADP
admet-3030	141	14	androgenic	androgenic	ADJ
admet-3030	141	15	stimulation	stimulation	NOUN
admet-3030	141	16	,	,	PUNCT
admet-3030	141	17	genetic	genetic	ADJ
admet-3030	141	18	predisposition	predisposition	NOUN
admet-3030	141	19	,	,	PUNCT
admet-3030	141	20	and	and	CCONJ
admet-3030	141	21	modulation	modulation	NOUN
admet-3030	141	22	of	of	ADP
admet-3030	141	23	signalling	signal	VERB
admet-3030	141	24	pathways	pathway	NOUN
admet-3030	141	25	.	.	PUNCT
admet-3030	142	1	future	future	ADJ
admet-3030	142	2	studies	study	NOUN
admet-3030	142	3	integrating	integrate	VERB
admet-3030	142	4	gwas	gwas	NOUN
admet-3030	142	5	,	,	PUNCT
admet-3030	142	6	epigenetic	epigenetic	ADJ
admet-3030	142	7	profiling	profiling	NOUN
admet-3030	142	8	,	,	PUNCT
admet-3030	142	9	and	and	CCONJ
admet-3030	142	10	functional	functional	ADJ
admet-3030	142	11	genomics	genomic	NOUN
admet-3030	142	12	will	will	AUX
admet-3030	142	13	be	be	AUX
admet-3030	142	14	instrumental	instrumental	ADJ
admet-3030	142	15	in	in	ADP
admet-3030	142	16	unravelling	unravel	VERB
admet-3030	142	17	the	the	DET
admet-3030	142	18	precise	precise	ADJ
admet-3030	142	19	molecular	molecular	ADJ
admet-3030	142	20	etiology	etiology	NOUN
admet-3030	142	21	and	and	CCONJ
admet-3030	142	22	identifying	identify	VERB
admet-3030	142	23	novel	novel	ADJ
admet-3030	142	24	therapeutic	therapeutic	ADJ
admet-3030	142	25	targets	target	NOUN
admet-3030	142	26	.	.	PUNCT
admet-3030	143	1	pathways	pathway	NOUN
admet-3030	143	2	and	and	CCONJ
admet-3030	143	3	mechanisms	mechanism	NOUN
admet-3030	143	4	of	of	ADP
admet-3030	143	5	androgenetic	androgenetic	ADJ
admet-3030	143	6	alopecia	alopecia	NOUN
admet-3030	143	7	and	and	CCONJ
admet-3030	143	8	alopecia	alopecia	NOUN
admet-3030	143	9	areata	areata	ADJ
admet-3030	143	10	aga	aga	NOUN
admet-3030	143	11	is	be	AUX
admet-3030	143	12	a	a	DET
admet-3030	143	13	multifactorial	multifactorial	ADJ
admet-3030	143	14	disorder	disorder	NOUN
admet-3030	143	15	that	that	PRON
admet-3030	143	16	is	be	AUX
admet-3030	143	17	driven	drive	VERB
admet-3030	143	18	by	by	ADP
admet-3030	143	19	genetic	genetic	ADJ
admet-3030	143	20	as	as	ADV
admet-3030	143	21	well	well	ADV
admet-3030	143	22	as	as	ADP
admet-3030	143	23	various	various	ADJ
admet-3030	143	24	environmental	environmental	ADJ
admet-3030	143	25	stressors	stressor	NOUN
admet-3030	143	26	.	.	PUNCT
admet-3030	144	1	kwack	kwack	VERB
admet-3030	144	2	et	et	NOUN
admet-3030	144	3	al	al	PROPN
admet-3030	144	4	.	.	PUNCT
admet-3030	145	1	[	[	X
admet-3030	145	2	54	54	NUM
admet-3030	145	3	]	]	PUNCT
admet-3030	145	4	have	have	AUX
admet-3030	145	5	described	describe	VERB
admet-3030	145	6	that	that	SCONJ
admet-3030	145	7	the	the	DET
admet-3030	145	8	dht	dht	NOUN
admet-3030	145	9	binding	bind	VERB
admet-3030	145	10	to	to	ADP
admet-3030	145	11	the	the	DET
admet-3030	145	12	dermal	dermal	ADJ
admet-3030	145	13	papilla	papilla	NOUN
admet-3030	145	14	increases	increase	VERB
admet-3030	145	15	the	the	DET
admet-3030	145	16	levels	level	NOUN
admet-3030	145	17	of	of	ADP
admet-3030	145	18	tgf	tgf	PROPN
admet-3030	145	19	-	-	PUNCT
admet-3030	145	20	β1	β1	PROPN
admet-3030	145	21	and	and	CCONJ
admet-3030	145	22	dkk-1	dkk-1	NUM
admet-3030	145	23	,	,	PUNCT
admet-3030	145	24	in	in	ADP
admet-3030	145	25	turn	turn	NOUN
admet-3030	145	26	suppressing	suppress	VERB
admet-3030	145	27	the	the	DET
admet-3030	145	28	wnt	wnt	NOUN
admet-3030	145	29	/	/	SYM
admet-3030	145	30	β	β	NOUN
admet-3030	145	31	-	-	ADJ
admet-3030	145	32	catenin	catenin	ADJ
admet-3030	145	33	signalling	signal	VERB
admet-3030	145	34	pathway	pathway	NOUN
admet-3030	145	35	,	,	PUNCT
admet-3030	145	36	preventing	prevent	VERB
admet-3030	145	37	the	the	DET
admet-3030	145	38	follicular	follicular	ADJ
admet-3030	145	39	regeneration	regeneration	NOUN
admet-3030	145	40	.	.	PUNCT
admet-3030	146	1	the	the	DET
admet-3030	146	2	scalp	scalp	NOUN
admet-3030	146	3	affected	affect	VERB
admet-3030	146	4	by	by	ADP
admet-3030	146	5	aga	aga	NOUN
admet-3030	146	6	will	will	AUX
admet-3030	146	7	exhibit	exhibit	VERB
admet-3030	146	8	perifollicular	perifollicular	ADJ
admet-3030	146	9	inflammation	inflammation	NOUN
admet-3030	146	10	due	due	ADP
admet-3030	146	11	to	to	ADP
admet-3030	146	12	elevated	elevated	ADJ
admet-3030	146	13	levels	level	NOUN
admet-3030	146	14	of	of	ADP
admet-3030	146	15	pro	pro	ADJ
admet-3030	146	16	-	-	ADJ
admet-3030	146	17	inflammatory	inflammatory	ADJ
admet-3030	146	18	cytokines	cytokine	NOUN
admet-3030	146	19	,	,	PUNCT
admet-3030	146	20	leading	lead	VERB
admet-3030	146	21	to	to	ADP
admet-3030	146	22	immune	immune	NOUN
admet-3030	146	23	-	-	PUNCT
admet-3030	146	24	mediated	mediate	VERB
admet-3030	146	25	damage	damage	NOUN
admet-3030	146	26	to	to	ADP
admet-3030	146	27	hair	hair	NOUN
admet-3030	146	28	follicles	follicle	NOUN
admet-3030	146	29	.	.	PUNCT
admet-3030	147	1	oxidative	oxidative	ADJ
admet-3030	147	2	stress	stress	NOUN
admet-3030	147	3	causes	cause	VERB
admet-3030	147	4	stem	stem	NOUN
admet-3030	147	5	cell	cell	NOUN
admet-3030	147	6	dysfunction	dysfunction	NOUN
admet-3030	147	7	and	and	CCONJ
admet-3030	147	8	activates	activate	VERB
admet-3030	147	9	the	the	DET
admet-3030	147	10	nf	nf	ADJ
admet-3030	147	11	-	-	PUNCT
admet-3030	147	12	κb	κb	NOUN
admet-3030	147	13	signalling	signal	VERB
admet-3030	147	14	pathway	pathway	NOUN
admet-3030	147	15	[	[	X
admet-3030	147	16	55	55	NUM
admet-3030	147	17	]	]	PUNCT
admet-3030	147	18	.	.	PUNCT
admet-3030	148	1	dihydrotestosterone	dihydrotestosterone	NOUN
admet-3030	148	2	and	and	CCONJ
admet-3030	148	3	wingless	wingless	NOUN
admet-3030	148	4	-	-	PUNCT
admet-3030	148	5	related	relate	VERB
admet-3030	148	6	integration	integration	NOUN
admet-3030	148	7	site	site	NOUN
admet-3030	148	8	suppression	suppression	NOUN
admet-3030	148	9	cycle	cycle	NOUN
admet-3030	148	10	androgenetic	androgenetic	ADJ
admet-3030	148	11	alopecia	alopecia	NOUN
admet-3030	148	12	dht	dht	NOUN
admet-3030	148	13	,	,	PUNCT
admet-3030	148	14	an	an	DET
admet-3030	148	15	androgen	androgen	NOUN
admet-3030	148	16	hormone	hormone	NOUN
admet-3030	148	17	,	,	PUNCT
admet-3030	148	18	is	be	AUX
admet-3030	148	19	one	one	NUM
admet-3030	148	20	of	of	ADP
admet-3030	148	21	the	the	DET
admet-3030	148	22	primary	primary	ADJ
admet-3030	148	23	culprits	culprit	NOUN
admet-3030	148	24	of	of	ADP
admet-3030	148	25	aga	aga	NOUN
admet-3030	148	26	in	in	ADP
admet-3030	148	27	individuals	individual	NOUN
admet-3030	148	28	with	with	ADP
admet-3030	148	29	a	a	DET
admet-3030	148	30	hereditary	hereditary	ADJ
admet-3030	148	31	predisposition	predisposition	NOUN
admet-3030	148	32	to	to	ADP
admet-3030	148	33	the	the	DET
admet-3030	148	34	condition	condition	NOUN
admet-3030	148	35	.	.	PUNCT
admet-3030	149	1	those	those	PRON
admet-3030	149	2	with	with	ADP
admet-3030	149	3	aga	aga	NOUN
admet-3030	149	4	heredity	heredity	NOUN
admet-3030	149	5	tend	tend	VERB
admet-3030	149	6	to	to	PART
admet-3030	149	7	have	have	VERB
admet-3030	149	8	more	more	ADJ
admet-3030	149	9	androgen	androgen	NOUN
admet-3030	149	10	receptors	receptor	NOUN
admet-3030	149	11	in	in	ADP
admet-3030	149	12	hair	hair	NOUN
admet-3030	149	13	follicles	follicle	NOUN
admet-3030	149	14	,	,	PUNCT
admet-3030	149	15	which	which	PRON
admet-3030	149	16	are	be	AUX
admet-3030	149	17	directly	directly	ADV
admet-3030	149	18	associated	associate	VERB
admet-3030	149	19	with	with	ADP
admet-3030	149	20	increased	increase	VERB
admet-3030	149	21	androgenic	androgenic	ADJ
admet-3030	149	22	activity	activity	NOUN
admet-3030	149	23	.	.	PUNCT
admet-3030	150	1	within	within	ADP
admet-3030	150	2	the	the	DET
admet-3030	150	3	hair	hair	NOUN
admet-3030	150	4	follicle	follicle	NOUN
admet-3030	150	5	,	,	PUNCT
admet-3030	150	6	the	the	DET
admet-3030	150	7	enzyme	enzyme	NOUN
admet-3030	150	8	5α	5α	ADJ
admet-3030	150	9	-	-	PUNCT
admet-3030	150	10	reductase	reductase	NOUN
admet-3030	150	11	catalyses	catalyse	VERB
admet-3030	150	12	the	the	DET
admet-3030	150	13	conversion	conversion	NOUN
admet-3030	150	14	of	of	ADP
admet-3030	150	15	testosterone	testosterone	NOUN
admet-3030	150	16	to	to	ADP
admet-3030	150	17	dht	dht	NOUN
admet-3030	150	18	.	.	PUNCT
admet-3030	151	1	the	the	DET
admet-3030	151	2	dht	dht	NOUN
admet-3030	151	3	formed	form	VERB
admet-3030	151	4	then	then	ADV
admet-3030	151	5	binds	bind	VERB
admet-3030	151	6	to	to	ADP
admet-3030	151	7	androgen	androgen	NOUN
admet-3030	151	8	receptors	receptor	NOUN
admet-3030	151	9	,	,	PUNCT
admet-3030	151	10	initiating	initiate	VERB
admet-3030	151	11	an	an	DET
admet-3030	151	12	intracellular	intracellular	ADJ
admet-3030	151	13	cascade	cascade	NOUN
admet-3030	151	14	that	that	PRON
admet-3030	151	15	leads	lead	VERB
admet-3030	151	16	to	to	ADP
admet-3030	151	17	hair	hair	NOUN
admet-3030	151	18	follicle	follicle	NOUN
admet-3030	151	19	miniaturization	miniaturization	NOUN
admet-3030	151	20	,	,	PUNCT
admet-3030	151	21	a	a	DET
admet-3030	151	22	shortened	shorten	VERB
admet-3030	151	23	anagen	anagen	NOUN
admet-3030	151	24	phase	phase	NOUN
admet-3030	151	25	,	,	PUNCT
admet-3030	151	26	and	and	CCONJ
admet-3030	151	27	a	a	DET
admet-3030	151	28	prolonged	prolonged	ADJ
admet-3030	151	29	telogen	telogen	NOUN
admet-3030	151	30	phase	phase	NOUN
admet-3030	151	31	,	,	PUNCT
admet-3030	151	32	ultimately	ultimately	ADV
admet-3030	151	33	resulting	result	VERB
admet-3030	151	34	in	in	ADP
admet-3030	151	35	visible	visible	ADJ
admet-3030	151	36	hair	hair	NOUN
admet-3030	151	37	loss	loss	NOUN
admet-3030	151	38	.	.	PUNCT
admet-3030	152	1	this	this	DET
admet-3030	152	2	process	process	NOUN
admet-3030	152	3	is	be	AUX
admet-3030	152	4	further	far	ADV
admet-3030	152	5	exacerbated	exacerbate	VERB
admet-3030	152	6	by	by	ADP
admet-3030	152	7	the	the	DET
admet-3030	152	8	production	production	NOUN
admet-3030	152	9	of	of	ADP
admet-3030	152	10	transforming	transform	VERB
admet-3030	152	11	growth	growth	NOUN
admet-3030	152	12	factor	factor	NOUN
admet-3030	152	13	-	-	PUNCT
admet-3030	152	14	beta	beta	NOUN
admet-3030	152	15	1	1	NUM
admet-3030	152	16	(	(	PUNCT
admet-3030	152	17	tgf	tgf	NOUN
admet-3030	152	18	-	-	PUNCT
admet-3030	152	19	β1	β1	PROPN
admet-3030	152	20	)	)	PUNCT
admet-3030	152	21	,	,	PUNCT
admet-3030	152	22	triggered	trigger	VERB
admet-3030	152	23	by	by	ADP
admet-3030	152	24	dht	dht	NOUN
admet-3030	152	25	,	,	PUNCT
admet-3030	152	26	which	which	PRON
admet-3030	152	27	promotes	promote	VERB
admet-3030	152	28	hair	hair	NOUN
admet-3030	152	29	follicle	follicle	NOUN
admet-3030	152	30	regression	regression	NOUN
admet-3030	152	31	and	and	CCONJ
admet-3030	152	32	,	,	PUNCT
admet-3030	152	33	in	in	ADP
admet-3030	152	34	turn	turn	NOUN
admet-3030	152	35	,	,	PUNCT
admet-3030	152	36	reduces	reduce	VERB
admet-3030	152	37	follicular	follicular	ADJ
admet-3030	152	38	activity	activity	NOUN
admet-3030	152	39	,	,	PUNCT
admet-3030	152	40	thereby	thereby	ADV
admet-3030	152	41	contributing	contribute	VERB
admet-3030	152	42	to	to	ADP
admet-3030	152	43	progressive	progressive	ADJ
admet-3030	152	44	hair	hair	NOUN
admet-3030	152	45	loss	loss	NOUN
admet-3030	152	46	(	(	PUNCT
admet-3030	152	47	figure	figure	NOUN
admet-3030	152	48	4	4	NUM
admet-3030	152	49	)	)	PUNCT
admet-3030	152	50	.	.	PUNCT
admet-3030	153	1	figure	figure	VERB
admet-3030	153	2	4	4	NUM
admet-3030	153	3	.	.	PUNCT
admet-3030	153	4	dht	dht	NOUN
admet-3030	153	5	-	-	PUNCT
admet-3030	153	6	wnt	wnt	PROPN
admet-3030	153	7	suppression	suppression	NOUN
admet-3030	153	8	cycle	cycle	NOUN
admet-3030	153	9	aga	aga	NOUN
admet-3030	153	10	in	in	ADP
admet-3030	153	11	rare	rare	ADJ
admet-3030	153	12	chronic	chronic	ADJ
admet-3030	153	13	inflammatory	inflammatory	ADJ
admet-3030	153	14	conditions	condition	NOUN
admet-3030	153	15	,	,	PUNCT
admet-3030	153	16	permanent	permanent	ADJ
admet-3030	153	17	hair	hair	NOUN
admet-3030	153	18	follicle	follicle	NOUN
admet-3030	153	19	damage	damage	NOUN
admet-3030	153	20	is	be	AUX
admet-3030	153	21	observed	observe	VERB
admet-3030	153	22	due	due	ADJ
admet-3030	153	23	to	to	ADP
admet-3030	153	24	fibrosis	fibrosis	NOUN
admet-3030	153	25	.	.	PUNCT
admet-3030	154	1	there	there	PRON
admet-3030	154	2	is	be	VERB
admet-3030	154	3	a	a	DET
admet-3030	154	4	need	need	NOUN
admet-3030	154	5	to	to	PART
admet-3030	154	6	develop	develop	VERB
admet-3030	154	7	targeted	targeted	ADJ
admet-3030	154	8	therapies	therapy	NOUN
admet-3030	154	9	that	that	SCONJ
admet-3030	154	10	not	not	PART
admet-3030	154	11	only	only	ADV
admet-3030	154	12	address	address	NOUN
admet-3030	154	13	androgen	androgen	NOUN
admet-3030	154	14	activity	activity	NOUN
admet-3030	154	15	but	but	CCONJ
admet-3030	154	16	also	also	ADV
admet-3030	154	17	immune	immune	ADJ
admet-3030	154	18	/	/	SYM
admet-3030	154	19	inflammatory	inflammatory	ADJ
admet-3030	154	20	responses	response	NOUN
admet-3030	154	21	.	.	PUNCT
admet-3030	155	1	various	various	ADJ
admet-3030	155	2	molecular	molecular	ADJ
admet-3030	155	3	pathways	pathway	NOUN
admet-3030	155	4	have	have	AUX
admet-3030	155	5	been	be	AUX
admet-3030	155	6	implicated	implicate	VERB
admet-3030	155	7	in	in	ADP
admet-3030	155	8	the	the	DET
admet-3030	155	9	pathogenesis	pathogenesis	NOUN
admet-3030	155	10	of	of	ADP
admet-3030	155	11	aa	aa	PROPN
admet-3030	155	12	.	.	PUNCT
admet-3030	156	1	zihyu	zihyu	PROPN
admet-3030	156	2	liu	liu	PROPN
admet-3030	156	3	and	and	CCONJ
admet-3030	156	4	xiaoyan	xiaoyan	PROPN
admet-3030	156	5	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	PROPN
admet-3030	156	6	r.	r.	PROPN
admet-3030	156	7	kapoor	kapoor	PROPN
admet-3030	156	8	et	et	PROPN
admet-3030	156	9	al	al	PROPN
admet-3030	156	10	.	.	PROPN
admet-3030	156	11	admet	admet	PROPN
admet-3030	156	12	&	&	CCONJ
admet-3030	156	13	dmpk	dmpk	PROPN
admet-3030	156	14	00(0	00(0	PROPN
admet-3030	156	15	)	)	PUNCT
admet-3030	156	16	(	(	PUNCT
admet-3030	156	17	2025	2025	NUM
admet-3030	156	18	)	)	PUNCT
admet-3030	156	19	3030	3030	NUM
admet-3030	156	20	8	8	NUM
admet-3030	156	21	liu	liu	PROPN
admet-3030	157	1	[	[	X
admet-3030	157	2	56	56	NUM
admet-3030	157	3	]	]	PUNCT
admet-3030	157	4	reviewed	review	VERB
admet-3030	157	5	several	several	ADJ
admet-3030	157	6	critical	critical	ADJ
admet-3030	157	7	signalling	signal	VERB
admet-3030	157	8	pathways	pathway	NOUN
admet-3030	157	9	involved	involve	VERB
admet-3030	157	10	in	in	ADP
admet-3030	157	11	aa	aa	NOUN
admet-3030	157	12	,	,	PUNCT
admet-3030	157	13	including	include	VERB
admet-3030	157	14	jak	jak	PROPN
admet-3030	157	15	-	-	PUNCT
admet-3030	157	16	stat	stat	PROPN
admet-3030	157	17	,	,	PUNCT
admet-3030	157	18	tgf	tgf	PROPN
admet-3030	157	19	-	-	PUNCT
admet-3030	157	20	β	β	PROPN
admet-3030	157	21	,	,	PUNCT
admet-3030	157	22	and	and	CCONJ
admet-3030	157	23	wnt	wnt	PROPN
admet-3030	157	24	/	/	SYM
admet-3030	157	25	βcatenin	βcatenin	ADJ
admet-3030	157	26	pathways	pathway	NOUN
admet-3030	157	27	.	.	PUNCT
admet-3030	158	1	these	these	DET
admet-3030	158	2	pathways	pathway	NOUN
admet-3030	158	3	are	be	AUX
admet-3030	158	4	dysregulated	dysregulate	VERB
admet-3030	158	5	in	in	ADP
admet-3030	158	6	aa	aa	NOUN
admet-3030	158	7	,	,	PUNCT
admet-3030	158	8	leading	lead	VERB
admet-3030	158	9	to	to	ADP
admet-3030	158	10	impaired	impaired	ADJ
admet-3030	158	11	hair	hair	NOUN
admet-3030	158	12	follicle	follicle	NOUN
admet-3030	158	13	growth	growth	NOUN
admet-3030	158	14	and	and	CCONJ
admet-3030	158	15	immune	immune	ADJ
admet-3030	158	16	responses	response	NOUN
admet-3030	158	17	.	.	PUNCT
admet-3030	159	1	additionally	additionally	ADV
admet-3030	159	2	,	,	PUNCT
admet-3030	159	3	factors	factor	NOUN
admet-3030	159	4	such	such	ADJ
admet-3030	159	5	as	as	ADP
admet-3030	159	6	oxidative	oxidative	ADJ
admet-3030	159	7	stress	stress	NOUN
admet-3030	159	8	,	,	PUNCT
admet-3030	159	9	gut	gut	NOUN
admet-3030	159	10	microbiome	microbiome	NOUN
admet-3030	159	11	imbalances	imbalance	NOUN
admet-3030	159	12	,	,	PUNCT
admet-3030	159	13	and	and	CCONJ
admet-3030	159	14	intestinal	intestinal	ADJ
admet-3030	159	15	barrier	barrier	NOUN
admet-3030	159	16	disruption	disruption	NOUN
admet-3030	159	17	have	have	AUX
admet-3030	159	18	been	be	AUX
admet-3030	159	19	identified	identify	VERB
admet-3030	159	20	as	as	ADP
admet-3030	159	21	contributors	contributor	NOUN
admet-3030	159	22	to	to	ADP
admet-3030	159	23	disease	disease	NOUN
admet-3030	159	24	progression	progression	NOUN
admet-3030	159	25	.	.	PUNCT
admet-3030	160	1	the	the	DET
admet-3030	160	2	authors	author	NOUN
admet-3030	160	3	proposed	propose	VERB
admet-3030	160	4	that	that	SCONJ
admet-3030	160	5	a	a	DET
admet-3030	160	6	combination	combination	NOUN
admet-3030	160	7	of	of	ADP
admet-3030	160	8	targeted	target	VERB
admet-3030	160	9	treatments	treatment	NOUN
admet-3030	160	10	addressing	address	VERB
admet-3030	160	11	these	these	DET
admet-3030	160	12	pathways	pathway	NOUN
admet-3030	160	13	could	could	AUX
admet-3030	160	14	improve	improve	VERB
admet-3030	160	15	outcomes	outcome	NOUN
admet-3030	160	16	for	for	ADP
admet-3030	160	17	aa	aa	NOUN
admet-3030	160	18	patients	patient	NOUN
admet-3030	160	19	.	.	PUNCT
admet-3030	161	1	moreover	moreover	ADV
admet-3030	161	2	,	,	PUNCT
admet-3030	161	3	baoyi	baoyi	PROPN
admet-3030	161	4	liu	liu	PROPN
admet-3030	161	5	et	et	PROPN
admet-3030	161	6	al	al	PROPN
admet-3030	161	7	.	.	PUNCT
admet-3030	162	1	[	[	X
admet-3030	162	2	57	57	NUM
admet-3030	162	3	]	]	PUNCT
admet-3030	162	4	conducted	conduct	VERB
admet-3030	162	5	a	a	DET
admet-3030	162	6	microarray	microarray	NOUN
admet-3030	162	7	analysis	analysis	NOUN
admet-3030	162	8	to	to	PART
admet-3030	162	9	identify	identify	VERB
admet-3030	162	10	prognostic	prognostic	ADJ
admet-3030	162	11	signatures	signature	NOUN
admet-3030	162	12	associated	associate	VERB
admet-3030	162	13	with	with	ADP
admet-3030	162	14	scalp	scalp	NOUN
admet-3030	162	15	diseases	disease	NOUN
admet-3030	162	16	like	like	ADP
admet-3030	162	17	aa	aa	NOUN
admet-3030	162	18	.	.	PUNCT
admet-3030	163	1	their	their	PRON
admet-3030	163	2	findings	finding	NOUN
admet-3030	163	3	indicated	indicate	VERB
admet-3030	163	4	upregulation	upregulation	NOUN
admet-3030	163	5	of	of	ADP
admet-3030	163	6	t	t	NOUN
admet-3030	163	7	-	-	PUNCT
admet-3030	163	8	cell	cell	NOUN
admet-3030	163	9	chemotaxis	chemotaxis	ADJ
admet-3030	163	10	and	and	CCONJ
admet-3030	163	11	interferon	interferon	ADJ
admet-3030	163	12	-	-	PUNCT
admet-3030	163	13	β	β	NOUN
admet-3030	163	14	responses	response	NOUN
admet-3030	163	15	,	,	PUNCT
admet-3030	163	16	along	along	ADP
admet-3030	163	17	with	with	ADP
admet-3030	163	18	downregulation	downregulation	NOUN
admet-3030	163	19	of	of	ADP
admet-3030	163	20	keratin	keratin	NOUN
admet-3030	163	21	filaments	filament	NOUN
admet-3030	163	22	,	,	PUNCT
admet-3030	163	23	suggesting	suggest	VERB
admet-3030	163	24	that	that	SCONJ
admet-3030	163	25	these	these	DET
admet-3030	163	26	changes	change	NOUN
admet-3030	163	27	may	may	AUX
admet-3030	163	28	serve	serve	VERB
admet-3030	163	29	as	as	ADP
admet-3030	163	30	biomarkers	biomarker	NOUN
admet-3030	163	31	of	of	ADP
admet-3030	163	32	aa	aa	PROPN
admet-3030	163	33	.	.	PUNCT
admet-3030	164	1	coda	coda	PROPN
admet-3030	164	2	&	&	CCONJ
admet-3030	164	3	sinha	sinha	PROPN
admet-3030	165	1	[	[	X
admet-3030	165	2	58	58	NUM
admet-3030	165	3	]	]	PUNCT
admet-3030	165	4	further	far	ADV
admet-3030	165	5	explored	explore	VERB
admet-3030	165	6	the	the	DET
admet-3030	165	7	clinical	clinical	ADJ
admet-3030	165	8	heterogeneity	heterogeneity	NOUN
admet-3030	165	9	of	of	ADP
admet-3030	165	10	aa	aa	NOUN
admet-3030	165	11	,	,	PUNCT
admet-3030	165	12	identifying	identify	VERB
admet-3030	165	13	dysregulated	dysregulated	ADJ
admet-3030	165	14	genes	gene	NOUN
admet-3030	165	15	and	and	CCONJ
admet-3030	165	16	transcriptional	transcriptional	ADJ
admet-3030	165	17	"	"	PUNCT
admet-3030	165	18	hot	hot	ADJ
admet-3030	165	19	spots	spot	NOUN
admet-3030	165	20	"	"	PUNCT
admet-3030	165	21	by	by	ADP
admet-3030	165	22	integrating	integrate	VERB
admet-3030	165	23	genome	genome	NOUN
admet-3030	165	24	-	-	PUNCT
admet-3030	165	25	wide	wide	ADJ
admet-3030	165	26	transcriptional	transcriptional	NOUN
admet-3030	165	27	and	and	CCONJ
admet-3030	165	28	genetic	genetic	ADJ
admet-3030	165	29	data	datum	NOUN
admet-3030	165	30	.	.	PUNCT
admet-3030	166	1	this	this	PRON
admet-3030	166	2	highlights	highlight	VERB
admet-3030	166	3	the	the	DET
admet-3030	166	4	importance	importance	NOUN
admet-3030	166	5	of	of	ADP
admet-3030	166	6	combining	combine	VERB
admet-3030	166	7	genetic	genetic	ADJ
admet-3030	166	8	and	and	CCONJ
admet-3030	166	9	transcriptional	transcriptional	ADJ
admet-3030	166	10	analyses	analysis	NOUN
admet-3030	166	11	to	to	PART
admet-3030	166	12	identify	identify	VERB
admet-3030	166	13	novel	novel	ADJ
admet-3030	166	14	biomarkers	biomarker	NOUN
admet-3030	166	15	and	and	CCONJ
admet-3030	166	16	improve	improve	VERB
admet-3030	166	17	clinical	clinical	ADJ
admet-3030	166	18	interventions	intervention	NOUN
admet-3030	166	19	.	.	PUNCT
admet-3030	167	1	the	the	DET
admet-3030	167	2	genes	gene	NOUN
admet-3030	167	3	that	that	PRON
admet-3030	167	4	modulate	modulate	VERB
admet-3030	167	5	aga	aga	NOUN
admet-3030	167	6	and	and	CCONJ
admet-3030	167	7	aa	aa	NOUN
admet-3030	167	8	are	be	AUX
admet-3030	167	9	shown	show	VERB
admet-3030	167	10	in	in	ADP
admet-3030	167	11	table	table	NOUN
admet-3030	167	12	2	2	NUM
admet-3030	167	13	.	.	PUNCT
admet-3030	167	14	table	table	NOUN
admet-3030	167	15	2	2	NUM
admet-3030	167	16	.	.	PUNCT
admet-3030	168	1	genes	gene	NOUN
admet-3030	168	2	responsible	responsible	ADJ
admet-3030	168	3	and	and	CCONJ
admet-3030	168	4	associated	associate	VERB
admet-3030	168	5	pathways	pathway	NOUN
admet-3030	168	6	for	for	ADP
admet-3030	168	7	modulating	modulate	VERB
admet-3030	168	8	androgenetic	androgenetic	ADJ
admet-3030	168	9	alopecia	alopecia	NOUN
admet-3030	168	10	aga	aga	PROPN
admet-3030	168	11	/	/	SYM
admet-3030	168	12	aa	aa	PROPN
admet-3030	168	13	gene	gene	NOUN
admet-3030	168	14	primary	primary	ADJ
admet-3030	168	15	pathway	pathway	NOUN
admet-3030	168	16	getting	getting	AUX
admet-3030	168	17	altered	alter	VERB
admet-3030	168	18	detailed	detailed	ADJ
admet-3030	168	19	pathway	pathway	NOUN
admet-3030	168	20	analysis	analysis	NOUN
admet-3030	168	21	aga	aga	PROPN
admet-3030	168	22	ar	ar	PROPN
admet-3030	168	23	(	(	PUNCT
admet-3030	168	24	androgen	androgen	NOUN
admet-3030	168	25	receptor	receptor	NOUN
admet-3030	168	26	)	)	PUNCT
admet-3030	168	27	androgen	androgen	NOUN
admet-3030	168	28	signalling	signal	VERB
admet-3030	168	29	[	[	X
admet-3030	168	30	28	28	NUM
admet-3030	168	31	-	-	SYM
admet-3030	168	32	31,37,45,59	31,37,45,59	NUM
admet-3030	168	33	]	]	PUNCT
admet-3030	168	34	shorter	short	ADJ
admet-3030	168	35	cag	cag	PROPN
admet-3030	168	36	repeats	repeat	VERB
admet-3030	168	37	+	+	CCONJ
admet-3030	168	38	rs6152	rs6152	NOUN
admet-3030	168	39	snp	snp	NOUN
admet-3030	168	40	→	→	SYM
admet-3030	168	41	↑ar	↑ar	X
admet-3030	168	42	activity	activity	NOUN
admet-3030	168	43	&	&	CCONJ
admet-3030	168	44	dht	dht	ADJ
admet-3030	168	45	binding	bind	VERB
admet-3030	168	46	→	→	SYM
admet-3030	168	47	↑androgen	↑androgen	ADV
admet-3030	168	48	-	-	PUNCT
admet-3030	168	49	responsive	responsive	ADJ
admet-3030	168	50	gene	gene	NOUN
admet-3030	168	51	expression	expression	NOUN
admet-3030	168	52	→	→	PUNCT
admet-3030	168	53	follicle	follicle	NOUN
admet-3030	168	54	miniaturization	miniaturization	NOUN
admet-3030	168	55	→	→	SYM
admet-3030	168	56	hair	hair	NOUN
admet-3030	168	57	loss	loss	NOUN
admet-3030	168	58	-	-	PUNCT
admet-3030	168	59	aga	aga	NOUN
admet-3030	168	60	srd5a2	srd5a2	VERB
admet-3030	168	61	5α	5α	ADJ
admet-3030	168	62	-	-	PUNCT
admet-3030	168	63	reductase	reductase	NOUN
admet-3030	168	64	type	type	NOUN
admet-3030	168	65	2	2	NUM
admet-3030	168	66	androgen	androgen	NOUN
admet-3030	168	67	signalling	signal	VERB
admet-3030	168	68	[	[	X
admet-3030	168	69	28,46,60	28,46,60	NUM
admet-3030	168	70	]	]	PUNCT
admet-3030	168	71	v89l	v89l	PROPN
admet-3030	168	72	(	(	PUNCT
admet-3030	168	73	rs523349	rs523349	PROPN
admet-3030	168	74	)	)	PUNCT
admet-3030	168	75	±	±	PROPN
admet-3030	168	76	a49	a49	PROPN
admet-3030	168	77	t	t	PROPN
admet-3030	168	78	→	→	SYM
admet-3030	168	79	↑5α	↑5α	ADJ
admet-3030	168	80	-	-	PUNCT
admet-3030	168	81	reductase	reductase	NOUN
admet-3030	168	82	activity	activity	NOUN
admet-3030	168	83	→	→	PUNCT
admet-3030	168	84	↑dht	↑dht	VERB
admet-3030	168	85	in	in	ADP
admet-3030	168	86	follicles	follicle	NOUN
admet-3030	168	87	→	→	SYM
admet-3030	168	88	miniaturization	miniaturization	NOUN
admet-3030	168	89	→	→	SYM
admet-3030	168	90	hair	hair	NOUN
admet-3030	168	91	loss	loss	NOUN
admet-3030	168	92	-	-	PUNCT
admet-3030	168	93	aga	aga	NOUN
admet-3030	168	94	dickkopf	dickkopf	VERB
admet-3030	168	95	-	-	PUNCT
admet-3030	168	96	related	relate	VERB
admet-3030	168	97	protein	protein	NOUN
admet-3030	168	98	1	1	NUM
admet-3030	168	99	(	(	PUNCT
admet-3030	168	100	dkk1	dkk1	PROPN
admet-3030	168	101	)	)	PUNCT
admet-3030	168	102	wnt	wnt	PROPN
admet-3030	168	103	/	/	SYM
admet-3030	168	104	β	β	NOUN
admet-3030	168	105	-	-	ADJ
admet-3030	168	106	catenin	catenin	NOUN
admet-3030	168	107	signalling	signal	VERB
admet-3030	168	108	[	[	X
admet-3030	168	109	39,54	39,54	NUM
admet-3030	168	110	]	]	X
admet-3030	168	111	↑dkk1	↑dkk1	PROPN
admet-3030	168	112	→	→	SYM
admet-3030	168	113	binds	bind	VERB
admet-3030	168	114	lrp5/6	lrp5/6	PUNCT
admet-3030	168	115	→	→	SYM
admet-3030	168	116	blocks	blocks	X
admet-3030	168	117	wnt	wnt	NOUN
admet-3030	168	118	signalling	signal	VERB
admet-3030	168	119	→	→	SYM
admet-3030	168	120	↓β	↓β	ADJ
admet-3030	168	121	-	-	ADJ
admet-3030	168	122	catenin	catenin	ADJ
admet-3030	168	123	activity	activity	NOUN
admet-3030	168	124	→	→	PUNCT
admet-3030	168	125	impaired	impaired	ADJ
admet-3030	168	126	follicle	follicle	NOUN
admet-3030	168	127	regeneration	regeneration	NOUN
admet-3030	168	128	→	→	SYM
admet-3030	168	129	hair	hair	NOUN
admet-3030	168	130	loss	loss	NOUN
admet-3030	168	131	-	-	PUNCT
admet-3030	168	132	aga	aga	NOUN
admet-3030	168	133	sfrp1/2	sfrp1/2	NOUN
admet-3030	168	134	wnt	wnt	PROPN
admet-3030	168	135	/	/	SYM
admet-3030	168	136	β	β	NOUN
admet-3030	168	137	-	-	ADJ
admet-3030	168	138	catenin	catenin	NOUN
admet-3030	168	139	signalling	signal	VERB
admet-3030	168	140	[	[	X
admet-3030	168	141	30,47	30,47	NUM
admet-3030	168	142	]	]	X
admet-3030	168	143	↑sfrps	↑sfrps	NOUN
admet-3030	169	1	→	→	SYM
admet-3030	169	2	bind	bind	VERB
admet-3030	169	3	wnt	wnt	PROPN
admet-3030	169	4	ligands	ligand	NOUN
admet-3030	169	5	(	(	PUNCT
admet-3030	169	6	decoy	decoy	NOUN
admet-3030	169	7	receptors	receptor	NOUN
admet-3030	169	8	)	)	PUNCT
admet-3030	169	9	→	→	PUNCT
admet-3030	169	10	inhibit	inhibit	VERB
admet-3030	169	11	wnt	wnt	NOUN
admet-3030	169	12	signalling	signal	VERB
admet-3030	169	13	→	→	SYM
admet-3030	169	14	↓follicle	↓follicle	X
admet-3030	169	15	activation	activation	NOUN
admet-3030	169	16	→	→	SYM
admet-3030	169	17	hair	hair	NOUN
admet-3030	169	18	loss	loss	NOUN
admet-3030	169	19	-	-	PUNCT
admet-3030	169	20	aga	aga	NOUN
admet-3030	169	21	wnt10a	wnt10a	NOUN
admet-3030	169	22	wnt	wnt	PROPN
admet-3030	169	23	/	/	SYM
admet-3030	169	24	β	β	NOUN
admet-3030	169	25	-	-	ADJ
admet-3030	169	26	catenin	catenin	NOUN
admet-3030	169	27	signalling	signal	VERB
admet-3030	169	28	[	[	X
admet-3030	169	29	31,32,34,61,62	31,32,34,61,62	NOUN
admet-3030	169	30	]	]	X
admet-3030	169	31	wnt10a	wnt10a	NOUN
admet-3030	169	32	→↑wnt	→↑wnt	X
admet-3030	169	33	signalling→stabalises	signalling→stabalise	NOUN
admet-3030	169	34	β	β	NOUN
admet-3030	169	35	-	-	SYM
admet-3030	169	36	catenin→	catenin→	ADJ
admet-3030	169	37	↑follicle	↑follicle	NOUN
admet-3030	169	38	activation→	activation→	PROPN
admet-3030	169	39	prevents	prevent	VERB
admet-3030	169	40	hair	hair	NOUN
admet-3030	169	41	loss	loss	NOUN
admet-3030	169	42	-	-	PUNCT
admet-3030	169	43	aga	aga	NOUN
admet-3030	169	44	if	if	SCONJ
admet-3030	169	45	mutation	mutation	NOUN
admet-3030	169	46	happens	happen	VERB
admet-3030	169	47	:	:	PUNCT
admet-3030	169	48	rs7349332	rs7349332	PROPN
admet-3030	169	49	(	(	PUNCT
admet-3030	169	50	snp	snp	ADJ
admet-3030	169	51	mutation)-wnt10a	mutation)-wnt10a	NOUN
admet-3030	169	52	variants	variant	NOUN
admet-3030	169	53	→↓wnt	→↓wnt	PART
admet-3030	169	54	signalling→↓follicle	signalling→↓follicle	NOUN
admet-3030	169	55	activation→promotes	activation→promote	VERB
admet-3030	169	56	hair	hair	NOUN
admet-3030	169	57	loss	loss	NOUN
admet-3030	169	58	-	-	PUNCT
admet-3030	169	59	aga	aga	NOUN
admet-3030	169	60	mtor	mtor	NOUN
admet-3030	169	61	,	,	PUNCT
admet-3030	169	62	slc7a1	slc7a1	NOUN
admet-3030	169	63	,	,	PUNCT
admet-3030	169	64	arg1	arg1	PROPN
admet-3030	169	65	/	/	SYM
admet-3030	169	66	arg2	arg2	PROPN
admet-3030	169	67	mtor	mtor	PROPN
admet-3030	169	68	/	/	SYM
admet-3030	169	69	arginine	arginine	NOUN
admet-3030	169	70	metabolism	metabolism	NOUN
admet-3030	170	1	[	[	X
admet-3030	170	2	63	63	NUM
admet-3030	170	3	]	]	X
admet-3030	170	4	snps	snps	NOUN
admet-3030	170	5	→	→	PUNCT
admet-3030	170	6	↓arginine	↓arginine	X
admet-3030	170	7	uptake	uptake	ADJ
admet-3030	170	8	+	+	CCONJ
admet-3030	170	9	↑ornithine	↑ornithine	ADJ
admet-3030	170	10	→	→	SYM
admet-3030	170	11	↓mtor	↓mtor	NOUN
admet-3030	170	12	signalling	signal	VERB
admet-3030	170	13	→	→	SYM
admet-3030	170	14	↓follicle	↓follicle	X
admet-3030	170	15	cell	cell	NOUN
admet-3030	170	16	proliferation	proliferation	NOUN
admet-3030	170	17	→	→	SYM
admet-3030	170	18	hair	hair	NOUN
admet-3030	170	19	loss	loss	NOUN
admet-3030	170	20	-	-	PUNCT
admet-3030	170	21	aga	aga	NOUN
admet-3030	170	22	nfkb1	nfkb1	SYM
admet-3030	170	23	,	,	PUNCT
admet-3030	170	24	rela	rela	PROPN
admet-3030	170	25	,	,	PUNCT
admet-3030	170	26	tnf	tnf	PROPN
admet-3030	170	27	,	,	PUNCT
admet-3030	170	28	il6	il6	PROPN
admet-3030	170	29	,	,	PUNCT
admet-3030	170	30	sod2	sod2	PROPN
admet-3030	170	31	,	,	PUNCT
admet-3030	170	32	etc	etc	X
admet-3030	170	33	.	.	X
admet-3030	170	34	nf	nf	X
admet-3030	170	35	-	-	PUNCT
admet-3030	170	36	κb	κb	NOUN
admet-3030	170	37	signalling	signal	VERB
admet-3030	170	38	(	(	PUNCT
admet-3030	170	39	inflammation	inflammation	NOUN
admet-3030	170	40	/	/	SYM
admet-3030	170	41	stress	stress	NOUN
admet-3030	170	42	)	)	PUNCT
admet-3030	171	1	[	[	X
admet-3030	171	2	42	42	NUM
admet-3030	171	3	]	]	PUNCT
admet-3030	171	4	oxidative	oxidative	ADJ
admet-3030	171	5	stress	stress	NOUN
admet-3030	171	6	→	→	SYM
admet-3030	171	7	nf	nf	ADJ
admet-3030	171	8	-	-	PUNCT
admet-3030	171	9	κb	κb	NOUN
admet-3030	171	10	activation	activation	NOUN
admet-3030	171	11	→	→	ADP
admet-3030	171	12	↑pro	↑pro	ADJ
admet-3030	171	13	-	-	ADJ
admet-3030	171	14	inflammatory	inflammatory	ADJ
admet-3030	171	15	genes	gene	NOUN
admet-3030	171	16	(	(	PUNCT
admet-3030	171	17	e.g.	e.g.	ADV
admet-3030	171	18	il6	il6	NOUN
admet-3030	171	19	,	,	PUNCT
admet-3030	171	20	tnfα	tnfα	NOUN
admet-3030	171	21	)	)	PUNCT
admet-3030	171	22	→	→	SYM
admet-3030	171	23	stem	stem	NOUN
admet-3030	171	24	cell	cell	NOUN
admet-3030	171	25	dysfunction	dysfunction	NOUN
admet-3030	171	26	&	&	CCONJ
admet-3030	171	27	follicle	follicle	NOUN
admet-3030	171	28	damage	damage	NOUN
admet-3030	171	29	→	→	SYM
admet-3030	171	30	hair	hair	NOUN
admet-3030	171	31	loss	loss	NOUN
admet-3030	171	32	-	-	PUNCT
admet-3030	171	33	aga	aga	NOUN
admet-3030	171	34	ptgds	ptgds	NOUN
admet-3030	171	35	(	(	PUNCT
admet-3030	171	36	prostaglandin	prostaglandin	NOUN
admet-3030	171	37	d2	d2	NOUN
admet-3030	171	38	synthase	synthase	NOUN
admet-3030	171	39	)	)	PUNCT
admet-3030	171	40	prostaglandin	prostaglandin	NOUN
admet-3030	171	41	pathway	pathway	NOUN
admet-3030	172	1	[	[	X
admet-3030	172	2	50	50	NUM
admet-3030	172	3	]	]	X
admet-3030	172	4	↑ptgds	↑ptgds	PROPN
admet-3030	172	5	→	→	PUNCT
admet-3030	172	6	↑pgd2	↑pgd2	VERB
admet-3030	172	7	in	in	ADP
admet-3030	172	8	follicles	follicle	NOUN
admet-3030	172	9	→	→	PUNCT
admet-3030	172	10	binds	bind	VERB
admet-3030	172	11	gpr44	gpr44	ADJ
admet-3030	172	12	receptor	receptor	NOUN
admet-3030	172	13	→	→	SYM
admet-3030	172	14	inhibitory	inhibitory	ADJ
admet-3030	172	15	signalling	signal	VERB
admet-3030	172	16	→	→	SYM
admet-3030	172	17	hair	hair	NOUN
admet-3030	172	18	growth	growth	NOUN
admet-3030	172	19	suppression	suppression	NOUN
admet-3030	172	20	→	→	SYM
admet-3030	173	1	hair	hair	NOUN
admet-3030	173	2	loss	loss	NOUN
admet-3030	173	3	-	-	PUNCT
admet-3030	173	4	aga	aga	NOUN
admet-3030	173	5	ptgdr2	ptgdr2	PROPN
admet-3030	173	6	(	(	PUNCT
admet-3030	173	7	gpr44	gpr44	PROPN
admet-3030	173	8	)	)	PUNCT
admet-3030	173	9	prostaglandin	prostaglandin	VERB
admet-3030	173	10	pathway	pathway	NOUN
admet-3030	173	11	[	[	X
admet-3030	173	12	50	50	NUM
admet-3030	173	13	]	]	SYM
admet-3030	173	14	↑ptgdr2	↑ptgdr2	NOUN
admet-3030	173	15	expression	expression	NOUN
admet-3030	173	16	→	→	PUNCT
admet-3030	173	17	↑sensitivity	↑sensitivity	NOUN
admet-3030	173	18	to	to	ADP
admet-3030	173	19	pgd2	pgd2	PROPN
admet-3030	173	20	→	→	SYM
admet-3030	173	21	inhibitory	inhibitory	ADJ
admet-3030	173	22	signalling	signal	VERB
admet-3030	173	23	→	→	SYM
admet-3030	173	24	early	early	ADJ
admet-3030	173	25	catagen	catagen	NOUN
admet-3030	173	26	/	/	SYM
admet-3030	173	27	telogen	telogen	NOUN
admet-3030	173	28	→	→	SYM
admet-3030	173	29	hair	hair	NOUN
admet-3030	173	30	loss	loss	NOUN
admet-3030	173	31	-	-	PUNCT
admet-3030	173	32	aga	aga	NOUN
admet-3030	173	33	srd5a1	srd5a1	NOUN
admet-3030	173	34	androgen	androgen	NOUN
admet-3030	173	35	signalling	signal	VERB
admet-3030	173	36	[	[	X
admet-3030	173	37	64	64	NUM
admet-3030	173	38	]	]	PUNCT
admet-3030	173	39	converts	convert	VERB
admet-3030	173	40	testosterone	testosterone	NOUN
admet-3030	173	41	to	to	ADP
admet-3030	173	42	dht	dht	NOUN
admet-3030	173	43	;	;	PUNCT
admet-3030	173	44	↑srd5a1	↑srd5a1	NOUN
admet-3030	173	45	expression	expression	NOUN
admet-3030	173	46	in	in	ADP
admet-3030	173	47	balding	bald	VERB
admet-3030	173	48	follicles	follicle	NOUN
admet-3030	173	49	→	→	PUNCT
admet-3030	173	50	↑dht	↑dht	ADJ
admet-3030	173	51	production	production	NOUN
admet-3030	173	52	→	→	SYM
admet-3030	173	53	enhanced	enhanced	ADJ
admet-3030	173	54	ar	ar	NOUN
admet-3030	173	55	activation	activation	NOUN
admet-3030	173	56	→	→	SYM
admet-3030	173	57	follicle	follicle	NOUN
admet-3030	173	58	miniaturization	miniaturization	NOUN
admet-3030	173	59	→	→	SYM
admet-3030	173	60	hair	hair	NOUN
admet-3030	173	61	loss	loss	NOUN
admet-3030	173	62	-	-	PUNCT
admet-3030	173	63	aga	aga	NOUN
admet-3030	173	64	eda2r	eda2r	PROPN
admet-3030	173	65	ar	ar	PROPN
admet-3030	173	66	/	/	SYM
admet-3030	173	67	eda2r	eda2r	PROPN
admet-3030	173	68	locus	locus	NOUN
admet-3030	173	69	interaction	interaction	NOUN
admet-3030	173	70	[	[	X
admet-3030	173	71	44	44	NUM
admet-3030	173	72	]	]	PUNCT
admet-3030	173	73	in	in	ADP
admet-3030	173	74	ld	ld	PROPN
admet-3030	173	75	with	with	ADP
admet-3030	173	76	ar	ar	NOUN
admet-3030	173	77	locus	locus	NOUN
admet-3030	173	78	;	;	PUNCT
admet-3030	173	79	may	may	AUX
admet-3030	173	80	regulate	regulate	VERB
admet-3030	173	81	ar	ar	NOUN
admet-3030	173	82	expression	expression	NOUN
admet-3030	173	83	or	or	CCONJ
admet-3030	173	84	ectodermal	ectodermal	ADJ
admet-3030	173	85	development	development	NOUN
admet-3030	173	86	pathways	pathway	NOUN
admet-3030	173	87	→	→	PUNCT
admet-3030	173	88	altered	alter	VERB
admet-3030	173	89	follicular	follicular	ADJ
admet-3030	173	90	development	development	NOUN
admet-3030	173	91	→	→	SYM
admet-3030	173	92	↑miniaturization	↑miniaturization	NOUN
admet-3030	173	93	→	→	SYM
admet-3030	173	94	hair	hair	NOUN
admet-3030	173	95	loss	loss	NOUN
admet-3030	173	96	-	-	PUNCT
admet-3030	173	97	aga	aga	NOUN
admet-3030	173	98	apcdd1	apcdd1	NOUN
admet-3030	174	1	wnt	wnt	PROPN
admet-3030	174	2	/	/	SYM
admet-3030	174	3	β	β	NOUN
admet-3030	174	4	-	-	ADJ
admet-3030	174	5	catenin	catenin	ADJ
admet-3030	174	6	signalling	signal	VERB
admet-3030	174	7	inhibition	inhibition	NOUN
admet-3030	174	8	[	[	X
admet-3030	174	9	46,53	46,53	NOUN
admet-3030	174	10	]	]	X
admet-3030	174	11	↑apcdd1	↑apcdd1	PROPN
admet-3030	174	12	inhibits	inhibit	VERB
admet-3030	174	13	wnt	wnt	NOUN
admet-3030	174	14	by	by	ADP
admet-3030	174	15	binding	bind	VERB
admet-3030	174	16	lrp5/6	lrp5/6	PROPN
admet-3030	174	17	or	or	CCONJ
admet-3030	174	18	wnt	wnt	PROPN
admet-3030	174	19	ligands	ligand	NOUN
admet-3030	174	20	→	→	SYM
admet-3030	174	21	↓β	↓β	ADJ
admet-3030	174	22	-	-	ADJ
admet-3030	174	23	catenin	catenin	ADJ
admet-3030	174	24	activity	activity	NOUN
admet-3030	174	25	→	→	SYM
admet-3030	174	26	↓hair	↓hair	X
admet-3030	174	27	follicle	follicle	NOUN
admet-3030	174	28	regeneration	regeneration	NOUN
admet-3030	174	29	→	→	SYM
admet-3030	174	30	miniaturization	miniaturization	NOUN
admet-3030	174	31	→	→	SYM
admet-3030	174	32	hair	hair	NOUN
admet-3030	174	33	loss	loss	NOUN
admet-3030	174	34	-	-	PUNCT
admet-3030	174	35	aga	aga	PROPN
admet-3030	174	36	bmp2	bmp2	PROPN
admet-3030	174	37	bmp	bmp	PROPN
admet-3030	174	38	/	/	SYM
admet-3030	174	39	tgf	tgf	PROPN
admet-3030	174	40	-	-	PUNCT
admet-3030	174	41	β	β	NOUN
admet-3030	174	42	signalling	signal	VERB
admet-3030	174	43	[	[	X
admet-3030	174	44	49,50	49,50	X
admet-3030	174	45	]	]	X
admet-3030	174	46	bmp2	bmp2	PROPN
admet-3030	174	47	regulates	regulate	VERB
admet-3030	174	48	follicle	follicle	NOUN
admet-3030	174	49	development	development	NOUN
admet-3030	174	50	;	;	PUNCT
admet-3030	174	51	↑bmp2	↑bmp2	PROPN
admet-3030	174	52	or	or	CCONJ
admet-3030	174	53	snps	snps	PROPN
admet-3030	174	54	→	→	SYM
admet-3030	174	55	telogen	telogen	NOUN
admet-3030	174	56	prolongation	prolongation	NOUN
admet-3030	174	57	+	+	CCONJ
admet-3030	174	58	anagen	anagen	NOUN
admet-3030	174	59	inhibition	inhibition	NOUN
admet-3030	174	60	→	→	PUNCT
admet-3030	174	61	↓stem	↓stem	NOUN
admet-3030	174	62	cell	cell	NOUN
admet-3030	174	63	proliferation	proliferation	NOUN
admet-3030	174	64	→	→	SYM
admet-3030	174	65	miniaturization	miniaturization	NOUN
admet-3030	174	66	→	→	SYM
admet-3030	174	67	hair	hair	NOUN
admet-3030	174	68	loss	loss	NOUN
admet-3030	174	69	-	-	PUNCT
admet-3030	174	70	aga	aga	NOUN
admet-3030	174	71	bdnf	bdnf	PROPN
admet-3030	174	72	(	(	PUNCT
admet-3030	174	73	brain	brain	NOUN
admet-3030	174	74	-	-	PUNCT
admet-3030	174	75	derived	derive	VERB
admet-3030	174	76	neurotrophic	neurotrophic	ADJ
admet-3030	174	77	factor	factor	NOUN
admet-3030	174	78	)	)	PUNCT
admet-3030	174	79	neurotrophin	neurotrophin	NOUN
admet-3030	174	80	signalling	signal	VERB
admet-3030	174	81	[	[	X
admet-3030	174	82	49,50	49,50	X
admet-3030	174	83	]	]	X
admet-3030	174	84	↓bdnf	↓bdnf	X
admet-3030	174	85	expression	expression	NOUN
admet-3030	174	86	or	or	CCONJ
admet-3030	174	87	val66met	val66met	VERB
admet-3030	174	88	variant	variant	NOUN
admet-3030	174	89	→	→	SYM
admet-3030	174	90	disrupted	disrupt	VERB
admet-3030	174	91	follicle	follicle	NOUN
admet-3030	174	92	innervation	innervation	NOUN
admet-3030	174	93	and	and	CCONJ
admet-3030	174	94	stem	stem	NOUN
admet-3030	174	95	cell	cell	NOUN
admet-3030	174	96	activity	activity	NOUN
admet-3030	174	97	→	→	PUNCT
admet-3030	174	98	impaired	impaired	ADJ
admet-3030	174	99	anagen	anagen	NOUN
admet-3030	174	100	entry	entry	NOUN
admet-3030	174	101	→	→	SYM
admet-3030	174	102	miniaturization	miniaturization	NOUN
admet-3030	174	103	→	→	SYM
admet-3030	174	104	hair	hair	NOUN
admet-3030	174	105	loss	loss	NOUN
admet-3030	174	106	-	-	PUNCT
admet-3030	174	107	aga	aga	NOUN
admet-3030	174	108	egr1	egr1	PROPN
admet-3030	174	109	transcriptional	transcriptional	ADJ
admet-3030	174	110	regulation	regulation	NOUN
admet-3030	174	111	[	[	X
admet-3030	174	112	48	48	NUM
admet-3030	174	113	]	]	PUNCT
admet-3030	174	114	↓egr1	↓egr1	PUNCT
admet-3030	174	115	in	in	ADP
admet-3030	174	116	frontal	frontal	ADJ
admet-3030	174	117	scalp	scalp	NOUN
admet-3030	174	118	→	→	SYM
admet-3030	174	119	↓growth	↓growth	NOUN
admet-3030	174	120	-	-	PUNCT
admet-3030	174	121	promoting	promote	VERB
admet-3030	174	122	gene	gene	NOUN
admet-3030	174	123	expression	expression	NOUN
admet-3030	174	124	→	→	PUNCT
admet-3030	174	125	↓follicle	↓follicle	VERB
admet-3030	174	126	renewal	renewal	NOUN
admet-3030	174	127	→	→	SYM
admet-3030	174	128	↑miniaturization	↑miniaturization	NOUN
admet-3030	174	129	→	→	SYM
admet-3030	174	130	hair	hair	NOUN
admet-3030	174	131	loss	loss	NOUN
admet-3030	174	132	-	-	PUNCT
admet-3030	174	133	aga	aga	NOUN
admet-3030	174	134	aa	aa	PROPN
admet-3030	174	135	stat3	stat3	PROPN
admet-3030	174	136	,	,	PUNCT
admet-3030	174	137	il13	il13	PROPN
admet-3030	174	138	,	,	PUNCT
admet-3030	174	139	il2ra	il2ra	NOUN
admet-3030	174	140	,	,	PUNCT
admet-3030	174	141	etc	etc	X
admet-3030	174	142	.	.	X
admet-3030	174	143	jak	jak	PROPN
admet-3030	174	144	-	-	PUNCT
admet-3030	174	145	stat	stat	PROPN
admet-3030	174	146	autoimmune	autoimmune	ADJ
admet-3030	174	147	inflammation	inflammation	NOUN
admet-3030	175	1	[	[	X
admet-3030	175	2	34	34	NUM
admet-3030	175	3	]	]	X
admet-3030	175	4	↓immune	↓immune	VERB
admet-3030	175	5	privilege	privilege	NOUN
admet-3030	175	6	→	→	SYM
admet-3030	175	7	↑ifn	↑ifn	NOUN
admet-3030	175	8	-	-	PUNCT
admet-3030	175	9	γ	γ	NOUN
admet-3030	175	10	/	/	SYM
admet-3030	175	11	il-15	il-15	NOUN
admet-3030	175	12	→	→	SYM
admet-3030	175	13	jak1	jak1	PROPN
admet-3030	175	14	/	/	SYM
admet-3030	175	15	jak2	jak2	PROPN
admet-3030	175	16	activation	activation	NOUN
admet-3030	175	17	→	→	SYM
admet-3030	175	18	stat1/3	stat1/3	ADJ
admet-3030	175	19	→	→	SYM
admet-3030	175	20	↑mhc	↑mhc	X
admet-3030	175	21	on	on	ADP
admet-3030	175	22	follicles	follicle	NOUN
admet-3030	175	23	→	→	PUNCT
admet-3030	175	24	cd8⁺	cd8⁺	NOUN
admet-3030	175	25	t	t	NOUN
admet-3030	175	26	cell	cell	NOUN
admet-3030	175	27	attack	attack	NOUN
admet-3030	175	28	→	→	PUNCT
admet-3030	175	29	follicle	follicle	NOUN
admet-3030	175	30	destruction	destruction	NOUN
admet-3030	175	31	→	→	SYM
admet-3030	175	32	hair	hair	NOUN
admet-3030	175	33	loss	loss	NOUN
admet-3030	175	34	-	-	PUNCT
admet-3030	175	35	aa	aa	NOUN
admet-3030	175	36	admet	admet	PROPN
admet-3030	175	37	&	&	CCONJ
admet-3030	175	38	dmpk	dmpk	PROPN
admet-3030	175	39	00(0	00(0	PROPN
admet-3030	175	40	)	)	PUNCT
admet-3030	175	41	(	(	PUNCT
admet-3030	175	42	2025	2025	NUM
admet-3030	175	43	)	)	PUNCT
admet-3030	175	44	3030	3030	NUM
admet-3030	175	45	precision	precision	NOUN
admet-3030	175	46	therapeutics	therapeutic	NOUN
admet-3030	175	47	in	in	ADP
admet-3030	175	48	non	non	ADJ
admet-3030	175	49	-	-	ADJ
admet-3030	175	50	scarring	scar	VERB
admet-3030	175	51	alopecia	alopecia	NOUN
admet-3030	175	52	doi	doi	NOUN
admet-3030	175	53	:	:	PUNCT
admet-3030	175	54	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	175	55	9	9	NUM
admet-3030	175	56	hair	hair	NOUN
admet-3030	175	57	follicle	follicle	NOUN
admet-3030	175	58	stem	stem	NOUN
admet-3030	175	59	cell	cell	NOUN
admet-3030	175	60	dysfunction	dysfunction	NOUN
admet-3030	175	61	yuanhong	yuanhong	PROPN
admet-3030	175	62	liu	liu	PROPN
admet-3030	175	63	et	et	PROPN
admet-3030	175	64	al	al	PROPN
admet-3030	175	65	.	.	PUNCT
admet-3030	176	1	[	[	X
admet-3030	176	2	65	65	NUM
admet-3030	176	3	]	]	PUNCT
admet-3030	176	4	examined	examine	VERB
admet-3030	176	5	the	the	DET
admet-3030	176	6	dysregulation	dysregulation	NOUN
admet-3030	176	7	of	of	ADP
admet-3030	176	8	hair	hair	NOUN
admet-3030	176	9	follicle	follicle	NOUN
admet-3030	176	10	stem	stem	NOUN
admet-3030	176	11	cells	cell	NOUN
admet-3030	176	12	as	as	ADP
admet-3030	176	13	a	a	DET
admet-3030	176	14	key	key	ADJ
admet-3030	176	15	mechanism	mechanism	NOUN
admet-3030	176	16	in	in	ADP
admet-3030	176	17	hair	hair	NOUN
admet-3030	176	18	loss	loss	NOUN
admet-3030	176	19	pathogenesis	pathogenesis	NOUN
admet-3030	176	20	.	.	PUNCT
admet-3030	177	1	changes	change	NOUN
admet-3030	177	2	in	in	ADP
admet-3030	177	3	the	the	DET
admet-3030	177	4	microenvironment	microenvironment	NOUN
admet-3030	177	5	,	,	PUNCT
admet-3030	177	6	such	such	ADJ
admet-3030	177	7	as	as	ADP
admet-3030	177	8	aging	age	VERB
admet-3030	177	9	,	,	PUNCT
admet-3030	177	10	diet	diet	NOUN
admet-3030	177	11	,	,	PUNCT
admet-3030	177	12	and	and	CCONJ
admet-3030	177	13	stress	stress	NOUN
admet-3030	177	14	,	,	PUNCT
admet-3030	177	15	can	can	AUX
admet-3030	177	16	disrupt	disrupt	VERB
admet-3030	177	17	the	the	DET
admet-3030	177	18	hair	hair	NOUN
admet-3030	177	19	follicle	follicle	NOUN
admet-3030	177	20	stem	stem	NOUN
admet-3030	177	21	cell	cell	NOUN
admet-3030	177	22	lifecycle	lifecycle	NOUN
admet-3030	177	23	.	.	PUNCT
admet-3030	178	1	the	the	DET
admet-3030	178	2	study	study	NOUN
admet-3030	178	3	identified	identify	VERB
admet-3030	178	4	mechanisms	mechanism	NOUN
admet-3030	178	5	,	,	PUNCT
admet-3030	178	6	including	include	VERB
admet-3030	178	7	decreased	decrease	VERB
admet-3030	178	8	lactate	lactate	NOUN
admet-3030	178	9	levels	level	NOUN
admet-3030	178	10	,	,	PUNCT
admet-3030	178	11	mtorc2	mtorc2	NOUN
admet-3030	178	12	deletions	deletion	NOUN
admet-3030	178	13	,	,	PUNCT
admet-3030	178	14	and	and	CCONJ
admet-3030	178	15	increased	increase	VERB
admet-3030	178	16	androgen	androgen	NOUN
admet-3030	178	17	receptor	receptor	NOUN
admet-3030	178	18	expression	expression	NOUN
admet-3030	178	19	,	,	PUNCT
admet-3030	178	20	as	as	ADP
admet-3030	178	21	contributing	contribute	VERB
admet-3030	178	22	factors	factor	NOUN
admet-3030	178	23	.	.	PUNCT
admet-3030	179	1	they	they	PRON
admet-3030	179	2	suggested	suggest	VERB
admet-3030	179	3	that	that	SCONJ
admet-3030	179	4	stimulating	stimulate	VERB
admet-3030	179	5	hair	hair	NOUN
admet-3030	179	6	follicle	follicle	NOUN
admet-3030	179	7	stem	stem	NOUN
admet-3030	179	8	cells	cell	NOUN
admet-3030	179	9	through	through	ADP
admet-3030	179	10	various	various	ADJ
admet-3030	179	11	therapeutic	therapeutic	ADJ
admet-3030	179	12	interventions	intervention	NOUN
admet-3030	179	13	could	could	AUX
admet-3030	179	14	potentially	potentially	ADV
admet-3030	179	15	improve	improve	VERB
admet-3030	179	16	hair	hair	NOUN
admet-3030	179	17	regrowth	regrowth	NOUN
admet-3030	179	18	.	.	PUNCT
admet-3030	180	1	telomere	telomere	NOUN
admet-3030	180	2	length	length	NOUN
admet-3030	180	3	and	and	CCONJ
admet-3030	180	4	genetic	genetic	ADJ
admet-3030	180	5	risk	risk	NOUN
admet-3030	180	6	factors	factor	NOUN
admet-3030	180	7	telomere	telomere	NOUN
admet-3030	180	8	length	length	NOUN
admet-3030	180	9	(	(	PUNCT
admet-3030	180	10	ltl	ltl	PROPN
admet-3030	180	11	)	)	PUNCT
admet-3030	180	12	has	have	AUX
admet-3030	180	13	been	be	AUX
admet-3030	180	14	identified	identify	VERB
admet-3030	180	15	as	as	ADP
admet-3030	180	16	a	a	DET
admet-3030	180	17	potential	potential	ADJ
admet-3030	180	18	genetic	genetic	ADJ
admet-3030	180	19	risk	risk	NOUN
admet-3030	180	20	factor	factor	NOUN
admet-3030	180	21	for	for	ADP
admet-3030	180	22	aa	aa	PROPN
admet-3030	180	23	.	.	PUNCT
admet-3030	181	1	yicheng	yicheng	PROPN
admet-3030	181	2	li	li	PROPN
admet-3030	181	3	et	et	PROPN
admet-3030	181	4	al	al	PROPN
admet-3030	181	5	.	.	PUNCT
admet-3030	182	1	[	[	X
admet-3030	182	2	66	66	NUM
admet-3030	182	3	]	]	PUNCT
admet-3030	182	4	conducted	conduct	VERB
admet-3030	182	5	a	a	DET
admet-3030	182	6	mendelian	mendelian	ADJ
admet-3030	182	7	randomization	randomization	NOUN
admet-3030	182	8	study	study	NOUN
admet-3030	182	9	using	use	VERB
admet-3030	182	10	gwas	gwas	PROPN
admet-3030	182	11	data	datum	NOUN
admet-3030	182	12	from	from	ADP
admet-3030	182	13	the	the	DET
admet-3030	182	14	fingen	fingen	PROPN
admet-3030	182	15	biobank	biobank	NOUN
admet-3030	182	16	and	and	CCONJ
admet-3030	182	17	found	find	VERB
admet-3030	182	18	that	that	SCONJ
admet-3030	182	19	shorter	short	ADJ
admet-3030	182	20	leukocyte	leukocyte	NOUN
admet-3030	182	21	telomere	telomere	NOUN
admet-3030	182	22	length	length	NOUN
admet-3030	182	23	increased	increase	VERB
admet-3030	182	24	the	the	DET
admet-3030	182	25	risk	risk	NOUN
admet-3030	182	26	of	of	ADP
admet-3030	182	27	aa	aa	NOUN
admet-3030	182	28	by	by	ADP
admet-3030	182	29	3.19	3.19	NUM
admet-3030	182	30	times	time	NOUN
admet-3030	182	31	.	.	PUNCT
admet-3030	183	1	their	their	PRON
admet-3030	183	2	findings	finding	NOUN
admet-3030	183	3	suggest	suggest	VERB
admet-3030	183	4	that	that	SCONJ
admet-3030	183	5	ltl	ltl	PROPN
admet-3030	183	6	could	could	AUX
admet-3030	183	7	serve	serve	VERB
admet-3030	183	8	as	as	ADP
admet-3030	183	9	a	a	DET
admet-3030	183	10	valuable	valuable	ADJ
admet-3030	183	11	genetic	genetic	ADJ
admet-3030	183	12	marker	marker	NOUN
admet-3030	183	13	for	for	ADP
admet-3030	183	14	predicting	predict	VERB
admet-3030	183	15	aa	aa	PROPN
admet-3030	183	16	susceptibility	susceptibility	NOUN
admet-3030	183	17	and	and	CCONJ
admet-3030	183	18	may	may	AUX
admet-3030	183	19	help	help	AUX
admet-3030	183	20	identify	identify	VERB
admet-3030	183	21	individuals	individual	NOUN
admet-3030	183	22	at	at	ADP
admet-3030	183	23	risk	risk	NOUN
admet-3030	183	24	for	for	ADP
admet-3030	183	25	early	early	ADJ
admet-3030	183	26	intervention	intervention	NOUN
admet-3030	183	27	.	.	PUNCT
admet-3030	184	1	single	single	ADJ
admet-3030	184	2	-	-	PUNCT
admet-3030	184	3	nucleotide	nucleotide	ADJ
admet-3030	184	4	polymorphisms	polymorphism	NOUN
admet-3030	184	5	in	in	ADP
admet-3030	184	6	androgenetic	androgenetic	ADJ
admet-3030	184	7	alopecia	alopecia	NOUN
admet-3030	184	8	it	it	PRON
admet-3030	184	9	was	be	AUX
admet-3030	184	10	reported	report	VERB
admet-3030	184	11	in	in	ADP
admet-3030	184	12	many	many	ADJ
admet-3030	184	13	studies	study	NOUN
admet-3030	184	14	that	that	SCONJ
admet-3030	184	15	single	single	ADJ
admet-3030	184	16	-	-	PUNCT
admet-3030	184	17	nucleotide	nucleotide	NOUN
admet-3030	184	18	polymorphisms	polymorphism	NOUN
admet-3030	184	19	(	(	PUNCT
admet-3030	184	20	snps	snps	PROPN
admet-3030	184	21	)	)	PUNCT
admet-3030	184	22	are	be	AUX
admet-3030	184	23	a	a	DET
admet-3030	184	24	promising	promising	ADJ
admet-3030	184	25	contributor	contributor	NOUN
admet-3030	184	26	to	to	AUX
admet-3030	184	27	aga	aga	PROPN
admet-3030	184	28	.	.	PUNCT
admet-3030	185	1	snps	snps	PROPN
admet-3030	185	2	directly	directly	ADV
admet-3030	185	3	affect	affect	VERB
admet-3030	185	4	gene	gene	NOUN
admet-3030	185	5	expression	expression	NOUN
admet-3030	185	6	and	and	CCONJ
admet-3030	185	7	protein	protein	NOUN
admet-3030	185	8	function	function	NOUN
admet-3030	185	9	,	,	PUNCT
admet-3030	185	10	leading	lead	VERB
admet-3030	185	11	to	to	ADP
admet-3030	185	12	changes	change	NOUN
admet-3030	185	13	in	in	ADP
admet-3030	185	14	follicular	follicular	ADJ
admet-3030	185	15	development	development	NOUN
admet-3030	185	16	and	and	CCONJ
admet-3030	185	17	alterations	alteration	NOUN
admet-3030	185	18	in	in	ADP
admet-3030	185	19	androgenic	androgenic	ADJ
admet-3030	185	20	pathways	pathway	NOUN
admet-3030	185	21	[	[	X
admet-3030	185	22	32	32	NUM
admet-3030	185	23	]	]	PUNCT
admet-3030	185	24	.	.	PUNCT
admet-3030	186	1	hence	hence	ADV
admet-3030	186	2	,	,	PUNCT
admet-3030	186	3	snps	snps	PROPN
admet-3030	186	4	play	play	VERB
admet-3030	186	5	a	a	DET
admet-3030	186	6	crucial	crucial	ADJ
admet-3030	186	7	role	role	NOUN
admet-3030	186	8	in	in	ADP
admet-3030	186	9	understanding	understand	VERB
admet-3030	186	10	individual	individual	ADJ
admet-3030	186	11	susceptibility	susceptibility	NOUN
admet-3030	186	12	to	to	ADP
admet-3030	186	13	aga	aga	VERB
admet-3030	186	14	and	and	CCONJ
admet-3030	186	15	can	can	AUX
admet-3030	186	16	also	also	ADV
admet-3030	186	17	serve	serve	VERB
admet-3030	186	18	as	as	ADP
admet-3030	186	19	promising	promise	VERB
admet-3030	186	20	targets	target	NOUN
admet-3030	186	21	for	for	ADP
admet-3030	186	22	personalized	personalized	ADJ
admet-3030	186	23	medicine	medicine	NOUN
admet-3030	186	24	.	.	PUNCT
admet-3030	187	1	snps	snps	PROPN
admet-3030	187	2	in	in	ADP
admet-3030	187	3	the	the	DET
admet-3030	187	4	pitx2	pitx2	NOUN
admet-3030	187	5	gene	gene	NOUN
admet-3030	187	6	that	that	PRON
admet-3030	187	7	cause	cause	VERB
admet-3030	187	8	aga	aga	NOUN
admet-3030	187	9	are	be	AUX
admet-3030	187	10	the	the	DET
admet-3030	187	11	most	most	ADV
admet-3030	187	12	distinctive	distinctive	ADJ
admet-3030	187	13	feature	feature	NOUN
admet-3030	187	14	identified	identify	VERB
admet-3030	187	15	in	in	ADP
admet-3030	187	16	the	the	DET
admet-3030	187	17	indian	indian	ADJ
admet-3030	187	18	population	population	NOUN
admet-3030	187	19	.	.	PUNCT
admet-3030	188	1	the	the	DET
admet-3030	188	2	most	most	ADV
admet-3030	188	3	reported	report	VERB
admet-3030	188	4	snps	snps	PROPN
admet-3030	188	5	of	of	ADP
admet-3030	188	6	the	the	DET
admet-3030	188	7	pitx2	pitx2	PROPN
admet-3030	188	8	gene	gene	NOUN
admet-3030	188	9	are	be	AUX
admet-3030	188	10	rs2200733	rs2200733	ADJ
admet-3030	188	11	,	,	PUNCT
admet-3030	188	12	rs13143308	rs13143308	NOUN
admet-3030	188	13	,	,	PUNCT
admet-3030	188	14	and	and	CCONJ
admet-3030	188	15	rs10033464	rs10033464	PROPN
admet-3030	188	16	and	and	CCONJ
admet-3030	188	17	the	the	DET
admet-3030	188	18	associated	associated	ADJ
admet-3030	188	19	molecular	molecular	ADJ
admet-3030	188	20	pathways	pathway	NOUN
admet-3030	188	21	,	,	PUNCT
admet-3030	188	22	which	which	PRON
admet-3030	188	23	are	be	AUX
admet-3030	188	24	getting	getting	AUX
admet-3030	188	25	altered	alter	VERB
admet-3030	188	26	,	,	PUNCT
admet-3030	188	27	are	be	AUX
admet-3030	188	28	wnt	wnt	NOUN
admet-3030	188	29	/	/	SYM
admet-3030	188	30	β	β	NOUN
admet-3030	188	31	-	-	ADJ
admet-3030	188	32	catenin	catenin	ADJ
admet-3030	188	33	signalling	signal	VERB
admet-3030	188	34	pathway	pathway	NOUN
admet-3030	188	35	,	,	PUNCT
admet-3030	188	36	androgenic	androgenic	ADJ
admet-3030	188	37	receptor	receptor	NOUN
admet-3030	188	38	(	(	PUNCT
admet-3030	188	39	ar	ar	NOUN
admet-3030	188	40	)	)	PUNCT
admet-3030	188	41	expression	expression	NOUN
admet-3030	188	42	and	and	CCONJ
admet-3030	188	43	5α	5α	ADJ
admet-3030	188	44	-	-	PUNCT
admet-3030	188	45	reductase	reductase	NOUN
admet-3030	188	46	pathway	pathway	NOUN
admet-3030	188	47	[	[	X
admet-3030	188	48	33	33	NUM
admet-3030	188	49	]	]	PUNCT
admet-3030	188	50	.	.	PUNCT
admet-3030	189	1	individuals	individual	NOUN
admet-3030	189	2	with	with	ADP
admet-3030	189	3	shorter	short	ADJ
admet-3030	189	4	repeats	repeat	NOUN
admet-3030	189	5	of	of	ADP
admet-3030	189	6	snp	snp	ADJ
admet-3030	189	7	rs6152	rs6152	NOUN
admet-3030	189	8	exhibit	exhibit	VERB
admet-3030	189	9	higher	high	ADJ
admet-3030	189	10	ar	ar	NOUN
admet-3030	189	11	activity	activity	NOUN
admet-3030	189	12	,	,	PUNCT
admet-3030	189	13	leading	lead	VERB
admet-3030	189	14	to	to	ADP
admet-3030	189	15	aga	aga	PROPN
admet-3030	189	16	.	.	PUNCT
admet-3030	190	1	the	the	DET
admet-3030	190	2	snps	snps	PROPN
admet-3030	190	3	of	of	ADP
admet-3030	190	4	the	the	DET
admet-3030	190	5	wnt10a	wnt10a	NOUN
admet-3030	190	6	gene	gene	NOUN
admet-3030	190	7	-rs7349332	-rs7349332	NOUN
admet-3030	190	8	and	and	CCONJ
admet-3030	190	9	srd5a2	srd5a2	PROPN
admet-3030	190	10	(	(	PUNCT
admet-3030	190	11	rs523349	rs523349	PROPN
admet-3030	190	12	)	)	PUNCT
admet-3030	190	13	have	have	VERB
admet-3030	190	14	direct	direct	ADJ
admet-3030	190	15	impacts	impact	NOUN
admet-3030	190	16	on	on	ADP
admet-3030	190	17	the	the	DET
admet-3030	190	18	5α	5α	ADJ
admet-3030	190	19	-	-	PUNCT
admet-3030	190	20	reductase	reductase	NOUN
admet-3030	190	21	functionality	functionality	NOUN
admet-3030	190	22	leading	lead	VERB
admet-3030	190	23	to	to	ADP
admet-3030	190	24	hair	hair	NOUN
admet-3030	190	25	follicle	follicle	NOUN
admet-3030	190	26	miniaturization	miniaturization	NOUN
admet-3030	190	27	[	[	X
admet-3030	190	28	35	35	NUM
admet-3030	190	29	]	]	PUNCT
admet-3030	190	30	.	.	PUNCT
admet-3030	191	1	few	few	ADJ
admet-3030	191	2	researchers	researcher	NOUN
admet-3030	191	3	have	have	AUX
admet-3030	191	4	also	also	ADV
admet-3030	191	5	reported	report	VERB
admet-3030	191	6	that	that	SCONJ
admet-3030	191	7	snps	snps	PROPN
admet-3030	191	8	modulate	modulate	VERB
admet-3030	191	9	the	the	DET
admet-3030	191	10	prostaglandin	prostaglandin	ADJ
admet-3030	191	11	pathway	pathway	NOUN
admet-3030	191	12	,	,	PUNCT
admet-3030	191	13	thereby	thereby	ADV
admet-3030	191	14	inhibiting	inhibit	VERB
admet-3030	191	15	or	or	CCONJ
admet-3030	191	16	stimulating	stimulate	VERB
admet-3030	191	17	hair	hair	NOUN
admet-3030	191	18	growth	growth	NOUN
admet-3030	191	19	.	.	PUNCT
admet-3030	192	1	ptgdr2	ptgdr2	NOUN
admet-3030	192	2	variants	variant	NOUN
admet-3030	192	3	(	(	PUNCT
admet-3030	192	4	rs533116	rs533116	PROPN
admet-3030	192	5	,	,	PUNCT
admet-3030	192	6	rs545659	rs545659	PROPN
admet-3030	192	7	)	)	PUNCT
admet-3030	192	8	and	and	CCONJ
admet-3030	192	9	ptgfr	ptgfr	NOUN
admet-3030	192	10	-	-	PUNCT
admet-3030	192	11	rs10782665	rs10782665	NOUN
admet-3030	192	12	are	be	AUX
admet-3030	192	13	among	among	ADP
admet-3030	192	14	the	the	DET
admet-3030	192	15	variants	variant	NOUN
admet-3030	192	16	that	that	PRON
admet-3030	192	17	modulate	modulate	VERB
admet-3030	192	18	the	the	DET
admet-3030	192	19	prostaglandin	prostaglandin	NOUN
admet-3030	192	20	pathways	pathway	NOUN
admet-3030	192	21	.	.	PUNCT
admet-3030	193	1	in	in	ADP
admet-3030	193	2	addition	addition	NOUN
admet-3030	193	3	to	to	ADP
admet-3030	193	4	the	the	DET
admet-3030	193	5	above	above	ADJ
admet-3030	193	6	applications	application	NOUN
admet-3030	193	7	,	,	PUNCT
admet-3030	193	8	some	some	DET
admet-3030	193	9	snps	snps	NOUN
admet-3030	193	10	,	,	PUNCT
admet-3030	193	11	such	such	ADJ
admet-3030	193	12	as	as	ADP
admet-3030	193	13	ptges2	ptges2	PROPN
admet-3030	193	14	(	(	PUNCT
admet-3030	193	15	rs13283456	rs13283456	NOUN
admet-3030	193	16	)	)	PUNCT
admet-3030	193	17	and	and	CCONJ
admet-3030	193	18	ace	ace	NOUN
admet-3030	193	19	(	(	PUNCT
admet-3030	193	20	rs4343	rs4343	PROPN
admet-3030	193	21	)	)	PUNCT
admet-3030	193	22	,	,	PUNCT
admet-3030	193	23	are	be	AUX
admet-3030	193	24	used	use	VERB
admet-3030	193	25	to	to	PART
admet-3030	193	26	analyse	analyse	VERB
admet-3030	193	27	treatment	treatment	NOUN
admet-3030	193	28	responses	response	NOUN
admet-3030	193	29	,	,	PUNCT
admet-3030	193	30	including	include	VERB
admet-3030	193	31	minoxidil	minoxidil	NOUN
admet-3030	193	32	[	[	X
admet-3030	193	33	35	35	NUM
admet-3030	193	34	]	]	PUNCT
admet-3030	193	35	.	.	PUNCT
admet-3030	194	1	additional	additional	ADJ
admet-3030	194	2	genes	gene	NOUN
admet-3030	194	3	involved	involve	VERB
admet-3030	194	4	in	in	ADP
admet-3030	194	5	aga	aga	NOUN
admet-3030	194	6	are	be	AUX
admet-3030	194	7	shown	show	VERB
admet-3030	194	8	in	in	ADP
admet-3030	194	9	table	table	NOUN
admet-3030	194	10	3	3	NUM
admet-3030	194	11	.	.	PUNCT
admet-3030	194	12	table	table	NOUN
admet-3030	194	13	3	3	NUM
admet-3030	194	14	.	.	X
admet-3030	194	15	aga	aga	NOUN
admet-3030	194	16	-	-	PUNCT
admet-3030	194	17	associated	associate	VERB
admet-3030	194	18	genes	gene	NOUN
admet-3030	194	19	and	and	CCONJ
admet-3030	194	20	snp	snp	ADJ
admet-3030	194	21	alterations	alteration	NOUN
admet-3030	194	22	gene	gene	NOUN
admet-3030	194	23	snps	snps	PROPN
admet-3030	194	24	or	or	CCONJ
admet-3030	194	25	variants	variant	NOUN
admet-3030	194	26	alterations	alteration	NOUN
admet-3030	194	27	pitx2	pitx2	NOUN
admet-3030	195	1	[	[	X
admet-3030	195	2	33	33	NUM
admet-3030	195	3	]	]	X
admet-3030	195	4	rs2200733	rs2200733	ADJ
admet-3030	195	5	,	,	PUNCT
admet-3030	195	6	rs13143308	rs13143308	NOUN
admet-3030	195	7	,	,	PUNCT
admet-3030	195	8	rs10033464	rs10033464	PROPN
admet-3030	195	9	wnt	wnt	PROPN
admet-3030	195	10	/	/	SYM
admet-3030	195	11	β	β	NOUN
admet-3030	195	12	-	-	ADJ
admet-3030	195	13	catenin	catenin	ADJ
admet-3030	195	14	signalling	signal	VERB
admet-3030	195	15	pathway	pathway	NOUN
admet-3030	195	16	,	,	PUNCT
admet-3030	195	17	ar	ar	NOUN
admet-3030	195	18	expression	expression	NOUN
admet-3030	195	19	,	,	PUNCT
admet-3030	195	20	and	and	CCONJ
admet-3030	195	21	5α	5α	ADJ
admet-3030	195	22	-	-	PUNCT
admet-3030	195	23	reductase	reductase	NOUN
admet-3030	195	24	ar	ar	NOUN
admet-3030	195	25	[	[	X
admet-3030	195	26	34	34	NUM
admet-3030	195	27	]	]	X
admet-3030	195	28	rs6152	rs6152	NOUN
admet-3030	195	29	alters	alter	VERB
admet-3030	195	30	ar	ar	NOUN
admet-3030	195	31	sensitivity	sensitivity	NOUN
admet-3030	195	32	wnt10a	wnt10a	NOUN
admet-3030	195	33	[	[	X
admet-3030	195	34	51	51	NUM
admet-3030	195	35	]	]	X
admet-3030	195	36	rs7349332	rs7349332	PROPN
admet-3030	195	37	wnt	wnt	NOUN
admet-3030	195	38	signalling	signal	VERB
admet-3030	195	39	pathway	pathway	NOUN
admet-3030	195	40	srd5a2	srd5a2	NOUN
admet-3030	196	1	[	[	X
admet-3030	196	2	35	35	NUM
admet-3030	196	3	]	]	SYM
admet-3030	196	4	rs523349	rs523349	ADJ
admet-3030	196	5	5α	5α	ADJ
admet-3030	196	6	-	-	PUNCT
admet-3030	196	7	reductase	reductase	NOUN
admet-3030	196	8	activity	activity	NOUN
admet-3030	196	9	and	and	CCONJ
admet-3030	196	10	dht	dht	NOUN
admet-3030	196	11	synthesis	synthesis	NOUN
admet-3030	196	12	ptgdr2	ptgdr2	NOUN
admet-3030	197	1	[	[	X
admet-3030	197	2	32	32	NUM
admet-3030	197	3	]	]	SYM
admet-3030	197	4	rs533116	rs533116	PROPN
admet-3030	197	5	,	,	PUNCT
admet-3030	197	6	rs545659	rs545659	PROPN
admet-3030	197	7	inhibits	inhibit	VERB
admet-3030	197	8	the	the	DET
admet-3030	197	9	expression	expression	NOUN
admet-3030	197	10	of	of	ADP
admet-3030	197	11	pgd2	pgd2	ADJ
admet-3030	197	12	expressionprevents	expressionprevent	NOUN
admet-3030	197	13	hair	hair	NOUN
admet-3030	197	14	growth	growth	NOUN
admet-3030	197	15	ptgfr	ptgfr	NOUN
admet-3030	198	1	[	[	X
admet-3030	198	2	37	37	NUM
admet-3030	198	3	]	]	PUNCT
admet-3030	198	4	rs10782665	rs10782665	NOUN
admet-3030	198	5	enhances	enhance	VERB
admet-3030	198	6	pgf2α	pgf2α	X
admet-3030	198	7	activity	activity	NOUN
admet-3030	198	8	-	-	PUNCT
admet-3030	198	9	stimulates	stimulate	NOUN
admet-3030	198	10	hair	hair	NOUN
admet-3030	198	11	growth	growth	NOUN
admet-3030	198	12	ptges2	ptges2	PROPN
admet-3030	199	1	[	[	X
admet-3030	199	2	32	32	NUM
admet-3030	199	3	]	]	PUNCT
admet-3030	199	4	rs13283456	rs13283456	NOUN
admet-3030	199	5	minoxidil	minoxidil	PROPN
admet-3030	199	6	efficacy	efficacy	NOUN
admet-3030	199	7	modulation	modulation	NOUN
admet-3030	199	8	-	-	PUNCT
admet-3030	199	9	prostaglandin	prostaglandin	NOUN
admet-3030	199	10	pathway	pathway	NOUN
admet-3030	199	11	alterations	alteration	NOUN
admet-3030	199	12	ace	ace	VERB
admet-3030	199	13	[	[	X
admet-3030	199	14	32	32	NUM
admet-3030	199	15	]	]	X
admet-3030	199	16	rs4343	rs4343	NOUN
admet-3030	199	17	impacts	impact	VERB
admet-3030	199	18	the	the	DET
admet-3030	199	19	vascular	vascular	ADJ
admet-3030	199	20	response	response	NOUN
admet-3030	199	21	;	;	PUNCT
admet-3030	199	22	minoxidil	minoxidil	ADJ
admet-3030	199	23	efficacy	efficacy	NOUN
admet-3030	199	24	modulation	modulation	NOUN
admet-3030	199	25	ebf1	ebf1	NOUN
admet-3030	200	1	[	[	X
admet-3030	200	2	51	51	NUM
admet-3030	200	3	]	]	X
admet-3030	200	4	rs929626	rs929626	PROPN
admet-3030	200	5	,	,	PUNCT
admet-3030	200	6	rs1081073	rs1081073	VERB
admet-3030	200	7	immunity	immunity	NOUN
admet-3030	200	8	modulation	modulation	NOUN
admet-3030	200	9	role	role	NOUN
admet-3030	200	10	of	of	ADP
admet-3030	200	11	micrornas	microrna	NOUN
admet-3030	200	12	in	in	ADP
admet-3030	200	13	androgenetic	androgenetic	ADJ
admet-3030	200	14	alopecia	alopecia	NOUN
admet-3030	200	15	micrornas	microrna	NOUN
admet-3030	200	16	(	(	PUNCT
admet-3030	200	17	mirnas	mirna	NOUN
admet-3030	200	18	)	)	PUNCT
admet-3030	200	19	are	be	AUX
admet-3030	200	20	key	key	ADJ
admet-3030	200	21	players	player	NOUN
admet-3030	200	22	in	in	ADP
admet-3030	200	23	regulating	regulate	VERB
admet-3030	200	24	the	the	DET
admet-3030	200	25	post	post	ADJ
admet-3030	200	26	-	-	ADJ
admet-3030	200	27	transcriptional	transcriptional	ADJ
admet-3030	200	28	gene	gene	NOUN
admet-3030	200	29	expression	expression	NOUN
admet-3030	200	30	[	[	X
admet-3030	200	31	36	36	NUM
admet-3030	200	32	]	]	PUNCT
admet-3030	200	33	.	.	PUNCT
admet-3030	201	1	evidence	evidence	NOUN
admet-3030	201	2	from	from	ADP
admet-3030	201	3	numerous	numerous	ADJ
admet-3030	201	4	studies	study	NOUN
admet-3030	201	5	indicates	indicate	VERB
admet-3030	201	6	that	that	SCONJ
admet-3030	201	7	mirnas	mirna	NOUN
admet-3030	201	8	are	be	AUX
admet-3030	201	9	involved	involve	VERB
admet-3030	201	10	in	in	ADP
admet-3030	201	11	the	the	DET
admet-3030	201	12	regulation	regulation	NOUN
admet-3030	201	13	of	of	ADP
admet-3030	201	14	hair	hair	NOUN
admet-3030	201	15	loss	loss	NOUN
admet-3030	201	16	[	[	X
admet-3030	201	17	37	37	NUM
admet-3030	201	18	]	]	PUNCT
admet-3030	201	19	.	.	PUNCT
admet-3030	202	1	the	the	DET
admet-3030	202	2	most	most	ADV
admet-3030	202	3	commonly	commonly	ADV
admet-3030	202	4	associated	associate	VERB
admet-3030	202	5	hair	hair	NOUN
admet-3030	202	6	disorder	disorder	NOUN
admet-3030	202	7	associated	associate	VERB
admet-3030	202	8	with	with	ADP
admet-3030	202	9	abnormal	abnormal	ADJ
admet-3030	202	10	mirna	mirna	NOUN
admet-3030	202	11	expression	expression	NOUN
admet-3030	202	12	is	be	AUX
admet-3030	202	13	aga	aga	NOUN
admet-3030	202	14	.	.	PUNCT
admet-3030	203	1	some	some	PRON
admet-3030	203	2	of	of	ADP
admet-3030	203	3	the	the	DET
admet-3030	203	4	pathways	pathway	NOUN
admet-3030	203	5	regulated	regulate	VERB
admet-3030	203	6	by	by	ADP
admet-3030	203	7	mirnas	mirna	NOUN
admet-3030	203	8	include	include	VERB
admet-3030	203	9	the	the	DET
admet-3030	203	10	wnt	wnt	NOUN
admet-3030	203	11	/	/	SYM
admet-3030	203	12	β	β	NOUN
admet-3030	203	13	-	-	ADJ
admet-3030	203	14	catenin	catenin	ADJ
admet-3030	203	15	signalling	signal	VERB
admet-3030	203	16	pathway	pathway	NOUN
admet-3030	203	17	,	,	PUNCT
admet-3030	203	18	which	which	PRON
admet-3030	203	19	promotes	promote	VERB
admet-3030	203	20	hair	hair	NOUN
admet-3030	203	21	growth	growth	NOUN
admet-3030	203	22	by	by	ADP
admet-3030	203	23	inhibiting	inhibit	VERB
admet-3030	203	24	the	the	DET
admet-3030	203	25	dkk1	dkk1	PROPN
admet-3030	203	26	[	[	X
admet-3030	203	27	5	5	NUM
admet-3030	203	28	]	]	PUNCT
admet-3030	203	29	.	.	PUNCT
admet-3030	204	1	increased	increase	VERB
admet-3030	204	2	levels	level	NOUN
admet-3030	204	3	of	of	ADP
admet-3030	204	4	mir-133b	mir-133b	NOUN
admet-3030	204	5	prevent	prevent	ADJ
admet-3030	204	6	follicular	follicular	ADJ
admet-3030	204	7	growth	growth	NOUN
admet-3030	204	8	.	.	PUNCT
admet-3030	205	1	besides	besides	SCONJ
admet-3030	205	2	individual	individual	ADJ
admet-3030	205	3	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	205	4	https://www.google.com/search?q=single+nucleotide+polymorphism&sca_esv=083f7bdd283a4f59&rlz=1c1chbd_enin1175in1175&sxsrf=ae3tifpriqfllasnyfml4soue6cjnjguua%3a1765001516048&ei=lmkzafbvauru4-ep56cnsqw&oq=snps+ful%3b&gs_lp=egxnd3mtd2l6lxnlcnaaahgciglttlbzigz1bdsqaggamgyqabgwgb4ybhaagbyyhjigeaayfhgemggqabgwgaoyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhkjsovaawneqcan4azabajgbiwkgacypqgegmc4xmc4yuaedyaea-aebmaipoalpekgcfmicbbajgcfcagoqixiabbgngiofwgikeaaygaqyqxikbcicdraagiaegemyiguyiwpcaggqabiabbila8icdhaagiaegledgimbgisdwgilec4ygaqysqmy0qmy0gmyqxidarimaxjharj4brioaxikbrila8iccxaagiaegledgisdwgizec4ygaqysqmyqxioaxikbrilaxieaxifa8icexaugiaegemypamyqamyiguyiwpcaggqabiabbixa8icbraagiaewgileaaygaqysqmygwhcag4qlhiabbixaxjraxjhacicnbaugiaegledgnedgnidgemygweypgmyxwey-auyqamyiguyiwmylwuy3aqy3gqy4atyaqhcag4qlhiabbjhariobrivaciccbaugiaegouewgipeaaygaqysqmygweychglwgilec4ygaqy0qmyxwhcagcqixgngoocwginec4y0qmyxweyjxjqasicebaagamytaiy6giyjwhyaqhcaguqlhiabmicdbaagiaegledgaoyc8iccraagiaegaoyc5gdc_efo5ctkazz6wo6bgyiarabgbssbwyzljewljkgb7v7sgcgmc4xmc4yuaewemihbzaums44ljbib2uacaa&sclient=gws-wiz-serp&ved=2ahukewic5iforairaxxdxgchhuzqmpmqgk4qegyiaqgaeaq	https://www.google.com/search?q=single+nucleotide+polymorphism&sca_esv=083f7bdd283a4f59&rlz=1c1chbd_enin1175in1175&sxsrf=ae3tifpriqfllasnyfml4soue6cjnjguua%3a1765001516048&ei=lmkzafbvauru4-ep56cnsqw&oq=snps+ful%3b&gs_lp=egxnd3mtd2l6lxnlcnaaahgciglttlbzigz1bdsqaggamgyqabgwgb4ybhaagbyyhjigeaayfhgemggqabgwgaoyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhkjsovaawneqcan4azabajgbiwkgacypqgegmc4xmc4yuaedyaea-aebmaipoalpekgcfmicbbajgcfcagoqixiabbgngiofwgikeaaygaqyqxikbcicdraagiaegemyiguyiwpcaggqabiabbila8icdhaagiaegledgimbgisdwgilec4ygaqysqmy0qmy0gmyqxidarimaxjharj4brioaxikbrila8iccxaagiaegledgisdwgizec4ygaqysqmyqxioaxikbrilaxieaxifa8icexaugiaegemypamyqamyiguyiwpcaggqabiabbixa8icbraagiaewgileaaygaqysqmygwhcag4qlhiabbixaxjraxjhacicnbaugiaegledgnedgnidgemygweypgmyxwey-auyqamyiguyiwmylwuy3aqy3gqy4atyaqhcag4qlhiabbjhariobrivaciccbaugiaegouewgipeaaygaqysqmygweychglwgilec4ygaqy0qmyxwhcagcqixgngoocwginec4y0qmyxweyjxjqasicebaagamytaiy6giyjwhyaqhcaguqlhiabmicdbaagiaegledgaoyc8iccraagiaegaoyc5gdc_efo5ctkazz6wo6bgyiarabgbssbwyzljewljkgb7v7sgcgmc4xmc4yuaewemihbzaums44ljbib2uacaa&sclient=gws-wiz-serp&ved=2ahukewic5iforairaxxdxgchhuzqmpmqgk4qegyiaqgaeaq	PROPN
admet-3030	205	5	r.	r.	PROPN
admet-3030	205	6	kapoor	kapoor	PROPN
admet-3030	205	7	et	et	PROPN
admet-3030	205	8	al	al	PROPN
admet-3030	205	9	.	.	PROPN
admet-3030	205	10	admet	admet	PROPN
admet-3030	205	11	&	&	CCONJ
admet-3030	205	12	dmpk	dmpk	PROPN
admet-3030	205	13	00(0	00(0	PROPN
admet-3030	205	14	)	)	PUNCT
admet-3030	205	15	(	(	PUNCT
admet-3030	205	16	2025	2025	NUM
admet-3030	205	17	)	)	PUNCT
admet-3030	205	18	3030	3030	NUM
admet-3030	205	19	10	10	NUM
admet-3030	205	20	micrornas	microrna	NOUN
admet-3030	205	21	,	,	PUNCT
admet-3030	205	22	a	a	DET
admet-3030	205	23	network	network	NOUN
admet-3030	205	24	comprising	comprise	VERB
admet-3030	205	25	lncrna	lncrna	NOUN
admet-3030	205	26	-	-	PUNCT
admet-3030	205	27	mirna	mirna	NOUN
admet-3030	205	28	-	-	PUNCT
admet-3030	205	29	mrna	mrna	PROPN
admet-3030	205	30	has	have	VERB
admet-3030	205	31	a	a	DET
admet-3030	205	32	significant	significant	ADJ
admet-3030	205	33	role	role	NOUN
admet-3030	205	34	in	in	ADP
admet-3030	205	35	the	the	DET
admet-3030	205	36	pathogenesis	pathogenesis	NOUN
admet-3030	205	37	of	of	ADP
admet-3030	205	38	aga	aga	PROPN
admet-3030	205	39	.	.	PUNCT
admet-3030	206	1	39	39	NUM
admet-3030	206	2	lncrna	lncrna	NOUN
admet-3030	206	3	ac010789.1	ac010789.1	NUM
admet-3030	206	4	delays	delay	NOUN
admet-3030	206	5	aga	aga	PROPN
admet-3030	206	6	progression	progression	NOUN
admet-3030	206	7	by	by	ADP
admet-3030	206	8	upregulating	upregulating	PROPN
admet-3030	206	9	wnt	wnt	PROPN
admet-3030	206	10	/	/	SYM
admet-3030	206	11	β	β	NOUN
admet-3030	206	12	-	-	ADJ
admet-3030	206	13	catenin	catenin	ADJ
admet-3030	206	14	signalling	signal	VERB
admet-3030	206	15	and	and	CCONJ
admet-3030	206	16	inhibiting	inhibit	VERB
admet-3030	206	17	mir21	mir21	NOUN
admet-3030	206	18	-	-	PUNCT
admet-3030	206	19	5p	5p	NUM
admet-3030	206	20	expression	expression	NOUN
admet-3030	206	21	[	[	X
admet-3030	206	22	67	67	NUM
admet-3030	206	23	]	]	PUNCT
admet-3030	206	24	.	.	PUNCT
admet-3030	207	1	the	the	DET
admet-3030	207	2	researchers	researcher	NOUN
admet-3030	207	3	reported	report	VERB
admet-3030	207	4	that	that	SCONJ
admet-3030	207	5	mir-324	mir-324	NOUN
admet-3030	207	6	-	-	PUNCT
admet-3030	207	7	3p	3p	NUM
admet-3030	207	8	is	be	AUX
admet-3030	207	9	absent	absent	ADJ
admet-3030	207	10	in	in	ADP
admet-3030	207	11	bald	bald	ADJ
admet-3030	207	12	stem	stem	NOUN
admet-3030	207	13	cells	cell	NOUN
admet-3030	207	14	,	,	PUNCT
admet-3030	207	15	making	make	VERB
admet-3030	207	16	it	it	PRON
admet-3030	207	17	a	a	DET
admet-3030	207	18	prominent	prominent	ADJ
admet-3030	207	19	marker	marker	NOUN
admet-3030	207	20	for	for	ADP
admet-3030	207	21	identifying	identify	VERB
admet-3030	207	22	the	the	DET
admet-3030	207	23	cause	cause	NOUN
admet-3030	207	24	of	of	ADP
admet-3030	207	25	hair	hair	NOUN
admet-3030	207	26	loss	loss	NOUN
admet-3030	207	27	[	[	X
admet-3030	207	28	68	68	NUM
admet-3030	207	29	]	]	PUNCT
admet-3030	207	30	.	.	PUNCT
admet-3030	208	1	hence	hence	ADV
admet-3030	208	2	,	,	PUNCT
admet-3030	208	3	it	it	PRON
admet-3030	208	4	is	be	AUX
admet-3030	208	5	clear	clear	ADJ
admet-3030	208	6	that	that	SCONJ
admet-3030	208	7	mirna	mirna	PROPN
admet-3030	208	8	can	can	AUX
admet-3030	208	9	be	be	AUX
admet-3030	208	10	used	use	VERB
admet-3030	208	11	in	in	ADP
admet-3030	208	12	both	both	CCONJ
admet-3030	208	13	the	the	DET
admet-3030	208	14	diagnosis	diagnosis	NOUN
admet-3030	208	15	and	and	CCONJ
admet-3030	208	16	treatment	treatment	NOUN
admet-3030	208	17	of	of	ADP
admet-3030	208	18	aga	aga	NOUN
admet-3030	208	19	.	.	PUNCT
admet-3030	209	1	the	the	DET
admet-3030	209	2	role	role	NOUN
admet-3030	209	3	of	of	ADP
admet-3030	209	4	mirna	mirna	NOUN
admet-3030	209	5	in	in	ADP
admet-3030	209	6	various	various	ADJ
admet-3030	209	7	pathways	pathway	NOUN
admet-3030	209	8	(	(	PUNCT
admet-3030	209	9	both	both	CCONJ
admet-3030	209	10	upregulation	upregulation	NOUN
admet-3030	209	11	and	and	CCONJ
admet-3030	209	12	downregulation	downregulation	NOUN
admet-3030	209	13	)	)	PUNCT
admet-3030	209	14	is	be	AUX
admet-3030	209	15	tabulated	tabulate	VERB
admet-3030	209	16	below	below	ADV
admet-3030	209	17	(	(	PUNCT
admet-3030	209	18	table	table	NOUN
admet-3030	209	19	4	4	NUM
admet-3030	209	20	)	)	PUNCT
admet-3030	209	21	.	.	PUNCT
admet-3030	210	1	table	table	NOUN
admet-3030	210	2	4	4	NUM
admet-3030	210	3	.	.	PUNCT
admet-3030	211	1	role	role	NOUN
admet-3030	211	2	of	of	ADP
admet-3030	211	3	micrornas	microrna	NOUN
admet-3030	211	4	in	in	ADP
admet-3030	211	5	aga	aga	PROPN
admet-3030	211	6	mirna	mirna	PROPN
admet-3030	211	7	expression	expression	NOUN
admet-3030	211	8	in	in	ADP
admet-3030	211	9	aga	aga	PROPN
admet-3030	211	10	primary	primary	NOUN
admet-3030	211	11	target(s	target(s	PROPN
admet-3030	211	12	)	)	PUNCT
admet-3030	211	13	effect	effect	NOUN
admet-3030	211	14	on	on	ADP
admet-3030	211	15	pathways	pathways	ADJ
admet-3030	211	16	functional	functional	ADJ
admet-3030	211	17	impact	impact	NOUN
admet-3030	211	18	mir-133b	mir-133b	NOUN
admet-3030	212	1	[	[	X
admet-3030	212	2	69	69	NUM
admet-3030	212	3	]	]	PUNCT
admet-3030	212	4	upregulated	upregulate	VERB
admet-3030	212	5	β	β	NOUN
admet-3030	212	6	-	-	ADJ
admet-3030	212	7	catenin	catenin	ADJ
admet-3030	212	8	↓	↓	NOUN
admet-3030	212	9	wnt	wnt	PROPN
admet-3030	212	10	/	/	SYM
admet-3030	212	11	β	β	NOUN
admet-3030	212	12	-	-	ADJ
admet-3030	212	13	catenin	catenin	ADJ
admet-3030	212	14	signalling	signal	VERB
admet-3030	212	15	aga	aga	NOUN
admet-3030	212	16	progression	progression	NOUN
admet-3030	212	17	-	-	PUNCT
admet-3030	212	18	hair	hair	NOUN
admet-3030	212	19	loss	loss	NOUN
admet-3030	212	20	mir-29a	mir-29a	NUM
admet-3030	212	21	/	/	SYM
admet-3030	212	22	b1	b1	NOUN
admet-3030	212	23	[	[	PUNCT
admet-3030	212	24	38	38	NUM
admet-3030	212	25	]	]	PUNCT
admet-3030	212	26	overexpression	overexpression	NOUN
admet-3030	212	27	wnt	wnt	NOUN
admet-3030	212	28	and	and	CCONJ
admet-3030	212	29	bmp	bmp	PROPN
admet-3030	212	30	pathway	pathway	NOUN
admet-3030	212	31	genes	gene	NOUN
admet-3030	212	32	↓	↓	NOUN
admet-3030	212	33	wnt	wnt	PROPN
admet-3030	212	34	signalling	signal	VERB
admet-3030	212	35	mir-107	mir-107	ADP
admet-3030	213	1	[	[	X
admet-3030	213	2	38	38	NUM
admet-3030	213	3	]	]	PUNCT
admet-3030	213	4	downregulated	downregulate	VERB
admet-3030	213	5	dkk1	dkk1	PROPN
admet-3030	213	6	↑	↑	PROPN
admet-3030	213	7	wnt	wnt	PROPN
admet-3030	213	8	/	/	SYM
admet-3030	213	9	β	β	NOUN
admet-3030	213	10	-	-	ADJ
admet-3030	213	11	catenin	catenin	ADJ
admet-3030	213	12	signalling	signal	VERB
admet-3030	213	13	aga	aga	NOUN
admet-3030	213	14	suppression	suppression	NOUN
admet-3030	213	15	-	-	PUNCT
admet-3030	213	16	hair	hair	NOUN
admet-3030	213	17	growth	growth	NOUN
admet-3030	213	18	mir-21	mir-21	NOUN
admet-3030	213	19	-	-	PUNCT
admet-3030	213	20	5p	5p	NOUN
admet-3030	214	1	[	[	X
admet-3030	214	2	67	67	NUM
admet-3030	214	3	]	]	PUNCT
admet-3030	214	4	downregulated	downregulate	VERB
admet-3030	214	5	wnt	wnt	PROPN
admet-3030	214	6	pathway	pathway	PROPN
admet-3030	214	7	components	components	PROPN
admet-3030	214	8	↑	↑	PROPN
admet-3030	214	9	hfsc	hfsc	PROPN
admet-3030	214	10	proliferation	proliferation	NOUN
admet-3030	214	11	via	via	ADP
admet-3030	214	12	wnt	wnt	PROPN
admet-3030	214	13	suppression	suppression	NOUN
admet-3030	214	14	polygenic	polygenic	ADJ
admet-3030	214	15	risk	risk	NOUN
admet-3030	214	16	scoring	scoring	NOUN
admet-3030	214	17	and	and	CCONJ
admet-3030	214	18	genome	genome	NOUN
admet-3030	214	19	-	-	PUNCT
admet-3030	214	20	wide	wide	ADJ
admet-3030	214	21	association	association	NOUN
admet-3030	214	22	studies	study	NOUN
admet-3030	214	23	limitations	limitation	VERB
admet-3030	214	24	polygenic	polygenic	ADJ
admet-3030	214	25	risk	risk	NOUN
admet-3030	214	26	scores	score	NOUN
admet-3030	214	27	(	(	PUNCT
admet-3030	214	28	prs	prs	NOUN
admet-3030	214	29	)	)	PUNCT
admet-3030	214	30	,	,	PUNCT
admet-3030	214	31	which	which	PRON
admet-3030	214	32	are	be	AUX
admet-3030	214	33	part	part	NOUN
admet-3030	214	34	of	of	ADP
admet-3030	214	35	genome	genome	NOUN
admet-3030	214	36	-	-	PUNCT
admet-3030	214	37	wide	wide	ADJ
admet-3030	214	38	association	association	NOUN
admet-3030	214	39	studies	study	NOUN
admet-3030	214	40	(	(	PUNCT
admet-3030	214	41	gwas	gwas	PROPN
admet-3030	214	42	)	)	PUNCT
admet-3030	214	43	,	,	PUNCT
admet-3030	214	44	help	help	VERB
admet-3030	214	45	analyse	analyse	VERB
admet-3030	214	46	an	an	DET
admet-3030	214	47	individual	individual	NOUN
admet-3030	214	48	’s	’s	PART
admet-3030	214	49	genetic	genetic	ADJ
admet-3030	214	50	makeup	makeup	NOUN
admet-3030	214	51	and	and	CCONJ
admet-3030	214	52	disease	disease	NOUN
admet-3030	214	53	susceptibility	susceptibility	NOUN
admet-3030	214	54	by	by	ADP
admet-3030	214	55	evaluating	evaluate	VERB
admet-3030	214	56	single	single	ADJ
admet-3030	214	57	-	-	PUNCT
admet-3030	214	58	nucleotide	nucleotide	NOUN
admet-3030	214	59	polymorphisms	polymorphism	NOUN
admet-3030	214	60	(	(	PUNCT
admet-3030	214	61	snps	snps	PROPN
admet-3030	214	62	)	)	PUNCT
admet-3030	215	1	[	[	X
admet-3030	215	2	70	70	NUM
admet-3030	215	3	]	]	PUNCT
admet-3030	215	4	.	.	PUNCT
admet-3030	216	1	prs	prs	NOUN
admet-3030	216	2	scores	score	NOUN
admet-3030	216	3	in	in	ADP
admet-3030	216	4	aga	aga	PROPN
admet-3030	216	5	are	be	AUX
admet-3030	216	6	used	use	VERB
admet-3030	216	7	to	to	PART
admet-3030	216	8	determine	determine	VERB
admet-3030	216	9	individual	individual	ADJ
admet-3030	216	10	susceptibility	susceptibility	NOUN
admet-3030	216	11	to	to	ADP
admet-3030	216	12	hair	hair	NOUN
admet-3030	216	13	loss	loss	NOUN
admet-3030	216	14	and	and	CCONJ
admet-3030	216	15	to	to	PART
admet-3030	216	16	analyse	analyse	VERB
admet-3030	216	17	associated	associated	ADJ
admet-3030	216	18	comorbidities	comorbiditie	NOUN
admet-3030	216	19	,	,	PUNCT
admet-3030	216	20	such	such	ADJ
admet-3030	216	21	as	as	ADP
admet-3030	216	22	covid-19	covid-19	PROPN
admet-3030	216	23	.	.	PUNCT
admet-3030	217	1	the	the	DET
admet-3030	217	2	severity	severity	NOUN
admet-3030	217	3	of	of	ADP
admet-3030	217	4	covid-19	covid-19	PROPN
admet-3030	217	5	is	be	AUX
admet-3030	217	6	directly	directly	ADV
admet-3030	217	7	associated	associate	VERB
admet-3030	217	8	with	with	ADP
admet-3030	217	9	hair	hair	NOUN
admet-3030	217	10	loss	loss	NOUN
admet-3030	217	11	in	in	ADP
admet-3030	217	12	individuals	individual	NOUN
admet-3030	217	13	.	.	PUNCT
admet-3030	218	1	researchers	researcher	NOUN
admet-3030	218	2	have	have	AUX
admet-3030	218	3	used	use	VERB
admet-3030	218	4	pathway	pathway	NOUN
admet-3030	218	5	-	-	PUNCT
admet-3030	218	6	based	base	VERB
admet-3030	218	7	prs	prs	NOUN
admet-3030	218	8	(	(	PUNCT
admet-3030	218	9	pprs	pprs	NOUN
admet-3030	218	10	)	)	PUNCT
admet-3030	218	11	,	,	PUNCT
admet-3030	218	12	which	which	PRON
admet-3030	218	13	has	have	AUX
admet-3030	218	14	helped	help	VERB
admet-3030	218	15	to	to	PART
admet-3030	218	16	understand	understand	VERB
admet-3030	218	17	the	the	DET
admet-3030	218	18	correlation	correlation	NOUN
admet-3030	218	19	between	between	ADP
admet-3030	218	20	aga	aga	NOUN
admet-3030	218	21	and	and	CCONJ
admet-3030	218	22	covid-19	covid-19	PROPN
admet-3030	219	1	[	[	X
admet-3030	219	2	71	71	NUM
admet-3030	219	3	]	]	PUNCT
admet-3030	219	4	.	.	PUNCT
admet-3030	220	1	alterations	alteration	NOUN
admet-3030	220	2	in	in	ADP
admet-3030	220	3	vitamin	vitamin	NOUN
admet-3030	220	4	metabolism	metabolism	NOUN
admet-3030	220	5	,	,	PUNCT
admet-3030	220	6	wnt	wnt	PROPN
admet-3030	220	7	signalling	signal	VERB
admet-3030	220	8	,	,	PUNCT
admet-3030	220	9	and	and	CCONJ
admet-3030	220	10	aryl	aryl	NOUN
admet-3030	220	11	hydrocarbon	hydrocarbon	NOUN
admet-3030	220	12	receptor	receptor	NOUN
admet-3030	220	13	signalling	signal	VERB
admet-3030	220	14	have	have	AUX
admet-3030	220	15	been	be	AUX
admet-3030	220	16	observed	observe	VERB
admet-3030	220	17	.	.	PUNCT
admet-3030	221	1	some	some	PRON
admet-3030	221	2	of	of	ADP
admet-3030	221	3	the	the	DET
admet-3030	221	4	most	most	ADV
admet-3030	221	5	common	common	ADJ
admet-3030	221	6	limitations	limitation	NOUN
admet-3030	221	7	observed	observe	VERB
admet-3030	221	8	in	in	ADP
admet-3030	221	9	polygenic	polygenic	ADJ
admet-3030	221	10	risk	risk	NOUN
admet-3030	221	11	scoring	scoring	NOUN
admet-3030	221	12	are	be	AUX
admet-3030	221	13	shown	show	VERB
admet-3030	221	14	in	in	ADP
admet-3030	221	15	figure	figure	NOUN
admet-3030	221	16	5	5	NUM
admet-3030	221	17	.	.	PUNCT
admet-3030	221	18	figure	figure	NOUN
admet-3030	221	19	5	5	NUM
admet-3030	221	20	.	.	PUNCT
admet-3030	221	21	limitations	limitation	NOUN
admet-3030	221	22	of	of	ADP
admet-3030	221	23	gwas	gwas	PROPN
admet-3030	221	24	scores	score	NOUN
admet-3030	221	25	in	in	ADP
admet-3030	221	26	aga	aga	NOUN
admet-3030	221	27	prediction	prediction	NOUN
admet-3030	221	28	diagnostic	diagnostic	ADJ
admet-3030	221	29	biomarkers	biomarker	NOUN
admet-3030	221	30	and	and	CCONJ
admet-3030	221	31	technological	technological	ADJ
admet-3030	221	32	advancements	advancement	NOUN
admet-3030	221	33	technological	technological	ADJ
admet-3030	221	34	advancements	advancement	NOUN
admet-3030	221	35	in	in	ADP
admet-3030	221	36	molecular	molecular	ADJ
admet-3030	221	37	diagnostics	diagnostic	NOUN
admet-3030	221	38	have	have	AUX
admet-3030	221	39	led	lead	VERB
admet-3030	221	40	to	to	ADP
admet-3030	221	41	the	the	DET
admet-3030	221	42	identification	identification	NOUN
admet-3030	221	43	of	of	ADP
admet-3030	221	44	new	new	ADJ
admet-3030	221	45	biomarkers	biomarker	NOUN
admet-3030	221	46	for	for	ADP
admet-3030	221	47	aa	aa	NOUN
admet-3030	221	48	.	.	PUNCT
admet-3030	222	1	jiachao	jiachao	PROPN
admet-3030	222	2	xiong	xiong	PROPN
admet-3030	222	3	et	et	PROPN
admet-3030	222	4	al	al	PROPN
admet-3030	222	5	.	.	PUNCT
admet-3030	223	1	[	[	X
admet-3030	223	2	72	72	NUM
admet-3030	223	3	]	]	PUNCT
admet-3030	223	4	used	use	VERB
admet-3030	223	5	gene	gene	NOUN
admet-3030	223	6	expression	expression	NOUN
admet-3030	223	7	and	and	CCONJ
admet-3030	223	8	regulatory	regulatory	ADJ
admet-3030	223	9	network	network	NOUN
admet-3030	223	10	analysis	analysis	NOUN
admet-3030	223	11	to	to	PART
admet-3030	223	12	identify	identify	VERB
admet-3030	223	13	four	four	NUM
admet-3030	223	14	key	key	ADJ
admet-3030	223	15	genes	gene	NOUN
admet-3030	223	16	,	,	PUNCT
admet-3030	223	17	lgr5	lgr5	PROPN
admet-3030	223	18	,	,	PUNCT
admet-3030	223	19	shisa2	shisa2	PROPN
admet-3030	223	20	,	,	PUNCT
admet-3030	223	21	hoxc13	hoxc13	NOUN
admet-3030	223	22	,	,	PUNCT
admet-3030	223	23	and	and	CCONJ
admet-3030	223	24	s100a3	s100a3	PROPN
admet-3030	223	25	,	,	PUNCT
admet-3030	223	26	as	as	ADP
admet-3030	223	27	diagnostic	diagnostic	ADJ
admet-3030	223	28	biomarkers	biomarker	NOUN
admet-3030	223	29	for	for	ADP
admet-3030	223	30	aa	aa	NOUN
admet-3030	223	31	.	.	PUNCT
admet-3030	224	1	they	they	PRON
admet-3030	224	2	recommended	recommend	VERB
admet-3030	224	3	gene	gene	NOUN
admet-3030	224	4	-	-	PUNCT
admet-3030	224	5	targeted	target	VERB
admet-3030	224	6	therapies	therapy	NOUN
admet-3030	224	7	such	such	ADJ
admet-3030	224	8	as	as	ADP
admet-3030	224	9	alecept	alecept	NOUN
admet-3030	224	10	and	and	CCONJ
admet-3030	224	11	siplizumab	siplizumab	NOUN
admet-3030	224	12	for	for	ADP
admet-3030	224	13	patients	patient	NOUN
admet-3030	224	14	with	with	ADP
admet-3030	224	15	severe	severe	ADJ
admet-3030	224	16	aa	aa	NOUN
admet-3030	224	17	.	.	PUNCT
admet-3030	225	1	in	in	ADP
admet-3030	225	2	a	a	DET
admet-3030	225	3	similar	similar	ADJ
admet-3030	225	4	vein	vein	NOUN
admet-3030	225	5	,	,	PUNCT
admet-3030	225	6	qingde	qingde	NOUN
admet-3030	225	7	zhou	zhou	PROPN
admet-3030	225	8	et	et	PROPN
admet-3030	225	9	al	al	PROPN
admet-3030	225	10	.	.	PUNCT
admet-3030	226	1	[	[	X
admet-3030	226	2	73	73	NUM
admet-3030	226	3	]	]	PUNCT
admet-3030	226	4	incorporated	incorporated	ADJ
admet-3030	226	5	machine	machine	NOUN
admet-3030	226	6	-	-	PUNCT
admet-3030	226	7	learning	learn	VERB
admet-3030	226	8	techniques	technique	NOUN
admet-3030	226	9	to	to	PART
admet-3030	226	10	identify	identify	VERB
admet-3030	226	11	immune	immune	ADJ
admet-3030	226	12	biomarkers	biomarker	NOUN
admet-3030	226	13	associated	associate	VERB
admet-3030	226	14	with	with	ADP
admet-3030	226	15	aa	aa	PROPN
admet-3030	226	16	.	.	PUNCT
admet-3030	227	1	their	their	PRON
admet-3030	227	2	research	research	NOUN
admet-3030	227	3	identified	identify	VERB
admet-3030	227	4	skap1	skap1	NOUN
admet-3030	227	5	,	,	PUNCT
admet-3030	227	6	pik3cg	pik3cg	PROPN
admet-3030	227	7	,	,	PUNCT
admet-3030	227	8	and	and	CCONJ
admet-3030	227	9	cd8a	cd8a	ADV
admet-3030	227	10	as	as	ADP
admet-3030	227	11	novel	novel	ADJ
admet-3030	227	12	immune	immune	ADJ
admet-3030	227	13	markers	marker	NOUN
admet-3030	227	14	,	,	PUNCT
admet-3030	227	15	which	which	PRON
admet-3030	227	16	could	could	AUX
admet-3030	227	17	be	be	AUX
admet-3030	227	18	used	use	VERB
admet-3030	227	19	for	for	ADP
admet-3030	227	20	early	early	ADJ
admet-3030	227	21	diagnosis	diagnosis	NOUN
admet-3030	227	22	and	and	CCONJ
admet-3030	227	23	targeted	target	VERB
admet-3030	227	24	treatment	treatment	NOUN
admet-3030	227	25	of	of	ADP
admet-3030	227	26	aa	aa	NOUN
admet-3030	227	27	.	.	PUNCT
admet-3030	228	1	admet	admet	PROPN
admet-3030	228	2	&	&	CCONJ
admet-3030	228	3	dmpk	dmpk	PROPN
admet-3030	228	4	00(0	00(0	PROPN
admet-3030	228	5	)	)	PUNCT
admet-3030	228	6	(	(	PUNCT
admet-3030	228	7	2025	2025	NUM
admet-3030	228	8	)	)	PUNCT
admet-3030	228	9	3030	3030	NUM
admet-3030	228	10	precision	precision	NOUN
admet-3030	228	11	therapeutics	therapeutic	NOUN
admet-3030	228	12	in	in	ADP
admet-3030	228	13	non	non	ADJ
admet-3030	228	14	-	-	ADJ
admet-3030	228	15	scarring	scar	VERB
admet-3030	228	16	alopecia	alopecia	NOUN
admet-3030	228	17	doi	doi	NOUN
admet-3030	228	18	:	:	PUNCT
admet-3030	228	19	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	228	20	11	11	NUM
admet-3030	228	21	the	the	DET
admet-3030	228	22	literature	literature	NOUN
admet-3030	228	23	indicates	indicate	VERB
admet-3030	228	24	that	that	SCONJ
admet-3030	228	25	aa	aa	PROPN
admet-3030	228	26	is	be	AUX
admet-3030	228	27	a	a	DET
admet-3030	228	28	complex	complex	ADJ
admet-3030	228	29	,	,	PUNCT
admet-3030	228	30	non	non	ADJ
admet-3030	228	31	-	-	ADJ
admet-3030	228	32	scarring	scarring	ADJ
admet-3030	228	33	form	form	NOUN
admet-3030	228	34	of	of	ADP
admet-3030	228	35	hair	hair	NOUN
admet-3030	228	36	loss	loss	NOUN
admet-3030	228	37	and	and	CCONJ
admet-3030	228	38	that	that	SCONJ
admet-3030	228	39	multiple	multiple	ADJ
admet-3030	228	40	genes	gene	NOUN
admet-3030	228	41	and	and	CCONJ
admet-3030	228	42	factors	factor	NOUN
admet-3030	228	43	are	be	AUX
admet-3030	228	44	involved	involve	VERB
admet-3030	228	45	.	.	PUNCT
admet-3030	228	46	immune	immune	ADJ
admet-3030	228	47	dysregulation	dysregulation	NOUN
admet-3030	228	48	,	,	PUNCT
admet-3030	228	49	psychological	psychological	ADJ
admet-3030	228	50	stress	stress	NOUN
admet-3030	228	51	,	,	PUNCT
admet-3030	228	52	oxidative	oxidative	ADJ
admet-3030	228	53	stress	stress	NOUN
admet-3030	228	54	,	,	PUNCT
admet-3030	228	55	and	and	CCONJ
admet-3030	228	56	alterations	alteration	NOUN
admet-3030	228	57	in	in	ADP
admet-3030	228	58	cytokine	cytokine	ADJ
admet-3030	228	59	and	and	CCONJ
admet-3030	228	60	chemokine	chemokine	ADJ
admet-3030	228	61	signalling	signal	VERB
admet-3030	228	62	pathways	pathway	NOUN
admet-3030	228	63	also	also	ADV
admet-3030	228	64	contribute	contribute	VERB
admet-3030	228	65	to	to	ADP
admet-3030	228	66	aa	aa	NOUN
admet-3030	229	1	[	[	X
admet-3030	229	2	74	74	NUM
admet-3030	229	3	]	]	PUNCT
admet-3030	229	4	.	.	PUNCT
admet-3030	230	1	hence	hence	ADV
admet-3030	230	2	,	,	PUNCT
admet-3030	230	3	a	a	DET
admet-3030	230	4	combination	combination	NOUN
admet-3030	230	5	of	of	ADP
admet-3030	230	6	different	different	ADJ
admet-3030	230	7	clinical	clinical	ADJ
admet-3030	230	8	interventions	intervention	NOUN
admet-3030	230	9	will	will	AUX
admet-3030	230	10	help	help	VERB
admet-3030	230	11	treat	treat	VERB
admet-3030	230	12	aa	aa	NOUN
admet-3030	230	13	.	.	PUNCT
admet-3030	231	1	unlike	unlike	ADP
admet-3030	231	2	aa	aa	NOUN
admet-3030	231	3	,	,	PUNCT
admet-3030	231	4	aga	aga	PROPN
admet-3030	231	5	is	be	AUX
admet-3030	231	6	caused	cause	VERB
admet-3030	231	7	by	by	ADP
admet-3030	231	8	androgens	androgen	NOUN
admet-3030	231	9	,	,	PUNCT
admet-3030	231	10	such	such	ADJ
admet-3030	231	11	as	as	ADP
admet-3030	231	12	dihydrotestosterone	dihydrotestosterone	NOUN
admet-3030	231	13	(	(	PUNCT
admet-3030	231	14	dht	dht	NOUN
admet-3030	231	15	)	)	PUNCT
admet-3030	231	16	,	,	PUNCT
admet-3030	231	17	resulting	result	VERB
admet-3030	231	18	in	in	ADP
admet-3030	231	19	hair	hair	NOUN
admet-3030	231	20	loss	loss	NOUN
admet-3030	231	21	and	and	CCONJ
admet-3030	231	22	thinning	thinning	NOUN
admet-3030	231	23	specifically	specifically	ADV
admet-3030	231	24	in	in	ADP
admet-3030	231	25	the	the	DET
admet-3030	231	26	scalp	scalp	NOUN
admet-3030	231	27	's	's	PART
admet-3030	231	28	temporal	temporal	ADJ
admet-3030	231	29	and	and	CCONJ
admet-3030	231	30	vertex	vertex	NOUN
admet-3030	231	31	regions	region	NOUN
admet-3030	231	32	[	[	X
admet-3030	231	33	75	75	NUM
admet-3030	231	34	]	]	PUNCT
admet-3030	231	35	.	.	PUNCT
admet-3030	232	1	aga	aga	PROPN
admet-3030	232	2	is	be	AUX
admet-3030	232	3	an	an	DET
admet-3030	232	4	x	x	ADV
admet-3030	232	5	-	-	ADJ
admet-3030	232	6	linked	link	VERB
admet-3030	232	7	inherited	inherit	VERB
admet-3030	232	8	disease	disease	NOUN
admet-3030	232	9	,	,	PUNCT
admet-3030	232	10	and	and	CCONJ
admet-3030	232	11	symptoms	symptom	NOUN
admet-3030	232	12	typically	typically	ADV
admet-3030	232	13	develop	develop	VERB
admet-3030	232	14	over	over	ADP
admet-3030	232	15	time	time	NOUN
admet-3030	232	16	.	.	PUNCT
admet-3030	233	1	in	in	ADP
admet-3030	233	2	this	this	DET
admet-3030	233	3	case	case	NOUN
admet-3030	233	4	,	,	PUNCT
admet-3030	233	5	specifically	specifically	ADV
admet-3030	233	6	,	,	PUNCT
admet-3030	233	7	the	the	DET
admet-3030	233	8	anagen	anagen	NOUN
admet-3030	233	9	phase	phase	NOUN
admet-3030	233	10	of	of	ADP
admet-3030	233	11	the	the	DET
admet-3030	233	12	hair	hair	NOUN
admet-3030	233	13	cycle	cycle	NOUN
admet-3030	233	14	is	be	AUX
admet-3030	233	15	shortened	shorten	VERB
admet-3030	233	16	,	,	PUNCT
admet-3030	233	17	leading	lead	VERB
admet-3030	233	18	to	to	ADP
admet-3030	233	19	hair	hair	NOUN
admet-3030	233	20	thinning	thinning	NOUN
admet-3030	233	21	.	.	PUNCT
admet-3030	234	1	some	some	PRON
admet-3030	234	2	of	of	ADP
admet-3030	234	3	the	the	DET
admet-3030	234	4	genes	gene	NOUN
admet-3030	234	5	involved	involve	VERB
admet-3030	234	6	in	in	ADP
admet-3030	234	7	the	the	DET
admet-3030	234	8	androgen	androgen	NOUN
admet-3030	234	9	signalling	signal	VERB
admet-3030	234	10	pathway	pathway	NOUN
admet-3030	234	11	include	include	VERB
admet-3030	234	12	the	the	DET
admet-3030	234	13	ar	ar	PROPN
admet-3030	234	14	,	,	PUNCT
admet-3030	234	15	fgf5	fgf5	ADJ
admet-3030	234	16	,	,	PUNCT
admet-3030	234	17	and	and	CCONJ
admet-3030	234	18	eda	eda	PROPN
admet-3030	234	19	genes	gene	NOUN
admet-3030	234	20	[	[	X
admet-3030	234	21	75	75	NUM
admet-3030	234	22	]	]	PUNCT
admet-3030	234	23	.	.	PUNCT
admet-3030	235	1	this	this	DET
admet-3030	235	2	gene	gene	NOUN
admet-3030	235	3	may	may	AUX
admet-3030	235	4	be	be	AUX
admet-3030	235	5	a	a	DET
admet-3030	235	6	potential	potential	ADJ
admet-3030	235	7	target	target	NOUN
admet-3030	235	8	for	for	ADP
admet-3030	235	9	the	the	DET
admet-3030	235	10	treatment	treatment	NOUN
admet-3030	235	11	of	of	ADP
admet-3030	235	12	aga	aga	NOUN
admet-3030	235	13	.	.	PUNCT
admet-3030	236	1	in	in	ADP
admet-3030	236	2	recent	recent	ADJ
admet-3030	236	3	years	year	NOUN
admet-3030	236	4	,	,	PUNCT
admet-3030	236	5	many	many	ADJ
admet-3030	236	6	researchers	researcher	NOUN
admet-3030	236	7	have	have	AUX
admet-3030	236	8	focused	focus	VERB
admet-3030	236	9	on	on	ADP
admet-3030	236	10	genetic	genetic	ADJ
admet-3030	236	11	analysis	analysis	NOUN
admet-3030	236	12	to	to	PART
admet-3030	236	13	predict	predict	VERB
admet-3030	236	14	the	the	DET
admet-3030	236	15	future	future	ADJ
admet-3030	236	16	risks	risk	NOUN
admet-3030	236	17	of	of	ADP
admet-3030	236	18	aga	aga	NOUN
admet-3030	236	19	.	.	PUNCT
admet-3030	237	1	few	few	ADJ
admet-3030	237	2	researchers	researcher	NOUN
admet-3030	237	3	have	have	AUX
admet-3030	237	4	provided	provide	VERB
admet-3030	237	5	evidence	evidence	NOUN
admet-3030	237	6	by	by	ADP
admet-3030	237	7	conducting	conduct	VERB
admet-3030	237	8	mendelian	mendelian	ADJ
admet-3030	237	9	randomization	randomization	NOUN
admet-3030	237	10	studies	study	NOUN
admet-3030	237	11	to	to	PART
admet-3030	237	12	understand	understand	VERB
admet-3030	237	13	the	the	DET
admet-3030	237	14	relationship	relationship	NOUN
admet-3030	237	15	between	between	ADP
admet-3030	237	16	metabolites	metabolite	NOUN
admet-3030	237	17	and	and	CCONJ
admet-3030	237	18	their	their	PRON
admet-3030	237	19	impact	impact	NOUN
admet-3030	237	20	on	on	ADP
admet-3030	237	21	the	the	DET
admet-3030	237	22	risk	risk	NOUN
admet-3030	237	23	of	of	ADP
admet-3030	237	24	aga	aga	NOUN
admet-3030	237	25	.	.	PUNCT
admet-3030	238	1	they	they	PRON
admet-3030	238	2	concluded	conclude	VERB
admet-3030	238	3	that	that	SCONJ
admet-3030	238	4	α	α	X
admet-3030	238	5	-	-	PUNCT
admet-3030	238	6	tocopherol	tocopherol	ADJ
admet-3030	238	7	levels	level	NOUN
admet-3030	238	8	decrease	decrease	VERB
admet-3030	238	9	and	and	CCONJ
admet-3030	238	10	that	that	SCONJ
admet-3030	238	11	supplementation	supplementation	NOUN
admet-3030	238	12	to	to	PART
admet-3030	238	13	balance	balance	VERB
admet-3030	238	14	this	this	PRON
admet-3030	238	15	reduces	reduce	VERB
admet-3030	238	16	the	the	DET
admet-3030	238	17	risk	risk	NOUN
admet-3030	238	18	of	of	ADP
admet-3030	238	19	aga	aga	PROPN
admet-3030	238	20	.	.	PUNCT
admet-3030	239	1	tailored	tailor	VERB
admet-3030	239	2	therapies	therapy	NOUN
admet-3030	239	3	for	for	ADP
admet-3030	239	4	treating	treat	VERB
admet-3030	239	5	non	non	ADJ
admet-3030	239	6	-	-	ADJ
admet-3030	239	7	scarring	scar	VERB
admet-3030	239	8	alopecia	alopecia	NOUN
admet-3030	239	9	various	various	ADJ
admet-3030	239	10	therapeutic	therapeutic	ADJ
admet-3030	239	11	strategies	strategy	NOUN
admet-3030	239	12	are	be	AUX
admet-3030	239	13	being	be	AUX
admet-3030	239	14	used	use	VERB
admet-3030	239	15	by	by	ADP
admet-3030	239	16	clinicians	clinician	NOUN
admet-3030	239	17	worldwide	worldwide	ADV
admet-3030	239	18	,	,	PUNCT
admet-3030	239	19	from	from	ADP
admet-3030	239	20	traditional	traditional	ADJ
admet-3030	239	21	to	to	ADP
admet-3030	239	22	advanced	advanced	ADJ
admet-3030	239	23	regenerative	regenerative	ADJ
admet-3030	239	24	treatments	treatment	NOUN
admet-3030	239	25	,	,	PUNCT
admet-3030	239	26	to	to	PART
admet-3030	239	27	improve	improve	VERB
admet-3030	239	28	hair	hair	NOUN
admet-3030	239	29	regrowth	regrowth	NOUN
admet-3030	239	30	and	and	CCONJ
admet-3030	239	31	prevent	prevent	VERB
admet-3030	239	32	hair	hair	NOUN
admet-3030	239	33	loss	loss	NOUN
admet-3030	239	34	.	.	PUNCT
admet-3030	240	1	some	some	PRON
admet-3030	240	2	of	of	ADP
admet-3030	240	3	the	the	DET
admet-3030	240	4	treatments	treatment	NOUN
admet-3030	240	5	that	that	PRON
admet-3030	240	6	are	be	AUX
admet-3030	240	7	currently	currently	ADV
admet-3030	240	8	in	in	ADP
admet-3030	240	9	use	use	NOUN
admet-3030	240	10	are	be	AUX
admet-3030	240	11	shown	show	VERB
admet-3030	240	12	below	below	ADV
admet-3030	240	13	(	(	PUNCT
admet-3030	240	14	figure	figure	NOUN
admet-3030	240	15	6	6	NUM
admet-3030	240	16	)	)	PUNCT
admet-3030	240	17	.	.	PUNCT
admet-3030	241	1	figure	figure	VERB
admet-3030	241	2	6	6	NUM
admet-3030	241	3	.	.	PUNCT
admet-3030	241	4	tailored	tailor	VERB
admet-3030	241	5	therapies	therapy	NOUN
admet-3030	241	6	for	for	ADP
admet-3030	241	7	non	non	ADJ
admet-3030	241	8	-	-	ADJ
admet-3030	241	9	scarring	scar	VERB
admet-3030	241	10	alopecia	alopecia	NOUN
admet-3030	241	11	traditional	traditional	ADJ
admet-3030	241	12	therapies	therapy	NOUN
admet-3030	241	13	minoxidil	minoxidil	NOUN
admet-3030	241	14	is	be	AUX
admet-3030	241	15	among	among	ADP
admet-3030	241	16	the	the	DET
admet-3030	241	17	most	most	ADV
admet-3030	241	18	commonly	commonly	ADV
admet-3030	241	19	prescribed	prescribe	VERB
admet-3030	241	20	drugs	drug	NOUN
admet-3030	241	21	for	for	ADP
admet-3030	241	22	the	the	DET
admet-3030	241	23	treatment	treatment	NOUN
admet-3030	241	24	of	of	ADP
admet-3030	241	25	aha	aha	INTJ
admet-3030	241	26	and	and	CCONJ
admet-3030	241	27	promotes	promote	VERB
admet-3030	241	28	blood	blood	NOUN
admet-3030	241	29	flow	flow	NOUN
admet-3030	241	30	to	to	ADP
admet-3030	241	31	hair	hair	NOUN
admet-3030	241	32	follicles	follicle	NOUN
admet-3030	241	33	[	[	X
admet-3030	241	34	76	76	NUM
admet-3030	241	35	]	]	PUNCT
admet-3030	241	36	.	.	PUNCT
admet-3030	242	1	minoxidil	minoxidil	PROPN
admet-3030	242	2	opens	open	VERB
admet-3030	242	3	the	the	DET
admet-3030	242	4	potassium	potassium	NOUN
admet-3030	242	5	channels	channel	NOUN
admet-3030	242	6	and	and	CCONJ
admet-3030	242	7	extends	extend	VERB
admet-3030	242	8	the	the	DET
admet-3030	242	9	anagen	anagen	NOUN
admet-3030	242	10	phase	phase	NOUN
admet-3030	242	11	.	.	PUNCT
admet-3030	243	1	finasteride	finasteride	PROPN
admet-3030	243	2	is	be	AUX
admet-3030	243	3	an	an	DET
admet-3030	243	4	androgen	androgen	NOUN
admet-3030	243	5	inhibitor	inhibitor	NOUN
admet-3030	243	6	that	that	PRON
admet-3030	243	7	helps	help	VERB
admet-3030	243	8	reduce	reduce	VERB
admet-3030	243	9	hair	hair	NOUN
admet-3030	243	10	thinning	thin	VERB
admet-3030	243	11	in	in	ADP
admet-3030	243	12	aga	aga	NOUN
admet-3030	243	13	patients	patient	NOUN
admet-3030	243	14	[	[	X
admet-3030	243	15	77	77	NUM
admet-3030	243	16	]	]	PUNCT
admet-3030	243	17	.	.	PUNCT
admet-3030	244	1	both	both	DET
admet-3030	244	2	systemic	systemic	ADJ
admet-3030	244	3	and	and	CCONJ
admet-3030	244	4	topical	topical	ADJ
admet-3030	244	5	steroids	steroid	NOUN
admet-3030	244	6	to	to	PART
admet-3030	244	7	treat	treat	VERB
admet-3030	244	8	aa	aa	NOUN
admet-3030	244	9	are	be	AUX
admet-3030	244	10	currently	currently	ADV
admet-3030	244	11	in	in	ADP
admet-3030	244	12	use	use	NOUN
admet-3030	244	13	;	;	PUNCT
admet-3030	244	14	they	they	PRON
admet-3030	244	15	are	be	AUX
admet-3030	244	16	prescribed	prescribe	VERB
admet-3030	244	17	based	base	VERB
admet-3030	244	18	on	on	ADP
admet-3030	244	19	the	the	DET
admet-3030	244	20	severity	severity	NOUN
admet-3030	244	21	of	of	ADP
admet-3030	244	22	aa	aa	PROPN
admet-3030	244	23	.	.	PUNCT
admet-3030	245	1	corticosteroids	corticosteroid	NOUN
admet-3030	245	2	prevent	prevent	VERB
admet-3030	245	3	the	the	DET
admet-3030	245	4	autoimmune	autoimmune	ADJ
admet-3030	245	5	effects	effect	NOUN
admet-3030	245	6	on	on	ADP
admet-3030	245	7	the	the	DET
admet-3030	245	8	hair	hair	NOUN
admet-3030	245	9	follicles	follicle	VERB
admet-3030	246	1	[	[	X
admet-3030	246	2	74	74	NUM
admet-3030	246	3	]	]	PUNCT
admet-3030	246	4	.	.	PUNCT
admet-3030	247	1	restoration	restoration	NOUN
admet-3030	247	2	of	of	ADP
admet-3030	247	3	the	the	DET
admet-3030	247	4	immune	immune	ADJ
admet-3030	247	5	system	system	NOUN
admet-3030	247	6	can	can	AUX
admet-3030	247	7	be	be	AUX
admet-3030	247	8	done	do	VERB
admet-3030	247	9	by	by	ADP
admet-3030	247	10	administration	administration	NOUN
admet-3030	247	11	of	of	ADP
admet-3030	247	12	medications	medication	NOUN
admet-3030	247	13	such	such	ADJ
admet-3030	247	14	as	as	ADP
admet-3030	247	15	diphencyprone	diphencyprone	NOUN
admet-3030	247	16	for	for	ADP
admet-3030	247	17	patients	patient	NOUN
admet-3030	247	18	who	who	PRON
admet-3030	247	19	are	be	AUX
admet-3030	247	20	suffering	suffer	VERB
admet-3030	247	21	from	from	ADP
admet-3030	247	22	severe	severe	ADJ
admet-3030	247	23	symptoms	symptom	NOUN
admet-3030	247	24	of	of	ADP
admet-3030	247	25	aa	aa	NOUN
admet-3030	247	26	.	.	PUNCT
admet-3030	248	1	cyclosporine	cyclosporine	PROPN
admet-3030	248	2	and	and	CCONJ
admet-3030	248	3	methotrexate	methotrexate	NOUN
admet-3030	248	4	are	be	AUX
admet-3030	248	5	the	the	DET
admet-3030	248	6	medications	medication	NOUN
admet-3030	248	7	that	that	PRON
admet-3030	248	8	are	be	AUX
admet-3030	248	9	administered	administer	VERB
admet-3030	248	10	last	last	ADV
admet-3030	248	11	if	if	SCONJ
admet-3030	248	12	the	the	DET
admet-3030	248	13	above	above	ADJ
admet-3030	248	14	medications	medication	NOUN
admet-3030	248	15	are	be	AUX
admet-3030	248	16	not	not	PART
admet-3030	248	17	working	work	VERB
admet-3030	248	18	for	for	ADP
admet-3030	248	19	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	PROPN
admet-3030	248	20	r.	r.	PROPN
admet-3030	248	21	kapoor	kapoor	PROPN
admet-3030	248	22	et	et	PROPN
admet-3030	248	23	al	al	PROPN
admet-3030	248	24	.	.	PROPN
admet-3030	248	25	admet	admet	PROPN
admet-3030	248	26	&	&	CCONJ
admet-3030	248	27	dmpk	dmpk	PROPN
admet-3030	248	28	00(0	00(0	PROPN
admet-3030	248	29	)	)	PUNCT
admet-3030	248	30	(	(	PUNCT
admet-3030	248	31	2025	2025	NUM
admet-3030	248	32	)	)	PUNCT
admet-3030	248	33	3030	3030	NUM
admet-3030	248	34	12	12	NUM
admet-3030	248	35	patients	patient	NOUN
admet-3030	248	36	suffering	suffer	VERB
admet-3030	248	37	from	from	ADP
admet-3030	248	38	severe	severe	ADJ
admet-3030	248	39	symptoms	symptom	NOUN
admet-3030	248	40	of	of	ADP
admet-3030	248	41	aa	aa	NOUN
admet-3030	248	42	[	[	X
admet-3030	248	43	78	78	NUM
admet-3030	248	44	]	]	PUNCT
admet-3030	248	45	.	.	PUNCT
admet-3030	249	1	even	even	ADV
admet-3030	249	2	though	though	SCONJ
admet-3030	249	3	these	these	DET
admet-3030	249	4	medications	medication	NOUN
admet-3030	249	5	are	be	AUX
admet-3030	249	6	effective	effective	ADJ
admet-3030	249	7	in	in	ADP
admet-3030	249	8	treating	treat	VERB
admet-3030	249	9	alopecia	alopecia	NOUN
admet-3030	249	10	,	,	PUNCT
admet-3030	249	11	there	there	PRON
admet-3030	249	12	is	be	VERB
admet-3030	249	13	a	a	DET
admet-3030	249	14	need	need	NOUN
admet-3030	249	15	to	to	PART
admet-3030	249	16	address	address	VERB
admet-3030	249	17	the	the	DET
admet-3030	249	18	symptoms	symptom	NOUN
admet-3030	249	19	based	base	VERB
admet-3030	249	20	on	on	ADP
admet-3030	249	21	the	the	DET
admet-3030	249	22	individual	individual	NOUN
admet-3030	249	23	's	's	PART
admet-3030	249	24	needs	need	NOUN
admet-3030	249	25	by	by	ADP
admet-3030	249	26	using	use	VERB
admet-3030	249	27	advanced	advanced	ADJ
admet-3030	249	28	technologies	technology	NOUN
admet-3030	249	29	.	.	PUNCT
admet-3030	250	1	targeted	target	VERB
admet-3030	250	2	therapies	therapy	NOUN
admet-3030	250	3	targeted	target	VERB
admet-3030	250	4	therapies	therapy	NOUN
admet-3030	250	5	primarily	primarily	ADV
admet-3030	250	6	target	target	VERB
admet-3030	250	7	specific	specific	ADJ
admet-3030	250	8	pathways	pathway	NOUN
admet-3030	250	9	that	that	PRON
admet-3030	250	10	hinder	hinder	VERB
admet-3030	250	11	hair	hair	NOUN
admet-3030	250	12	growth	growth	NOUN
admet-3030	250	13	.	.	PUNCT
admet-3030	251	1	the	the	DET
admet-3030	251	2	jak	jak	PROPN
admet-3030	251	3	-	-	PUNCT
admet-3030	251	4	stat	stat	PROPN
admet-3030	251	5	pathway	pathway	NOUN
admet-3030	251	6	is	be	AUX
admet-3030	251	7	a	a	DET
admet-3030	251	8	signalling	signal	VERB
admet-3030	251	9	pathway	pathway	NOUN
admet-3030	251	10	involved	involve	VERB
admet-3030	251	11	in	in	ADP
admet-3030	251	12	immune	immune	ADJ
admet-3030	251	13	cell	cell	NOUN
admet-3030	251	14	activation	activation	NOUN
admet-3030	251	15	and	and	CCONJ
admet-3030	251	16	in	in	ADP
admet-3030	251	17	hair	hair	NOUN
admet-3030	251	18	follicle	follicle	NOUN
admet-3030	251	19	destruction	destruction	NOUN
admet-3030	251	20	[	[	X
admet-3030	251	21	79	79	NUM
admet-3030	251	22	]	]	PUNCT
admet-3030	251	23	.	.	PUNCT
admet-3030	252	1	tofacitinib	tofacitinib	PROPN
admet-3030	252	2	and	and	CCONJ
admet-3030	252	3	ruxolitinib	ruxolitinib	NOUN
admet-3030	252	4	are	be	AUX
admet-3030	252	5	the	the	DET
admet-3030	252	6	most	most	ADV
admet-3030	252	7	commonly	commonly	ADV
admet-3030	252	8	recommended	recommend	VERB
admet-3030	252	9	jak	jak	PROPN
admet-3030	252	10	inhibitors	inhibitor	NOUN
admet-3030	252	11	that	that	PRON
admet-3030	252	12	block	block	VERB
admet-3030	252	13	jak1	jak1	NOUN
admet-3030	252	14	and	and	CCONJ
admet-3030	252	15	jak3	jak3	PROPN
admet-3030	252	16	,	,	PUNCT
admet-3030	252	17	respectively	respectively	ADV
admet-3030	252	18	,	,	PUNCT
admet-3030	252	19	resulting	result	VERB
admet-3030	252	20	in	in	ADP
admet-3030	252	21	hair	hair	NOUN
admet-3030	252	22	regrowth	regrowth	NOUN
admet-3030	252	23	[	[	X
admet-3030	252	24	80	80	NUM
admet-3030	252	25	]	]	PUNCT
admet-3030	252	26	.	.	PUNCT
admet-3030	253	1	other	other	ADJ
admet-3030	253	2	molecules	molecule	NOUN
admet-3030	253	3	are	be	AUX
admet-3030	253	4	still	still	ADV
admet-3030	253	5	in	in	ADP
admet-3030	253	6	clinical	clinical	ADJ
admet-3030	253	7	trials	trial	NOUN
admet-3030	253	8	,	,	PUNCT
admet-3030	253	9	and	and	CCONJ
admet-3030	253	10	targeting	target	VERB
admet-3030	253	11	various	various	ADJ
admet-3030	253	12	molecular	molecular	ADJ
admet-3030	253	13	pathways	pathway	NOUN
admet-3030	253	14	with	with	ADP
admet-3030	253	15	small	small	ADJ
admet-3030	253	16	-	-	PUNCT
admet-3030	253	17	molecule	molecule	NOUN
admet-3030	253	18	inhibitors	inhibitor	NOUN
admet-3030	253	19	or	or	CCONJ
admet-3030	253	20	enhancers	enhancer	NOUN
admet-3030	253	21	will	will	AUX
admet-3030	253	22	promote	promote	VERB
admet-3030	253	23	hair	hair	NOUN
admet-3030	253	24	regrowth	regrowth	NOUN
admet-3030	253	25	.	.	PUNCT
admet-3030	254	1	non	non	ADJ
admet-3030	254	2	-	-	ADJ
admet-3030	254	3	coding	coding	ADJ
admet-3030	254	4	rnas	rna	NOUN
admet-3030	254	5	are	be	AUX
admet-3030	254	6	involved	involve	VERB
admet-3030	254	7	in	in	ADP
admet-3030	254	8	gene	gene	NOUN
admet-3030	254	9	expression	expression	NOUN
admet-3030	254	10	,	,	PUNCT
admet-3030	254	11	and	and	CCONJ
admet-3030	254	12	sirna	sirna	PROPN
admet-3030	254	13	can	can	AUX
admet-3030	254	14	be	be	AUX
admet-3030	254	15	used	use	VERB
admet-3030	254	16	to	to	PART
admet-3030	254	17	target	target	VERB
admet-3030	254	18	aga	aga	NOUN
admet-3030	254	19	.	.	PUNCT
admet-3030	255	1	this	this	PRON
admet-3030	255	2	will	will	AUX
admet-3030	255	3	help	help	VERB
admet-3030	255	4	downregulate	downregulate	NOUN
admet-3030	255	5	ar	ar	NOUN
admet-3030	255	6	expression	expression	NOUN
admet-3030	255	7	and	and	CCONJ
admet-3030	255	8	prevent	prevent	VERB
admet-3030	255	9	hair	hair	NOUN
admet-3030	255	10	follicle	follicle	NOUN
admet-3030	255	11	miniaturization	miniaturization	NOUN
admet-3030	255	12	.	.	PUNCT
admet-3030	256	1	in	in	ADP
admet-3030	256	2	the	the	DET
admet-3030	256	3	past	past	NOUN
admet-3030	256	4	,	,	PUNCT
admet-3030	256	5	symptom	symptom	NOUN
admet-3030	256	6	-	-	PUNCT
admet-3030	256	7	based	base	VERB
admet-3030	256	8	treatments	treatment	NOUN
admet-3030	256	9	were	be	AUX
admet-3030	256	10	used	use	VERB
admet-3030	256	11	to	to	PART
admet-3030	256	12	address	address	VERB
admet-3030	256	13	the	the	DET
admet-3030	256	14	biological	biological	ADJ
admet-3030	256	15	mechanisms	mechanism	NOUN
admet-3030	256	16	of	of	ADP
admet-3030	256	17	aga	aga	NOUN
admet-3030	256	18	-	-	PUNCT
admet-3030	256	19	associated	associate	VERB
admet-3030	256	20	hair	hair	NOUN
admet-3030	256	21	loss	loss	NOUN
admet-3030	256	22	.	.	PUNCT
admet-3030	257	1	the	the	DET
admet-3030	257	2	most	most	ADV
admet-3030	257	3	significant	significant	ADJ
admet-3030	257	4	breakthrough	breakthrough	NOUN
admet-3030	257	5	in	in	ADP
admet-3030	257	6	the	the	DET
admet-3030	257	7	treatment	treatment	NOUN
admet-3030	257	8	of	of	ADP
admet-3030	257	9	aga	aga	NOUN
admet-3030	257	10	was	be	AUX
admet-3030	257	11	observed	observe	VERB
admet-3030	257	12	in	in	ADP
admet-3030	257	13	1998	1998	NUM
admet-3030	257	14	,	,	PUNCT
admet-3030	257	15	when	when	SCONJ
admet-3030	257	16	the	the	DET
admet-3030	257	17	administration	administration	NOUN
admet-3030	257	18	of	of	ADP
admet-3030	257	19	finasteride	finasteride	ADJ
admet-3030	257	20	and	and	CCONJ
admet-3030	257	21	dutasteride	dutasteride	ADV
admet-3030	257	22	reduced	reduce	VERB
admet-3030	257	23	dht	dht	NOUN
admet-3030	257	24	levels	level	NOUN
admet-3030	257	25	by	by	ADP
admet-3030	257	26	inhibiting	inhibit	VERB
admet-3030	257	27	the	the	DET
admet-3030	257	28	enzyme	enzyme	NOUN
admet-3030	257	29	5α	5α	ADJ
admet-3030	257	30	-	-	PUNCT
admet-3030	257	31	reductase	reductase	NOUN
admet-3030	257	32	[	[	X
admet-3030	257	33	81	81	NUM
admet-3030	257	34	]	]	PUNCT
admet-3030	257	35	.	.	PUNCT
admet-3030	258	1	oxidative	oxidative	ADJ
admet-3030	258	2	stress	stress	NOUN
admet-3030	258	3	is	be	AUX
admet-3030	258	4	another	another	DET
admet-3030	258	5	factor	factor	NOUN
admet-3030	258	6	contributing	contribute	VERB
admet-3030	258	7	to	to	ADP
admet-3030	258	8	aga	aga	NOUN
admet-3030	258	9	;	;	PUNCT
admet-3030	258	10	hence	hence	ADV
admet-3030	258	11	,	,	PUNCT
admet-3030	258	12	antioxidant	antioxidant	ADJ
admet-3030	258	13	treatments	treatment	NOUN
admet-3030	258	14	and	and	CCONJ
admet-3030	258	15	prp	prp	PROPN
admet-3030	258	16	were	be	AUX
admet-3030	258	17	recommended	recommend	VERB
admet-3030	258	18	to	to	PART
admet-3030	258	19	neutralize	neutralize	VERB
admet-3030	258	20	free	free	ADJ
admet-3030	258	21	radicals	radical	NOUN
admet-3030	258	22	and	and	CCONJ
admet-3030	258	23	prevent	prevent	VERB
admet-3030	258	24	the	the	DET
admet-3030	258	25	degeneration	degeneration	NOUN
admet-3030	258	26	of	of	ADP
admet-3030	258	27	follicular	follicular	ADJ
admet-3030	258	28	stem	stem	NOUN
admet-3030	258	29	cells	cell	NOUN
admet-3030	258	30	[	[	X
admet-3030	258	31	82	82	NUM
admet-3030	258	32	]	]	PUNCT
admet-3030	258	33	.	.	PUNCT
admet-3030	259	1	hawkshaw	hawkshaw	PROPN
admet-3030	259	2	et	et	PROPN
admet-3030	259	3	al	al	PROPN
admet-3030	259	4	.	.	PUNCT
admet-3030	260	1	[	[	X
admet-3030	260	2	83	83	NUM
admet-3030	260	3	]	]	PUNCT
admet-3030	260	4	reported	report	VERB
admet-3030	260	5	that	that	SCONJ
admet-3030	260	6	molecules	molecule	NOUN
admet-3030	260	7	such	such	ADJ
admet-3030	260	8	as	as	ADP
admet-3030	260	9	way-316606	way-316606	NOUN
admet-3030	260	10	enhance	enhance	VERB
admet-3030	260	11	expression	expression	NOUN
admet-3030	260	12	of	of	ADP
admet-3030	260	13	the	the	DET
admet-3030	260	14	wnt	wnt	PROPN
admet-3030	260	15	/	/	SYM
admet-3030	260	16	β	β	NOUN
admet-3030	260	17	-	-	ADJ
admet-3030	260	18	catenin	catenin	ADJ
admet-3030	260	19	signalling	signal	VERB
admet-3030	260	20	pathway	pathway	NOUN
admet-3030	260	21	,	,	PUNCT
admet-3030	260	22	a	a	DET
admet-3030	260	23	pathway	pathway	NOUN
admet-3030	260	24	required	require	VERB
admet-3030	260	25	for	for	ADP
admet-3030	260	26	active	active	ADJ
admet-3030	260	27	hair	hair	NOUN
admet-3030	260	28	growth	growth	NOUN
admet-3030	260	29	.	.	PUNCT
admet-3030	261	1	similar	similar	ADJ
admet-3030	261	2	studies	study	NOUN
admet-3030	261	3	were	be	AUX
admet-3030	261	4	conducted	conduct	VERB
admet-3030	261	5	by	by	ADP
admet-3030	261	6	bellani	bellani	PROPN
admet-3030	261	7	et	et	PROPN
admet-3030	261	8	al	al	PROPN
admet-3030	261	9	.	.	PUNCT
admet-3030	262	1	[	[	X
admet-3030	262	2	61	61	NUM
admet-3030	262	3	]	]	PUNCT
admet-3030	262	4	,	,	PUNCT
admet-3030	262	5	who	who	PRON
admet-3030	262	6	summarised	summarise	VERB
admet-3030	262	7	the	the	DET
admet-3030	262	8	importance	importance	NOUN
admet-3030	262	9	of	of	ADP
admet-3030	262	10	the	the	DET
admet-3030	262	11	wnt	wnt	NOUN
admet-3030	262	12	/	/	SYM
admet-3030	262	13	β	β	NOUN
admet-3030	262	14	-	-	ADJ
admet-3030	262	15	catenin	catenin	ADJ
admet-3030	262	16	,	,	PUNCT
admet-3030	262	17	sonic	sonic	ADJ
admet-3030	262	18	hedgehog	hedgehog	NOUN
admet-3030	262	19	(	(	PUNCT
admet-3030	262	20	shh	shh	NOUN
admet-3030	262	21	)	)	PUNCT
admet-3030	262	22	,	,	PUNCT
admet-3030	262	23	bmp	bmp	NOUN
admet-3030	262	24	,	,	PUNCT
admet-3030	262	25	and	and	CCONJ
admet-3030	262	26	notch	notch	ADJ
admet-3030	262	27	pathways	pathway	NOUN
admet-3030	262	28	as	as	ADP
admet-3030	262	29	promising	promise	VERB
admet-3030	262	30	targets	target	NOUN
admet-3030	262	31	for	for	ADP
admet-3030	262	32	hair	hair	NOUN
admet-3030	262	33	restoration	restoration	NOUN
admet-3030	262	34	.	.	PUNCT
admet-3030	263	1	the	the	DET
admet-3030	263	2	usage	usage	NOUN
admet-3030	263	3	of	of	ADP
admet-3030	263	4	anti	anti	ADJ
admet-3030	263	5	-	-	ADJ
admet-3030	263	6	tgf	tgf	ADJ
admet-3030	263	7	-	-	PUNCT
admet-3030	263	8	β	β	NOUN
admet-3030	263	9	agents	agent	NOUN
admet-3030	263	10	and	and	CCONJ
admet-3030	263	11	even	even	ADV
admet-3030	263	12	botulinum	botulinum	ADJ
admet-3030	263	13	toxin	toxin	NOUN
admet-3030	263	14	a	a	PRON
admet-3030	263	15	to	to	PART
admet-3030	263	16	prevent	prevent	VERB
admet-3030	263	17	follicular	follicular	ADJ
admet-3030	263	18	fibrosis	fibrosis	NOUN
admet-3030	263	19	has	have	AUX
admet-3030	263	20	also	also	ADV
admet-3030	263	21	gained	gain	VERB
admet-3030	263	22	importance	importance	NOUN
admet-3030	263	23	.	.	PUNCT
admet-3030	264	1	β	β	X
admet-3030	264	2	-	-	ADJ
admet-3030	264	3	catenin	catenin	ADJ
admet-3030	264	4	stability	stability	NOUN
admet-3030	264	5	can	can	AUX
admet-3030	264	6	be	be	AUX
admet-3030	264	7	modulated	modulate	VERB
admet-3030	264	8	by	by	ADP
admet-3030	264	9	valproic	valproic	ADJ
admet-3030	264	10	acid	acid	NOUN
admet-3030	264	11	and	and	CCONJ
admet-3030	264	12	lithium	lithium	NOUN
admet-3030	264	13	chloride	chloride	NOUN
admet-3030	264	14	,	,	PUNCT
admet-3030	264	15	thereby	thereby	ADV
admet-3030	264	16	promoting	promote	VERB
admet-3030	264	17	follicular	follicular	ADJ
admet-3030	264	18	stem	stem	NOUN
admet-3030	264	19	cell	cell	NOUN
admet-3030	264	20	regeneration	regeneration	NOUN
admet-3030	264	21	.	.	PUNCT
admet-3030	265	1	in	in	ADP
admet-3030	265	2	recent	recent	ADJ
admet-3030	265	3	years	year	NOUN
admet-3030	265	4	,	,	PUNCT
admet-3030	265	5	corticosteroids	corticosteroid	NOUN
admet-3030	265	6	and	and	CCONJ
admet-3030	265	7	anti	anti	ADJ
admet-3030	265	8	-	-	ADJ
admet-3030	265	9	tnf	tnf	ADJ
admet-3030	265	10	agents	agent	NOUN
admet-3030	265	11	have	have	AUX
admet-3030	265	12	been	be	AUX
admet-3030	265	13	prescribed	prescribe	VERB
admet-3030	265	14	to	to	PART
admet-3030	265	15	minimize	minimize	VERB
admet-3030	265	16	local	local	ADJ
admet-3030	265	17	immune	immune	ADJ
admet-3030	265	18	inflammation	inflammation	NOUN
admet-3030	265	19	,	,	PUNCT
admet-3030	265	20	as	as	SCONJ
admet-3030	265	21	inflammation	inflammation	NOUN
admet-3030	265	22	in	in	ADP
admet-3030	265	23	some	some	DET
admet-3030	265	24	cases	case	NOUN
admet-3030	265	25	can	can	AUX
admet-3030	265	26	lead	lead	VERB
admet-3030	265	27	to	to	ADP
admet-3030	265	28	aga	aga	PROPN
admet-3030	265	29	.	.	PUNCT
admet-3030	266	1	technological	technological	ADJ
admet-3030	266	2	advances	advance	NOUN
admet-3030	266	3	have	have	AUX
admet-3030	266	4	shifted	shift	VERB
admet-3030	266	5	traditional	traditional	ADJ
admet-3030	266	6	therapies	therapy	NOUN
admet-3030	266	7	toward	toward	ADP
admet-3030	266	8	personalized	personalized	ADJ
admet-3030	266	9	approaches	approach	NOUN
admet-3030	266	10	,	,	PUNCT
admet-3030	266	11	treating	treat	VERB
admet-3030	266	12	diseases	disease	NOUN
admet-3030	266	13	at	at	ADP
admet-3030	266	14	the	the	DET
admet-3030	266	15	genetic	genetic	ADJ
admet-3030	266	16	or	or	CCONJ
admet-3030	266	17	cellular	cellular	ADJ
admet-3030	266	18	levels	level	NOUN
admet-3030	266	19	rather	rather	ADV
admet-3030	266	20	than	than	ADP
admet-3030	266	21	at	at	ADP
admet-3030	266	22	the	the	DET
admet-3030	266	23	surface	surface	NOUN
admet-3030	266	24	.	.	PUNCT
admet-3030	267	1	the	the	DET
admet-3030	267	2	aga	aga	NOUN
admet-3030	267	3	treatment	treatment	NOUN
admet-3030	267	4	strategies	strategy	NOUN
admet-3030	267	5	from	from	ADP
admet-3030	267	6	the	the	DET
admet-3030	267	7	past	past	NOUN
admet-3030	267	8	to	to	ADP
admet-3030	267	9	the	the	DET
admet-3030	267	10	present	present	NOUN
admet-3030	267	11	are	be	AUX
admet-3030	267	12	shown	show	VERB
admet-3030	267	13	in	in	ADP
admet-3030	267	14	figure	figure	NOUN
admet-3030	267	15	7	7	NUM
admet-3030	267	16	.	.	PUNCT
admet-3030	267	17	figure	figure	VERB
admet-3030	267	18	7	7	NUM
admet-3030	267	19	.	.	PUNCT
admet-3030	267	20	advancements	advancement	NOUN
admet-3030	267	21	in	in	ADP
admet-3030	267	22	aga	aga	NOUN
admet-3030	267	23	treatment	treatment	NOUN
admet-3030	267	24	strategies	strategy	NOUN
admet-3030	267	25	many	many	ADJ
admet-3030	267	26	gene	gene	NOUN
admet-3030	267	27	therapies	therapy	NOUN
admet-3030	267	28	are	be	AUX
admet-3030	267	29	under	under	ADP
admet-3030	267	30	clinical	clinical	ADJ
admet-3030	267	31	study	study	NOUN
admet-3030	267	32	,	,	PUNCT
admet-3030	267	33	in	in	ADP
admet-3030	267	34	which	which	PRON
admet-3030	267	35	sirna	sirna	PROPN
admet-3030	267	36	targeting	target	VERB
admet-3030	267	37	regulates	regulate	VERB
admet-3030	267	38	hair	hair	NOUN
admet-3030	267	39	follicle	follicle	NOUN
admet-3030	267	40	development	development	NOUN
admet-3030	267	41	,	,	PUNCT
admet-3030	267	42	and	and	CCONJ
admet-3030	267	43	associated	associated	ADJ
admet-3030	267	44	pathways	pathway	NOUN
admet-3030	267	45	include	include	VERB
admet-3030	267	46	wnt	wnt	NOUN
admet-3030	267	47	/	/	SYM
admet-3030	267	48	β	β	NOUN
admet-3030	267	49	-	-	ADJ
admet-3030	267	50	catenin	catenin	ADJ
admet-3030	267	51	signalling	signalling	ADJ
admet-3030	267	52	and	and	CCONJ
admet-3030	267	53	dht	dht	NOUN
admet-3030	267	54	receptors	receptor	NOUN
admet-3030	267	55	[	[	X
admet-3030	267	56	38	38	NUM
admet-3030	267	57	]	]	PUNCT
admet-3030	267	58	.	.	PUNCT
admet-3030	268	1	however	however	ADV
admet-3030	268	2	,	,	PUNCT
admet-3030	268	3	there	there	PRON
admet-3030	268	4	exists	exist	VERB
admet-3030	268	5	a	a	DET
admet-3030	268	6	limitation	limitation	NOUN
admet-3030	268	7	of	of	ADP
admet-3030	268	8	biological	biological	ADJ
admet-3030	268	9	barriers	barrier	NOUN
admet-3030	268	10	.	.	PUNCT
admet-3030	269	1	regenerative	regenerative	ADJ
admet-3030	269	2	cellular	cellular	ADJ
admet-3030	269	3	therapies	therapy	NOUN
admet-3030	269	4	these	these	PRON
admet-3030	269	5	are	be	AUX
admet-3030	269	6	some	some	PRON
admet-3030	269	7	of	of	ADP
admet-3030	269	8	the	the	DET
admet-3030	269	9	most	most	ADV
admet-3030	269	10	recommended	recommended	ADJ
admet-3030	269	11	alternative	alternative	ADJ
admet-3030	269	12	therapies	therapy	NOUN
admet-3030	269	13	to	to	ADP
admet-3030	269	14	the	the	DET
admet-3030	269	15	traditional	traditional	ADJ
admet-3030	269	16	treatments	treatment	NOUN
admet-3030	269	17	of	of	ADP
admet-3030	269	18	alopecia	alopecia	NOUN
admet-3030	269	19	.	.	PUNCT
admet-3030	270	1	their	their	PRON
admet-3030	270	2	mechanism	mechanism	NOUN
admet-3030	270	3	of	of	ADP
admet-3030	270	4	action	action	NOUN
admet-3030	270	5	is	be	AUX
admet-3030	270	6	to	to	PART
admet-3030	270	7	stimulate	stimulate	VERB
admet-3030	270	8	the	the	DET
admet-3030	270	9	hair	hair	NOUN
admet-3030	270	10	follicles	follicle	NOUN
admet-3030	270	11	and	and	CCONJ
admet-3030	270	12	promote	promote	VERB
admet-3030	270	13	hair	hair	NOUN
admet-3030	270	14	growth	growth	NOUN
admet-3030	270	15	.	.	PUNCT
admet-3030	271	1	stem	stem	NOUN
admet-3030	271	2	cell	cell	NOUN
admet-3030	271	3	therapies	therapy	NOUN
admet-3030	271	4	:	:	PUNCT
admet-3030	271	5	stem	stem	NOUN
admet-3030	271	6	cells	cell	NOUN
admet-3030	271	7	derived	derive	VERB
admet-3030	271	8	from	from	ADP
admet-3030	271	9	adipose	adipose	ADJ
admet-3030	271	10	tissue	tissue	NOUN
admet-3030	271	11	,	,	PUNCT
admet-3030	271	12	bone	bone	NOUN
admet-3030	271	13	marrow	marrow	NOUN
admet-3030	271	14	,	,	PUNCT
admet-3030	271	15	or	or	CCONJ
admet-3030	271	16	the	the	DET
admet-3030	271	17	umbilical	umbilical	ADJ
admet-3030	271	18	cord	cord	NOUN
admet-3030	271	19	can	can	AUX
admet-3030	271	20	be	be	AUX
admet-3030	271	21	administered	administer	VERB
admet-3030	271	22	via	via	ADP
admet-3030	271	23	admet	admet	PROPN
admet-3030	271	24	&	&	CCONJ
admet-3030	271	25	dmpk	dmpk	PROPN
admet-3030	271	26	00(0	00(0	PROPN
admet-3030	271	27	)	)	PUNCT
admet-3030	271	28	(	(	PUNCT
admet-3030	271	29	2025	2025	NUM
admet-3030	271	30	)	)	PUNCT
admet-3030	271	31	3030	3030	NUM
admet-3030	271	32	precision	precision	NOUN
admet-3030	271	33	therapeutics	therapeutic	NOUN
admet-3030	271	34	in	in	ADP
admet-3030	271	35	non	non	ADJ
admet-3030	271	36	-	-	ADJ
admet-3030	271	37	scarring	scar	VERB
admet-3030	271	38	alopecia	alopecia	NOUN
admet-3030	271	39	doi	doi	NOUN
admet-3030	271	40	:	:	PUNCT
admet-3030	271	41	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	271	42	13	13	NUM
admet-3030	271	43	intralesional	intralesional	ADJ
admet-3030	271	44	injection	injection	NOUN
admet-3030	271	45	for	for	ADP
admet-3030	271	46	hair	hair	NOUN
admet-3030	271	47	regrowth	regrowth	NOUN
admet-3030	272	1	[	[	X
admet-3030	272	2	2	2	NUM
admet-3030	272	3	]	]	PUNCT
admet-3030	272	4	.	.	PUNCT
admet-3030	273	1	stem	stem	NOUN
admet-3030	273	2	cells	cell	NOUN
admet-3030	273	3	modulate	modulate	VERB
admet-3030	273	4	growth	growth	NOUN
admet-3030	273	5	factors	factor	NOUN
admet-3030	273	6	such	such	ADJ
admet-3030	273	7	as	as	ADP
admet-3030	273	8	vegf	vegf	PROPN
admet-3030	273	9	and	and	CCONJ
admet-3030	273	10	igfbp-1	igfbp-1	PROPN
admet-3030	273	11	,	,	PUNCT
admet-3030	273	12	which	which	PRON
admet-3030	273	13	enhance	enhance	VERB
admet-3030	273	14	blood	blood	NOUN
admet-3030	273	15	flow	flow	NOUN
admet-3030	273	16	to	to	ADP
admet-3030	273	17	hair	hair	NOUN
admet-3030	273	18	follicles	follicle	NOUN
admet-3030	273	19	and	and	CCONJ
admet-3030	273	20	restore	restore	VERB
admet-3030	273	21	hair	hair	NOUN
admet-3030	273	22	growth	growth	NOUN
admet-3030	273	23	[	[	X
admet-3030	273	24	84	84	NUM
admet-3030	273	25	]	]	PUNCT
admet-3030	273	26	.	.	PUNCT
admet-3030	274	1	prp	prp	PROPN
admet-3030	274	2	is	be	AUX
admet-3030	274	3	the	the	DET
admet-3030	274	4	second	second	ADJ
admet-3030	274	5	most	most	ADV
admet-3030	274	6	widely	widely	ADV
admet-3030	274	7	used	use	VERB
admet-3030	274	8	regenerative	regenerative	ADJ
admet-3030	274	9	hair	hair	NOUN
admet-3030	274	10	follicular	follicular	ADJ
admet-3030	274	11	therapy	therapy	NOUN
admet-3030	274	12	,	,	PUNCT
admet-3030	274	13	in	in	ADP
admet-3030	274	14	which	which	PRON
admet-3030	274	15	the	the	DET
admet-3030	274	16	patient	patient	NOUN
admet-3030	274	17	's	's	PART
admet-3030	274	18	plasma	plasma	NOUN
admet-3030	274	19	,	,	PUNCT
admet-3030	274	20	rich	rich	ADJ
admet-3030	274	21	in	in	ADP
admet-3030	274	22	platelets	platelet	NOUN
admet-3030	274	23	,	,	PUNCT
admet-3030	274	24	growth	growth	NOUN
admet-3030	274	25	factors	factor	NOUN
admet-3030	274	26	,	,	PUNCT
admet-3030	274	27	and	and	CCONJ
admet-3030	274	28	cytokines	cytokine	NOUN
admet-3030	274	29	,	,	PUNCT
admet-3030	274	30	is	be	AUX
admet-3030	274	31	injected	inject	VERB
admet-3030	274	32	into	into	ADP
admet-3030	274	33	the	the	DET
admet-3030	274	34	scalp	scalp	NOUN
admet-3030	274	35	to	to	PART
admet-3030	274	36	promote	promote	VERB
admet-3030	274	37	hair	hair	NOUN
admet-3030	274	38	growth	growth	NOUN
admet-3030	274	39	[	[	X
admet-3030	274	40	84	84	NUM
admet-3030	274	41	]	]	PUNCT
admet-3030	274	42	.	.	PUNCT
admet-3030	275	1	exosome	exosome	PROPN
admet-3030	275	2	therapy	therapy	NOUN
admet-3030	275	3	is	be	AUX
admet-3030	275	4	a	a	DET
admet-3030	275	5	cell	cell	NOUN
admet-3030	275	6	-	-	PUNCT
admet-3030	275	7	based	base	VERB
admet-3030	275	8	regenerative	regenerative	ADJ
admet-3030	275	9	therapy	therapy	NOUN
admet-3030	275	10	that	that	PRON
admet-3030	275	11	promotes	promote	VERB
admet-3030	275	12	follicular	follicular	ADJ
admet-3030	275	13	regeneration	regeneration	NOUN
admet-3030	275	14	[	[	X
admet-3030	275	15	85	85	NUM
admet-3030	275	16	]	]	PUNCT
admet-3030	275	17	.	.	PUNCT
admet-3030	276	1	novel	novel	ADJ
admet-3030	276	2	biomimetic	biomimetic	ADJ
admet-3030	276	3	peptides	peptide	NOUN
admet-3030	276	4	and	and	CCONJ
admet-3030	276	5	growth	growth	NOUN
admet-3030	276	6	factor	factor	NOUN
admet-3030	276	7	-	-	PUNCT
admet-3030	276	8	based	base	VERB
admet-3030	276	9	formulations	formulation	NOUN
admet-3030	276	10	such	such	ADJ
admet-3030	276	11	as	as	ADP
admet-3030	276	12	qr678	qr678	NOUN
admet-3030	276	13	®	®	NOUN
admet-3030	276	14	have	have	AUX
admet-3030	276	15	demonstrated	demonstrate	VERB
admet-3030	276	16	efficacy	efficacy	NOUN
admet-3030	276	17	in	in	ADP
admet-3030	276	18	promoting	promote	VERB
admet-3030	276	19	hair	hair	NOUN
admet-3030	276	20	follicle	follicle	NOUN
admet-3030	276	21	regeneration	regeneration	NOUN
admet-3030	276	22	and	and	CCONJ
admet-3030	276	23	represent	represent	VERB
admet-3030	276	24	a	a	DET
admet-3030	276	25	significant	significant	ADJ
admet-3030	276	26	advancement	advancement	NOUN
admet-3030	276	27	in	in	ADP
admet-3030	276	28	non	non	ADJ
admet-3030	276	29	-	-	ADJ
admet-3030	276	30	invasive	invasive	ADJ
admet-3030	276	31	treatment	treatment	NOUN
admet-3030	276	32	approaches	approach	NOUN
admet-3030	276	33	[	[	X
admet-3030	276	34	61,78	61,78	NUM
admet-3030	276	35	-	-	PUNCT
admet-3030	276	36	92	92	NUM
admet-3030	276	37	]	]	PUNCT
admet-3030	276	38	.	.	PUNCT
admet-3030	277	1	preclinical	preclinical	ADJ
admet-3030	277	2	and	and	CCONJ
admet-3030	277	3	clinical	clinical	ADJ
admet-3030	277	4	investigations	investigation	NOUN
admet-3030	277	5	have	have	AUX
admet-3030	277	6	consistently	consistently	ADV
admet-3030	277	7	demonstrated	demonstrate	VERB
admet-3030	277	8	the	the	DET
admet-3030	277	9	safety	safety	NOUN
admet-3030	277	10	and	and	CCONJ
admet-3030	277	11	efficacy	efficacy	NOUN
admet-3030	277	12	of	of	ADP
admet-3030	277	13	qr678	qr678	PROPN
admet-3030	277	14	neo	neo	NOUN
admet-3030	277	15	®	®	NOUN
admet-3030	277	16	in	in	ADP
admet-3030	277	17	diverse	diverse	ADJ
admet-3030	277	18	alopecia	alopecia	NOUN
admet-3030	277	19	phenotypes	phenotype	NOUN
admet-3030	277	20	[	[	X
admet-3030	277	21	91	91	NUM
admet-3030	277	22	-	-	SYM
admet-3030	277	23	101	101	NUM
admet-3030	277	24	]	]	PUNCT
admet-3030	277	25	.	.	PUNCT
admet-3030	278	1	as	as	SCONJ
admet-3030	278	2	shown	show	VERB
admet-3030	278	3	in	in	ADP
admet-3030	278	4	figure	figure	NOUN
admet-3030	278	5	8	8	NUM
admet-3030	278	6	,	,	PUNCT
admet-3030	278	7	qr678	qr678	X
admet-3030	278	8	neo	neo	NOUN
admet-3030	278	9	®	®	NOUN
admet-3030	278	10	demonstrates	demonstrate	VERB
admet-3030	278	11	therapeutic	therapeutic	ADJ
admet-3030	278	12	efficacy	efficacy	NOUN
admet-3030	278	13	by	by	ADP
admet-3030	278	14	targeting	target	VERB
admet-3030	278	15	the	the	DET
admet-3030	278	16	wnt	wnt	NOUN
admet-3030	278	17	/	/	SYM
admet-3030	278	18	β	β	NOUN
admet-3030	278	19	-	-	NOUN
admet-3030	278	20	catenin	catenin	NOUN
admet-3030	278	21	and	and	CCONJ
admet-3030	278	22	akt	akt	PROPN
admet-3030	278	23	/	/	SYM
admet-3030	278	24	mapk	mapk	NOUN
admet-3030	278	25	pathways	pathway	NOUN
admet-3030	278	26	,	,	PUNCT
admet-3030	278	27	which	which	PRON
admet-3030	278	28	are	be	AUX
admet-3030	278	29	essential	essential	ADJ
admet-3030	278	30	for	for	ADP
admet-3030	278	31	activating	activate	VERB
admet-3030	278	32	follicular	follicular	ADJ
admet-3030	278	33	stem	stem	NOUN
admet-3030	278	34	cells	cell	NOUN
admet-3030	278	35	,	,	PUNCT
admet-3030	278	36	promoting	promote	VERB
admet-3030	278	37	angiogenesis	angiogenesis	NOUN
admet-3030	278	38	,	,	PUNCT
admet-3030	278	39	and	and	CCONJ
admet-3030	278	40	prolonging	prolong	VERB
admet-3030	278	41	the	the	DET
admet-3030	278	42	anagen	anagen	NOUN
admet-3030	278	43	phase	phase	NOUN
admet-3030	278	44	.	.	PUNCT
admet-3030	279	1	this	this	DET
admet-3030	279	2	highlights	highlight	VERB
admet-3030	279	3	the	the	DET
admet-3030	279	4	role	role	NOUN
admet-3030	279	5	of	of	ADP
admet-3030	279	6	qr678	qr678	PROPN
admet-3030	279	7	®	®	NOUN
admet-3030	279	8	as	as	ADP
admet-3030	279	9	a	a	DET
admet-3030	279	10	comprehensive	comprehensive	ADJ
admet-3030	279	11	,	,	PUNCT
admet-3030	279	12	pathway	pathway	NOUN
admet-3030	279	13	-	-	PUNCT
admet-3030	279	14	based	base	VERB
admet-3030	279	15	regenerative	regenerative	ADJ
admet-3030	279	16	therapy	therapy	NOUN
admet-3030	279	17	for	for	ADP
admet-3030	279	18	hair	hair	NOUN
admet-3030	279	19	restoration	restoration	NOUN
admet-3030	279	20	.	.	PUNCT
admet-3030	280	1	recent	recent	ADJ
admet-3030	280	2	clinical	clinical	ADJ
admet-3030	280	3	investigations	investigation	NOUN
admet-3030	280	4	indicate	indicate	VERB
admet-3030	280	5	that	that	SCONJ
admet-3030	280	6	microneedling	microneedling	NOUN
admet-3030	280	7	and	and	CCONJ
admet-3030	280	8	dermaroller	dermaroller	NOUN
admet-3030	280	9	-	-	PUNCT
admet-3030	280	10	assisted	assist	VERB
admet-3030	280	11	delivery	delivery	NOUN
admet-3030	280	12	significantly	significantly	ADV
admet-3030	280	13	enhance	enhance	VERB
admet-3030	280	14	scalp	scalp	NOUN
admet-3030	280	15	penetration	penetration	NOUN
admet-3030	280	16	and	and	CCONJ
admet-3030	280	17	efficacy	efficacy	NOUN
admet-3030	280	18	of	of	ADP
admet-3030	280	19	qr678	qr678	PROPN
admet-3030	280	20	neo	neo	PROPN
admet-3030	280	21	®	®	NOUN
admet-3030	280	22	,	,	PUNCT
admet-3030	280	23	with	with	ADP
admet-3030	280	24	trials	trial	NOUN
admet-3030	280	25	confirming	confirm	VERB
admet-3030	280	26	superior	superior	ADJ
admet-3030	280	27	follicular	follicular	ADJ
admet-3030	280	28	regeneration	regeneration	NOUN
admet-3030	280	29	compared	compare	VERB
admet-3030	280	30	with	with	ADP
admet-3030	280	31	minoxidil	minoxidil	ADJ
admet-3030	280	32	and	and	CCONJ
admet-3030	280	33	finasteride	finasteride	ADV
admet-3030	280	34	,	,	PUNCT
admet-3030	280	35	especially	especially	ADV
admet-3030	280	36	as	as	SCONJ
admet-3030	280	37	monotherapy	monotherapy	NOUN
admet-3030	280	38	[	[	X
admet-3030	280	39	102	102	NUM
admet-3030	280	40	-	-	SYM
admet-3030	280	41	105	105	NUM
admet-3030	280	42	]	]	PUNCT
admet-3030	280	43	.	.	PUNCT
admet-3030	281	1	in	in	ADP
admet-3030	281	2	addition	addition	NOUN
admet-3030	281	3	to	to	ADP
admet-3030	281	4	its	its	PRON
admet-3030	281	5	role	role	NOUN
admet-3030	281	6	in	in	ADP
admet-3030	281	7	alopecia	alopecia	NOUN
admet-3030	281	8	management	management	NOUN
admet-3030	281	9	,	,	PUNCT
admet-3030	281	10	qr678	qr678	X
admet-3030	281	11	neo	neo	NOUN
admet-3030	281	12	®	®	NOUN
admet-3030	281	13	has	have	AUX
admet-3030	281	14	also	also	ADV
admet-3030	281	15	been	be	AUX
admet-3030	281	16	validated	validate	VERB
admet-3030	281	17	as	as	ADP
admet-3030	281	18	an	an	DET
admet-3030	281	19	intraoperative	intraoperative	NOUN
admet-3030	281	20	adjunct	adjunct	ADJ
admet-3030	281	21	in	in	ADP
admet-3030	281	22	follicular	follicular	ADJ
admet-3030	281	23	unit	unit	NOUN
admet-3030	281	24	extraction	extraction	NOUN
admet-3030	281	25	,	,	PUNCT
admet-3030	281	26	where	where	SCONJ
admet-3030	281	27	its	its	PRON
admet-3030	281	28	use	use	NOUN
admet-3030	281	29	as	as	ADP
admet-3030	281	30	a	a	DET
admet-3030	281	31	graft	graft	NOUN
admet-3030	281	32	-	-	PUNCT
admet-3030	281	33	holding	hold	VERB
admet-3030	281	34	medium	medium	NOUN
admet-3030	281	35	significantly	significantly	ADV
admet-3030	281	36	improved	improve	VERB
admet-3030	281	37	follicle	follicle	NOUN
admet-3030	281	38	viability	viability	NOUN
admet-3030	281	39	and	and	CCONJ
admet-3030	281	40	donor	donor	NOUN
admet-3030	281	41	site	site	NOUN
admet-3030	281	42	recovery	recovery	NOUN
admet-3030	282	1	[	[	X
admet-3030	282	2	106	106	NUM
admet-3030	282	3	]	]	PUNCT
admet-3030	282	4	.	.	PUNCT
admet-3030	283	1	figure	figure	NOUN
admet-3030	283	2	8	8	NUM
admet-3030	283	3	.	.	PUNCT
admet-3030	284	1	role	role	NOUN
admet-3030	284	2	of	of	ADP
admet-3030	284	3	qr678	qr678	PROPN
admet-3030	284	4	neo	neo	NOUN
admet-3030	284	5	®	®	NOUN
admet-3030	284	6	in	in	ADP
admet-3030	284	7	non	non	ADJ
admet-3030	284	8	-	-	ADJ
admet-3030	284	9	scarring	scar	VERB
admet-3030	284	10	alopecia	alopecia	NOUN
admet-3030	284	11	[	[	X
admet-3030	284	12	90	90	NUM
admet-3030	284	13	]	]	PUNCT
admet-3030	284	14	integration	integration	NOUN
admet-3030	284	15	of	of	ADP
admet-3030	284	16	artificial	artificial	ADJ
admet-3030	284	17	intelligence	intelligence	NOUN
admet-3030	284	18	and	and	CCONJ
admet-3030	284	19	machine	machine	NOUN
admet-3030	284	20	learning	learning	NOUN
admet-3030	284	21	models	model	NOUN
admet-3030	284	22	holds	hold	VERB
admet-3030	284	23	further	further	ADJ
admet-3030	284	24	potential	potential	NOUN
admet-3030	284	25	for	for	ADP
admet-3030	284	26	improving	improve	VERB
admet-3030	284	27	early	early	ADJ
admet-3030	284	28	diagnosis	diagnosis	NOUN
admet-3030	284	29	and	and	CCONJ
admet-3030	284	30	treatment	treatment	NOUN
admet-3030	284	31	planning	planning	NOUN
admet-3030	284	32	.	.	PUNCT
admet-3030	285	1	even	even	ADV
admet-3030	285	2	though	though	SCONJ
admet-3030	285	3	some	some	PRON
admet-3030	285	4	of	of	ADP
admet-3030	285	5	these	these	DET
admet-3030	285	6	methods	method	NOUN
admet-3030	285	7	are	be	AUX
admet-3030	285	8	currently	currently	ADV
admet-3030	285	9	in	in	ADP
admet-3030	285	10	use	use	NOUN
admet-3030	285	11	,	,	PUNCT
admet-3030	285	12	there	there	PRON
admet-3030	285	13	is	be	VERB
admet-3030	285	14	no	no	DET
admet-3030	285	15	standardization	standardization	NOUN
admet-3030	285	16	of	of	ADP
admet-3030	285	17	isolation	isolation	NOUN
admet-3030	285	18	,	,	PUNCT
admet-3030	285	19	injection	injection	NOUN
admet-3030	285	20	dosage	dosage	NOUN
admet-3030	285	21	routes	route	NOUN
admet-3030	285	22	,	,	PUNCT
admet-3030	285	23	etc	etc	X
admet-3030	285	24	.	.	X
admet-3030	285	25	,	,	PUNCT
admet-3030	285	26	which	which	PRON
admet-3030	285	27	limits	limit	VERB
admet-3030	285	28	their	their	PRON
admet-3030	285	29	efficacy	efficacy	NOUN
admet-3030	285	30	.	.	PUNCT
admet-3030	286	1	tailored	tailor	VERB
admet-3030	286	2	therapies	therapy	NOUN
admet-3030	286	3	based	base	VERB
admet-3030	286	4	on	on	ADP
admet-3030	286	5	single	single	ADJ
admet-3030	286	6	nucleotide	nucleotide	ADJ
admet-3030	286	7	polymorphisms	polymorphism	NOUN
admet-3030	286	8	snp	snp	ADJ
admet-3030	286	9	identification	identification	NOUN
admet-3030	286	10	helps	help	VERB
admet-3030	286	11	to	to	PART
admet-3030	286	12	tailor	tailor	VERB
admet-3030	286	13	treatment	treatment	NOUN
admet-3030	286	14	for	for	ADP
admet-3030	286	15	aga	aga	NOUN
admet-3030	286	16	based	base	VERB
admet-3030	286	17	on	on	ADP
admet-3030	286	18	the	the	DET
admet-3030	286	19	individual	individual	NOUN
admet-3030	286	20	's	's	PART
admet-3030	286	21	genetic	genetic	ADJ
admet-3030	286	22	makeup	makeup	NOUN
admet-3030	286	23	,	,	PUNCT
admet-3030	286	24	thereby	thereby	ADV
admet-3030	286	25	minimizing	minimize	VERB
admet-3030	286	26	side	side	NOUN
admet-3030	286	27	effects	effect	NOUN
admet-3030	286	28	.	.	PUNCT
admet-3030	287	1	individuals	individual	NOUN
admet-3030	287	2	who	who	PRON
admet-3030	287	3	have	have	VERB
admet-3030	287	4	srd5a2	srd5a2	NOUN
admet-3030	287	5	polymorphisms	polymorphism	NOUN
admet-3030	287	6	exhibit	exhibit	VERB
admet-3030	287	7	varied	varied	ADJ
admet-3030	287	8	responses	response	NOUN
admet-3030	287	9	to	to	AUX
admet-3030	287	10	finasteride	finasteride	VERB
admet-3030	287	11	and	and	CCONJ
admet-3030	287	12	dutasteride	dutasteride	VERB
admet-3030	288	1	[	[	X
admet-3030	288	2	35	35	NUM
admet-3030	288	3	]	]	PUNCT
admet-3030	288	4	.	.	PUNCT
admet-3030	289	1	the	the	DET
admet-3030	289	2	same	same	ADJ
admet-3030	289	3	can	can	AUX
admet-3030	289	4	be	be	AUX
admet-3030	289	5	observed	observe	VERB
admet-3030	289	6	in	in	ADP
admet-3030	289	7	people	people	NOUN
admet-3030	289	8	who	who	PRON
admet-3030	289	9	have	have	VERB
admet-3030	289	10	snps	snps	PROPN
admet-3030	289	11	in	in	ADP
admet-3030	289	12	the	the	DET
admet-3030	289	13	ptges2	ptges2	NOUN
admet-3030	289	14	and	and	CCONJ
admet-3030	289	15	ace	ace	VERB
admet-3030	289	16	genes	gene	NOUN
admet-3030	289	17	for	for	ADP
admet-3030	289	18	other	other	ADJ
admet-3030	289	19	drugs	drug	NOUN
admet-3030	289	20	,	,	PUNCT
admet-3030	289	21	such	such	ADJ
admet-3030	289	22	as	as	ADP
admet-3030	289	23	minoxidil	minoxidil	ADJ
admet-3030	289	24	.	.	PUNCT
admet-3030	290	1	few	few	ADJ
admet-3030	290	2	studies	study	NOUN
admet-3030	290	3	have	have	AUX
admet-3030	290	4	reported	report	VERB
admet-3030	290	5	that	that	SCONJ
admet-3030	290	6	individuals	individual	NOUN
admet-3030	290	7	with	with	ADP
admet-3030	290	8	favourable	favourable	ADJ
admet-3030	290	9	variants	variant	NOUN
admet-3030	290	10	show	show	VERB
admet-3030	290	11	significant	significant	ADJ
admet-3030	290	12	regrowth	regrowth	NOUN
admet-3030	290	13	,	,	PUNCT
admet-3030	290	14	whereas	whereas	SCONJ
admet-3030	290	15	those	those	PRON
admet-3030	290	16	without	without	ADP
admet-3030	290	17	these	these	DET
admet-3030	290	18	variants	variant	NOUN
admet-3030	290	19	may	may	AUX
admet-3030	290	20	not	not	PART
admet-3030	290	21	support	support	VERB
admet-3030	290	22	hair	hair	NOUN
admet-3030	290	23	growth	growth	NOUN
admet-3030	290	24	.	.	PUNCT
admet-3030	291	1	it	it	PRON
admet-3030	291	2	was	be	AUX
admet-3030	291	3	also	also	ADV
admet-3030	291	4	reported	report	VERB
admet-3030	291	5	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	PROPN
admet-3030	292	1	https://www.google.com/search?q=single+nucleotide+polymorphism&sca_esv=083f7bdd283a4f59&rlz=1c1chbd_enin1175in1175&sxsrf=ae3tifpriqfllasnyfml4soue6cjnjguua%3a1765001516048&ei=lmkzafbvauru4-ep56cnsqw&oq=snps+ful%3b&gs_lp=egxnd3mtd2l6lxnlcnaaahgciglttlbzigz1bdsqaggamgyqabgwgb4ybhaagbyyhjigeaayfhgemggqabgwgaoyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhkjsovaawneqcan4azabajgbiwkgacypqgegmc4xmc4yuaedyaea-aebmaipoalpekgcfmicbbajgcfcagoqixiabbgngiofwgikeaaygaqyqxikbcicdraagiaegemyiguyiwpcaggqabiabbila8icdhaagiaegledgimbgisdwgilec4ygaqysqmy0qmy0gmyqxidarimaxjharj4brioaxikbrila8iccxaagiaegledgisdwgizec4ygaqysqmyqxioaxikbrilaxieaxifa8icexaugiaegemypamyqamyiguyiwpcaggqabiabbixa8icbraagiaewgileaaygaqysqmygwhcag4qlhiabbixaxjraxjhacicnbaugiaegledgnedgnidgemygweypgmyxwey-auyqamyiguyiwmylwuy3aqy3gqy4atyaqhcag4qlhiabbjhariobrivaciccbaugiaegouewgipeaaygaqysqmygweychglwgilec4ygaqy0qmyxwhcagcqixgngoocwginec4y0qmyxweyjxjqasicebaagamytaiy6giyjwhyaqhcaguqlhiabmicdbaagiaegledgaoyc8iccraagiaegaoyc5gdc_efo5ctkazz6wo6bgyiarabgbssbwyzljewljkgb7v7sgcgmc4xmc4yuaewemihbzaums44ljbib2uacaa&sclient=gws-wiz-serp&ved=2ahukewic5iforairaxxdxgchhuzqmpmqgk4qegyiaqgaeaq	https://www.google.com/search?q=single+nucleotide+polymorphism&sca_esv=083f7bdd283a4f59&rlz=1c1chbd_enin1175in1175&sxsrf=ae3tifpriqfllasnyfml4soue6cjnjguua%3a1765001516048&ei=lmkzafbvauru4-ep56cnsqw&oq=snps+ful%3b&gs_lp=egxnd3mtd2l6lxnlcnaaahgciglttlbzigz1bdsqaggamgyqabgwgb4ybhaagbyyhjigeaayfhgemggqabgwgaoyhjigeaayfhgemgyqabgwgb4ybhaagbyyhjigeaayfhgemgyqabgwgb4ybhaagbyyhkjsovaawneqcan4azabajgbiwkgacypqgegmc4xmc4yuaedyaea-aebmaipoalpekgcfmicbbajgcfcagoqixiabbgngiofwgikeaaygaqyqxikbcicdraagiaegemyiguyiwpcaggqabiabbila8icdhaagiaegledgimbgisdwgilec4ygaqysqmy0qmy0gmyqxidarimaxjharj4brioaxikbrila8iccxaagiaegledgisdwgizec4ygaqysqmyqxioaxikbrilaxieaxifa8icexaugiaegemypamyqamyiguyiwpcaggqabiabbixa8icbraagiaewgileaaygaqysqmygwhcag4qlhiabbixaxjraxjhacicnbaugiaegledgnedgnidgemygweypgmyxwey-auyqamyiguyiwmylwuy3aqy3gqy4atyaqhcag4qlhiabbjhariobrivaciccbaugiaegouewgipeaaygaqysqmygweychglwgilec4ygaqy0qmyxwhcagcqixgngoocwginec4y0qmyxweyjxjqasicebaagamytaiy6giyjwhyaqhcaguqlhiabmicdbaagiaegledgaoyc8iccraagiaegaoyc5gdc_efo5ctkazz6wo6bgyiarabgbssbwyzljewljkgb7v7sgcgmc4xmc4yuaewemihbzaums44ljbib2uacaa&sclient=gws-wiz-serp&ved=2ahukewic5iforairaxxdxgchhuzqmpmqgk4qegyiaqgaeaq	PROPN
admet-3030	292	2	r.	r.	PROPN
admet-3030	292	3	kapoor	kapoor	PROPN
admet-3030	292	4	et	et	PROPN
admet-3030	292	5	al	al	PROPN
admet-3030	292	6	.	.	PROPN
admet-3030	292	7	admet	admet	PROPN
admet-3030	292	8	&	&	CCONJ
admet-3030	292	9	dmpk	dmpk	PROPN
admet-3030	292	10	00(0	00(0	PROPN
admet-3030	292	11	)	)	PUNCT
admet-3030	292	12	(	(	PUNCT
admet-3030	292	13	2025	2025	NUM
admet-3030	292	14	)	)	PUNCT
admet-3030	292	15	3030	3030	NUM
admet-3030	292	16	14	14	NUM
admet-3030	292	17	that	that	SCONJ
admet-3030	292	18	prostaglandin	prostaglandin	NOUN
admet-3030	292	19	-	-	PUNCT
admet-3030	292	20	based	base	VERB
admet-3030	292	21	therapies	therapy	NOUN
admet-3030	292	22	,	,	PUNCT
admet-3030	292	23	which	which	PRON
admet-3030	292	24	are	be	AUX
admet-3030	292	25	also	also	ADV
admet-3030	292	26	based	base	VERB
admet-3030	292	27	on	on	ADP
admet-3030	292	28	snps	snps	PROPN
admet-3030	292	29	,	,	PUNCT
admet-3030	292	30	are	be	AUX
admet-3030	292	31	in	in	ADP
admet-3030	292	32	use	use	NOUN
admet-3030	292	33	for	for	ADP
admet-3030	292	34	hair	hair	NOUN
admet-3030	292	35	treatment	treatment	NOUN
admet-3030	292	36	.	.	PUNCT
admet-3030	293	1	individuals	individual	NOUN
admet-3030	293	2	with	with	ADP
admet-3030	293	3	higher	high	ADJ
admet-3030	293	4	levels	level	NOUN
admet-3030	293	5	of	of	ADP
admet-3030	293	6	pgd2	pgd2	ADJ
admet-3030	293	7	expression	expression	NOUN
admet-3030	293	8	favour	favour	NOUN
admet-3030	293	9	hair	hair	NOUN
admet-3030	293	10	regrowth	regrowth	NOUN
admet-3030	293	11	when	when	SCONJ
admet-3030	293	12	treated	treat	VERB
admet-3030	293	13	with	with	ADP
admet-3030	293	14	pgd2	pgd2	ADJ
admet-3030	293	15	inhibitors	inhibitor	NOUN
admet-3030	293	16	[	[	X
admet-3030	293	17	85	85	NUM
admet-3030	293	18	]	]	PUNCT
admet-3030	293	19	.	.	PUNCT
admet-3030	294	1	it	it	PRON
admet-3030	294	2	is	be	AUX
admet-3030	294	3	recommended	recommend	VERB
admet-3030	294	4	that	that	SCONJ
admet-3030	294	5	for	for	ADP
admet-3030	294	6	patients	patient	NOUN
admet-3030	294	7	suffering	suffer	VERB
admet-3030	294	8	from	from	ADP
admet-3030	294	9	existing	exist	VERB
admet-3030	294	10	comorbidities	comorbiditie	NOUN
admet-3030	294	11	,	,	PUNCT
admet-3030	294	12	there	there	PRON
admet-3030	294	13	is	be	VERB
admet-3030	294	14	a	a	DET
admet-3030	294	15	need	need	NOUN
admet-3030	294	16	to	to	PART
admet-3030	294	17	study	study	VERB
admet-3030	294	18	both	both	PRON
admet-3030	294	19	metabolic	metabolic	NOUN
admet-3030	294	20	profiling	profiling	NOUN
admet-3030	294	21	and	and	CCONJ
admet-3030	294	22	genetic	genetic	ADJ
admet-3030	294	23	makeup	makeup	NOUN
admet-3030	294	24	(	(	PUNCT
admet-3030	294	25	snps	snps	PROPN
admet-3030	294	26	)	)	PUNCT
admet-3030	294	27	to	to	PART
admet-3030	294	28	bring	bring	VERB
admet-3030	294	29	about	about	ADP
admet-3030	294	30	positive	positive	ADJ
admet-3030	294	31	outcomes	outcome	NOUN
admet-3030	294	32	.	.	PUNCT
admet-3030	295	1	other	other	ADJ
admet-3030	295	2	therapies	therapy	NOUN
admet-3030	295	3	and	and	CCONJ
admet-3030	295	4	treatments	treatment	VERB
admet-3030	295	5	phytochemicals	phytochemical	NOUN
admet-3030	295	6	such	such	ADJ
admet-3030	295	7	as	as	ADP
admet-3030	295	8	decursin	decursin	NOUN
admet-3030	295	9	,	,	PUNCT
admet-3030	295	10	ginsenosides	ginsenoside	NOUN
admet-3030	295	11	,	,	PUNCT
admet-3030	295	12	rosmarinic	rosmarinic	ADJ
admet-3030	295	13	acid	acid	NOUN
admet-3030	295	14	,	,	PUNCT
admet-3030	295	15	sulforaphane	sulforaphane	NOUN
admet-3030	295	16	,	,	PUNCT
admet-3030	295	17	etc	etc	X
admet-3030	295	18	.	.	X
admet-3030	295	19	,	,	PUNCT
admet-3030	295	20	are	be	AUX
admet-3030	295	21	being	be	AUX
admet-3030	295	22	used	use	VERB
admet-3030	295	23	for	for	ADP
admet-3030	295	24	hair	hair	NOUN
admet-3030	295	25	regeneration	regeneration	NOUN
admet-3030	295	26	[	[	X
admet-3030	295	27	87	87	NUM
admet-3030	295	28	]	]	PUNCT
admet-3030	295	29	.	.	PUNCT
admet-3030	296	1	various	various	ADJ
admet-3030	296	2	studies	study	NOUN
admet-3030	296	3	also	also	ADV
admet-3030	296	4	reported	report	VERB
admet-3030	296	5	that	that	SCONJ
admet-3030	296	6	certain	certain	ADJ
admet-3030	296	7	psychological	psychological	ADJ
admet-3030	296	8	comorbidities	comorbiditie	NOUN
admet-3030	296	9	,	,	PUNCT
admet-3030	296	10	such	such	ADJ
admet-3030	296	11	as	as	ADP
admet-3030	296	12	stress	stress	NOUN
admet-3030	296	13	,	,	PUNCT
admet-3030	296	14	significantly	significantly	ADV
admet-3030	296	15	impact	impact	VERB
admet-3030	296	16	hair	hair	NOUN
admet-3030	296	17	growth	growth	NOUN
admet-3030	296	18	;	;	PUNCT
admet-3030	296	19	hence	hence	ADV
admet-3030	296	20	,	,	PUNCT
admet-3030	296	21	cognitive	cognitive	ADJ
admet-3030	296	22	-	-	PUNCT
admet-3030	296	23	behavioural	behavioural	ADJ
admet-3030	296	24	therapy	therapy	NOUN
admet-3030	296	25	(	(	PUNCT
admet-3030	296	26	cbt	cbt	NOUN
admet-3030	296	27	)	)	PUNCT
admet-3030	296	28	and	and	CCONJ
admet-3030	296	29	meditation	meditation	NOUN
admet-3030	296	30	are	be	AUX
admet-3030	296	31	recommended	recommend	VERB
admet-3030	296	32	to	to	PART
admet-3030	296	33	reduce	reduce	VERB
admet-3030	296	34	stress	stress	NOUN
admet-3030	296	35	and	and	CCONJ
admet-3030	296	36	prevent	prevent	VERB
admet-3030	296	37	the	the	DET
admet-3030	296	38	recurrence	recurrence	NOUN
admet-3030	296	39	of	of	ADP
admet-3030	296	40	aa	aa	NOUN
admet-3030	297	1	[	[	X
admet-3030	297	2	88	88	NUM
admet-3030	297	3	]	]	PUNCT
admet-3030	297	4	.	.	PUNCT
admet-3030	298	1	advances	advance	NOUN
admet-3030	298	2	in	in	ADP
admet-3030	298	3	gut	gut	NOUN
admet-3030	298	4	microbiome	microbiome	NOUN
admet-3030	298	5	analysis	analysis	NOUN
admet-3030	298	6	and	and	CCONJ
admet-3030	298	7	associated	associate	VERB
admet-3030	298	8	supplements	supplement	NOUN
admet-3030	298	9	have	have	AUX
admet-3030	298	10	also	also	ADV
admet-3030	298	11	been	be	AUX
admet-3030	298	12	shown	show	VERB
admet-3030	298	13	to	to	PART
admet-3030	298	14	improve	improve	VERB
admet-3030	298	15	hair	hair	NOUN
admet-3030	298	16	growth	growth	NOUN
admet-3030	298	17	[	[	X
admet-3030	298	18	83	83	NUM
admet-3030	298	19	]	]	PUNCT
admet-3030	298	20	.	.	PUNCT
admet-3030	299	1	in	in	ADP
admet-3030	299	2	addition	addition	NOUN
admet-3030	299	3	,	,	PUNCT
admet-3030	299	4	integrating	integrate	VERB
admet-3030	299	5	technological	technological	ADJ
admet-3030	299	6	advancements	advancement	NOUN
admet-3030	299	7	into	into	ADP
admet-3030	299	8	diagnostic	diagnostic	ADJ
admet-3030	299	9	methods	method	NOUN
admet-3030	299	10	will	will	AUX
admet-3030	299	11	enhance	enhance	VERB
admet-3030	299	12	treatment	treatment	NOUN
admet-3030	299	13	.	.	PUNCT
admet-3030	300	1	concluding	conclude	VERB
admet-3030	300	2	remarks	remark	NOUN
admet-3030	300	3	and	and	CCONJ
admet-3030	300	4	future	future	ADJ
admet-3030	300	5	directions	direction	NOUN
admet-3030	300	6	non	non	ADJ
admet-3030	300	7	-	-	ADJ
admet-3030	300	8	scarring	scarring	ADJ
admet-3030	300	9	alopecia	alopecia	NOUN
admet-3030	300	10	,	,	PUNCT
admet-3030	300	11	encompassing	encompass	VERB
admet-3030	300	12	conditions	condition	NOUN
admet-3030	300	13	such	such	ADJ
admet-3030	300	14	as	as	ADP
admet-3030	300	15	androgenetic	androgenetic	ADJ
admet-3030	300	16	alopecia	alopecia	NOUN
admet-3030	300	17	(	(	PUNCT
admet-3030	300	18	aga	aga	NOUN
admet-3030	300	19	)	)	PUNCT
admet-3030	300	20	and	and	CCONJ
admet-3030	300	21	alopecia	alopecia	NOUN
admet-3030	300	22	areata	areata	ADJ
admet-3030	300	23	(	(	PUNCT
admet-3030	300	24	aa	aa	NOUN
admet-3030	300	25	)	)	PUNCT
admet-3030	300	26	,	,	PUNCT
admet-3030	300	27	is	be	AUX
admet-3030	300	28	a	a	DET
admet-3030	300	29	complex	complex	ADJ
admet-3030	300	30	,	,	PUNCT
admet-3030	300	31	multifactorial	multifactorial	ADJ
admet-3030	300	32	disorder	disorder	NOUN
admet-3030	300	33	influenced	influence	VERB
admet-3030	300	34	by	by	ADP
admet-3030	300	35	genetic	genetic	ADJ
admet-3030	300	36	predisposition	predisposition	NOUN
admet-3030	300	37	,	,	PUNCT
admet-3030	300	38	immune	immune	ADJ
admet-3030	300	39	dysregulation	dysregulation	NOUN
admet-3030	300	40	,	,	PUNCT
admet-3030	300	41	and	and	CCONJ
admet-3030	300	42	environmental	environmental	ADJ
admet-3030	300	43	stressors	stressor	NOUN
admet-3030	300	44	.	.	PUNCT
admet-3030	301	1	a	a	DET
admet-3030	301	2	comprehensive	comprehensive	ADJ
admet-3030	301	3	understanding	understanding	NOUN
admet-3030	301	4	of	of	ADP
admet-3030	301	5	individual	individual	ADJ
admet-3030	301	6	genetic	genetic	ADJ
admet-3030	301	7	makeup	makeup	NOUN
admet-3030	301	8	and	and	CCONJ
admet-3030	301	9	molecular	molecular	ADJ
admet-3030	301	10	alterations	alteration	NOUN
admet-3030	301	11	particularly	particularly	ADV
admet-3030	301	12	within	within	ADP
admet-3030	301	13	key	key	ADJ
admet-3030	301	14	pathways	pathway	NOUN
admet-3030	301	15	such	such	ADJ
admet-3030	301	16	as	as	ADP
admet-3030	301	17	jak	jak	PROPN
admet-3030	301	18	-	-	PUNCT
admet-3030	301	19	stat	stat	PROPN
admet-3030	301	20	and	and	CCONJ
admet-3030	301	21	androgen	androgen	NOUN
admet-3030	301	22	receptor	receptor	NOUN
admet-3030	301	23	signalling	signal	VERB
admet-3030	301	24	can	can	AUX
admet-3030	301	25	facilitate	facilitate	VERB
admet-3030	301	26	the	the	DET
admet-3030	301	27	development	development	NOUN
admet-3030	301	28	of	of	ADP
admet-3030	301	29	personalized	personalize	VERB
admet-3030	301	30	therapeutic	therapeutic	ADJ
admet-3030	301	31	strategies	strategy	NOUN
admet-3030	301	32	for	for	ADP
admet-3030	301	33	effective	effective	ADJ
admet-3030	301	34	hair	hair	NOUN
admet-3030	301	35	regrowth	regrowth	NOUN
admet-3030	301	36	.	.	PUNCT
admet-3030	302	1	advancements	advancement	NOUN
admet-3030	302	2	in	in	ADP
admet-3030	302	3	genomic	genomic	ADJ
admet-3030	302	4	technologies	technology	NOUN
admet-3030	302	5	,	,	PUNCT
admet-3030	302	6	including	include	VERB
admet-3030	302	7	genome	genome	NOUN
admet-3030	302	8	-	-	PUNCT
admet-3030	302	9	wide	wide	ADJ
admet-3030	302	10	association	association	NOUN
admet-3030	302	11	studies	study	NOUN
admet-3030	302	12	(	(	PUNCT
admet-3030	302	13	gwas	gwas	PROPN
admet-3030	302	14	)	)	PUNCT
admet-3030	302	15	and	and	CCONJ
admet-3030	302	16	nextgeneration	nextgeneration	NOUN
admet-3030	302	17	sequencing	sequence	VERB
admet-3030	302	18	(	(	PUNCT
admet-3030	302	19	ngs	ng	NOUN
admet-3030	302	20	)	)	PUNCT
admet-3030	302	21	,	,	PUNCT
admet-3030	302	22	are	be	AUX
admet-3030	302	23	increasingly	increasingly	ADV
admet-3030	302	24	employed	employ	VERB
admet-3030	302	25	to	to	PART
admet-3030	302	26	identify	identify	VERB
admet-3030	302	27	genetic	genetic	ADJ
admet-3030	302	28	markers	marker	NOUN
admet-3030	302	29	predictive	predictive	ADJ
admet-3030	302	30	of	of	ADP
admet-3030	302	31	early	early	ADJ
admet-3030	302	32	-	-	PUNCT
admet-3030	302	33	onset	onset	NOUN
admet-3030	302	34	alopecia	alopecia	NOUN
admet-3030	302	35	.	.	PUNCT
admet-3030	303	1	moreover	moreover	ADV
admet-3030	303	2	,	,	PUNCT
admet-3030	303	3	elucidation	elucidation	NOUN
admet-3030	303	4	of	of	ADP
admet-3030	303	5	the	the	DET
admet-3030	303	6	intricate	intricate	ADJ
admet-3030	303	7	interplay	interplay	NOUN
admet-3030	303	8	among	among	ADP
admet-3030	303	9	immune	immune	ADJ
admet-3030	303	10	dysfunction	dysfunction	NOUN
admet-3030	303	11	,	,	PUNCT
admet-3030	303	12	oxidative	oxidative	ADJ
admet-3030	303	13	and	and	CCONJ
admet-3030	303	14	psychological	psychological	ADJ
admet-3030	303	15	stress	stress	NOUN
admet-3030	303	16	,	,	PUNCT
admet-3030	303	17	hormonal	hormonal	ADJ
admet-3030	303	18	imbalances	imbalance	NOUN
admet-3030	303	19	,	,	PUNCT
admet-3030	303	20	and	and	CCONJ
admet-3030	303	21	comorbid	comorbid	NOUN
admet-3030	303	22	conditions	condition	NOUN
admet-3030	303	23	provides	provide	VERB
admet-3030	303	24	deeper	deep	ADJ
admet-3030	303	25	insight	insight	NOUN
admet-3030	303	26	into	into	ADP
admet-3030	303	27	disease	disease	NOUN
admet-3030	303	28	pathophysiology	pathophysiology	NOUN
admet-3030	303	29	.	.	PUNCT
admet-3030	304	1	emerging	emerge	VERB
admet-3030	304	2	therapeutic	therapeutic	ADJ
admet-3030	304	3	modalities	modality	NOUN
admet-3030	304	4	,	,	PUNCT
admet-3030	304	5	including	include	VERB
admet-3030	304	6	platelet	platelet	ADJ
admet-3030	304	7	-	-	PUNCT
admet-3030	304	8	rich	rich	ADJ
admet-3030	304	9	plasma	plasma	NOUN
admet-3030	304	10	(	(	PUNCT
admet-3030	304	11	prp	prp	PROPN
admet-3030	304	12	)	)	PUNCT
admet-3030	304	13	,	,	PUNCT
admet-3030	304	14	stem	stem	NOUN
admet-3030	304	15	cell	cell	NOUN
admet-3030	304	16	therapy	therapy	NOUN
admet-3030	304	17	,	,	PUNCT
admet-3030	304	18	exosome	exosome	NOUN
admet-3030	304	19	-	-	PUNCT
admet-3030	304	20	based	base	VERB
admet-3030	304	21	treatments	treatment	NOUN
admet-3030	304	22	,	,	PUNCT
admet-3030	304	23	corticosteroids	corticosteroid	NOUN
admet-3030	304	24	,	,	PUNCT
admet-3030	304	25	and	and	CCONJ
admet-3030	304	26	gene	gene	NOUN
admet-3030	304	27	-	-	PUNCT
admet-3030	304	28	editing	edit	VERB
admet-3030	304	29	technologies	technology	NOUN
admet-3030	304	30	such	such	ADJ
admet-3030	304	31	as	as	ADP
admet-3030	304	32	crispr	crispr	NOUN
admet-3030	304	33	,	,	PUNCT
admet-3030	304	34	show	show	VERB
admet-3030	304	35	promising	promising	ADJ
admet-3030	304	36	results	result	NOUN
admet-3030	304	37	.	.	PUNCT
admet-3030	305	1	integration	integration	NOUN
admet-3030	305	2	of	of	ADP
admet-3030	305	3	artificial	artificial	ADJ
admet-3030	305	4	intelligence	intelligence	NOUN
admet-3030	305	5	and	and	CCONJ
admet-3030	305	6	machine	machine	NOUN
admet-3030	305	7	learning	learning	NOUN
admet-3030	305	8	models	model	NOUN
admet-3030	305	9	holds	hold	VERB
admet-3030	305	10	further	further	ADJ
admet-3030	305	11	potential	potential	NOUN
admet-3030	305	12	for	for	ADP
admet-3030	305	13	improving	improve	VERB
admet-3030	305	14	early	early	ADJ
admet-3030	305	15	diagnosis	diagnosis	NOUN
admet-3030	305	16	and	and	CCONJ
admet-3030	305	17	treatment	treatment	NOUN
admet-3030	305	18	planning	planning	NOUN
admet-3030	305	19	.	.	PUNCT
admet-3030	306	1	however	however	ADV
admet-3030	306	2	,	,	PUNCT
admet-3030	306	3	current	current	ADJ
admet-3030	306	4	therapeutic	therapeutic	ADJ
admet-3030	306	5	approaches	approach	NOUN
admet-3030	306	6	face	face	VERB
admet-3030	306	7	challenges	challenge	NOUN
admet-3030	306	8	related	relate	VERB
admet-3030	306	9	to	to	ADP
admet-3030	306	10	standardization	standardization	NOUN
admet-3030	306	11	,	,	PUNCT
admet-3030	306	12	delivery	delivery	NOUN
admet-3030	306	13	methods	method	NOUN
admet-3030	306	14	,	,	PUNCT
admet-3030	306	15	and	and	CCONJ
admet-3030	306	16	biological	biological	ADJ
admet-3030	306	17	barriers	barrier	NOUN
admet-3030	306	18	.	.	PUNCT
admet-3030	307	1	future	future	ADJ
admet-3030	307	2	research	research	NOUN
admet-3030	307	3	should	should	AUX
admet-3030	307	4	focus	focus	VERB
admet-3030	307	5	on	on	ADP
admet-3030	307	6	overcoming	overcome	VERB
admet-3030	307	7	these	these	DET
admet-3030	307	8	limitations	limitation	NOUN
admet-3030	307	9	through	through	ADP
admet-3030	307	10	the	the	DET
admet-3030	307	11	optimization	optimization	NOUN
admet-3030	307	12	of	of	ADP
admet-3030	307	13	combination	combination	NOUN
admet-3030	307	14	therapies	therapy	NOUN
admet-3030	307	15	and	and	CCONJ
admet-3030	307	16	multimodal	multimodal	NOUN
admet-3030	307	17	approaches	approach	NOUN
admet-3030	307	18	to	to	PART
admet-3030	307	19	enhance	enhance	VERB
admet-3030	307	20	clinical	clinical	ADJ
admet-3030	307	21	outcomes	outcome	NOUN
admet-3030	307	22	and	and	CCONJ
admet-3030	307	23	ensure	ensure	VERB
admet-3030	307	24	long	long	ADJ
admet-3030	307	25	-	-	PUNCT
admet-3030	307	26	term	term	NOUN
admet-3030	307	27	remission	remission	NOUN
admet-3030	307	28	in	in	ADP
admet-3030	307	29	patients	patient	NOUN
admet-3030	307	30	with	with	ADP
admet-3030	307	31	non	non	ADJ
admet-3030	307	32	-	-	ADJ
admet-3030	307	33	scarring	scarring	ADJ
admet-3030	307	34	alopecia	alopecia	NOUN
admet-3030	307	35	.	.	PUNCT
admet-3030	308	1	by	by	ADP
admet-3030	308	2	2050	2050	NUM
admet-3030	308	3	,	,	PUNCT
admet-3030	308	4	due	due	ADP
admet-3030	308	5	to	to	ADP
admet-3030	308	6	rapid	rapid	ADJ
admet-3030	308	7	advances	advance	NOUN
admet-3030	308	8	in	in	ADP
admet-3030	308	9	technology	technology	NOUN
admet-3030	308	10	integration	integration	NOUN
admet-3030	308	11	,	,	PUNCT
admet-3030	308	12	trichology	trichology	NOUN
admet-3030	308	13	may	may	AUX
admet-3030	308	14	revolutionize	revolutionize	VERB
admet-3030	308	15	treatments	treatment	NOUN
admet-3030	308	16	through	through	ADP
admet-3030	308	17	precision	precision	NOUN
admet-3030	308	18	medicine	medicine	NOUN
admet-3030	308	19	,	,	PUNCT
admet-3030	308	20	in	in	ADP
admet-3030	308	21	which	which	PRON
admet-3030	308	22	therapies	therapy	NOUN
admet-3030	308	23	will	will	AUX
admet-3030	308	24	be	be	AUX
admet-3030	308	25	tailored	tailor	VERB
admet-3030	308	26	to	to	ADP
admet-3030	308	27	each	each	DET
admet-3030	308	28	individual	individual	NOUN
admet-3030	308	29	’s	’s	PART
admet-3030	308	30	genetic	genetic	ADJ
admet-3030	308	31	profile	profile	NOUN
admet-3030	308	32	.	.	PUNCT
admet-3030	309	1	patients	patient	NOUN
admet-3030	309	2	diagnosed	diagnose	VERB
admet-3030	309	3	with	with	ADP
admet-3030	309	4	ar	ar	NOUN
admet-3030	309	5	/	/	SYM
admet-3030	309	6	srd5a2	srd5a2	NOUN
admet-3030	309	7	variants	variant	NOUN
admet-3030	309	8	will	will	AUX
admet-3030	309	9	receive	receive	VERB
admet-3030	309	10	treatments	treatment	NOUN
admet-3030	309	11	targeting	target	VERB
admet-3030	309	12	androgen	androgen	NOUN
admet-3030	309	13	receptors	receptor	NOUN
admet-3030	309	14	,	,	PUNCT
admet-3030	309	15	while	while	SCONJ
admet-3030	309	16	those	those	PRON
admet-3030	309	17	with	with	ADP
admet-3030	309	18	mutations	mutation	NOUN
admet-3030	309	19	in	in	ADP
admet-3030	309	20	the	the	DET
admet-3030	309	21	wnt	wnt	PROPN
admet-3030	309	22	pathway	pathway	NOUN
admet-3030	309	23	may	may	AUX
admet-3030	309	24	benefit	benefit	VERB
admet-3030	309	25	from	from	ADP
admet-3030	309	26	dkk-1	dkk-1	NOUN
admet-3030	309	27	inhibitors	inhibitor	NOUN
admet-3030	309	28	or	or	CCONJ
admet-3030	309	29	wnt	wnt	NOUN
admet-3030	309	30	activators	activator	NOUN
admet-3030	309	31	.	.	PUNCT
admet-3030	310	1	similarly	similarly	ADV
admet-3030	310	2	,	,	PUNCT
admet-3030	310	3	individuals	individual	NOUN
admet-3030	310	4	diagnosed	diagnose	VERB
admet-3030	310	5	with	with	ADP
admet-3030	310	6	aga	aga	NOUN
admet-3030	310	7	due	due	ADP
admet-3030	310	8	to	to	ADP
admet-3030	310	9	other	other	ADJ
admet-3030	310	10	pathways	pathway	NOUN
admet-3030	310	11	,	,	PUNCT
admet-3030	310	12	metabolic	metabolic	NOUN
admet-3030	310	13	factors	factor	NOUN
admet-3030	310	14	,	,	PUNCT
admet-3030	310	15	or	or	CCONJ
admet-3030	310	16	microbiome	microbiome	NOUN
admet-3030	310	17	alterations	alteration	NOUN
admet-3030	310	18	will	will	AUX
admet-3030	310	19	receive	receive	VERB
admet-3030	310	20	tailored	tailor	VERB
admet-3030	310	21	targeted	target	VERB
admet-3030	310	22	therapies	therapy	NOUN
admet-3030	310	23	.	.	PUNCT
admet-3030	311	1	technologies	technology	NOUN
admet-3030	311	2	such	such	ADJ
admet-3030	311	3	as	as	ADP
admet-3030	311	4	ngs	ng	NOUN
admet-3030	311	5	,	,	PUNCT
admet-3030	311	6	polygenic	polygenic	ADJ
admet-3030	311	7	scoring	scoring	NOUN
admet-3030	311	8	,	,	PUNCT
admet-3030	311	9	and	and	CCONJ
admet-3030	311	10	ai	ai	ADJ
admet-3030	311	11	-	-	PUNCT
admet-3030	311	12	based	base	VERB
admet-3030	311	13	tools	tool	NOUN
admet-3030	311	14	will	will	AUX
admet-3030	311	15	help	help	VERB
admet-3030	311	16	clinicians	clinician	NOUN
admet-3030	311	17	create	create	VERB
admet-3030	311	18	digital	digital	ADJ
admet-3030	311	19	twins	twin	NOUN
admet-3030	311	20	of	of	ADP
admet-3030	311	21	patients	patient	NOUN
admet-3030	311	22	,	,	PUNCT
admet-3030	311	23	enabling	enable	VERB
admet-3030	311	24	simulation	simulation	NOUN
admet-3030	311	25	of	of	ADP
admet-3030	311	26	treatments	treatment	NOUN
admet-3030	311	27	before	before	ADP
admet-3030	311	28	actual	actual	ADJ
admet-3030	311	29	therapy	therapy	NOUN
admet-3030	311	30	.	.	PUNCT
admet-3030	312	1	the	the	DET
admet-3030	312	2	future	future	NOUN
admet-3030	312	3	of	of	ADP
admet-3030	312	4	trichology	trichology	NOUN
admet-3030	312	5	will	will	AUX
admet-3030	312	6	focus	focus	VERB
admet-3030	312	7	on	on	ADP
admet-3030	312	8	translating	translate	VERB
admet-3030	312	9	genetics	genetic	NOUN
admet-3030	312	10	at	at	ADP
admet-3030	312	11	the	the	DET
admet-3030	312	12	molecular	molecular	ADJ
admet-3030	312	13	level	level	NOUN
admet-3030	312	14	into	into	ADP
admet-3030	312	15	individualized	individualized	ADJ
admet-3030	312	16	therapies	therapy	NOUN
admet-3030	312	17	,	,	PUNCT
admet-3030	312	18	ensuring	ensure	VERB
admet-3030	312	19	lifelong	lifelong	ADJ
admet-3030	312	20	follicular	follicular	ADJ
admet-3030	312	21	resilience	resilience	NOUN
admet-3030	312	22	and	and	CCONJ
admet-3030	312	23	reshaping	reshape	VERB
admet-3030	312	24	the	the	DET
admet-3030	312	25	field	field	NOUN
admet-3030	312	26	of	of	ADP
admet-3030	312	27	hair	hair	NOUN
admet-3030	312	28	care	care	NOUN
admet-3030	312	29	treatment	treatment	NOUN
admet-3030	312	30	.	.	PUNCT
admet-3030	313	1	admet	admet	PROPN
admet-3030	313	2	&	&	CCONJ
admet-3030	313	3	dmpk	dmpk	PROPN
admet-3030	313	4	00(0	00(0	PROPN
admet-3030	313	5	)	)	PUNCT
admet-3030	313	6	(	(	PUNCT
admet-3030	313	7	2025	2025	NUM
admet-3030	313	8	)	)	PUNCT
admet-3030	313	9	3030	3030	NUM
admet-3030	313	10	precision	precision	NOUN
admet-3030	313	11	therapeutics	therapeutic	NOUN
admet-3030	313	12	in	in	ADP
admet-3030	313	13	non	non	ADJ
admet-3030	313	14	-	-	ADJ
admet-3030	313	15	scarring	scar	VERB
admet-3030	313	16	alopecia	alopecia	NOUN
admet-3030	313	17	doi	doi	NOUN
admet-3030	313	18	:	:	PUNCT
admet-3030	313	19	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	313	20	15	15	NUM
admet-3030	313	21	funding	funding	NOUN
admet-3030	313	22	:	:	PUNCT
admet-3030	313	23	this	this	DET
admet-3030	313	24	research	research	NOUN
admet-3030	313	25	did	do	AUX
admet-3030	313	26	not	not	PART
admet-3030	313	27	receive	receive	VERB
admet-3030	313	28	any	any	DET
admet-3030	313	29	specific	specific	ADJ
admet-3030	313	30	grant	grant	NOUN
admet-3030	313	31	from	from	ADP
admet-3030	313	32	funding	fund	VERB
admet-3030	313	33	agencies	agency	NOUN
admet-3030	313	34	in	in	ADP
admet-3030	313	35	the	the	DET
admet-3030	313	36	public	public	ADJ
admet-3030	313	37	,	,	PUNCT
admet-3030	313	38	commercial	commercial	ADJ
admet-3030	313	39	,	,	PUNCT
admet-3030	313	40	or	or	CCONJ
admet-3030	313	41	not	not	PART
admet-3030	313	42	-	-	PUNCT
admet-3030	313	43	for	for	ADP
admet-3030	313	44	-	-	PUNCT
admet-3030	313	45	profit	profit	NOUN
admet-3030	313	46	sectors	sector	NOUN
admet-3030	313	47	.	.	PUNCT
admet-3030	314	1	acknowledgements	acknowledgement	NOUN
admet-3030	314	2	:	:	PUNCT
admet-3030	314	3	the	the	DET
admet-3030	314	4	authors	author	NOUN
admet-3030	314	5	are	be	AUX
admet-3030	314	6	thankful	thankful	ADJ
admet-3030	314	7	to	to	ADP
admet-3030	314	8	esthetic	esthetic	ADJ
admet-3030	314	9	creations	creation	NOUN
admet-3030	314	10	international	international	PROPN
admet-3030	314	11	pvt	pvt	PROPN
admet-3030	314	12	ltd	ltd	PROPN
admet-3030	314	13	for	for	ADP
admet-3030	314	14	providing	provide	VERB
admet-3030	314	15	the	the	DET
admet-3030	314	16	necessary	necessary	ADJ
admet-3030	314	17	documentation	documentation	NOUN
admet-3030	314	18	.	.	PUNCT
admet-3030	315	1	conflict	conflict	NOUN
admet-3030	315	2	of	of	ADP
admet-3030	315	3	interest	interest	NOUN
admet-3030	315	4	:	:	PUNCT
admet-3030	315	5	r.	r.	PROPN
admet-3030	315	6	k.	k.	PROPN
admet-3030	315	7	,	,	PUNCT
admet-3030	315	8	d.	d.	PROPN
admet-3030	315	9	b.	b.	PROPN
admet-3030	315	10	,	,	PUNCT
admet-3030	315	11	d.	d.	PROPN
admet-3030	315	12	bo	bo	PROPN
admet-3030	315	13	.	.	PROPN
admet-3030	315	14	,	,	PUNCT
admet-3030	315	15	r.	r.	PROPN
admet-3030	315	16	p.	p.	PROPN
admet-3030	315	17	,	,	PUNCT
admet-3030	315	18	m.	m.	PROPN
admet-3030	315	19	p.	p.	PROPN
admet-3030	315	20	,	,	PUNCT
admet-3030	315	21	p.	p.	PROPN
admet-3030	315	22	s.	s.	PROPN
admet-3030	315	23	,	,	PUNCT
admet-3030	315	24	m.	m.	NOUN
admet-3030	315	25	m	m	PROPN
admet-3030	315	26	and	and	CCONJ
admet-3030	315	27	d.	d.	PROPN
admet-3030	315	28	s	s	PRON
admet-3030	315	29	are	be	AUX
admet-3030	315	30	affiliated	affiliate	VERB
admet-3030	315	31	with	with	ADP
admet-3030	315	32	institutions	institution	NOUN
admet-3030	315	33	actively	actively	ADV
admet-3030	315	34	engaged	engage	VERB
admet-3030	315	35	in	in	ADP
admet-3030	315	36	research	research	NOUN
admet-3030	315	37	and	and	CCONJ
admet-3030	315	38	innovation	innovation	NOUN
admet-3030	315	39	in	in	ADP
admet-3030	315	40	hair	hair	NOUN
admet-3030	315	41	restoration	restoration	NOUN
admet-3030	315	42	therapies	therapy	NOUN
admet-3030	315	43	,	,	PUNCT
admet-3030	315	44	including	include	VERB
admet-3030	315	45	qr678	qr678	PROPN
admet-3030	315	46	neo	neo	NOUN
admet-3030	315	47	®	®	NOUN
admet-3030	315	48	.	.	PUNCT
admet-3030	316	1	these	these	DET
admet-3030	316	2	professional	professional	ADJ
admet-3030	316	3	associations	association	NOUN
admet-3030	316	4	are	be	AUX
admet-3030	316	5	disclosed	disclose	VERB
admet-3030	316	6	in	in	ADP
admet-3030	316	7	the	the	DET
admet-3030	316	8	interest	interest	NOUN
admet-3030	316	9	of	of	ADP
admet-3030	316	10	transparency	transparency	NOUN
admet-3030	316	11	.	.	PUNCT
admet-3030	317	1	no	no	DET
admet-3030	317	2	external	external	ADJ
admet-3030	317	3	funding	funding	NOUN
admet-3030	317	4	influenced	influence	VERB
admet-3030	317	5	the	the	DET
admet-3030	317	6	preparation	preparation	NOUN
admet-3030	317	7	of	of	ADP
admet-3030	317	8	this	this	DET
admet-3030	317	9	review	review	NOUN
admet-3030	317	10	.	.	PUNCT
admet-3030	318	1	consent	consent	NOUN
admet-3030	318	2	to	to	PART
admet-3030	318	3	publish	publish	VERB
admet-3030	318	4	:	:	PUNCT
admet-3030	318	5	the	the	DET
admet-3030	318	6	authors	author	NOUN
admet-3030	318	7	confirm	confirm	VERB
admet-3030	318	8	that	that	SCONJ
admet-3030	318	9	this	this	DET
admet-3030	318	10	paper	paper	NOUN
admet-3030	318	11	does	do	AUX
admet-3030	318	12	not	not	PART
admet-3030	318	13	include	include	VERB
admet-3030	318	14	any	any	DET
admet-3030	318	15	data	datum	NOUN
admet-3030	318	16	that	that	PRON
admet-3030	318	17	would	would	AUX
admet-3030	318	18	require	require	VERB
admet-3030	318	19	obtaining	obtain	VERB
admet-3030	318	20	publication	publication	NOUN
admet-3030	318	21	consent	consent	NOUN
admet-3030	318	22	from	from	ADP
admet-3030	318	23	any	any	DET
admet-3030	318	24	individuals	individual	NOUN
admet-3030	318	25	.	.	PUNCT
admet-3030	319	1	references	reference	NOUN
admet-3030	319	2	[	[	X
admet-3030	319	3	1	1	NUM
admet-3030	319	4	]	]	PUNCT
admet-3030	319	5	l.	l.	PROPN
admet-3030	319	6	alhanshali	alhanshali	PROPN
admet-3030	319	7	,	,	PUNCT
admet-3030	319	8	m.g	m.g	PROPN
admet-3030	319	9	.	.	PROPN
admet-3030	319	10	buontempo	buontempo	PROPN
admet-3030	319	11	,	,	PUNCT
admet-3030	319	12	k.i	k.i	PROPN
admet-3030	319	13	.	.	PUNCT
admet-3030	320	1	lo	lo	PROPN
admet-3030	320	2	sicco	sicco	PROPN
admet-3030	320	3	,	,	PUNCT
admet-3030	320	4	j.	j.	PROPN
admet-3030	320	5	shapiro	shapiro	PROPN
admet-3030	320	6	.	.	PUNCT
admet-3030	321	1	alopecia	alopecia	NOUN
admet-3030	321	2	areata	areata	NOUN
admet-3030	321	3	:	:	PUNCT
admet-3030	321	4	burden	burden	NOUN
admet-3030	321	5	of	of	ADP
admet-3030	321	6	disease	disease	NOUN
admet-3030	321	7	,	,	PUNCT
admet-3030	321	8	approach	approach	NOUN
admet-3030	321	9	to	to	ADP
admet-3030	321	10	treatment	treatment	NOUN
admet-3030	321	11	,	,	PUNCT
admet-3030	321	12	and	and	CCONJ
admet-3030	321	13	current	current	ADJ
admet-3030	321	14	unmet	unmet	NOUN
admet-3030	321	15	needs	need	NOUN
admet-3030	321	16	.	.	PUNCT
admet-3030	322	1	clinical	clinical	ADJ
admet-3030	322	2	,	,	PUNCT
admet-3030	322	3	cosmetic	cosmetic	ADJ
admet-3030	322	4	and	and	CCONJ
admet-3030	322	5	investigational	investigational	ADJ
admet-3030	322	6	dermatology	dermatology	NOUN
admet-3030	322	7	16	16	NUM
admet-3030	322	8	(	(	PUNCT
admet-3030	322	9	2023	2023	NUM
admet-3030	322	10	)	)	PUNCT
admet-3030	322	11	803	803	NUM
admet-3030	322	12	-	-	SYM
admet-3030	322	13	820	820	NUM
admet-3030	322	14	.	.	PUNCT
admet-3030	323	1	https://dx.doi.org/10.2147/ccid.s376096	https://dx.doi.org/10.2147/ccid.s376096	NOUN
admet-3030	324	1	[	[	X
admet-3030	324	2	2	2	NUM
admet-3030	324	3	]	]	X
admet-3030	324	4	t.c	t.c	PROPN
admet-3030	324	5	.	.	PROPN
admet-3030	324	6	anudeep	anudeep	PROPN
admet-3030	324	7	,	,	PUNCT
admet-3030	324	8	m.	m.	NOUN
admet-3030	324	9	jeyaraman	jeyaraman	PROPN
admet-3030	324	10	,	,	PUNCT
admet-3030	324	11	s.	s.	PROPN
admet-3030	324	12	muthu	muthu	PROPN
admet-3030	324	13	,	,	PUNCT
admet-3030	324	14	r.l	r.l	PROPN
admet-3030	324	15	.	.	PROPN
admet-3030	324	16	rajendran	rajendran	PROPN
admet-3030	324	17	,	,	PUNCT
admet-3030	324	18	p.	p.	NOUN
admet-3030	324	19	gangadaran	gangadaran	NOUN
admet-3030	324	20	,	,	PUNCT
admet-3030	324	21	p.c	p.c	PROPN
admet-3030	324	22	.	.	PROPN
admet-3030	324	23	mishra	mishra	PROPN
admet-3030	324	24	,	,	PUNCT
admet-3030	324	25	s.	s.	PROPN
admet-3030	324	26	sharma	sharma	PROPN
admet-3030	324	27	,	,	PUNCT
admet-3030	324	28	s.k	s.k	PROPN
admet-3030	324	29	.	.	PROPN
admet-3030	324	30	jha	jha	PROPN
admet-3030	324	31	,	,	PUNCT
admet-3030	324	32	b.c	b.c	PROPN
admet-3030	324	33	.	.	PROPN
admet-3030	324	34	ahn	ahn	PROPN
admet-3030	324	35	.	.	PUNCT
admet-3030	324	36	advancing	advance	VERB
admet-3030	324	37	regenerative	regenerative	ADJ
admet-3030	324	38	cellular	cellular	ADJ
admet-3030	324	39	therapies	therapy	NOUN
admet-3030	324	40	in	in	ADP
admet-3030	324	41	non	non	ADJ
admet-3030	324	42	-	-	ADJ
admet-3030	324	43	scarring	scar	VERB
admet-3030	324	44	alopecia	alopecia	NOUN
admet-3030	324	45	.	.	PUNCT
admet-3030	325	1	pharmaceutics	pharmaceutic	NOUN
admet-3030	325	2	14	14	NUM
admet-3030	325	3	(	(	PUNCT
admet-3030	325	4	2022	2022	NUM
admet-3030	325	5	)	)	PUNCT
admet-3030	325	6	612	612	NUM
admet-3030	325	7	.	.	PUNCT
admet-3030	326	1	https://dx.doi.org/10.3390/pharmaceutics14030612	https://dx.doi.org/10.3390/pharmaceutics14030612	PROPN
admet-3030	327	1	[	[	X
admet-3030	327	2	3	3	NUM
admet-3030	327	3	]	]	PUNCT
admet-3030	327	4	a.	a.	NOUN
admet-3030	327	5	martinez	martinez	PROPN
admet-3030	327	6	-	-	PUNCT
admet-3030	327	7	lopez	lopez	NOUN
admet-3030	327	8	,	,	PUNCT
admet-3030	327	9	t.	t.	PROPN
admet-3030	327	10	montero	montero	PROPN
admet-3030	327	11	-	-	PUNCT
admet-3030	327	12	vilchez	vilchez	PROPN
admet-3030	327	13	,	,	PUNCT
admet-3030	327	14	á	á	PROPN
admet-3030	327	15	.	.	PUNCT
admet-3030	327	16	sierra	sierra	PROPN
admet-3030	327	17	-	-	PUNCT
admet-3030	327	18	sánchez	sánchez	PROPN
admet-3030	327	19	,	,	PUNCT
admet-3030	327	20	a.	a.	PROPN
admet-3030	327	21	molina	molina	PROPN
admet-3030	327	22	-	-	PUNCT
admet-3030	327	23	leyva	leyva	PROPN
admet-3030	327	24	,	,	PUNCT
admet-3030	327	25	s.	s.	PROPN
admet-3030	327	26	arias	arias	PROPN
admet-3030	327	27	-	-	PUNCT
admet-3030	327	28	santiago	santiago	PROPN
admet-3030	327	29	.	.	PUNCT
admet-3030	328	1	advanced	advanced	ADJ
admet-3030	328	2	medical	medical	ADJ
admet-3030	328	3	therapies	therapy	NOUN
admet-3030	328	4	in	in	ADP
admet-3030	328	5	the	the	DET
admet-3030	328	6	management	management	NOUN
admet-3030	328	7	of	of	ADP
admet-3030	328	8	non	non	ADJ
admet-3030	328	9	-	-	ADJ
admet-3030	328	10	scarring	scarring	ADJ
admet-3030	328	11	alopecia	alopecia	NOUN
admet-3030	328	12	:	:	PUNCT
admet-3030	328	13	areata	areata	ADJ
admet-3030	328	14	and	and	CCONJ
admet-3030	328	15	androgenic	androgenic	ADJ
admet-3030	328	16	alopecia	alopecia	NOUN
admet-3030	328	17	.	.	PUNCT
admet-3030	329	1	international	international	ADJ
admet-3030	329	2	journal	journal	NOUN
admet-3030	329	3	of	of	ADP
admet-3030	329	4	molecular	molecular	ADJ
admet-3030	329	5	sciences	science	NOUN
admet-3030	329	6	21	21	NUM
admet-3030	329	7	(	(	PUNCT
admet-3030	329	8	2020	2020	NUM
admet-3030	329	9	)	)	PUNCT
admet-3030	329	10	8390	8390	NUM
admet-3030	329	11	.	.	PUNCT
admet-3030	330	1	https://dx.doi.org/10.3390/ijms21218390	https://dx.doi.org/10.3390/ijms21218390	PROPN
admet-3030	331	1	[	[	X
admet-3030	331	2	4	4	X
admet-3030	331	3	]	]	X
admet-3030	331	4	y.	y.	PROPN
admet-3030	331	5	ibrahim	ibrahim	PROPN
admet-3030	331	6	,	,	PUNCT
admet-3030	331	7	a.	a.	PROPN
admet-3030	331	8	hamed	hamed	PROPN
admet-3030	331	9	,	,	PUNCT
admet-3030	331	10	a.	a.	PROPN
admet-3030	331	11	saeed	saeed	PROPN
admet-3030	331	12	,	,	PUNCT
admet-3030	331	13	g.	g.	PROPN
admet-3030	331	14	khalik	khalik	PROPN
admet-3030	331	15	,	,	PUNCT
admet-3030	331	16	e.	e.	PROPN
admet-3030	331	17	behiry	behiry	PROPN
admet-3030	331	18	.	.	PUNCT
admet-3030	332	1	evaluation	evaluation	NOUN
admet-3030	332	2	of	of	ADP
admet-3030	332	3	oxidative	oxidative	ADJ
admet-3030	332	4	stress	stress	NOUN
admet-3030	332	5	markers	marker	NOUN
admet-3030	332	6	in	in	ADP
admet-3030	332	7	androgenetic	androgenetic	ADJ
admet-3030	332	8	alopecia	alopecia	NOUN
admet-3030	332	9	patients	patient	NOUN
admet-3030	332	10	.	.	PUNCT
admet-3030	333	1	benha	benha	NOUN
admet-3030	333	2	journal	journal	PROPN
admet-3030	333	3	of	of	ADP
admet-3030	333	4	applied	apply	VERB
admet-3030	333	5	sciences	science	NOUN
admet-3030	333	6	8	8	NUM
admet-3030	333	7	(	(	PUNCT
admet-3030	333	8	2023	2023	NUM
admet-3030	333	9	)	)	PUNCT
admet-3030	333	10	105	105	NUM
admet-3030	333	11	-	-	SYM
admet-3030	333	12	110	110	NUM
admet-3030	333	13	.	.	PUNCT
admet-3030	334	1	https://dx.doi.org/10.21608/bjas.2024.261687.1307	https://dx.doi.org/10.21608/bjas.2024.261687.1307	PROPN
admet-3030	335	1	[	[	X
admet-3030	335	2	5	5	NUM
admet-3030	335	3	]	]	PUNCT
admet-3030	335	4	a.	a.	NOUN
admet-3030	335	5	kakunje	kakunje	PROPN
admet-3030	335	6	,	,	PUNCT
admet-3030	335	7	a.	a.	NOUN
admet-3030	335	8	prabhu	prabhu	PROPN
admet-3030	335	9	,	,	PUNCT
admet-3030	335	10	r.	r.	PROPN
admet-3030	335	11	pookoth	pookoth	PROPN
admet-3030	335	12	,	,	PUNCT
admet-3030	335	13	s.	s.	PROPN
admet-3030	335	14	e	e	PROPN
admet-3030	335	15	s	s	PROPN
admet-3030	335	16	,	,	PUNCT
admet-3030	335	17	r.	r.	PROPN
admet-3030	335	18	karkal	karkal	PROPN
admet-3030	335	19	,	,	PUNCT
admet-3030	335	20	p.	p.	PROPN
admet-3030	335	21	kumar	kumar	PROPN
admet-3030	335	22	,	,	PUNCT
admet-3030	335	23	n.	n.	PROPN
admet-3030	335	24	gupta	gupta	PROPN
admet-3030	335	25	.	.	PUNCT
admet-3030	336	1	a	a	DET
admet-3030	336	2	perspective	perspective	NOUN
admet-3030	336	3	on	on	ADP
admet-3030	336	4	predictive	predictive	ADJ
admet-3030	336	5	markers	marker	NOUN
admet-3030	336	6	of	of	ADP
admet-3030	336	7	alopecia	alopecia	NOUN
admet-3030	336	8	.	.	PUNCT
admet-3030	337	1	archives	archive	NOUN
admet-3030	337	2	of	of	ADP
admet-3030	337	3	medicine	medicine	NOUN
admet-3030	337	4	and	and	CCONJ
admet-3030	337	5	health	health	NOUN
admet-3030	337	6	sciences	science	NOUN
admet-3030	337	7	8	8	NUM
admet-3030	337	8	(	(	PUNCT
admet-3030	337	9	2020	2020	NUM
admet-3030	337	10	)	)	PUNCT
admet-3030	337	11	263	263	NUM
admet-3030	337	12	.	.	PUNCT
admet-3030	338	1	https://dx.doi.org/10.4103/amhs.amhs_228_20	https://dx.doi.org/10.4103/amhs.amhs_228_20	NUM
admet-3030	339	1	[	[	X
admet-3030	339	2	6	6	NUM
admet-3030	339	3	]	]	PUNCT
admet-3030	339	4	m.	m.	NOUN
admet-3030	339	5	van	van	PROPN
admet-3030	339	6	dalen	dalen	PROPN
admet-3030	339	7	,	,	PUNCT
admet-3030	339	8	k.s	k.s	PROPN
admet-3030	339	9	.	.	PROPN
admet-3030	339	10	muller	muller	PROPN
admet-3030	339	11	,	,	PUNCT
admet-3030	339	12	j.m	j.m	PROPN
admet-3030	339	13	.	.	PROPN
admet-3030	339	14	kasperkovitz	kasperkovitz	NOUN
admet-3030	339	15	-	-	PUNCT
admet-3030	339	16	oosterloo	oosterloo	ADJ
admet-3030	339	17	,	,	PUNCT
admet-3030	339	18	j.m.e	j.m.e	NOUN
admet-3030	339	19	.	.	PUNCT
admet-3030	339	20	okkerse	okkerse	PROPN
admet-3030	339	21	,	,	PUNCT
admet-3030	339	22	s.	s.	PROPN
admet-3030	339	23	pasmans	pasmans	PROPN
admet-3030	339	24	.	.	PUNCT
admet-3030	340	1	anxiety	anxiety	NOUN
admet-3030	340	2	,	,	PUNCT
admet-3030	340	3	depression	depression	NOUN
admet-3030	340	4	,	,	PUNCT
admet-3030	340	5	and	and	CCONJ
admet-3030	340	6	quality	quality	NOUN
admet-3030	340	7	of	of	ADP
admet-3030	340	8	life	life	NOUN
admet-3030	340	9	in	in	ADP
admet-3030	340	10	children	child	NOUN
admet-3030	340	11	and	and	CCONJ
admet-3030	340	12	adults	adult	NOUN
admet-3030	340	13	with	with	ADP
admet-3030	340	14	alopecia	alopecia	NOUN
admet-3030	340	15	areata	areata	NOUN
admet-3030	340	16	:	:	PUNCT
admet-3030	340	17	a	a	DET
admet-3030	340	18	systematic	systematic	ADJ
admet-3030	340	19	review	review	NOUN
admet-3030	340	20	and	and	CCONJ
admet-3030	340	21	meta	meta	ADJ
admet-3030	340	22	-	-	PUNCT
admet-3030	340	23	analysis	analysis	NOUN
admet-3030	340	24	.	.	PUNCT
admet-3030	341	1	frontiers	frontier	NOUN
admet-3030	341	2	in	in	ADP
admet-3030	341	3	medicine	medicine	NOUN
admet-3030	341	4	(	(	PUNCT
admet-3030	341	5	lausanne	lausanne	PROPN
admet-3030	341	6	)	)	PUNCT
admet-3030	341	7	9	9	NUM
admet-3030	341	8	(	(	PUNCT
admet-3030	341	9	2022	2022	NUM
admet-3030	341	10	)	)	PUNCT
admet-3030	341	11	1054898	1054898	NUM
admet-3030	341	12	.	.	PUNCT
admet-3030	342	1	https://dx.doi.org/10.3389/fmed.2022.1054898	https://dx.doi.org/10.3389/fmed.2022.1054898	VERB
admet-3030	343	1	[	[	X
admet-3030	343	2	7	7	X
admet-3030	343	3	]	]	X
admet-3030	343	4	i.	i.	NOUN
admet-3030	343	5	šutić	šutić	PROPN
admet-3030	343	6	udović	udović	ADV
admet-3030	343	7	,	,	PUNCT
admet-3030	343	8	n.	n.	PROPN
admet-3030	343	9	hlača	hlača	PROPN
admet-3030	343	10	,	,	PUNCT
admet-3030	343	11	l.p	l.p	PROPN
admet-3030	343	12	.	.	PROPN
admet-3030	343	13	massari	massari	PROPN
admet-3030	343	14	,	,	PUNCT
admet-3030	343	15	i.	i.	PROPN
admet-3030	343	16	brajac	brajac	PROPN
admet-3030	343	17	,	,	PUNCT
admet-3030	343	18	m.	m.	PROPN
admet-3030	343	19	kaštelan	kaštelan	PROPN
admet-3030	343	20	,	,	PUNCT
admet-3030	343	21	m.	m.	NOUN
admet-3030	343	22	vičić	vičić	NOUN
admet-3030	343	23	.	.	PUNCT
admet-3030	344	1	deciphering	decipher	VERB
admet-3030	344	2	the	the	DET
admet-3030	344	3	complex	complex	ADJ
admet-3030	344	4	immunopathogenesis	immunopathogenesis	NOUN
admet-3030	344	5	of	of	ADP
admet-3030	344	6	alopecia	alopecia	NOUN
admet-3030	344	7	areata	areata	ADJ
admet-3030	344	8	.	.	PUNCT
admet-3030	345	1	international	international	ADJ
admet-3030	345	2	journal	journal	NOUN
admet-3030	345	3	of	of	ADP
admet-3030	345	4	molecular	molecular	ADJ
admet-3030	345	5	sciences	science	NOUN
admet-3030	345	6	25	25	NUM
admet-3030	345	7	(	(	PUNCT
admet-3030	345	8	2024	2024	NUM
admet-3030	345	9	)	)	PUNCT
admet-3030	345	10	5652	5652	NUM
admet-3030	345	11	.	.	PUNCT
admet-3030	346	1	https://dx.doi.org/10.3390/ijms25115652	https://dx.doi.org/10.3390/ijms25115652	PROPN
admet-3030	347	1	[	[	X
admet-3030	347	2	8	8	NUM
admet-3030	347	3	]	]	PUNCT
admet-3030	347	4	x.	x.	NOUN
admet-3030	347	5	luo	luo	PROPN
admet-3030	347	6	,	,	PUNCT
admet-3030	347	7	x.	x.	PROPN
admet-3030	347	8	ni	ni	PROPN
admet-3030	347	9	,	,	PUNCT
admet-3030	347	10	j.	j.	PROPN
admet-3030	347	11	zhi	zhi	PROPN
admet-3030	347	12	,	,	PUNCT
admet-3030	347	13	x.	x.	PROPN
admet-3030	347	14	jiang	jiang	PROPN
admet-3030	347	15	,	,	PUNCT
admet-3030	347	16	r.	r.	PROPN
admet-3030	347	17	bai	bai	PROPN
admet-3030	347	18	.	.	PUNCT
admet-3030	348	1	small	small	ADJ
admet-3030	348	2	molecule	molecule	NOUN
admet-3030	348	3	agents	agent	NOUN
admet-3030	348	4	against	against	ADP
admet-3030	348	5	alopecia	alopecia	NOUN
admet-3030	348	6	:	:	PUNCT
admet-3030	348	7	potential	potential	ADJ
admet-3030	348	8	targets	target	NOUN
admet-3030	348	9	and	and	CCONJ
admet-3030	348	10	related	related	ADJ
admet-3030	348	11	pathways	pathway	NOUN
admet-3030	348	12	.	.	PUNCT
admet-3030	349	1	european	european	ADJ
admet-3030	349	2	journal	journal	PROPN
admet-3030	349	3	of	of	ADP
admet-3030	349	4	medicinal	medicinal	ADJ
admet-3030	349	5	chemistry	chemistry	NOUN
admet-3030	349	6	276	276	NUM
admet-3030	349	7	(	(	PUNCT
admet-3030	349	8	2024	2024	NUM
admet-3030	349	9	)	)	PUNCT
admet-3030	349	10	116666	116666	NUM
admet-3030	349	11	.	.	PUNCT
admet-3030	350	1	https://dx.doi.org/10.1016/j.ejmech.2024.116666	https://dx.doi.org/10.1016/j.ejmech.2024.116666	PROPN
admet-3030	351	1	[	[	X
admet-3030	351	2	9	9	NUM
admet-3030	351	3	]	]	X
admet-3030	351	4	r.s	r.s	PROPN
admet-3030	351	5	.	.	PROPN
admet-3030	351	6	ho	ho	PROPN
admet-3030	351	7	.	.	PUNCT
admet-3030	352	1	ongoing	ongoing	ADJ
admet-3030	352	2	concerns	concern	NOUN
admet-3030	352	3	regarding	regard	VERB
admet-3030	352	4	finasteride	finasteride	NOUN
admet-3030	352	5	for	for	ADP
admet-3030	352	6	the	the	DET
admet-3030	352	7	treatment	treatment	NOUN
admet-3030	352	8	of	of	ADP
admet-3030	352	9	male	male	NOUN
admet-3030	352	10	-	-	PUNCT
admet-3030	352	11	pattern	pattern	NOUN
admet-3030	352	12	androgenetic	androgenetic	ADJ
admet-3030	352	13	alopecia	alopecia	NOUN
admet-3030	352	14	.	.	PUNCT
admet-3030	353	1	jama	jama	PROPN
admet-3030	353	2	dermatology	dermatology	NOUN
admet-3030	353	3	157	157	NUM
admet-3030	353	4	(	(	PUNCT
admet-3030	353	5	2021	2021	NUM
admet-3030	353	6	)	)	PUNCT
admet-3030	353	7	25	25	NUM
admet-3030	353	8	-	-	SYM
admet-3030	353	9	26	26	NUM
admet-3030	353	10	.	.	PUNCT
admet-3030	354	1	https://dx.doi.org/10.1001/jamadermatol.2020.3384	https://dx.doi.org/10.1001/jamadermatol.2020.3384	PROPN
admet-3030	355	1	[	[	X
admet-3030	355	2	10	10	NUM
admet-3030	355	3	]	]	PUNCT
admet-3030	355	4	x.	x.	NOUN
admet-3030	355	5	wang	wang	PROPN
admet-3030	355	6	,	,	PUNCT
admet-3030	355	7	y.	y.	PROPN
admet-3030	355	8	liu	liu	PROPN
admet-3030	355	9	,	,	PUNCT
admet-3030	355	10	j.	j.	PROPN
admet-3030	355	11	he	he	PROPN
admet-3030	355	12	,	,	PUNCT
admet-3030	355	13	j.	j.	PROPN
admet-3030	355	14	wang	wang	PROPN
admet-3030	355	15	,	,	PUNCT
admet-3030	355	16	x.	x.	PROPN
admet-3030	355	17	chen	chen	PROPN
admet-3030	355	18	,	,	PUNCT
admet-3030	355	19	r.	r.	PROPN
admet-3030	355	20	yang	yang	PROPN
admet-3030	355	21	.	.	PUNCT
admet-3030	356	1	regulation	regulation	NOUN
admet-3030	356	2	of	of	ADP
admet-3030	356	3	signaling	signal	VERB
admet-3030	356	4	pathways	pathway	NOUN
admet-3030	356	5	in	in	ADP
admet-3030	356	6	hair	hair	NOUN
admet-3030	356	7	follicle	follicle	NOUN
admet-3030	356	8	stem	stem	NOUN
admet-3030	356	9	cells	cell	NOUN
admet-3030	356	10	.	.	PUNCT
admet-3030	357	1	burns	burn	NOUN
admet-3030	357	2	&	&	CCONJ
admet-3030	357	3	trauma	trauma	PROPN
admet-3030	357	4	10	10	NUM
admet-3030	357	5	(	(	PUNCT
admet-3030	357	6	2022	2022	NUM
admet-3030	357	7	)	)	PUNCT
admet-3030	357	8	tkac022	tkac022	PROPN
admet-3030	357	9	.	.	PUNCT
admet-3030	358	1	https://dx.doi.org/10.1093/burnst/tkac022	https://dx.doi.org/10.1093/burnst/tkac022	PROPN
admet-3030	359	1	[	[	X
admet-3030	359	2	11	11	NUM
admet-3030	359	3	]	]	X
admet-3030	359	4	l.a	l.a	PROPN
admet-3030	359	5	.	.	PROPN
admet-3030	359	6	mendoza	mendoza	PROPN
admet-3030	359	7	,	,	PUNCT
admet-3030	359	8	g.g	g.g	PROPN
admet-3030	359	9	.	.	PROPN
admet-3030	359	10	ocampo	ocampo	PROPN
admet-3030	359	11	,	,	PUNCT
admet-3030	359	12	y.a	y.a	PROPN
admet-3030	359	13	.	.	PROPN
admet-3030	359	14	abarca	abarca	PROPN
admet-3030	359	15	-	-	PUNCT
admet-3030	359	16	pineda	pineda	PROPN
admet-3030	359	17	,	,	PUNCT
admet-3030	359	18	m.	m.	NOUN
admet-3030	359	19	ahmad	ahmad	PROPN
admet-3030	359	20	khan	khan	PROPN
admet-3030	359	21	,	,	PUNCT
admet-3030	359	22	y.	y.	PROPN
admet-3030	359	23	ahmadi	ahmadi	PROPN
admet-3030	359	24	,	,	PUNCT
admet-3030	359	25	n.	n.	PROPN
admet-3030	359	26	brown	brown	PROPN
admet-3030	359	27	,	,	PUNCT
admet-3030	359	28	d.	d.	PROPN
admet-3030	359	29	deowan	deowan	PROPN
admet-3030	359	30	,	,	PUNCT
admet-3030	359	31	z.	z.	PROPN
admet-3030	359	32	nazir	nazir	PROPN
admet-3030	359	33	.	.	PUNCT
admet-3030	360	1	comprehensive	comprehensive	ADJ
admet-3030	360	2	review	review	NOUN
admet-3030	360	3	on	on	ADP
admet-3030	360	4	hair	hair	NOUN
admet-3030	360	5	loss	loss	NOUN
admet-3030	360	6	and	and	CCONJ
admet-3030	360	7	restorative	restorative	ADJ
admet-3030	360	8	techniques	technique	NOUN
admet-3030	360	9	:	:	PUNCT
admet-3030	360	10	advances	advance	NOUN
admet-3030	360	11	in	in	ADP
admet-3030	360	12	diagnostic	diagnostic	ADJ
admet-3030	360	13	,	,	PUNCT
admet-3030	360	14	artistry	artistry	PROPN
admet-3030	360	15	,	,	PUNCT
admet-3030	360	16	and	and	CCONJ
admet-3030	360	17	surgical	surgical	ADJ
admet-3030	360	18	innovation	innovation	NOUN
admet-3030	360	19	.	.	PUNCT
admet-3030	361	1	cureus	cureus	NOUN
admet-3030	361	2	17	17	NUM
admet-3030	361	3	(	(	PUNCT
admet-3030	361	4	2025	2025	NUM
admet-3030	361	5	)	)	PUNCT
admet-3030	361	6	e82991	e82991	PROPN
admet-3030	361	7	.	.	PUNCT
admet-3030	361	8	https://dx.doi.org/10.7759/cureus.82991	https://dx.doi.org/10.7759/cureus.82991	PUNCT
admet-3030	362	1	[	[	X
admet-3030	362	2	12	12	NUM
admet-3030	362	3	]	]	X
admet-3030	362	4	c.y	c.y	PROPN
admet-3030	362	5	.	.	PROPN
admet-3030	362	6	ho	ho	PROPN
admet-3030	362	7	,	,	PUNCT
admet-3030	362	8	c.y	c.y	PROPN
admet-3030	362	9	.	.	PROPN
admet-3030	362	10	wu	wu	PROPN
admet-3030	362	11	,	,	PUNCT
admet-3030	362	12	j.y	j.y	PROPN
admet-3030	362	13	.	.	PROPN
admet-3030	362	14	chen	chen	PROPN
admet-3030	362	15	,	,	PUNCT
admet-3030	362	16	c.y	c.y	PROPN
admet-3030	362	17	.	.	PROPN
admet-3030	362	18	wu	wu	PROPN
admet-3030	362	19	.	.	PUNCT
admet-3030	363	1	clinical	clinical	ADJ
admet-3030	363	2	and	and	CCONJ
admet-3030	363	3	genetic	genetic	ADJ
admet-3030	363	4	aspects	aspect	NOUN
admet-3030	363	5	of	of	ADP
admet-3030	363	6	alopecia	alopecia	NOUN
admet-3030	363	7	areata	areata	NOUN
admet-3030	363	8	:	:	PUNCT
admet-3030	363	9	a	a	DET
admet-3030	363	10	cutting	cut	VERB
admet-3030	363	11	edge	edge	NOUN
admet-3030	363	12	review	review	NOUN
admet-3030	363	13	.	.	PUNCT
admet-3030	364	1	genes	gene	NOUN
admet-3030	364	2	(	(	PUNCT
admet-3030	364	3	basel	basel	PROPN
admet-3030	364	4	)	)	PUNCT
admet-3030	364	5	14	14	NUM
admet-3030	364	6	(	(	PUNCT
admet-3030	364	7	2023	2023	NUM
admet-3030	364	8	)	)	PUNCT
admet-3030	364	9	1362	1362	NUM
admet-3030	364	10	.	.	PUNCT
admet-3030	365	1	https://dx.doi.org/10.3390/genes14071362	https://dx.doi.org/10.3390/genes14071362	PROPN
admet-3030	365	2	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	365	3	https://doi.org/10.2147/ccid.s376096	https://doi.org/10.2147/ccid.s376096	ADP
admet-3030	365	4	https://doi.org/10.3390/pharmaceutics14030612	https://doi.org/10.3390/pharmaceutics14030612	NOUN
admet-3030	365	5	https://doi.org/10.3390/ijms21218390	https://doi.org/10.3390/ijms21218390	NOUN
admet-3030	365	6	https://doi.org/10.21608/bjas.2024.261687.1307	https://doi.org/10.21608/bjas.2024.261687.1307	X
admet-3030	365	7	https://doi.org/10.4103/amhs.amhs_228_20	https://doi.org/10.4103/amhs.amhs_228_20	NOUN
admet-3030	365	8	https://doi.org/10.3389/fmed.2022.1054898	https://doi.org/10.3389/fmed.2022.1054898	PROPN
admet-3030	365	9	https://doi.org/10.3390/ijms25115652	https://doi.org/10.3390/ijms25115652	PROPN
admet-3030	365	10	https://doi.org/10.1016/j.ejmech.2024.116666	https://doi.org/10.1016/j.ejmech.2024.116666	PROPN
admet-3030	365	11	https://doi.org/10.1001/jamadermatol.2020.3384	https://doi.org/10.1001/jamadermatol.2020.3384	PROPN
admet-3030	365	12	https://doi.org/10.1093/burnst/tkac022	https://doi.org/10.1093/burnst/tkac022	NOUN
admet-3030	365	13	https://doi.org/10.7759/cureus.82991	https://doi.org/10.7759/cureus.82991	PROPN
admet-3030	365	14	https://doi.org/10.3390/genes14071362	https://doi.org/10.3390/genes14071362	PROPN
admet-3030	365	15	r.	r.	PROPN
admet-3030	365	16	kapoor	kapoor	PROPN
admet-3030	365	17	et	et	PROPN
admet-3030	365	18	al	al	PROPN
admet-3030	365	19	.	.	PROPN
admet-3030	365	20	admet	admet	PROPN
admet-3030	365	21	&	&	CCONJ
admet-3030	365	22	dmpk	dmpk	PROPN
admet-3030	365	23	00(0	00(0	PROPN
admet-3030	365	24	)	)	PUNCT
admet-3030	365	25	(	(	PUNCT
admet-3030	365	26	2025	2025	NUM
admet-3030	365	27	)	)	PUNCT
admet-3030	365	28	3030	3030	NUM
admet-3030	365	29	16	16	NUM
admet-3030	366	1	[	[	X
admet-3030	366	2	13	13	NUM
admet-3030	366	3	]	]	PUNCT
admet-3030	366	4	h.	h.	NOUN
admet-3030	366	5	englander	englander	PROPN
admet-3030	366	6	,	,	PUNCT
admet-3030	366	7	b.	b.	PROPN
admet-3030	366	8	paiewonsky	paiewonsky	PROPN
admet-3030	366	9	,	,	PUNCT
admet-3030	366	10	l.	l.	PROPN
admet-3030	366	11	castelo	castelo	PROPN
admet-3030	366	12	-	-	PUNCT
admet-3030	366	13	soccio	soccio	NOUN
admet-3030	366	14	.	.	PUNCT
admet-3030	367	1	alopecia	alopecia	NOUN
admet-3030	367	2	areata	areata	NOUN
admet-3030	367	3	:	:	PUNCT
admet-3030	367	4	a	a	DET
admet-3030	367	5	review	review	NOUN
admet-3030	367	6	of	of	ADP
admet-3030	367	7	the	the	DET
admet-3030	367	8	genetic	genetic	ADJ
admet-3030	367	9	variants	variant	NOUN
admet-3030	367	10	and	and	CCONJ
admet-3030	367	11	immunodeficiency	immunodeficiency	NOUN
admet-3030	367	12	disorders	disorder	NOUN
admet-3030	367	13	associated	associate	VERB
admet-3030	367	14	with	with	ADP
admet-3030	367	15	alopecia	alopecia	NOUN
admet-3030	367	16	areata	areata	ADJ
admet-3030	367	17	.	.	PUNCT
admet-3030	368	1	skin	skin	NOUN
admet-3030	368	2	appendage	appendage	NOUN
admet-3030	368	3	disorders	disorder	NOUN
admet-3030	368	4	9	9	NUM
admet-3030	368	5	(	(	PUNCT
admet-3030	368	6	2023	2023	NUM
admet-3030	368	7	)	)	PUNCT
admet-3030	368	8	325	325	NUM
admet-3030	368	9	-	-	SYM
admet-3030	368	10	332	332	NUM
admet-3030	368	11	.	.	PUNCT
admet-3030	369	1	https://dx.doi.org/10.1159/000530432	https://dx.doi.org/10.1159/000530432	NOUN
admet-3030	370	1	[	[	X
admet-3030	370	2	14	14	NUM
admet-3030	370	3	]	]	X
admet-3030	370	4	n.	n.	NOUN
admet-3030	370	5	gokce	gokce	PROPN
admet-3030	370	6	,	,	PUNCT
admet-3030	370	7	n.	n.	PROPN
admet-3030	370	8	basgoz	basgoz	PROPN
admet-3030	370	9	,	,	PUNCT
admet-3030	370	10	s.	s.	PROPN
admet-3030	370	11	kenanoglu	kenanoglu	PROPN
admet-3030	370	12	,	,	PUNCT
admet-3030	370	13	h.	h.	PROPN
admet-3030	370	14	akalin	akalin	PROPN
admet-3030	370	15	,	,	PUNCT
admet-3030	370	16	y.	y.	PROPN
admet-3030	370	17	ozkul	ozkul	PROPN
admet-3030	370	18	,	,	PUNCT
admet-3030	370	19	m.c	m.c	PROPN
admet-3030	370	20	.	.	PROPN
admet-3030	370	21	ergoren	ergoren	PROPN
admet-3030	370	22	,	,	PUNCT
admet-3030	370	23	t.	t.	NOUN
admet-3030	370	24	beccari	beccari	PROPN
admet-3030	370	25	,	,	PUNCT
admet-3030	370	26	m.	m.	PROPN
admet-3030	370	27	bertelli	bertelli	PROPN
admet-3030	370	28	,	,	PUNCT
admet-3030	370	29	m.	m.	NOUN
admet-3030	370	30	dundar	dundar	PROPN
admet-3030	370	31	.	.	PUNCT
admet-3030	371	1	an	an	DET
admet-3030	371	2	overview	overview	NOUN
admet-3030	371	3	of	of	ADP
admet-3030	371	4	the	the	DET
admet-3030	371	5	genetic	genetic	ADJ
admet-3030	371	6	aspects	aspect	NOUN
admet-3030	371	7	of	of	ADP
admet-3030	371	8	hair	hair	NOUN
admet-3030	371	9	loss	loss	NOUN
admet-3030	371	10	and	and	CCONJ
admet-3030	371	11	its	its	PRON
admet-3030	371	12	connection	connection	NOUN
admet-3030	371	13	with	with	ADP
admet-3030	371	14	nutrition	nutrition	NOUN
admet-3030	371	15	.	.	PUNCT
admet-3030	372	1	journal	journal	NOUN
admet-3030	372	2	of	of	ADP
admet-3030	372	3	preventive	preventive	ADJ
admet-3030	372	4	medicine	medicine	NOUN
admet-3030	372	5	and	and	CCONJ
admet-3030	372	6	hygiene	hygiene	VERB
admet-3030	372	7	63	63	NUM
admet-3030	372	8	(	(	PUNCT
admet-3030	372	9	2022	2022	NUM
admet-3030	372	10	)	)	PUNCT
admet-3030	372	11	e228	e228	PROPN
admet-3030	372	12	-	-	PUNCT
admet-3030	372	13	e238	e238	PROPN
admet-3030	372	14	.	.	PUNCT
admet-3030	373	1	https://dx.doi.org/10.15167/24214248/jpmh2022.63.2s3.2765	https://dx.doi.org/10.15167/24214248/jpmh2022.63.2s3.2765	PROPN
admet-3030	374	1	[	[	X
admet-3030	374	2	15	15	NUM
admet-3030	374	3	]	]	X
admet-3030	374	4	f.b	f.b	PROPN
admet-3030	374	5	.	.	PROPN
admet-3030	374	6	basmanav	basmanav	PROPN
admet-3030	374	7	,	,	PUNCT
admet-3030	374	8	r.c	r.c	PROPN
admet-3030	374	9	.	.	PROPN
admet-3030	374	10	betz	betz	PROPN
admet-3030	374	11	.	.	PUNCT
admet-3030	375	1	translational	translational	ADJ
admet-3030	375	2	impact	impact	NOUN
admet-3030	375	3	of	of	ADP
admet-3030	375	4	omics	omic	NOUN
admet-3030	375	5	studies	study	NOUN
admet-3030	375	6	in	in	ADP
admet-3030	375	7	alopecia	alopecia	NOUN
admet-3030	375	8	areata	areata	NOUN
admet-3030	375	9	:	:	PUNCT
admet-3030	375	10	recent	recent	ADJ
admet-3030	375	11	advances	advance	NOUN
admet-3030	375	12	and	and	CCONJ
admet-3030	375	13	future	future	ADJ
admet-3030	375	14	perspectives	perspective	NOUN
admet-3030	375	15	.	.	PUNCT
admet-3030	376	1	expert	expert	NOUN
admet-3030	376	2	review	review	NOUN
admet-3030	376	3	of	of	ADP
admet-3030	376	4	clinical	clinical	ADJ
admet-3030	376	5	immunology	immunology	NOUN
admet-3030	376	6	18	18	NUM
admet-3030	376	7	(	(	PUNCT
admet-3030	376	8	2022	2022	NUM
admet-3030	376	9	)	)	PUNCT
admet-3030	376	10	845	845	NUM
admet-3030	376	11	-	-	NOUN
admet-3030	376	12	857	857	NUM
admet-3030	376	13	.	.	PUNCT
admet-3030	377	1	https://dx.doi.org/10.1080/1744666x.2022.2096590	https://dx.doi.org/10.1080/1744666x.2022.2096590	PRON
admet-3030	378	1	[	[	X
admet-3030	378	2	16	16	NUM
admet-3030	378	3	]	]	PUNCT
admet-3030	378	4	k.	k.	PROPN
admet-3030	378	5	anastassakis	anastassakis	PROPN
admet-3030	378	6	.	.	PUNCT
admet-3030	379	1	androgenetic	androgenetic	ADJ
admet-3030	379	2	alopecia	alopecia	NOUN
admet-3030	379	3	from	from	ADP
admet-3030	379	4	a	a	PRON
admet-3030	379	5	to	to	ADP
admet-3030	379	6	z	z	NOUN
admet-3030	379	7	:	:	PUNCT
admet-3030	379	8	vol.1	vol.1	ADJ
admet-3030	379	9	basic	basic	ADJ
admet-3030	379	10	science	science	NOUN
admet-3030	379	11	,	,	PUNCT
admet-3030	379	12	diagnosis	diagnosis	NOUN
admet-3030	379	13	,	,	PUNCT
admet-3030	379	14	etiology	etiology	NOUN
admet-3030	379	15	,	,	PUNCT
admet-3030	379	16	and	and	CCONJ
admet-3030	379	17	related	related	ADJ
admet-3030	379	18	disorders	disorder	NOUN
admet-3030	379	19	,	,	PUNCT
admet-3030	379	20	springer	springer	NOUN
admet-3030	379	21	nature	nature	NOUN
admet-3030	379	22	,	,	PUNCT
admet-3030	379	23	2022	2022	NUM
admet-3030	379	24	.	.	PUNCT
admet-3030	380	1	https://dx.doi.org/10.1007/978-3-030-76111-0	https://dx.doi.org/10.1007/978-3-030-76111-0	PROPN
admet-3030	380	2	[	[	X
admet-3030	380	3	17	17	NUM
admet-3030	380	4	]	]	PUNCT
admet-3030	380	5	s.	s.	PROPN
admet-3030	380	6	amir	amir	PROPN
admet-3030	380	7	,	,	PUNCT
admet-3030	380	8	s.t.a	s.t.a	PROPN
admet-3030	380	9	.	.	PROPN
admet-3030	380	10	shah	shah	PROPN
admet-3030	380	11	,	,	PUNCT
admet-3030	380	12	c.	c.	PROPN
admet-3030	380	13	mamoulakis	mamoulakis	PROPN
admet-3030	380	14	,	,	PUNCT
admet-3030	380	15	a.o	a.o	PROPN
admet-3030	380	16	.	.	PROPN
admet-3030	380	17	docea	docea	PROPN
admet-3030	380	18	,	,	PUNCT
admet-3030	380	19	o.i	o.i	PROPN
admet-3030	380	20	.	.	PROPN
admet-3030	380	21	kalantzi	kalantzi	PROPN
admet-3030	380	22	,	,	PUNCT
admet-3030	380	23	a.	a.	NOUN
admet-3030	380	24	zachariou	zachariou	PROPN
admet-3030	380	25	,	,	PUNCT
admet-3030	380	26	d.	d.	PROPN
admet-3030	380	27	calina	calina	PROPN
admet-3030	380	28	,	,	PUNCT
admet-3030	380	29	f.	f.	PROPN
admet-3030	380	30	carvalho	carvalho	PROPN
admet-3030	380	31	,	,	PUNCT
admet-3030	380	32	n.	n.	PROPN
admet-3030	380	33	sofikitis	sofikitis	PROPN
admet-3030	380	34	,	,	PUNCT
admet-3030	380	35	a.	a.	NOUN
admet-3030	380	36	makrigiannakis	makrigiannakis	PROPN
admet-3030	380	37	,	,	PUNCT
admet-3030	380	38	a.	a.	PROPN
admet-3030	380	39	tsatsakis	tsatsakis	PROPN
admet-3030	380	40	.	.	PUNCT
admet-3030	381	1	endocrine	endocrine	ADJ
admet-3030	381	2	disruptors	disruptor	NOUN
admet-3030	381	3	acting	act	VERB
admet-3030	381	4	on	on	ADP
admet-3030	381	5	estrogen	estrogen	NOUN
admet-3030	381	6	and	and	CCONJ
admet-3030	381	7	androgen	androgen	NOUN
admet-3030	381	8	pathways	pathway	NOUN
admet-3030	381	9	cause	cause	VERB
admet-3030	381	10	reproductive	reproductive	ADJ
admet-3030	381	11	disorders	disorder	NOUN
admet-3030	381	12	through	through	ADP
admet-3030	381	13	multiple	multiple	ADJ
admet-3030	381	14	mechanisms	mechanism	NOUN
admet-3030	381	15	:	:	PUNCT
admet-3030	381	16	a	a	DET
admet-3030	381	17	review	review	NOUN
admet-3030	381	18	.	.	PUNCT
admet-3030	382	1	international	international	ADJ
admet-3030	382	2	journal	journal	PROPN
admet-3030	382	3	of	of	ADP
admet-3030	382	4	environmental	environmental	ADJ
admet-3030	382	5	research	research	NOUN
admet-3030	382	6	and	and	CCONJ
admet-3030	382	7	public	public	ADJ
admet-3030	382	8	health	health	NOUN
admet-3030	382	9	18	18	NUM
admet-3030	382	10	(	(	PUNCT
admet-3030	382	11	2021	2021	NUM
admet-3030	382	12	)	)	PUNCT
admet-3030	382	13	1464	1464	NUM
admet-3030	382	14	.	.	PUNCT
admet-3030	383	1	https://dx.doi.org/10.3390/ijerph18041464	https://dx.doi.org/10.3390/ijerph18041464	VERB
admet-3030	384	1	[	[	X
admet-3030	384	2	18	18	NUM
admet-3030	384	3	]	]	PUNCT
admet-3030	384	4	z.	z.	PROPN
admet-3030	384	5	zhou	zhou	PROPN
admet-3030	384	6	,	,	PUNCT
admet-3030	384	7	s.	s.	PROPN
admet-3030	384	8	song	song	PROPN
admet-3030	384	9	,	,	PUNCT
admet-3030	384	10	z.	z.	PROPN
admet-3030	384	11	gao	gao	PROPN
admet-3030	384	12	,	,	PUNCT
admet-3030	384	13	j.	j.	PROPN
admet-3030	384	14	wu	wu	PROPN
admet-3030	384	15	,	,	PUNCT
admet-3030	384	16	j.	j.	PROPN
admet-3030	384	17	ma	ma	PROPN
admet-3030	384	18	,	,	PUNCT
admet-3030	384	19	y.	y.	PROPN
admet-3030	384	20	cui	cui	PROPN
admet-3030	384	21	.	.	PUNCT
admet-3030	385	1	the	the	DET
admet-3030	385	2	efficacy	efficacy	NOUN
admet-3030	385	3	and	and	CCONJ
admet-3030	385	4	safety	safety	NOUN
admet-3030	385	5	of	of	ADP
admet-3030	385	6	dutasteride	dutasteride	NOUN
admet-3030	385	7	compared	compare	VERB
admet-3030	385	8	with	with	ADP
admet-3030	385	9	finasteride	finasteride	NOUN
admet-3030	385	10	in	in	ADP
admet-3030	385	11	treating	treat	VERB
admet-3030	385	12	men	man	NOUN
admet-3030	385	13	with	with	ADP
admet-3030	385	14	androgenetic	androgenetic	ADJ
admet-3030	385	15	alopecia	alopecia	NOUN
admet-3030	385	16	:	:	PUNCT
admet-3030	385	17	a	a	DET
admet-3030	385	18	systematic	systematic	ADJ
admet-3030	385	19	review	review	NOUN
admet-3030	385	20	and	and	CCONJ
admet-3030	385	21	meta	meta	ADJ
admet-3030	385	22	-	-	PUNCT
admet-3030	385	23	analysis	analysis	NOUN
admet-3030	385	24	.	.	PUNCT
admet-3030	386	1	clinical	clinical	ADJ
admet-3030	386	2	interventions	intervention	NOUN
admet-3030	386	3	in	in	ADP
admet-3030	386	4	aging	age	VERB
admet-3030	386	5	14	14	NUM
admet-3030	386	6	(	(	PUNCT
admet-3030	386	7	2019	2019	NUM
admet-3030	386	8	)	)	PUNCT
admet-3030	386	9	399	399	NUM
admet-3030	386	10	-	-	SYM
admet-3030	386	11	406	406	NUM
admet-3030	386	12	.	.	PUNCT
admet-3030	387	1	https://dx.doi.org/10.2147/cia.s192435	https://dx.doi.org/10.2147/cia.s192435	VERB
admet-3030	387	2	[	[	X
admet-3030	387	3	19	19	NUM
admet-3030	387	4	]	]	X
admet-3030	387	5	u.	u.	PROPN
admet-3030	387	6	panich	panich	PROPN
admet-3030	387	7	,	,	PUNCT
admet-3030	387	8	g.	g.	PROPN
admet-3030	387	9	sittithumcharee	sittithumcharee	PROPN
admet-3030	387	10	,	,	PUNCT
admet-3030	387	11	n.	n.	PROPN
admet-3030	387	12	rathviboon	rathviboon	PROPN
admet-3030	387	13	,	,	PUNCT
admet-3030	387	14	s.	s.	PROPN
admet-3030	387	15	jirawatnotai	jirawatnotai	PROPN
admet-3030	387	16	.	.	PUNCT
admet-3030	388	1	ultraviolet	ultraviolet	ADJ
admet-3030	388	2	radiation	radiation	NOUN
admet-3030	388	3	-	-	PUNCT
admet-3030	388	4	induced	induce	VERB
admet-3030	388	5	skin	skin	NOUN
admet-3030	388	6	aging	aging	NOUN
admet-3030	388	7	:	:	PUNCT
admet-3030	388	8	the	the	DET
admet-3030	388	9	role	role	NOUN
admet-3030	388	10	of	of	ADP
admet-3030	388	11	dna	dna	PROPN
admet-3030	388	12	damage	damage	NOUN
admet-3030	388	13	and	and	CCONJ
admet-3030	388	14	oxidative	oxidative	ADJ
admet-3030	388	15	stress	stress	NOUN
admet-3030	388	16	in	in	ADP
admet-3030	388	17	epidermal	epidermal	ADJ
admet-3030	388	18	stem	stem	NOUN
admet-3030	388	19	cell	cell	NOUN
admet-3030	388	20	damage	damage	NOUN
admet-3030	388	21	mediated	mediate	VERB
admet-3030	388	22	skin	skin	NOUN
admet-3030	388	23	aging	aging	NOUN
admet-3030	388	24	.	.	PUNCT
admet-3030	389	1	stem	stem	NOUN
admet-3030	389	2	cells	cell	NOUN
admet-3030	389	3	international	international	ADJ
admet-3030	389	4	2016	2016	NUM
admet-3030	389	5	(	(	PUNCT
admet-3030	389	6	2016	2016	NUM
admet-3030	389	7	)	)	PUNCT
admet-3030	389	8	7370642	7370642	NUM
admet-3030	389	9	.	.	PUNCT
admet-3030	390	1	https://dx.doi.org/10.1155/2016/7370642	https://dx.doi.org/10.1155/2016/7370642	PROPN
admet-3030	390	2	[	[	PUNCT
admet-3030	390	3	20	20	NUM
admet-3030	390	4	]	]	SYM
admet-3030	390	5	a.a	a.a	PROPN
admet-3030	390	6	.	.	PROPN
admet-3030	390	7	alotiby	alotiby	PROPN
admet-3030	390	8	.	.	PUNCT
admet-3030	391	1	integrating	integrate	VERB
admet-3030	391	2	psychological	psychological	ADJ
admet-3030	391	3	support	support	NOUN
admet-3030	391	4	and	and	CCONJ
admet-3030	391	5	topical	topical	ADJ
admet-3030	391	6	therapy	therapy	NOUN
admet-3030	391	7	for	for	ADP
admet-3030	391	8	the	the	DET
admet-3030	391	9	effective	effective	ADJ
admet-3030	391	10	management	management	NOUN
admet-3030	391	11	of	of	ADP
admet-3030	391	12	stress	stress	NOUN
admet-3030	391	13	-	-	PUNCT
admet-3030	391	14	induced	induce	VERB
admet-3030	391	15	alopecia	alopecia	NOUN
admet-3030	391	16	areata	areata	NOUN
admet-3030	391	17	:	:	PUNCT
admet-3030	391	18	a	a	DET
admet-3030	391	19	case	case	NOUN
admet-3030	391	20	report	report	NOUN
admet-3030	391	21	.	.	PUNCT
admet-3030	392	1	cureus	cureus	NOUN
admet-3030	392	2	17	17	NUM
admet-3030	392	3	(	(	PUNCT
admet-3030	392	4	2025	2025	NUM
admet-3030	392	5	)	)	PUNCT
admet-3030	392	6	e77317	e77317	PROPN
admet-3030	392	7	.	.	PUNCT
admet-3030	392	8	https://dx.doi.org/10.7759/cureus.77317	https://dx.doi.org/10.7759/cureus.77317	NOUN
admet-3030	393	1	[	[	X
admet-3030	393	2	21	21	NUM
admet-3030	393	3	]	]	X
admet-3030	393	4	r.	r.	PROPN
admet-3030	393	5	cuevas	cuevas	PROPN
admet-3030	393	6	-	-	PUNCT
admet-3030	393	7	diaz	diaz	PROPN
admet-3030	393	8	duran	duran	PROPN
admet-3030	393	9	,	,	PUNCT
admet-3030	393	10	e.	e.	PROPN
admet-3030	393	11	martinez	martinez	PROPN
admet-3030	393	12	-	-	PUNCT
admet-3030	393	13	ledesma	ledesma	PROPN
admet-3030	393	14	,	,	PUNCT
admet-3030	393	15	m.	m.	NOUN
admet-3030	393	16	garcia	garcia	PROPN
admet-3030	393	17	-	-	PUNCT
admet-3030	393	18	garcia	garcia	PROPN
admet-3030	393	19	,	,	PUNCT
admet-3030	393	20	d.	d.	PROPN
admet-3030	393	21	bajo	bajo	PROPN
admet-3030	393	22	gauzin	gauzin	PROPN
admet-3030	393	23	,	,	PUNCT
admet-3030	393	24	a.	a.	NOUN
admet-3030	393	25	sarro	sarro	NOUN
admet-3030	393	26	-	-	PUNCT
admet-3030	393	27	ramírez	ramírez	NOUN
admet-3030	393	28	,	,	PUNCT
admet-3030	393	29	c.	c.	PROPN
admet-3030	393	30	gonzalez	gonzalez	PROPN
admet-3030	393	31	-	-	PUNCT
admet-3030	393	32	carrillo	carrillo	PROPN
admet-3030	393	33	,	,	PUNCT
admet-3030	393	34	d.	d.	PROPN
admet-3030	393	35	rodríguez	rodríguez	PROPN
admet-3030	393	36	-	-	PUNCT
admet-3030	393	37	sardin	sardin	NOUN
admet-3030	393	38	,	,	PUNCT
admet-3030	393	39	a.	a.	NOUN
admet-3030	393	40	fuentes	fuentes	PROPN
admet-3030	393	41	,	,	PUNCT
admet-3030	393	42	a.	a.	PROPN
admet-3030	393	43	cardenas	cardenas	PROPN
admet-3030	393	44	-	-	PUNCT
admet-3030	393	45	lopez	lopez	NOUN
admet-3030	393	46	.	.	PUNCT
admet-3030	394	1	the	the	DET
admet-3030	394	2	biology	biology	NOUN
admet-3030	394	3	and	and	CCONJ
admet-3030	394	4	genomics	genomic	NOUN
admet-3030	394	5	of	of	ADP
admet-3030	394	6	human	human	ADJ
admet-3030	394	7	hair	hair	NOUN
admet-3030	394	8	follicles	follicle	NOUN
admet-3030	394	9	:	:	PUNCT
admet-3030	394	10	a	a	DET
admet-3030	394	11	focus	focus	NOUN
admet-3030	394	12	on	on	ADP
admet-3030	394	13	androgenetic	androgenetic	ADJ
admet-3030	394	14	alopecia	alopecia	NOUN
admet-3030	394	15	.	.	PUNCT
admet-3030	395	1	international	international	ADJ
admet-3030	395	2	journal	journal	NOUN
admet-3030	395	3	of	of	ADP
admet-3030	395	4	molecular	molecular	ADJ
admet-3030	395	5	sciences	science	NOUN
admet-3030	395	6	25	25	NUM
admet-3030	395	7	(	(	PUNCT
admet-3030	395	8	2024	2024	NUM
admet-3030	395	9	)	)	PUNCT
admet-3030	395	10	2542	2542	NUM
admet-3030	395	11	.	.	PUNCT
admet-3030	396	1	https://dx.doi.org/10.3390/ijms25052542	https://dx.doi.org/10.3390/ijms25052542	PROPN
admet-3030	397	1	[	[	X
admet-3030	397	2	22	22	NUM
admet-3030	397	3	]	]	PUNCT
admet-3030	397	4	x.	x.	PROPN
admet-3030	397	5	zong	zong	PROPN
admet-3030	397	6	,	,	PUNCT
admet-3030	397	7	s.	s.	PROPN
admet-3030	397	8	yang	yang	PROPN
admet-3030	397	9	,	,	PUNCT
admet-3030	397	10	z.	z.	PROPN
admet-3030	397	11	tang	tang	PROPN
admet-3030	397	12	,	,	PUNCT
admet-3030	397	13	x.	x.	PROPN
admet-3030	397	14	li	li	PROPN
admet-3030	397	15	,	,	PUNCT
admet-3030	397	16	d.	d.	PROPN
admet-3030	397	17	long	long	PROPN
admet-3030	397	18	,	,	PUNCT
admet-3030	397	19	d.	d.	PROPN
admet-3030	397	20	wang	wang	PROPN
admet-3030	397	21	.	.	PUNCT
admet-3030	398	1	1,25-(oh)(2)d(3	1,25-(oh)(2)d(3	NUM
admet-3030	398	2	)	)	PUNCT
admet-3030	398	3	promotes	promote	VERB
admet-3030	398	4	hair	hair	NOUN
admet-3030	398	5	growth	growth	NOUN
admet-3030	398	6	by	by	ADP
admet-3030	398	7	inhibiting	inhibit	VERB
admet-3030	398	8	nlrp3	nlrp3	NOUN
admet-3030	398	9	/	/	SYM
admet-3030	398	10	il-1β	il-1β	PROPN
admet-3030	398	11	and	and	CCONJ
admet-3030	398	12	hif-1α	hif-1α	PROPN
admet-3030	398	13	/	/	SYM
admet-3030	398	14	il-1β	il-1β	PROPN
admet-3030	398	15	signaling	signal	VERB
admet-3030	398	16	pathways	pathway	NOUN
admet-3030	398	17	.	.	PUNCT
admet-3030	399	1	journal	journal	NOUN
admet-3030	399	2	of	of	ADP
admet-3030	399	3	nutritional	nutritional	ADJ
admet-3030	399	4	biochemistry	biochemistry	NOUN
admet-3030	399	5	132	132	NUM
admet-3030	399	6	(	(	PUNCT
admet-3030	399	7	2024	2024	NUM
admet-3030	399	8	)	)	PUNCT
admet-3030	399	9	109695	109695	NUM
admet-3030	399	10	.	.	PUNCT
admet-3030	400	1	https://dx.doi.org/10.1016/j.jnutbio.2024.109695	https://dx.doi.org/10.1016/j.jnutbio.2024.109695	NUM
admet-3030	401	1	[	[	X
admet-3030	401	2	23	23	NUM
admet-3030	401	3	]	]	X
admet-3030	401	4	r.m	r.m	PROPN
admet-3030	401	5	.	.	PROPN
admet-3030	401	6	trüeb	trüeb	PROPN
admet-3030	401	7	,	,	PUNCT
admet-3030	401	8	h.	h.	PROPN
admet-3030	401	9	dutra	dutra	PROPN
admet-3030	401	10	rezende	rezende	PROPN
admet-3030	401	11	,	,	PUNCT
admet-3030	401	12	m.f.r	m.f.r	NOUN
admet-3030	401	13	.	.	PUNCT
admet-3030	402	1	gavazzoni	gavazzoni	PROPN
admet-3030	402	2	dias	dias	PROPN
admet-3030	402	3	,	,	PUNCT
admet-3030	402	4	d.	d.	PROPN
admet-3030	402	5	silva	silva	PROPN
admet-3030	402	6	polito	polito	PROPN
admet-3030	402	7	,	,	PUNCT
admet-3030	402	8	s.	s.	PROPN
admet-3030	402	9	de	de	PROPN
admet-3030	402	10	abreu	abreu	PROPN
admet-3030	402	11	neves	neves	PROPN
admet-3030	402	12	salles	salles	PROPN
admet-3030	402	13	.	.	PUNCT
admet-3030	403	1	bacterial	bacterial	ADJ
admet-3030	403	2	diseases	disease	NOUN
admet-3030	403	3	,	,	PUNCT
admet-3030	403	4	in	in	ADP
admet-3030	403	5	hair	hair	NOUN
admet-3030	403	6	in	in	ADP
admet-3030	403	7	infectious	infectious	ADJ
admet-3030	403	8	disease	disease	NOUN
admet-3030	403	9	:	:	PUNCT
admet-3030	403	10	recognition	recognition	NOUN
admet-3030	403	11	,	,	PUNCT
admet-3030	403	12	treatment	treatment	NOUN
admet-3030	403	13	,	,	PUNCT
admet-3030	403	14	and	and	CCONJ
admet-3030	403	15	prevention	prevention	NOUN
admet-3030	403	16	,	,	PUNCT
admet-3030	403	17	springer	springer	NOUN
admet-3030	403	18	,	,	PUNCT
admet-3030	403	19	cham	cham	PROPN
admet-3030	403	20	,	,	PUNCT
admet-3030	403	21	switzerland	switzerland	PROPN
admet-3030	403	22	,	,	PUNCT
admet-3030	403	23	2023	2023	NUM
admet-3030	403	24	,	,	PUNCT
admet-3030	403	25	p.	p.	NOUN
admet-3030	403	26	35	35	NUM
admet-3030	403	27	-	-	SYM
admet-3030	403	28	127	127	NUM
admet-3030	403	29	.	.	PUNCT
admet-3030	404	1	https://doi.org/10.1007/978-3-031-30754-6	https://doi.org/10.1007/978-3-031-30754-6	PROPN
admet-3030	405	1	[	[	X
admet-3030	405	2	24	24	NUM
admet-3030	405	3	]	]	X
admet-3030	405	4	y.	y.	PROPN
admet-3030	405	5	lin	lin	PROPN
admet-3030	405	6	,	,	PUNCT
admet-3030	405	7	x.	x.	PROPN
admet-3030	405	8	wu	wu	PROPN
admet-3030	405	9	,	,	PUNCT
admet-3030	405	10	y.	y.	PROPN
admet-3030	405	11	yang	yang	PROPN
admet-3030	405	12	,	,	PUNCT
admet-3030	405	13	y.	y.	PROPN
admet-3030	405	14	wu	wu	PROPN
admet-3030	405	15	,	,	PUNCT
admet-3030	405	16	l.	l.	PROPN
admet-3030	405	17	xiang	xiang	PROPN
admet-3030	405	18	,	,	PUNCT
admet-3030	405	19	c.	c.	PROPN
admet-3030	405	20	zhang	zhang	PROPN
admet-3030	405	21	.	.	PUNCT
admet-3030	406	1	the	the	DET
admet-3030	406	2	multifaceted	multifaceted	ADJ
admet-3030	406	3	role	role	NOUN
admet-3030	406	4	of	of	ADP
admet-3030	406	5	autophagy	autophagy	NOUN
admet-3030	406	6	in	in	ADP
admet-3030	406	7	skin	skin	NOUN
admet-3030	406	8	autoimmune	autoimmune	ADJ
admet-3030	406	9	disorders	disorder	NOUN
admet-3030	406	10	:	:	PUNCT
admet-3030	406	11	a	a	DET
admet-3030	406	12	guardian	guardian	NOUN
admet-3030	406	13	or	or	CCONJ
admet-3030	406	14	culprit	culprit	NOUN
admet-3030	406	15	?	?	PUNCT
admet-3030	407	1	frontiers	frontier	NOUN
admet-3030	407	2	in	in	ADP
admet-3030	407	3	immunology	immunology	NOUN
admet-3030	407	4	15	15	NUM
admet-3030	407	5	(	(	PUNCT
admet-3030	407	6	2024	2024	NUM
admet-3030	407	7	)	)	PUNCT
admet-3030	407	8	1343987	1343987	NUM
admet-3030	407	9	.	.	PUNCT
admet-3030	408	1	https://dx.doi.org/10.3389/fimmu.2024.1343987	https://dx.doi.org/10.3389/fimmu.2024.1343987	X
admet-3030	409	1	[	[	X
admet-3030	409	2	25	25	NUM
admet-3030	409	3	]	]	X
admet-3030	409	4	y.	y.	PROPN
admet-3030	409	5	li	li	PROPN
admet-3030	409	6	,	,	PUNCT
admet-3030	409	7	s.	s.	PROPN
admet-3030	409	8	yang	yang	PROPN
admet-3030	409	9	,	,	PUNCT
admet-3030	409	10	m.	m.	PROPN
admet-3030	409	11	liao	liao	PROPN
admet-3030	409	12	,	,	PUNCT
admet-3030	409	13	z.	z.	PROPN
admet-3030	409	14	zheng	zheng	PROPN
admet-3030	409	15	,	,	PUNCT
admet-3030	409	16	m.	m.	PROPN
admet-3030	409	17	li	li	PROPN
admet-3030	409	18	,	,	PUNCT
admet-3030	409	19	x.	x.	PROPN
admet-3030	409	20	wei	wei	PROPN
admet-3030	409	21	,	,	PUNCT
admet-3030	409	22	m.	m.	PROPN
admet-3030	409	23	liu	liu	PROPN
admet-3030	409	24	,	,	PUNCT
admet-3030	409	25	l.	l.	PROPN
admet-3030	409	26	yang	yang	PROPN
admet-3030	409	27	.	.	PUNCT
admet-3030	409	28	association	association	PROPN
admet-3030	409	29	between	between	ADP
admet-3030	409	30	genetically	genetically	ADV
admet-3030	409	31	predicted	predict	VERB
admet-3030	409	32	leukocyte	leukocyte	NOUN
admet-3030	409	33	telomere	telomere	NOUN
admet-3030	409	34	length	length	NOUN
admet-3030	409	35	and	and	CCONJ
admet-3030	409	36	non	non	ADJ
admet-3030	409	37	-	-	ADJ
admet-3030	409	38	scarring	scarring	ADJ
admet-3030	409	39	alopecia	alopecia	NOUN
admet-3030	409	40	:	:	PUNCT
admet-3030	409	41	a	a	DET
admet-3030	409	42	two	two	NUM
admet-3030	409	43	-	-	PUNCT
admet-3030	409	44	sample	sample	NOUN
admet-3030	409	45	mendelian	mendelian	ADJ
admet-3030	409	46	randomization	randomization	NOUN
admet-3030	409	47	study	study	NOUN
admet-3030	409	48	.	.	PUNCT
admet-3030	410	1	frontiers	frontier	NOUN
admet-3030	410	2	in	in	ADP
admet-3030	410	3	immunology	immunology	NOUN
admet-3030	410	4	13	13	NUM
admet-3030	410	5	(	(	PUNCT
admet-3030	410	6	2022	2022	NUM
admet-3030	410	7	)	)	PUNCT
admet-3030	410	8	1072573	1072573	NUM
admet-3030	410	9	.	.	PUNCT
admet-3030	411	1	https://dx.doi.org/10.3389/fimmu.2022.1072573	https://dx.doi.org/10.3389/fimmu.2022.1072573	NOUN
admet-3030	412	1	[	[	X
admet-3030	412	2	26	26	NUM
admet-3030	412	3	]	]	PUNCT
admet-3030	412	4	p.	p.	PROPN
admet-3030	412	5	wu	wu	PROPN
admet-3030	412	6	,	,	PUNCT
admet-3030	412	7	k.	k.	PROPN
admet-3030	412	8	tian	tian	PROPN
admet-3030	412	9	,	,	PUNCT
admet-3030	412	10	s.	s.	PROPN
admet-3030	412	11	gao	gao	PROPN
admet-3030	412	12	,	,	PUNCT
admet-3030	412	13	z.	z.	PROPN
admet-3030	412	14	jia	jia	PROPN
admet-3030	412	15	,	,	PUNCT
admet-3030	412	16	w.	w.	PROPN
admet-3030	412	17	xu	xu	PROPN
admet-3030	412	18	,	,	PUNCT
admet-3030	412	19	x.	x.	PROPN
admet-3030	412	20	wang	wang	PROPN
admet-3030	412	21	,	,	PUNCT
admet-3030	412	22	l.	l.	PROPN
admet-3030	412	23	wu	wu	PROPN
admet-3030	412	24	.	.	PUNCT
admet-3030	413	1	interleukin-33	interleukin-33	ADJ
admet-3030	413	2	links	link	NOUN
admet-3030	413	3	asthma	asthma	NOUN
admet-3030	413	4	to	to	ADP
admet-3030	413	5	alopecia	alopecia	NOUN
admet-3030	413	6	areata	areata	NOUN
admet-3030	413	7	:	:	PUNCT
admet-3030	413	8	mendelian	mendelian	ADJ
admet-3030	413	9	randomization	randomization	NOUN
admet-3030	413	10	and	and	CCONJ
admet-3030	413	11	mediation	mediation	NOUN
admet-3030	413	12	analysis	analysis	NOUN
admet-3030	413	13	.	.	PUNCT
admet-3030	414	1	skin	skin	NOUN
admet-3030	414	2	research	research	NOUN
admet-3030	414	3	and	and	CCONJ
admet-3030	414	4	technology	technology	NOUN
admet-3030	414	5	30	30	NUM
admet-3030	414	6	(	(	PUNCT
admet-3030	414	7	2024	2024	NUM
admet-3030	414	8	)	)	PUNCT
admet-3030	415	1	e13864	e13864	INTJ
admet-3030	415	2	.	.	PUNCT
admet-3030	416	1	https://dx.doi.org/10.1111/srt.13864	https://dx.doi.org/10.1111/srt.13864	PROPN
admet-3030	417	1	[	[	X
admet-3030	417	2	27	27	NUM
admet-3030	417	3	]	]	PUNCT
admet-3030	417	4	l.	l.	PROPN
admet-3030	417	5	pan	pan	PROPN
admet-3030	417	6	,	,	PUNCT
admet-3030	417	7	p.	p.	PROPN
admet-3030	417	8	moog	moog	PROPN
admet-3030	417	9	,	,	PUNCT
admet-3030	417	10	c.	c.	PROPN
admet-3030	417	11	li	li	PROPN
admet-3030	417	12	,	,	PUNCT
admet-3030	417	13	l.	l.	PROPN
admet-3030	417	14	steinbacher	steinbacher	PROPN
admet-3030	417	15	,	,	PUNCT
admet-3030	417	16	s.	s.	PROPN
admet-3030	417	17	knoedler	knoedler	PROPN
admet-3030	417	18	,	,	PUNCT
admet-3030	417	19	h.	h.	PROPN
admet-3030	417	20	kükrek	kükrek	PROPN
admet-3030	417	21	,	,	PUNCT
admet-3030	417	22	u.	u.	PROPN
admet-3030	417	23	dornseifer	dornseifer	PROPN
admet-3030	417	24	,	,	PUNCT
admet-3030	417	25	h.g	h.g	PROPN
admet-3030	417	26	.	.	PROPN
admet-3030	417	27	machens	machens	PROPN
admet-3030	417	28	,	,	PUNCT
admet-3030	417	29	j.	j.	PROPN
admet-3030	417	30	jiang	jiang	PROPN
admet-3030	417	31	.	.	PUNCT
admet-3030	418	1	exploring	explore	VERB
admet-3030	418	2	the	the	DET
admet-3030	418	3	association	association	NOUN
admet-3030	418	4	between	between	ADP
admet-3030	418	5	multidimensional	multidimensional	ADJ
admet-3030	418	6	dietary	dietary	ADJ
admet-3030	418	7	patterns	pattern	NOUN
admet-3030	418	8	and	and	CCONJ
admet-3030	418	9	non	non	ADJ
admet-3030	418	10	-	-	ADJ
admet-3030	418	11	scarring	scarring	ADJ
admet-3030	418	12	hair	hair	NOUN
admet-3030	418	13	loss	loss	NOUN
admet-3030	418	14	using	use	VERB
admet-3030	418	15	mendelian	mendelian	ADJ
admet-3030	418	16	randomization	randomization	NOUN
admet-3030	418	17	.	.	PUNCT
admet-3030	419	1	nutrients	nutrient	NOUN
admet-3030	419	2	17	17	NUM
admet-3030	419	3	(	(	PUNCT
admet-3030	419	4	2025	2025	NUM
admet-3030	419	5	)	)	PUNCT
admet-3030	419	6	2569	2569	NUM
admet-3030	419	7	.	.	PUNCT
admet-3030	420	1	https://dx.doi.org/10.3390/nu17152569	https://dx.doi.org/10.3390/nu17152569	PROPN
admet-3030	420	2	https://doi.org/10.1159/000530432	https://doi.org/10.1159/000530432	X
admet-3030	420	3	https://doi.org/10.15167/2421-4248/jpmh2022.63.2s3.2765	https://doi.org/10.15167/2421-4248/jpmh2022.63.2s3.2765	PROPN
admet-3030	421	1	https://doi.org/10.15167/2421-4248/jpmh2022.63.2s3.2765	https://doi.org/10.15167/2421-4248/jpmh2022.63.2s3.2765	PROPN
admet-3030	421	2	https://doi.org/10.1080/1744666x.2022.2096590	https://doi.org/10.1080/1744666x.2022.2096590	X
admet-3030	421	3	https://doi.org/10.1007/978-3-030-76111-0	https://doi.org/10.1007/978-3-030-76111-0	PROPN
admet-3030	421	4	https://dx.doi.org/10.3390/ijerph18041464	https://dx.doi.org/10.3390/ijerph18041464	NOUN
admet-3030	421	5	https://doi.org/10.2147/cia.s192435	https://doi.org/10.2147/cia.s192435	NUM
admet-3030	422	1	https://doi.org/10.1155/2016/7370642	https://doi.org/10.1155/2016/7370642	VERB
admet-3030	422	2	https://doi.org/10.7759/cureus.77317	https://doi.org/10.7759/cureus.77317	ADJ
admet-3030	422	3	https://doi.org/10.3390/ijms25052542	https://doi.org/10.3390/ijms25052542	ADJ
admet-3030	422	4	https://doi.org/10.1016/j.jnutbio.2024.109695	https://doi.org/10.1016/j.jnutbio.2024.109695	NOUN
admet-3030	422	5	https://doi.org/10.3389/fimmu.2024.1343987	https://doi.org/10.3389/fimmu.2024.1343987	PROPN
admet-3030	422	6	https://doi.org/10.3389/fimmu.2022.1072573	https://doi.org/10.3389/fimmu.2022.1072573	PROPN
admet-3030	422	7	https://doi.org/10.1111/srt.13864	https://doi.org/10.1111/srt.13864	PROPN
admet-3030	422	8	https://doi.org/10.3390/nu17152569	https://doi.org/10.3390/nu17152569	PROPN
admet-3030	422	9	admet	admet	PROPN
admet-3030	422	10	&	&	CCONJ
admet-3030	422	11	dmpk	dmpk	PROPN
admet-3030	422	12	00(0	00(0	PROPN
admet-3030	422	13	)	)	PUNCT
admet-3030	422	14	(	(	PUNCT
admet-3030	422	15	2025	2025	NUM
admet-3030	422	16	)	)	PUNCT
admet-3030	422	17	3030	3030	NUM
admet-3030	422	18	precision	precision	NOUN
admet-3030	422	19	therapeutics	therapeutic	NOUN
admet-3030	422	20	in	in	ADP
admet-3030	422	21	non	non	ADJ
admet-3030	422	22	-	-	ADJ
admet-3030	422	23	scarring	scar	VERB
admet-3030	422	24	alopecia	alopecia	NOUN
admet-3030	422	25	doi	doi	NOUN
admet-3030	422	26	:	:	PUNCT
admet-3030	422	27	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	422	28	17	17	NUM
admet-3030	423	1	[	[	X
admet-3030	423	2	28	28	NUM
admet-3030	423	3	]	]	X
admet-3030	423	4	a.	a.	PROPN
admet-3030	423	5	borde	borde	PROPN
admet-3030	423	6	,	,	PUNCT
admet-3030	423	7	a.	a.	NOUN
admet-3030	423	8	åstrand	åstrand	NOUN
admet-3030	423	9	.	.	PUNCT
admet-3030	424	1	alopecia	alopecia	NOUN
admet-3030	424	2	areata	areata	NOUN
admet-3030	424	3	and	and	CCONJ
admet-3030	424	4	the	the	DET
admet-3030	424	5	gut	gut	NOUN
admet-3030	424	6	-	-	PUNCT
admet-3030	424	7	the	the	DET
admet-3030	424	8	link	link	NOUN
admet-3030	424	9	opens	open	VERB
admet-3030	424	10	up	up	ADP
admet-3030	424	11	for	for	ADP
admet-3030	424	12	novel	novel	ADJ
admet-3030	424	13	therapeutic	therapeutic	ADJ
admet-3030	424	14	interventions	intervention	NOUN
admet-3030	424	15	.	.	PUNCT
admet-3030	425	1	expert	expert	ADJ
admet-3030	425	2	opinion	opinion	NOUN
admet-3030	425	3	on	on	ADP
admet-3030	425	4	therapeutic	therapeutic	ADJ
admet-3030	425	5	targets	target	NOUN
admet-3030	425	6	22	22	NUM
admet-3030	425	7	(	(	PUNCT
admet-3030	425	8	2018	2018	NUM
admet-3030	425	9	)	)	PUNCT
admet-3030	425	10	503	503	NUM
admet-3030	425	11	-	-	SYM
admet-3030	425	12	511	511	NUM
admet-3030	425	13	.	.	PUNCT
admet-3030	426	1	https://dx.doi.org/10.1080/14728222.2018.1481504	https://dx.doi.org/10.1080/14728222.2018.1481504	PRON
admet-3030	426	2	[	[	X
admet-3030	426	3	29	29	NUM
admet-3030	426	4	]	]	X
admet-3030	426	5	j.y	j.y	PROPN
admet-3030	426	6	.	.	PROPN
admet-3030	426	7	lee	lee	PROPN
admet-3030	426	8	,	,	PUNCT
admet-3030	426	9	h.j	h.j	PROPN
admet-3030	426	10	.	.	PROPN
admet-3030	426	11	lim	lim	PROPN
admet-3030	426	12	,	,	PUNCT
admet-3030	426	13	s.h	s.h	PROPN
admet-3030	426	14	.	.	PROPN
admet-3030	426	15	kim	kim	PROPN
admet-3030	426	16	,	,	PUNCT
admet-3030	426	17	g.j	g.j	PROPN
admet-3030	426	18	.	.	PROPN
admet-3030	426	19	lee	lee	PROPN
admet-3030	426	20	,	,	PUNCT
admet-3030	426	21	k.h	k.h	PROPN
admet-3030	426	22	.	.	PROPN
admet-3030	426	23	nam	nam	PROPN
admet-3030	426	24	,	,	PUNCT
admet-3030	426	25	j.	j.	PROPN
admet-3030	426	26	park	park	PROPN
admet-3030	426	27	,	,	PUNCT
admet-3030	426	28	j.k	j.k	PROPN
admet-3030	426	29	.	.	PUNCT
admet-3030	426	30	choi	choi	PROPN
admet-3030	426	31	.	.	PUNCT
admet-3030	426	32	decreased	decrease	VERB
admet-3030	426	33	cd19(+)cd24(hi)cd38(hi	cd19(+)cd24(hi)cd38(hi	NOUN
admet-3030	426	34	)	)	PUNCT
admet-3030	426	35	regulatory	regulatory	ADJ
admet-3030	426	36	b	b	PROPN
admet-3030	426	37	cells	cell	NOUN
admet-3030	426	38	in	in	ADP
admet-3030	426	39	alopecia	alopecia	NOUN
admet-3030	426	40	areata	areata	NOUN
admet-3030	426	41	.	.	PUNCT
admet-3030	427	1	journal	journal	NOUN
admet-3030	427	2	of	of	ADP
admet-3030	427	3	investigative	investigative	ADJ
admet-3030	427	4	dermatology	dermatology	NOUN
admet-3030	427	5	144	144	NUM
admet-3030	427	6	(	(	PUNCT
admet-3030	427	7	2024	2024	NUM
admet-3030	427	8	)	)	PUNCT
admet-3030	427	9	20802083.e2087	20802083.e2087	NUM
admet-3030	427	10	.	.	PUNCT
admet-3030	428	1	https://dx.doi.org/10.1016/j.jid.2024.02.004	https://dx.doi.org/10.1016/j.jid.2024.02.004	PROPN
admet-3030	428	2	[	[	X
admet-3030	428	3	30	30	NUM
admet-3030	428	4	]	]	X
admet-3030	428	5	n.a	n.a	PROPN
admet-3030	428	6	.	.	PROPN
admet-3030	428	7	hibberts	hibberts	PROPN
admet-3030	428	8	,	,	PUNCT
admet-3030	428	9	a.e	a.e	PROPN
admet-3030	428	10	.	.	PROPN
admet-3030	428	11	howell	howell	PROPN
admet-3030	428	12	,	,	PUNCT
admet-3030	428	13	v.a	v.a	PROPN
admet-3030	428	14	.	.	PROPN
admet-3030	428	15	randall	randall	PROPN
admet-3030	428	16	.	.	PUNCT
admet-3030	429	1	balding	bald	VERB
admet-3030	429	2	hair	hair	NOUN
admet-3030	429	3	follicle	follicle	NOUN
admet-3030	429	4	dermal	dermal	NOUN
admet-3030	429	5	papilla	papilla	NOUN
admet-3030	429	6	cells	cell	NOUN
admet-3030	429	7	contain	contain	VERB
admet-3030	429	8	higher	high	ADJ
admet-3030	429	9	levels	level	NOUN
admet-3030	429	10	of	of	ADP
admet-3030	429	11	androgen	androgen	NOUN
admet-3030	429	12	receptors	receptor	NOUN
admet-3030	429	13	than	than	ADP
admet-3030	429	14	those	those	PRON
admet-3030	429	15	from	from	ADP
admet-3030	429	16	non	non	ADJ
admet-3030	429	17	-	-	ADJ
admet-3030	429	18	balding	balding	ADJ
admet-3030	429	19	scalp	scalp	NOUN
admet-3030	429	20	.	.	PUNCT
admet-3030	430	1	journal	journal	PROPN
admet-3030	430	2	of	of	ADP
admet-3030	430	3	endocrinology	endocrinology	NOUN
admet-3030	430	4	156	156	NUM
admet-3030	430	5	(	(	PUNCT
admet-3030	430	6	1998	1998	NUM
admet-3030	430	7	)	)	PUNCT
admet-3030	430	8	59	59	NUM
admet-3030	430	9	-	-	SYM
admet-3030	430	10	65	65	NUM
admet-3030	430	11	.	.	PUNCT
admet-3030	431	1	https://dx.doi.org/10.1677/joe.0.1560059	https://dx.doi.org/10.1677/joe.0.1560059	PROPN
admet-3030	432	1	[	[	X
admet-3030	432	2	31	31	NUM
admet-3030	432	3	]	]	X
admet-3030	432	4	r.c	r.c	PROPN
admet-3030	432	5	.	.	PROPN
admet-3030	432	6	stone	stone	PROPN
admet-3030	432	7	,	,	PUNCT
admet-3030	432	8	a.	a.	PROPN
admet-3030	432	9	aviv	aviv	PROPN
admet-3030	432	10	,	,	PUNCT
admet-3030	432	11	r.	r.	PROPN
admet-3030	432	12	paus	paus	PROPN
admet-3030	432	13	.	.	PUNCT
admet-3030	433	1	telomere	telomere	NOUN
admet-3030	433	2	dynamics	dynamic	NOUN
admet-3030	433	3	and	and	CCONJ
admet-3030	433	4	telomerase	telomerase	NOUN
admet-3030	433	5	in	in	ADP
admet-3030	433	6	the	the	DET
admet-3030	433	7	biology	biology	NOUN
admet-3030	433	8	of	of	ADP
admet-3030	433	9	hair	hair	NOUN
admet-3030	433	10	follicles	follicle	NOUN
admet-3030	433	11	and	and	CCONJ
admet-3030	433	12	their	their	PRON
admet-3030	433	13	stem	stem	NOUN
admet-3030	433	14	cells	cell	NOUN
admet-3030	433	15	as	as	ADP
admet-3030	433	16	a	a	DET
admet-3030	433	17	model	model	NOUN
admet-3030	433	18	for	for	ADP
admet-3030	433	19	aging	age	VERB
admet-3030	433	20	research	research	NOUN
admet-3030	433	21	.	.	PUNCT
admet-3030	434	1	journal	journal	NOUN
admet-3030	434	2	of	of	ADP
admet-3030	434	3	investigative	investigative	ADJ
admet-3030	434	4	dermatology	dermatology	NOUN
admet-3030	434	5	141	141	NUM
admet-3030	434	6	(	(	PUNCT
admet-3030	434	7	2021	2021	NUM
admet-3030	434	8	)	)	PUNCT
admet-3030	434	9	1031	1031	NUM
admet-3030	434	10	-	-	SYM
admet-3030	434	11	1040	1040	NUM
admet-3030	434	12	.	.	PUNCT
admet-3030	435	1	https://dx.doi.org/10.1016/j.jid.2020.12.006	https://dx.doi.org/10.1016/j.jid.2020.12.006	PROPN
admet-3030	436	1	[	[	X
admet-3030	436	2	32	32	NUM
admet-3030	436	3	]	]	X
admet-3030	436	4	m.p	m.p	PROPN
admet-3030	436	5	.	.	PROPN
admet-3030	436	6	francès	francès	PROPN
admet-3030	436	7	,	,	PUNCT
admet-3030	436	8	l.	l.	PROPN
admet-3030	436	9	vila	vila	PROPN
admet-3030	436	10	-	-	PUNCT
admet-3030	436	11	vecilla	vecilla	PROPN
admet-3030	436	12	,	,	PUNCT
admet-3030	436	13	v.	v.	CCONJ
admet-3030	436	14	russo	russo	PROPN
admet-3030	436	15	,	,	PUNCT
admet-3030	436	16	h.	h.	PROPN
admet-3030	436	17	caetano	caetano	PROPN
admet-3030	436	18	polonini	polonini	PROPN
admet-3030	436	19	,	,	PUNCT
admet-3030	436	20	g.t	g.t	PROPN
admet-3030	436	21	.	.	PROPN
admet-3030	436	22	de	de	PROPN
admet-3030	436	23	souza	souza	PROPN
admet-3030	436	24	.	.	PUNCT
admet-3030	437	1	utilising	utilise	VERB
admet-3030	437	2	snp	snp	ADJ
admet-3030	437	3	association	association	NOUN
admet-3030	437	4	analysis	analysis	NOUN
admet-3030	437	5	as	as	ADP
admet-3030	437	6	a	a	DET
admet-3030	437	7	prospective	prospective	ADJ
admet-3030	437	8	approach	approach	NOUN
admet-3030	437	9	for	for	ADP
admet-3030	437	10	personalising	personalise	VERB
admet-3030	437	11	androgenetic	androgenetic	ADJ
admet-3030	437	12	alopecia	alopecia	NOUN
admet-3030	437	13	treatment	treatment	NOUN
admet-3030	437	14	.	.	PUNCT
admet-3030	438	1	dermatology	dermatology	NOUN
admet-3030	438	2	and	and	CCONJ
admet-3030	438	3	therapy	therapy	NOUN
admet-3030	438	4	(	(	PUNCT
admet-3030	438	5	heidelberg	heidelberg	PROPN
admet-3030	438	6	)	)	PUNCT
admet-3030	438	7	14	14	NUM
admet-3030	438	8	(	(	PUNCT
admet-3030	438	9	2024	2024	NUM
admet-3030	438	10	)	)	PUNCT
admet-3030	438	11	971	971	NUM
admet-3030	438	12	-	-	SYM
admet-3030	438	13	981	981	NUM
admet-3030	438	14	.	.	PUNCT
admet-3030	438	15	https://dx.doi.org/10.1007/s13555-024-01142-y	https://dx.doi.org/10.1007/s13555-024-01142-y	VERB
admet-3030	439	1	[	[	X
admet-3030	439	2	33	33	NUM
admet-3030	439	3	]	]	PUNCT
admet-3030	439	4	m.	m.	NOUN
admet-3030	439	5	murugan	murugan	PROPN
admet-3030	439	6	,	,	PUNCT
admet-3030	439	7	i.p	i.p	PROPN
admet-3030	439	8	.	.	PROPN
admet-3030	439	9	sadasivam	sadasivam	PROPN
admet-3030	439	10	,	,	PUNCT
admet-3030	439	11	a.	a.	NOUN
admet-3030	439	12	manoharan	manoharan	NOUN
admet-3030	439	13	,	,	PUNCT
admet-3030	439	14	s.	s.	PROPN
admet-3030	439	15	jayakumar	jayakumar	PROPN
admet-3030	439	16	,	,	PUNCT
admet-3030	439	17	y.	y.	PROPN
admet-3030	439	18	vetriselvan	vetriselvan	PROPN
admet-3030	439	19	,	,	PUNCT
admet-3030	439	20	m.s	m.s	PROPN
admet-3030	439	21	.	.	PROPN
admet-3030	439	22	samuel	samuel	PROPN
admet-3030	439	23	,	,	PUNCT
admet-3030	439	24	r.	r.	PROPN
admet-3030	439	25	sambandam	sambandam	PROPN
admet-3030	439	26	.	.	PUNCT
admet-3030	440	1	association	association	PROPN
admet-3030	440	2	between	between	ADP
admet-3030	440	3	pitx2	pitx2	NOUN
admet-3030	440	4	polymorphism	polymorphism	NOUN
admet-3030	440	5	and	and	CCONJ
admet-3030	440	6	androgenetic	androgenetic	ADJ
admet-3030	440	7	alopecia	alopecia	NOUN
admet-3030	440	8	in	in	ADP
admet-3030	440	9	the	the	DET
admet-3030	440	10	indian	indian	ADJ
admet-3030	440	11	population	population	NOUN
admet-3030	440	12	.	.	PUNCT
admet-3030	441	1	indian	indian	PROPN
admet-3030	441	2	journal	journal	PROPN
admet-3030	441	3	of	of	ADP
admet-3030	441	4	dermatology	dermatology	NOUN
admet-3030	441	5	,	,	PUNCT
admet-3030	441	6	venereology	venereology	NOUN
admet-3030	441	7	and	and	CCONJ
admet-3030	441	8	leprology	leprology	NOUN
admet-3030	441	9	91	91	NUM
admet-3030	441	10	(	(	PUNCT
admet-3030	441	11	2025	2025	NUM
admet-3030	441	12	)	)	PUNCT
admet-3030	441	13	158	158	NUM
admet-3030	441	14	-	-	SYM
admet-3030	441	15	162	162	NUM
admet-3030	441	16	.	.	PUNCT
admet-3030	442	1	https://dx.doi.org/10.25259/ijdvl_1147_2023	https://dx.doi.org/10.25259/ijdvl_1147_2023	PROPN
admet-3030	443	1	[	[	X
admet-3030	443	2	34	34	NUM
admet-3030	443	3	]	]	X
admet-3030	443	4	r.	r.	PROPN
admet-3030	443	5	kucerova	kucerova	PROPN
admet-3030	443	6	,	,	PUNCT
admet-3030	443	7	m.	m.	NOUN
admet-3030	443	8	bienova	bienova	PROPN
admet-3030	443	9	,	,	PUNCT
admet-3030	443	10	m.	m.	PROPN
admet-3030	443	11	kral	kral	PROPN
admet-3030	443	12	,	,	PUNCT
admet-3030	443	13	j.	j.	PROPN
admet-3030	443	14	bouchal	bouchal	PROPN
admet-3030	443	15	,	,	PUNCT
admet-3030	443	16	k.s	k.s	PROPN
admet-3030	443	17	.	.	PROPN
admet-3030	443	18	trtkova	trtkova	PROPN
admet-3030	443	19	,	,	PUNCT
admet-3030	443	20	a.	a.	PROPN
admet-3030	443	21	burdova	burdova	PROPN
admet-3030	443	22	,	,	PUNCT
admet-3030	443	23	v.	v.	ADP
admet-3030	443	24	student	student	NOUN
admet-3030	443	25	,	,	PUNCT
admet-3030	443	26	z.	z.	PROPN
admet-3030	443	27	kolar	kolar	PROPN
admet-3030	443	28	.	.	PUNCT
admet-3030	444	1	androgenetic	androgenetic	ADJ
admet-3030	444	2	alopecia	alopecia	NOUN
admet-3030	444	3	and	and	CCONJ
admet-3030	444	4	polymorphism	polymorphism	NOUN
admet-3030	444	5	of	of	ADP
admet-3030	444	6	the	the	DET
admet-3030	444	7	androgen	androgen	NOUN
admet-3030	444	8	receptor	receptor	NOUN
admet-3030	444	9	gene	gene	NOUN
admet-3030	444	10	(	(	PUNCT
admet-3030	444	11	snp	snp	ADJ
admet-3030	444	12	rs6152	rs6152	NOUN
admet-3030	444	13	)	)	PUNCT
admet-3030	444	14	in	in	ADP
admet-3030	444	15	patients	patient	NOUN
admet-3030	444	16	with	with	ADP
admet-3030	444	17	benign	benign	ADJ
admet-3030	444	18	prostate	prostate	NOUN
admet-3030	444	19	hyperplasia	hyperplasia	NOUN
admet-3030	444	20	or	or	CCONJ
admet-3030	444	21	prostate	prostate	NOUN
admet-3030	444	22	cancer	cancer	NOUN
admet-3030	444	23	.	.	PUNCT
admet-3030	445	1	journal	journal	NOUN
admet-3030	445	2	of	of	ADP
admet-3030	445	3	the	the	DET
admet-3030	445	4	european	european	PROPN
admet-3030	445	5	academy	academy	PROPN
admet-3030	445	6	of	of	ADP
admet-3030	445	7	dermatology	dermatology	NOUN
admet-3030	445	8	and	and	CCONJ
admet-3030	445	9	venereology	venereology	NOUN
admet-3030	445	10	29	29	NUM
admet-3030	445	11	(	(	PUNCT
admet-3030	445	12	2015	2015	NUM
admet-3030	445	13	)	)	PUNCT
admet-3030	445	14	91	91	NUM
admet-3030	445	15	-	-	SYM
admet-3030	445	16	96	96	NUM
admet-3030	445	17	.	.	PUNCT
admet-3030	446	1	https://dx.doi.org/10.1111/jdv.12468	https://dx.doi.org/10.1111/jdv.12468	NOUN
admet-3030	447	1	[	[	X
admet-3030	447	2	35	35	NUM
admet-3030	447	3	]	]	X
admet-3030	447	4	l.	l.	PROPN
admet-3030	447	5	vila	vila	PROPN
admet-3030	447	6	-	-	PUNCT
admet-3030	447	7	vecilla	vecilla	PROPN
admet-3030	447	8	,	,	PUNCT
admet-3030	447	9	v.	v.	CCONJ
admet-3030	447	10	russo	russo	PROPN
admet-3030	447	11	,	,	PUNCT
admet-3030	447	12	g.	g.	PROPN
admet-3030	447	13	souza	souza	PROPN
admet-3030	447	14	.	.	PUNCT
admet-3030	448	1	genomic	genomic	ADJ
admet-3030	448	2	markers	marker	NOUN
admet-3030	448	3	and	and	CCONJ
admet-3030	448	4	personalized	personalized	ADJ
admet-3030	448	5	medicine	medicine	NOUN
admet-3030	448	6	in	in	ADP
admet-3030	448	7	androgenetic	androgenetic	ADJ
admet-3030	448	8	alopecia	alopecia	NOUN
admet-3030	448	9	.	.	PUNCT
admet-3030	449	1	cosmetics	cosmetic	NOUN
admet-3030	449	2	11	11	NUM
admet-3030	449	3	(	(	PUNCT
admet-3030	449	4	2024	2024	NUM
admet-3030	449	5	)	)	PUNCT
admet-3030	449	6	148	148	NUM
admet-3030	449	7	.	.	PUNCT
admet-3030	450	1	https://dx.doi.org/10.3390/cosmetics11050148	https://dx.doi.org/10.3390/cosmetics11050148	PROPN
admet-3030	450	2	[	[	X
admet-3030	450	3	36	36	NUM
admet-3030	450	4	]	]	X
admet-3030	450	5	m.	m.	NOUN
admet-3030	450	6	pu	pu	PROPN
admet-3030	450	7	,	,	PUNCT
admet-3030	450	8	j.	j.	PROPN
admet-3030	450	9	chen	chen	PROPN
admet-3030	450	10	,	,	PUNCT
admet-3030	450	11	z.	z.	PROPN
admet-3030	450	12	tao	tao	PROPN
admet-3030	450	13	,	,	PUNCT
admet-3030	450	14	l.	l.	PROPN
admet-3030	450	15	miao	miao	PROPN
admet-3030	450	16	,	,	PUNCT
admet-3030	450	17	x.	x.	PROPN
admet-3030	450	18	qi	qi	PROPN
admet-3030	450	19	,	,	PUNCT
admet-3030	450	20	y.	y.	PROPN
admet-3030	450	21	wang	wang	PROPN
admet-3030	450	22	,	,	PUNCT
admet-3030	450	23	j.	j.	PROPN
admet-3030	450	24	ren	ren	PROPN
admet-3030	450	25	.	.	PUNCT
admet-3030	451	1	regulatory	regulatory	ADJ
admet-3030	451	2	network	network	NOUN
admet-3030	451	3	of	of	ADP
admet-3030	451	4	mirna	mirna	PROPN
admet-3030	451	5	on	on	ADP
admet-3030	451	6	its	its	PRON
admet-3030	451	7	target	target	NOUN
admet-3030	451	8	:	:	PUNCT
admet-3030	451	9	coordination	coordination	NOUN
admet-3030	451	10	between	between	ADP
admet-3030	451	11	transcriptional	transcriptional	NOUN
admet-3030	451	12	and	and	CCONJ
admet-3030	451	13	post	post	ADJ
admet-3030	451	14	-	-	ADJ
admet-3030	451	15	transcriptional	transcriptional	ADJ
admet-3030	451	16	regulation	regulation	NOUN
admet-3030	451	17	of	of	ADP
admet-3030	451	18	gene	gene	NOUN
admet-3030	451	19	expression	expression	NOUN
admet-3030	451	20	.	.	PUNCT
admet-3030	452	1	cellular	cellular	ADJ
admet-3030	452	2	and	and	CCONJ
admet-3030	452	3	molecular	molecular	ADJ
admet-3030	452	4	life	life	NOUN
admet-3030	452	5	sciences	science	NOUN
admet-3030	452	6	76	76	NUM
admet-3030	452	7	(	(	PUNCT
admet-3030	452	8	2019	2019	NUM
admet-3030	452	9	)	)	PUNCT
admet-3030	452	10	441	441	NUM
admet-3030	452	11	-	-	SYM
admet-3030	452	12	451	451	NUM
admet-3030	452	13	.	.	PUNCT
admet-3030	453	1	https://dx.doi.org/10.1007/s00018-0182940-7	https://dx.doi.org/10.1007/s00018-0182940-7	PROPN
admet-3030	454	1	[	[	X
admet-3030	454	2	37	37	NUM
admet-3030	454	3	]	]	PUNCT
admet-3030	454	4	s.	s.	PROPN
admet-3030	454	5	paul	paul	PROPN
admet-3030	454	6	,	,	PUNCT
admet-3030	454	7	i.	i.	PROPN
admet-3030	454	8	licona	licona	PROPN
admet-3030	454	9	-	-	PUNCT
admet-3030	454	10	vázquez	vázquez	NOUN
admet-3030	454	11	,	,	PUNCT
admet-3030	454	12	f.i	f.i	PROPN
admet-3030	454	13	.	.	PROPN
admet-3030	454	14	serrano	serrano	PROPN
admet-3030	454	15	-	-	PUNCT
admet-3030	454	16	cano	cano	PROPN
admet-3030	454	17	,	,	PUNCT
admet-3030	454	18	n.	n.	PROPN
admet-3030	454	19	frías	frías	PROPN
admet-3030	454	20	-	-	PUNCT
admet-3030	454	21	reid	reid	PROPN
admet-3030	454	22	,	,	PUNCT
admet-3030	454	23	c.	c.	PROPN
admet-3030	454	24	pacheco	pacheco	PROPN
admet-3030	454	25	-	-	PUNCT
admet-3030	454	26	dorantes	dorantes	PROPN
admet-3030	454	27	,	,	PUNCT
admet-3030	454	28	s.	s.	PROPN
admet-3030	454	29	pathak	pathak	PROPN
admet-3030	454	30	,	,	PUNCT
admet-3030	454	31	s.	s.	PROPN
admet-3030	454	32	chakraborty	chakraborty	PROPN
admet-3030	454	33	,	,	PUNCT
admet-3030	454	34	a.	a.	PROPN
admet-3030	454	35	srivastava	srivastava	PROPN
admet-3030	454	36	.	.	PUNCT
admet-3030	455	1	current	current	ADJ
admet-3030	455	2	insight	insight	NOUN
admet-3030	455	3	into	into	ADP
admet-3030	455	4	the	the	DET
admet-3030	455	5	functions	function	NOUN
admet-3030	455	6	of	of	ADP
admet-3030	455	7	micrornas	microrna	NOUN
admet-3030	455	8	in	in	ADP
admet-3030	455	9	common	common	ADJ
admet-3030	455	10	human	human	ADJ
admet-3030	455	11	hair	hair	NOUN
admet-3030	455	12	loss	loss	NOUN
admet-3030	455	13	disorders	disorder	NOUN
admet-3030	455	14	:	:	PUNCT
admet-3030	455	15	a	a	DET
admet-3030	455	16	mini	mini	ADJ
admet-3030	455	17	review	review	NOUN
admet-3030	455	18	.	.	PUNCT
admet-3030	456	1	human	human	ADJ
admet-3030	456	2	cell	cell	NOUN
admet-3030	456	3	34	34	NUM
admet-3030	456	4	(	(	PUNCT
admet-3030	456	5	2021	2021	NUM
admet-3030	456	6	)	)	PUNCT
admet-3030	456	7	1040	1040	NUM
admet-3030	456	8	-	-	SYM
admet-3030	456	9	1050	1050	NUM
admet-3030	456	10	.	.	PUNCT
admet-3030	457	1	https://dx.doi.org/10.1007/s13577021-00540-0	https://dx.doi.org/10.1007/s13577021-00540-0	NOUN
admet-3030	458	1	[	[	X
admet-3030	458	2	38	38	NUM
admet-3030	458	3	]	]	PUNCT
admet-3030	458	4	d.	d.	PROPN
admet-3030	458	5	papukashvili	papukashvili	PROPN
admet-3030	458	6	,	,	PUNCT
admet-3030	458	7	n.	n.	NOUN
admet-3030	458	8	rcheulishvili	rcheulishvili	NOUN
admet-3030	458	9	,	,	PUNCT
admet-3030	458	10	c.	c.	PROPN
admet-3030	458	11	liu	liu	PROPN
admet-3030	458	12	,	,	PUNCT
admet-3030	458	13	f.	f.	PROPN
admet-3030	458	14	xie	xie	PROPN
admet-3030	458	15	,	,	PUNCT
admet-3030	458	16	d.	d.	PROPN
admet-3030	458	17	tyagi	tyagi	PROPN
admet-3030	458	18	,	,	PUNCT
admet-3030	458	19	y.	y.	PROPN
admet-3030	458	20	he	he	PRON
admet-3030	458	21	,	,	PUNCT
admet-3030	458	22	p.g	p.g	PROPN
admet-3030	458	23	.	.	PROPN
admet-3030	458	24	wang	wang	PROPN
admet-3030	458	25	.	.	PUNCT
admet-3030	459	1	perspectives	perspective	NOUN
admet-3030	459	2	on	on	ADP
admet-3030	459	3	mirnas	mirna	NOUN
admet-3030	459	4	targeting	target	VERB
admet-3030	459	5	dkk1	dkk1	PROPN
admet-3030	459	6	for	for	ADP
admet-3030	459	7	developing	develop	VERB
admet-3030	459	8	hair	hair	NOUN
admet-3030	459	9	regeneration	regeneration	NOUN
admet-3030	459	10	therapy	therapy	NOUN
admet-3030	459	11	.	.	PUNCT
admet-3030	460	1	cells	cell	NOUN
admet-3030	460	2	10	10	NUM
admet-3030	460	3	(	(	PUNCT
admet-3030	460	4	2021	2021	NUM
admet-3030	460	5	)	)	PUNCT
admet-3030	460	6	.	.	PUNCT
admet-3030	461	1	https://dx.doi.org/10.3390/cells10112957	https://dx.doi.org/10.3390/cells10112957	NOUN
admet-3030	462	1	[	[	X
admet-3030	462	2	39	39	NUM
admet-3030	462	3	]	]	PUNCT
admet-3030	462	4	h.	h.	PROPN
admet-3030	462	5	wei	wei	PROPN
admet-3030	462	6	,	,	PUNCT
admet-3030	462	7	t.	t.	PROPN
admet-3030	462	8	yi	yi	PROPN
admet-3030	462	9	,	,	PUNCT
admet-3030	462	10	q.	q.	PROPN
admet-3030	462	11	li	li	PROPN
admet-3030	462	12	,	,	PUNCT
admet-3030	462	13	y.	y.	PROPN
admet-3030	462	14	guo	guo	PROPN
admet-3030	462	15	,	,	PUNCT
admet-3030	462	16	c.	c.	PROPN
admet-3030	462	17	shen	shen	PROPN
admet-3030	462	18	,	,	PUNCT
admet-3030	462	19	p.	p.	PROPN
admet-3030	462	20	jin	jin	PROPN
admet-3030	462	21	.	.	PUNCT
admet-3030	463	1	application	application	NOUN
admet-3030	463	2	of	of	ADP
admet-3030	463	3	lncrna	lncrna	NOUN
admet-3030	463	4	-	-	PUNCT
admet-3030	463	5	mirna	mirna	NOUN
admet-3030	463	6	-	-	PUNCT
admet-3030	463	7	mrna	mrna	PROPN
admet-3030	463	8	cerna	cerna	PROPN
admet-3030	463	9	network	network	NOUN
admet-3030	463	10	analysis	analysis	NOUN
admet-3030	463	11	in	in	ADP
admet-3030	463	12	the	the	DET
admet-3030	463	13	treatment	treatment	NOUN
admet-3030	463	14	of	of	ADP
admet-3030	463	15	androgenic	androgenic	ADJ
admet-3030	463	16	alopecia	alopecia	NOUN
admet-3030	463	17	.	.	PUNCT
admet-3030	464	1	journal	journal	PROPN
admet-3030	464	2	of	of	ADP
admet-3030	464	3	clinical	clinical	ADJ
admet-3030	464	4	laboratory	laboratory	NOUN
admet-3030	464	5	analysis	analysis	NOUN
admet-3030	464	6	37	37	NUM
admet-3030	464	7	(	(	PUNCT
admet-3030	464	8	2023	2023	NUM
admet-3030	464	9	)	)	PUNCT
admet-3030	464	10	e24791	e24791	PROPN
admet-3030	464	11	.	.	PUNCT
admet-3030	464	12	https://dx.doi.org/10.1002/jcla.24791	https://dx.doi.org/10.1002/jcla.24791	PUNCT
admet-3030	465	1	[	[	X
admet-3030	465	2	40	40	NUM
admet-3030	465	3	]	]	X
admet-3030	465	4	o.m	o.m	PROPN
admet-3030	465	5	.	.	PROPN
admet-3030	465	6	atrooz	atrooz	PROPN
admet-3030	465	7	,	,	PUNCT
admet-3030	465	8	n.	n.	PROPN
admet-3030	465	9	reihani	reihani	PROPN
admet-3030	465	10	,	,	PUNCT
admet-3030	465	11	m.r	m.r	PROPN
admet-3030	465	12	.	.	PROPN
admet-3030	465	13	mozafari	mozafari	PROPN
admet-3030	465	14	,	,	PUNCT
admet-3030	465	15	a.	a.	PROPN
admet-3030	465	16	salawi	salawi	PROPN
admet-3030	465	17	,	,	PUNCT
admet-3030	465	18	e.	e.	PROPN
admet-3030	465	19	taghavi	taghavi	PROPN
admet-3030	465	20	.	.	PUNCT
admet-3030	466	1	enhancing	enhance	VERB
admet-3030	466	2	hair	hair	NOUN
admet-3030	466	3	regeneration	regeneration	NOUN
admet-3030	466	4	:	:	PUNCT
admet-3030	466	5	recent	recent	ADJ
admet-3030	466	6	progress	progress	NOUN
admet-3030	466	7	in	in	ADP
admet-3030	466	8	tailoring	tailor	VERB
admet-3030	466	9	nanostructured	nanostructure	VERB
admet-3030	466	10	lipid	lipid	NOUN
admet-3030	466	11	carriers	carrier	NOUN
admet-3030	466	12	through	through	ADP
admet-3030	466	13	surface	surface	NOUN
admet-3030	466	14	modification	modification	NOUN
admet-3030	466	15	strategies	strategy	NOUN
admet-3030	466	16	.	.	PUNCT
admet-3030	467	1	admet	admet	PROPN
admet-3030	467	2	&	&	CCONJ
admet-3030	467	3	dmpk	dmpk	PROPN
admet-3030	467	4	12	12	NUM
admet-3030	467	5	(	(	PUNCT
admet-3030	467	6	2024	2024	NUM
admet-3030	467	7	)	)	PUNCT
admet-3030	467	8	431	431	NUM
admet-3030	467	9	-	-	SYM
admet-3030	467	10	462	462	NUM
admet-3030	467	11	.	.	PUNCT
admet-3030	467	12	https://dx.doi.org/10.5599/admet.2376	https://dx.doi.org/10.5599/admet.2376	X
admet-3030	468	1	[	[	X
admet-3030	468	2	41	41	NUM
admet-3030	468	3	]	]	PUNCT
admet-3030	468	4	q.	q.	PROPN
admet-3030	468	5	chen	chen	PROPN
admet-3030	468	6	,	,	PUNCT
admet-3030	468	7	t.	t.	PROPN
admet-3030	468	8	yang	yang	PROPN
admet-3030	468	9	,	,	PUNCT
admet-3030	468	10	j.	j.	PROPN
admet-3030	468	11	cheng	cheng	PROPN
admet-3030	468	12	,	,	PUNCT
admet-3030	468	13	q.	q.	PROPN
admet-3030	468	14	zhao	zhao	PROPN
admet-3030	468	15	.	.	PUNCT
admet-3030	469	1	exploring	explore	VERB
admet-3030	469	2	the	the	DET
admet-3030	469	3	shared	share	VERB
admet-3030	469	4	genetic	genetic	ADJ
admet-3030	469	5	mechanisms	mechanism	NOUN
admet-3030	469	6	of	of	ADP
admet-3030	469	7	atopic	atopic	NOUN
admet-3030	469	8	dermatitis	dermatitis	NOUN
admet-3030	469	9	and	and	CCONJ
admet-3030	469	10	alopecia	alopecia	NOUN
admet-3030	469	11	areata	areata	ADJ
admet-3030	469	12	via	via	ADP
admet-3030	469	13	bioinformatics	bioinformatics	NOUN
admet-3030	469	14	approaches	approach	NOUN
admet-3030	469	15	.	.	PUNCT
admet-3030	470	1	archives	archive	NOUN
admet-3030	470	2	of	of	ADP
admet-3030	470	3	dermatological	dermatological	ADJ
admet-3030	470	4	research	research	NOUN
admet-3030	470	5	317	317	NUM
admet-3030	470	6	(	(	PUNCT
admet-3030	470	7	2025	2025	NUM
admet-3030	470	8	)	)	PUNCT
admet-3030	470	9	448	448	NUM
admet-3030	470	10	.	.	PUNCT
admet-3030	470	11	https://dx.doi.org/10.1007/s00403-025-04004-5	https://dx.doi.org/10.1007/s00403-025-04004-5	PUNCT
admet-3030	471	1	[	[	X
admet-3030	471	2	42	42	NUM
admet-3030	471	3	]	]	X
admet-3030	471	4	y.	y.	PROPN
admet-3030	471	5	du	du	PROPN
admet-3030	471	6	,	,	PUNCT
admet-3030	471	7	c.	c.	PROPN
admet-3030	471	8	lu	lu	PROPN
admet-3030	471	9	,	,	PUNCT
admet-3030	471	10	l.	l.	PROPN
admet-3030	471	11	bi	bi	PROPN
admet-3030	471	12	,	,	PUNCT
admet-3030	471	13	c.	c.	PROPN
admet-3030	471	14	wang	wang	PROPN
admet-3030	471	15	,	,	PUNCT
admet-3030	471	16	m.	m.	NOUN
admet-3030	471	17	zhao	zhao	PROPN
admet-3030	471	18	,	,	PUNCT
admet-3030	471	19	y.	y.	PROPN
admet-3030	471	20	ding	ding	PROPN
admet-3030	471	21	,	,	PUNCT
admet-3030	471	22	w.	w.	PROPN
admet-3030	471	23	fan	fan	PROPN
admet-3030	471	24	.	.	PUNCT
admet-3030	472	1	causal	causal	ADJ
admet-3030	472	2	effects	effect	NOUN
admet-3030	472	3	of	of	ADP
admet-3030	472	4	genetically	genetically	ADV
admet-3030	472	5	determined	determined	ADJ
admet-3030	472	6	metabolites	metabolite	NOUN
admet-3030	472	7	on	on	ADP
admet-3030	472	8	androgenetic	androgenetic	ADJ
admet-3030	472	9	alopecia	alopecia	NOUN
admet-3030	472	10	:	:	PUNCT
admet-3030	472	11	a	a	DET
admet-3030	472	12	two	two	NUM
admet-3030	472	13	-	-	PUNCT
admet-3030	472	14	sample	sample	NOUN
admet-3030	472	15	mendelian	mendelian	ADJ
admet-3030	472	16	randomization	randomization	NOUN
admet-3030	472	17	analysis	analysis	NOUN
admet-3030	472	18	.	.	PUNCT
admet-3030	473	1	skin	skin	NOUN
admet-3030	473	2	research	research	NOUN
admet-3030	473	3	and	and	CCONJ
admet-3030	473	4	technology	technology	NOUN
admet-3030	473	5	30	30	NUM
admet-3030	473	6	(	(	PUNCT
admet-3030	473	7	2024	2024	NUM
admet-3030	473	8	)	)	PUNCT
admet-3030	473	9	e13732	e13732	PROPN
admet-3030	473	10	.	.	PUNCT
admet-3030	474	1	https://dx.doi.org/10.1111/srt.13732	https://dx.doi.org/10.1111/srt.13732	PROPN
admet-3030	474	2	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	474	3	https://doi.org/10.1080/14728222.2018.1481504	https://doi.org/10.1080/14728222.2018.1481504	PROPN
admet-3030	474	4	https://doi.org/10.1016/j.jid.2024.02.004	https://doi.org/10.1016/j.jid.2024.02.004	PROPN
admet-3030	474	5	https://doi.org/10.1677/joe.0.1560059	https://doi.org/10.1677/joe.0.1560059	PROPN
admet-3030	475	1	https://doi.org/10.1016/j.jid.2020.12.006	https://doi.org/10.1016/j.jid.2020.12.006	NOUN
admet-3030	475	2	https://doi.org/10.1007/s13555-024-01142-y	https://doi.org/10.1007/s13555-024-01142-y	VERB
admet-3030	475	3	https://doi.org/10.25259/ijdvl_1147_2023	https://doi.org/10.25259/ijdvl_1147_2023	PROPN
admet-3030	475	4	https://doi.org/10.1111/jdv.12468	https://doi.org/10.1111/jdv.12468	PROPN
admet-3030	475	5	https://doi.org/10.3390/cosmetics11050148	https://doi.org/10.3390/cosmetics11050148	NOUN
admet-3030	475	6	https://doi.org/10.1007/s00018-018-2940-7	https://doi.org/10.1007/s00018-018-2940-7	NUM
admet-3030	475	7	https://doi.org/10.1007/s00018-018-2940-7	https://doi.org/10.1007/s00018-018-2940-7	NUM
admet-3030	475	8	https://doi.org/10.1007/s13577-021-00540-0	https://doi.org/10.1007/s13577-021-00540-0	NUM
admet-3030	475	9	https://doi.org/10.1007/s13577-021-00540-0	https://doi.org/10.1007/s13577-021-00540-0	NUM
admet-3030	475	10	https://doi.org/10.3390/cells10112957	https://doi.org/10.3390/cells10112957	NOUN
admet-3030	475	11	https://doi.org/10.1002/jcla.24791	https://doi.org/10.1002/jcla.24791	ADV
admet-3030	475	12	https://doi.org/10.5599/admet.2376	https://doi.org/10.5599/admet.2376	NOUN
admet-3030	475	13	https://doi.org/10.1007/s00403-025-04004-5	https://doi.org/10.1007/s00403-025-04004-5	PROPN
admet-3030	476	1	https://doi.org/10.1111/srt.13732	https://doi.org/10.1111/srt.13732	PROPN
admet-3030	476	2	r.	r.	PROPN
admet-3030	476	3	kapoor	kapoor	PROPN
admet-3030	476	4	et	et	PROPN
admet-3030	476	5	al	al	PROPN
admet-3030	476	6	.	.	PROPN
admet-3030	476	7	admet	admet	PROPN
admet-3030	476	8	&	&	CCONJ
admet-3030	476	9	dmpk	dmpk	PROPN
admet-3030	476	10	00(0	00(0	PROPN
admet-3030	476	11	)	)	PUNCT
admet-3030	476	12	(	(	PUNCT
admet-3030	476	13	2025	2025	NUM
admet-3030	476	14	)	)	PUNCT
admet-3030	476	15	3030	3030	NUM
admet-3030	476	16	18	18	NUM
admet-3030	476	17	[	[	X
admet-3030	476	18	43	43	NUM
admet-3030	476	19	]	]	X
admet-3030	476	20	j.a	j.a	PROPN
admet-3030	476	21	.	.	PROPN
admet-3030	476	22	ellis	ellis	PROPN
admet-3030	476	23	,	,	PUNCT
admet-3030	476	24	k.j	k.j	PROPN
admet-3030	476	25	.	.	PROPN
admet-3030	476	26	scurrah	scurrah	PROPN
admet-3030	476	27	,	,	PUNCT
admet-3030	476	28	j.e	j.e	PROPN
admet-3030	476	29	.	.	PROPN
admet-3030	476	30	cobb	cobb	PROPN
admet-3030	476	31	,	,	PUNCT
admet-3030	476	32	s.g	s.g	PROPN
admet-3030	476	33	.	.	PROPN
admet-3030	476	34	zaloumis	zaloumis	PROPN
admet-3030	476	35	,	,	PUNCT
admet-3030	476	36	a.e	a.e	PROPN
admet-3030	476	37	.	.	PROPN
admet-3030	476	38	duncan	duncan	PROPN
admet-3030	476	39	,	,	PUNCT
admet-3030	476	40	s.b	s.b	PROPN
admet-3030	476	41	.	.	PROPN
admet-3030	476	42	harrap	harrap	PROPN
admet-3030	476	43	.	.	PUNCT
admet-3030	477	1	baldness	baldness	PROPN
admet-3030	477	2	and	and	CCONJ
admet-3030	477	3	the	the	DET
admet-3030	477	4	androgen	androgen	NOUN
admet-3030	477	5	receptor	receptor	NOUN
admet-3030	477	6	:	:	PUNCT
admet-3030	477	7	the	the	DET
admet-3030	477	8	ar	ar	PROPN
admet-3030	477	9	polyglycine	polyglycine	NOUN
admet-3030	477	10	repeat	repeat	NOUN
admet-3030	477	11	polymorphism	polymorphism	NOUN
admet-3030	477	12	does	do	AUX
admet-3030	477	13	not	not	PART
admet-3030	477	14	confer	confer	VERB
admet-3030	477	15	susceptibility	susceptibility	NOUN
admet-3030	477	16	to	to	ADP
admet-3030	477	17	androgenetic	androgenetic	ADJ
admet-3030	477	18	alopecia	alopecia	NOUN
admet-3030	477	19	.	.	PUNCT
admet-3030	478	1	human	human	ADJ
admet-3030	478	2	genetics	genetic	NOUN
admet-3030	478	3	121	121	NUM
admet-3030	478	4	(	(	PUNCT
admet-3030	478	5	2007	2007	NUM
admet-3030	478	6	)	)	PUNCT
admet-3030	478	7	451	451	NUM
admet-3030	478	8	-	-	SYM
admet-3030	478	9	457	457	NUM
admet-3030	478	10	.	.	PUNCT
admet-3030	479	1	https://dx.doi.org/10.1007/s00439-006-0317-8	https://dx.doi.org/10.1007/s00439-006-0317-8	NUM
admet-3030	480	1	[	[	X
admet-3030	480	2	44	44	NUM
admet-3030	480	3	]	]	X
admet-3030	480	4	d.a	d.a	PROPN
admet-3030	480	5	.	.	PROPN
admet-3030	480	6	prodi	prodi	PROPN
admet-3030	480	7	,	,	PUNCT
admet-3030	480	8	n.	n.	PROPN
admet-3030	480	9	pirastu	pirastu	PROPN
admet-3030	480	10	,	,	PUNCT
admet-3030	480	11	g.	g.	PROPN
admet-3030	480	12	maninchedda	maninchedda	PROPN
admet-3030	480	13	,	,	PUNCT
admet-3030	480	14	a.	a.	PROPN
admet-3030	480	15	sassu	sassu	PROPN
admet-3030	480	16	,	,	PUNCT
admet-3030	480	17	a.	a.	PROPN
admet-3030	480	18	picciau	picciau	PROPN
admet-3030	480	19	,	,	PUNCT
admet-3030	480	20	m.a	m.a	PROPN
admet-3030	480	21	.	.	PROPN
admet-3030	480	22	palmas	palmas	PROPN
admet-3030	480	23	,	,	PUNCT
admet-3030	480	24	a.	a.	PROPN
admet-3030	480	25	mossa	mossa	PROPN
admet-3030	480	26	,	,	PUNCT
admet-3030	480	27	i.	i.	PROPN
admet-3030	480	28	persico	persico	PROPN
admet-3030	480	29	,	,	PUNCT
admet-3030	480	30	m.	m.	NOUN
admet-3030	480	31	adamo	adamo	PROPN
admet-3030	480	32	,	,	PUNCT
admet-3030	480	33	a.	a.	NOUN
admet-3030	480	34	angius	angius	PROPN
admet-3030	480	35	,	,	PUNCT
admet-3030	480	36	m.	m.	PROPN
admet-3030	480	37	pirastu	pirastu	PROPN
admet-3030	480	38	.	.	PROPN
admet-3030	480	39	eda2r	eda2r	PROPN
admet-3030	480	40	is	be	AUX
admet-3030	480	41	associated	associate	VERB
admet-3030	480	42	with	with	ADP
admet-3030	480	43	androgenetic	androgenetic	ADJ
admet-3030	480	44	alopecia	alopecia	NOUN
admet-3030	480	45	.	.	PUNCT
admet-3030	481	1	journal	journal	PROPN
admet-3030	481	2	of	of	ADP
admet-3030	481	3	investigative	investigative	ADJ
admet-3030	481	4	dermatology	dermatology	NOUN
admet-3030	481	5	128	128	NUM
admet-3030	481	6	(	(	PUNCT
admet-3030	481	7	2008	2008	NUM
admet-3030	481	8	)	)	PUNCT
admet-3030	481	9	2268	2268	NUM
admet-3030	481	10	-	-	SYM
admet-3030	481	11	2270	2270	NUM
admet-3030	481	12	.	.	PUNCT
admet-3030	482	1	https://dx.doi.org/10.1038/jid.2008.60	https://dx.doi.org/10.1038/jid.2008.60	PROPN
admet-3030	482	2	[	[	X
admet-3030	482	3	45	45	NUM
admet-3030	482	4	]	]	PUNCT
admet-3030	482	5	a.	a.	NOUN
admet-3030	482	6	elgobashy	elgobashy	PROPN
admet-3030	482	7	,	,	PUNCT
admet-3030	482	8	n.	n.	PROPN
admet-3030	482	9	el	el	PROPN
admet-3030	482	10	-	-	PUNCT
admet-3030	482	11	nefiawy	nefiawy	PROPN
admet-3030	482	12	,	,	PUNCT
admet-3030	482	13	s.	s.	PROPN
admet-3030	482	14	el	el	PROPN
admet-3030	482	15	-	-	PUNCT
admet-3030	482	16	sayed	sayed	PROPN
admet-3030	482	17	,	,	PUNCT
admet-3030	482	18	s.	s.	PROPN
admet-3030	482	19	magdy	magdy	PROPN
admet-3030	482	20	,	,	PUNCT
admet-3030	482	21	w.	w.	PROPN
admet-3030	482	22	abdelmoez	abdelmoez	PROPN
admet-3030	482	23	.	.	PUNCT
admet-3030	483	1	a	a	DET
admet-3030	483	2	review	review	NOUN
admet-3030	483	3	on	on	ADP
admet-3030	483	4	androgenic	androgenic	ADJ
admet-3030	483	5	alopecia	alopecia	NOUN
admet-3030	483	6	:	:	PUNCT
admet-3030	483	7	etiology	etiology	NOUN
admet-3030	483	8	,	,	PUNCT
admet-3030	483	9	pathogenesis	pathogenesis	NOUN
admet-3030	483	10	,	,	PUNCT
admet-3030	483	11	pharmacological	pharmacological	NOUN
admet-3030	483	12	and	and	CCONJ
admet-3030	483	13	non	non	ADJ
admet-3030	483	14	-	-	ADJ
admet-3030	483	15	pharmacological	pharmacological	ADJ
admet-3030	483	16	treatment	treatment	NOUN
admet-3030	483	17	approaches	approach	NOUN
admet-3030	483	18	.	.	PUNCT
admet-3030	484	1	ain	ain	PROPN
admet-3030	484	2	shams	sham	VERB
admet-3030	484	3	medical	medical	ADJ
admet-3030	484	4	journal	journal	NOUN
admet-3030	484	5	75	75	NUM
admet-3030	484	6	(	(	PUNCT
admet-3030	484	7	2024	2024	NUM
admet-3030	484	8	)	)	PUNCT
admet-3030	484	9	587	587	NUM
admet-3030	484	10	-	-	SYM
admet-3030	484	11	602	602	NUM
admet-3030	484	12	.	.	PUNCT
admet-3030	485	1	https://dx.doi.org/10.21608/asmj.2024.299393.1282	https://dx.doi.org/10.21608/asmj.2024.299393.1282	PROPN
admet-3030	485	2	[	[	X
admet-3030	485	3	46	46	NUM
admet-3030	485	4	]	]	X
admet-3030	485	5	y.	y.	PROPN
admet-3030	485	6	shimomura	shimomura	PROPN
admet-3030	485	7	,	,	PUNCT
admet-3030	485	8	d.	d.	PROPN
admet-3030	485	9	agalliu	agalliu	PROPN
admet-3030	485	10	,	,	PUNCT
admet-3030	485	11	a.	a.	NOUN
admet-3030	485	12	vonica	vonica	PROPN
admet-3030	485	13	,	,	PUNCT
admet-3030	485	14	v.	v.	PROPN
admet-3030	485	15	luria	luria	PROPN
admet-3030	485	16	,	,	PUNCT
admet-3030	485	17	m.	m.	PROPN
admet-3030	485	18	wajid	wajid	PROPN
admet-3030	485	19	,	,	PUNCT
admet-3030	485	20	a.	a.	PROPN
admet-3030	485	21	baumer	baumer	PROPN
admet-3030	485	22	,	,	PUNCT
admet-3030	485	23	s.	s.	PROPN
admet-3030	485	24	belli	belli	PROPN
admet-3030	485	25	,	,	PUNCT
admet-3030	485	26	l.	l.	PROPN
admet-3030	485	27	petukhova	petukhova	PROPN
admet-3030	485	28	,	,	PUNCT
admet-3030	485	29	a.	a.	NOUN
admet-3030	485	30	schinzel	schinzel	PROPN
admet-3030	485	31	,	,	PUNCT
admet-3030	485	32	a.h	a.h	PROPN
admet-3030	485	33	.	.	PROPN
admet-3030	485	34	brivanlou	brivanlou	PROPN
admet-3030	485	35	,	,	PUNCT
admet-3030	485	36	b.a	b.a	PROPN
admet-3030	485	37	.	.	PROPN
admet-3030	485	38	barres	barre	NOUN
admet-3030	485	39	,	,	PUNCT
admet-3030	485	40	a.m.	a.m.	PROPN
admet-3030	485	41	christiano	christiano	PROPN
admet-3030	485	42	.	.	PUNCT
admet-3030	486	1	apcdd1	apcdd1	PROPN
admet-3030	486	2	is	be	AUX
admet-3030	486	3	a	a	DET
admet-3030	486	4	novel	novel	ADJ
admet-3030	486	5	wnt	wnt	NOUN
admet-3030	486	6	inhibitor	inhibitor	NOUN
admet-3030	486	7	mutated	mutate	VERB
admet-3030	486	8	in	in	ADP
admet-3030	486	9	hereditary	hereditary	ADJ
admet-3030	486	10	hypotrichosis	hypotrichosis	NOUN
admet-3030	486	11	simplex	simplex	NOUN
admet-3030	486	12	.	.	PUNCT
admet-3030	487	1	nature	nature	NOUN
admet-3030	487	2	464	464	NUM
admet-3030	487	3	(	(	PUNCT
admet-3030	487	4	2010	2010	NUM
admet-3030	487	5	)	)	PUNCT
admet-3030	487	6	1043	1043	NUM
admet-3030	487	7	-	-	SYM
admet-3030	487	8	1047	1047	NUM
admet-3030	487	9	.	.	PUNCT
admet-3030	488	1	https://dx.doi.org/10.1038/nature08875	https://dx.doi.org/10.1038/nature08875	PROPN
admet-3030	489	1	[	[	X
admet-3030	489	2	47	47	NUM
admet-3030	489	3	]	]	X
admet-3030	489	4	g.j	g.j	PROPN
admet-3030	489	5	.	.	PROPN
admet-3030	489	6	leirós	leirós	PROPN
admet-3030	489	7	,	,	PUNCT
admet-3030	489	8	a.i	a.i	PROPN
admet-3030	489	9	.	.	PROPN
admet-3030	489	10	attorresi	attorresi	PROPN
admet-3030	489	11	,	,	PUNCT
admet-3030	489	12	m.e	m.e	PROPN
admet-3030	489	13	.	.	PROPN
admet-3030	489	14	balañá	balañá	NOUN
admet-3030	489	15	.	.	PUNCT
admet-3030	490	1	hair	hair	NOUN
admet-3030	490	2	follicle	follicle	NOUN
admet-3030	490	3	stem	stem	NOUN
admet-3030	490	4	cell	cell	NOUN
admet-3030	490	5	differentiation	differentiation	NOUN
admet-3030	490	6	is	be	AUX
admet-3030	490	7	inhibited	inhibit	VERB
admet-3030	490	8	through	through	ADP
admet-3030	490	9	cross	cross	NOUN
admet-3030	490	10	-	-	NOUN
admet-3030	490	11	talk	talk	NOUN
admet-3030	490	12	between	between	ADP
admet-3030	490	13	wnt	wnt	PROPN
admet-3030	490	14	/	/	SYM
admet-3030	490	15	β	β	NOUN
admet-3030	490	16	-	-	ADJ
admet-3030	490	17	catenin	catenin	ADJ
admet-3030	490	18	and	and	CCONJ
admet-3030	490	19	androgen	androgen	NOUN
admet-3030	490	20	signalling	signal	VERB
admet-3030	490	21	in	in	ADP
admet-3030	490	22	dermal	dermal	ADJ
admet-3030	490	23	papilla	papilla	NOUN
admet-3030	490	24	cells	cell	NOUN
admet-3030	490	25	from	from	ADP
admet-3030	490	26	patients	patient	NOUN
admet-3030	490	27	with	with	ADP
admet-3030	490	28	androgenetic	androgenetic	ADJ
admet-3030	490	29	alopecia	alopecia	NOUN
admet-3030	490	30	.	.	PUNCT
admet-3030	491	1	british	british	ADJ
admet-3030	491	2	journal	journal	PROPN
admet-3030	491	3	of	of	ADP
admet-3030	491	4	dermatology	dermatology	NOUN
admet-3030	491	5	166	166	NUM
admet-3030	491	6	(	(	PUNCT
admet-3030	491	7	2012	2012	NUM
admet-3030	491	8	)	)	PUNCT
admet-3030	491	9	1035	1035	NUM
admet-3030	491	10	-	-	SYM
admet-3030	491	11	1042	1042	NUM
admet-3030	491	12	.	.	PUNCT
admet-3030	492	1	https://dx.doi.org/10.1111/j.1365-2133.2012.10856.x	https://dx.doi.org/10.1111/j.1365-2133.2012.10856.x	PRON
admet-3030	493	1	[	[	X
admet-3030	493	2	48	48	NUM
admet-3030	493	3	]	]	PUNCT
admet-3030	493	4	p.	p.	NOUN
admet-3030	493	5	mirmirani	mirmirani	PROPN
admet-3030	493	6	,	,	PUNCT
admet-3030	493	7	m.	m.	NOUN
admet-3030	493	8	consolo	consolo	PROPN
admet-3030	493	9	,	,	PUNCT
admet-3030	493	10	p.	p.	NOUN
admet-3030	493	11	oyetakin	oyetakin	NOUN
admet-3030	493	12	-	-	PUNCT
admet-3030	493	13	white	white	ADJ
admet-3030	493	14	,	,	PUNCT
admet-3030	493	15	e.	e.	PROPN
admet-3030	493	16	baron	baron	PROPN
admet-3030	493	17	,	,	PUNCT
admet-3030	493	18	p.	p.	NOUN
admet-3030	493	19	leahy	leahy	PROPN
admet-3030	493	20	,	,	PUNCT
admet-3030	493	21	p.	p.	NOUN
admet-3030	493	22	karnik	karnik	PROPN
admet-3030	493	23	.	.	PUNCT
admet-3030	494	1	similar	similar	ADJ
admet-3030	494	2	response	response	NOUN
admet-3030	494	3	patterns	pattern	NOUN
admet-3030	494	4	to	to	ADP
admet-3030	494	5	topical	topical	ADJ
admet-3030	494	6	minoxidil	minoxidil	NOUN
admet-3030	494	7	foam	foam	NOUN
admet-3030	494	8	5	5	NUM
admet-3030	494	9	%	%	NOUN
admet-3030	494	10	in	in	ADP
admet-3030	494	11	frontal	frontal	ADJ
admet-3030	494	12	and	and	CCONJ
admet-3030	494	13	vertex	vertex	NOUN
admet-3030	494	14	scalp	scalp	NOUN
admet-3030	494	15	of	of	ADP
admet-3030	494	16	men	man	NOUN
admet-3030	494	17	with	with	ADP
admet-3030	494	18	androgenetic	androgenetic	ADJ
admet-3030	494	19	alopecia	alopecia	NOUN
admet-3030	494	20	:	:	PUNCT
admet-3030	494	21	a	a	DET
admet-3030	494	22	microarray	microarray	NOUN
admet-3030	494	23	analysis	analysis	NOUN
admet-3030	494	24	.	.	PUNCT
admet-3030	495	1	british	british	ADJ
admet-3030	495	2	journal	journal	PROPN
admet-3030	495	3	of	of	ADP
admet-3030	495	4	dermatology	dermatology	NOUN
admet-3030	495	5	172	172	NUM
admet-3030	495	6	(	(	PUNCT
admet-3030	495	7	2015	2015	NUM
admet-3030	495	8	)	)	PUNCT
admet-3030	495	9	1555	1555	NUM
admet-3030	495	10	-	-	SYM
admet-3030	495	11	1561	1561	NUM
admet-3030	495	12	.	.	PUNCT
admet-3030	496	1	https://dx.doi.org/10.1111/bjd.13399	https://dx.doi.org/10.1111/bjd.13399	PROPN
admet-3030	497	1	[	[	X
admet-3030	497	2	49	49	NUM
admet-3030	497	3	]	]	PUNCT
admet-3030	497	4	t.	t.	NOUN
admet-3030	497	5	midorikawa	midorikawa	PROPN
admet-3030	497	6	,	,	PUNCT
admet-3030	497	7	t.	t.	PROPN
admet-3030	497	8	chikazawa	chikazawa	PROPN
admet-3030	497	9	,	,	PUNCT
admet-3030	497	10	t.	t.	NOUN
admet-3030	497	11	yoshino	yoshino	PROPN
admet-3030	497	12	,	,	PUNCT
admet-3030	497	13	k.	k.	PROPN
admet-3030	497	14	takada	takada	PROPN
admet-3030	497	15	,	,	PUNCT
admet-3030	497	16	s.	s.	PROPN
admet-3030	497	17	arase	arase	PROPN
admet-3030	497	18	.	.	PUNCT
admet-3030	498	1	different	different	ADJ
admet-3030	498	2	gene	gene	NOUN
admet-3030	498	3	expression	expression	NOUN
admet-3030	498	4	profile	profile	NOUN
admet-3030	498	5	observed	observe	VERB
admet-3030	498	6	in	in	ADP
admet-3030	498	7	dermal	dermal	ADJ
admet-3030	498	8	papilla	papilla	NOUN
admet-3030	498	9	cells	cell	NOUN
admet-3030	498	10	related	relate	VERB
admet-3030	498	11	to	to	ADP
admet-3030	498	12	androgenic	androgenic	ADJ
admet-3030	498	13	alopecia	alopecia	NOUN
admet-3030	498	14	by	by	ADP
admet-3030	498	15	dna	dna	PROPN
admet-3030	498	16	macroarray	macroarray	PROPN
admet-3030	498	17	analysis	analysis	NOUN
admet-3030	498	18	.	.	PUNCT
admet-3030	499	1	journal	journal	NOUN
admet-3030	499	2	of	of	ADP
admet-3030	499	3	dermatological	dermatological	ADJ
admet-3030	499	4	science	science	NOUN
admet-3030	499	5	36	36	NUM
admet-3030	499	6	(	(	PUNCT
admet-3030	499	7	2004	2004	NUM
admet-3030	499	8	)	)	PUNCT
admet-3030	499	9	25	25	NUM
admet-3030	499	10	-	-	SYM
admet-3030	499	11	32	32	NUM
admet-3030	499	12	.	.	PUNCT
admet-3030	500	1	https://dx.doi.org/10.1016/j.jdermsci.2004.05.001	https://dx.doi.org/10.1016/j.jdermsci.2004.05.001	NOUN
admet-3030	501	1	[	[	X
admet-3030	501	2	50	50	NUM
admet-3030	501	3	]	]	X
admet-3030	501	4	l.a	l.a	PROPN
admet-3030	501	5	.	.	PROPN
admet-3030	501	6	garza	garza	PROPN
admet-3030	501	7	,	,	PUNCT
admet-3030	501	8	y.	y.	PROPN
admet-3030	501	9	liu	liu	PROPN
admet-3030	501	10	,	,	PUNCT
admet-3030	501	11	z.	z.	PROPN
admet-3030	501	12	yang	yang	PROPN
admet-3030	501	13	,	,	PUNCT
admet-3030	501	14	b.	b.	PROPN
admet-3030	501	15	alagesan	alagesan	PROPN
admet-3030	501	16	,	,	PUNCT
admet-3030	501	17	j.a	j.a	PROPN
admet-3030	501	18	.	.	PROPN
admet-3030	501	19	lawson	lawson	PROPN
admet-3030	501	20	,	,	PUNCT
admet-3030	501	21	s.m	s.m	PROPN
admet-3030	501	22	.	.	PROPN
admet-3030	501	23	norberg	norberg	PROPN
admet-3030	501	24	,	,	PUNCT
admet-3030	501	25	d.e	d.e	PROPN
admet-3030	501	26	.	.	PROPN
admet-3030	501	27	loy	loy	PROPN
admet-3030	501	28	,	,	PUNCT
admet-3030	501	29	t.	t.	PROPN
admet-3030	501	30	zhao	zhao	PROPN
admet-3030	501	31	,	,	PUNCT
admet-3030	501	32	h.b	h.b	PROPN
admet-3030	501	33	.	.	PROPN
admet-3030	501	34	blatt	blatt	PROPN
admet-3030	501	35	,	,	PUNCT
admet-3030	501	36	d.c	d.c	PROPN
admet-3030	501	37	.	.	PROPN
admet-3030	501	38	stanton	stanton	PROPN
admet-3030	501	39	,	,	PUNCT
admet-3030	501	40	l.	l.	PROPN
admet-3030	501	41	carrasco	carrasco	PROPN
admet-3030	501	42	,	,	PUNCT
admet-3030	501	43	g.	g.	PROPN
admet-3030	501	44	ahluwalia	ahluwalia	PROPN
admet-3030	501	45	,	,	PUNCT
admet-3030	501	46	s.m	s.m	PROPN
admet-3030	501	47	.	.	PROPN
admet-3030	501	48	fischer	fischer	PROPN
admet-3030	501	49	,	,	PUNCT
admet-3030	501	50	g.a	g.a	PROPN
admet-3030	501	51	.	.	PROPN
admet-3030	501	52	fitzgerald	fitzgerald	PROPN
admet-3030	501	53	,	,	PUNCT
admet-3030	501	54	g.	g.	PROPN
admet-3030	501	55	cotsarelis	cotsarelis	PROPN
admet-3030	501	56	.	.	PUNCT
admet-3030	502	1	prostaglandin	prostaglandin	PROPN
admet-3030	502	2	d2	d2	PROPN
admet-3030	502	3	inhibits	inhibit	VERB
admet-3030	502	4	hair	hair	NOUN
admet-3030	502	5	growth	growth	NOUN
admet-3030	502	6	and	and	CCONJ
admet-3030	502	7	is	be	AUX
admet-3030	502	8	elevated	elevate	VERB
admet-3030	502	9	in	in	ADP
admet-3030	502	10	bald	bald	ADJ
admet-3030	502	11	scalp	scalp	NOUN
admet-3030	502	12	of	of	ADP
admet-3030	502	13	men	man	NOUN
admet-3030	502	14	with	with	ADP
admet-3030	502	15	androgenetic	androgenetic	ADJ
admet-3030	502	16	alopecia	alopecia	NOUN
admet-3030	502	17	.	.	PUNCT
admet-3030	503	1	science	science	PROPN
admet-3030	503	2	translational	translational	ADJ
admet-3030	503	3	medicine	medicine	NOUN
admet-3030	503	4	4	4	NUM
admet-3030	503	5	(	(	PUNCT
admet-3030	503	6	2012	2012	NUM
admet-3030	503	7	)	)	PUNCT
admet-3030	503	8	126ra134	126ra134	NUM
admet-3030	503	9	.	.	PUNCT
admet-3030	503	10	https://dx.doi.org/10.1126/scitranslmed.3003122	https://dx.doi.org/10.1126/scitranslmed.3003122	X
admet-3030	504	1	[	[	X
admet-3030	504	2	51	51	NUM
admet-3030	504	3	]	]	PUNCT
admet-3030	504	4	s.	s.	PROPN
admet-3030	504	5	heilmann	heilmann	PROPN
admet-3030	504	6	,	,	PUNCT
admet-3030	504	7	a.k	a.k	PROPN
admet-3030	504	8	.	.	PROPN
admet-3030	504	9	kiefer	kiefer	PROPN
admet-3030	504	10	,	,	PUNCT
admet-3030	504	11	n.	n.	PROPN
admet-3030	504	12	fricker	fricker	PROPN
admet-3030	504	13	,	,	PUNCT
admet-3030	504	14	d.	d.	PROPN
admet-3030	504	15	drichel	drichel	PROPN
admet-3030	504	16	,	,	PUNCT
admet-3030	504	17	a.m.	a.m.	PROPN
admet-3030	504	18	hillmer	hillmer	PROPN
admet-3030	504	19	,	,	PUNCT
admet-3030	504	20	c.	c.	PROPN
admet-3030	504	21	herold	herold	PROPN
admet-3030	504	22	,	,	PUNCT
admet-3030	504	23	j.y	j.y	PROPN
admet-3030	504	24	.	.	PROPN
admet-3030	504	25	tung	tung	PROPN
admet-3030	504	26	,	,	PUNCT
admet-3030	504	27	n.	n.	PROPN
admet-3030	504	28	eriksson	eriksson	PROPN
admet-3030	504	29	,	,	PUNCT
admet-3030	504	30	s.	s.	PROPN
admet-3030	504	31	redler	redler	PROPN
admet-3030	504	32	,	,	PUNCT
admet-3030	504	33	r.c	r.c	PROPN
admet-3030	504	34	.	.	PROPN
admet-3030	504	35	betz	betz	PROPN
admet-3030	504	36	,	,	PUNCT
admet-3030	504	37	r.	r.	PROPN
admet-3030	504	38	li	li	PROPN
admet-3030	504	39	,	,	PUNCT
admet-3030	504	40	a.	a.	PROPN
admet-3030	504	41	kárason	kárason	PROPN
admet-3030	504	42	,	,	PUNCT
admet-3030	504	43	d.r	d.r	PROPN
admet-3030	504	44	.	.	PROPN
admet-3030	504	45	nyholt	nyholt	PROPN
admet-3030	504	46	,	,	PUNCT
admet-3030	504	47	k.	k.	PROPN
admet-3030	504	48	song	song	PROPN
admet-3030	504	49	,	,	PUNCT
admet-3030	504	50	s.h	s.h	PROPN
admet-3030	504	51	.	.	PROPN
admet-3030	504	52	vermeulen	vermeulen	PROPN
admet-3030	504	53	,	,	PUNCT
admet-3030	504	54	s.	s.	PROPN
admet-3030	504	55	kanoni	kanoni	PROPN
admet-3030	504	56	,	,	PUNCT
admet-3030	504	57	g.	g.	PROPN
admet-3030	504	58	dedoussis	dedoussis	PROPN
admet-3030	504	59	,	,	PUNCT
admet-3030	504	60	n.g	n.g	PROPN
admet-3030	504	61	.	.	PROPN
admet-3030	504	62	martin	martin	PROPN
admet-3030	504	63	,	,	PUNCT
admet-3030	504	64	l.a	l.a	PROPN
admet-3030	504	65	.	.	PROPN
admet-3030	504	66	kiemeney	kiemeney	PROPN
admet-3030	504	67	,	,	PUNCT
admet-3030	504	68	v.	v.	PROPN
admet-3030	504	69	mooser	mooser	PROPN
admet-3030	504	70	,	,	PUNCT
admet-3030	504	71	k.	k.	PROPN
admet-3030	504	72	stefansson	stefansson	PROPN
admet-3030	504	73	,	,	PUNCT
admet-3030	504	74	j.b	j.b	PROPN
admet-3030	504	75	.	.	PUNCT
admet-3030	504	76	richards	richards	PROPN
admet-3030	504	77	,	,	PUNCT
admet-3030	504	78	t.	t.	PROPN
admet-3030	504	79	becker	becker	PROPN
admet-3030	504	80	,	,	PUNCT
admet-3030	504	81	f.f	f.f	PROPN
admet-3030	504	82	.	.	PROPN
admet-3030	504	83	brockschmidt	brockschmidt	PROPN
admet-3030	504	84	,	,	PUNCT
admet-3030	504	85	d.a	d.a	PROPN
admet-3030	504	86	.	.	PROPN
admet-3030	504	87	hinds	hinds	PROPN
admet-3030	504	88	,	,	PUNCT
admet-3030	504	89	m.m	m.m	PROPN
admet-3030	504	90	.	.	PROPN
admet-3030	505	1	nöthen	nöthen	ADV
admet-3030	505	2	.	.	PUNCT
admet-3030	506	1	androgenetic	androgenetic	ADJ
admet-3030	506	2	alopecia	alopecia	NOUN
admet-3030	506	3	:	:	PUNCT
admet-3030	506	4	identification	identification	NOUN
admet-3030	506	5	of	of	ADP
admet-3030	506	6	four	four	NUM
admet-3030	506	7	genetic	genetic	ADJ
admet-3030	506	8	risk	risk	NOUN
admet-3030	506	9	loci	loci	NOUN
admet-3030	506	10	and	and	CCONJ
admet-3030	506	11	evidence	evidence	NOUN
admet-3030	506	12	for	for	ADP
admet-3030	506	13	the	the	DET
admet-3030	506	14	contribution	contribution	NOUN
admet-3030	506	15	of	of	ADP
admet-3030	506	16	wnt	wnt	NOUN
admet-3030	506	17	signaling	signal	VERB
admet-3030	506	18	to	to	ADP
admet-3030	506	19	its	its	PRON
admet-3030	506	20	etiology	etiology	NOUN
admet-3030	506	21	.	.	PUNCT
admet-3030	507	1	journal	journal	PROPN
admet-3030	507	2	of	of	ADP
admet-3030	507	3	investigative	investigative	ADJ
admet-3030	507	4	dermatology	dermatology	NOUN
admet-3030	507	5	133	133	NUM
admet-3030	507	6	(	(	PUNCT
admet-3030	507	7	2013	2013	NUM
admet-3030	507	8	)	)	PUNCT
admet-3030	507	9	1489	1489	NUM
admet-3030	507	10	-	-	SYM
admet-3030	507	11	1496	1496	NUM
admet-3030	507	12	.	.	PUNCT
admet-3030	508	1	https://dx.doi.org/10.1038/jid.2013.43	https://dx.doi.org/10.1038/jid.2013.43	PROPN
admet-3030	508	2	[	[	X
admet-3030	508	3	52	52	NUM
admet-3030	508	4	]	]	X
admet-3030	508	5	v.h	v.h	PROPN
admet-3030	508	6	.	.	PROPN
admet-3030	508	7	price	price	NOUN
admet-3030	508	8	.	.	PUNCT
admet-3030	509	1	treatment	treatment	NOUN
admet-3030	509	2	of	of	ADP
admet-3030	509	3	hair	hair	NOUN
admet-3030	509	4	loss	loss	NOUN
admet-3030	509	5	.	.	PUNCT
admet-3030	510	1	new	new	PROPN
admet-3030	510	2	england	england	PROPN
admet-3030	510	3	journal	journal	PROPN
admet-3030	510	4	of	of	ADP
admet-3030	510	5	medicine	medicine	NOUN
admet-3030	510	6	341	341	NUM
admet-3030	510	7	(	(	PUNCT
admet-3030	510	8	1999	1999	NUM
admet-3030	510	9	)	)	PUNCT
admet-3030	510	10	964	964	NUM
admet-3030	510	11	-	-	SYM
admet-3030	510	12	973	973	NUM
admet-3030	510	13	.	.	PUNCT
admet-3030	511	1	https://dx.doi.org/10.1056/nejm199909233411307	https://dx.doi.org/10.1056/nejm199909233411307	NOUN
admet-3030	512	1	[	[	X
admet-3030	512	2	53	53	NUM
admet-3030	512	3	]	]	PUNCT
admet-3030	512	4	d.	d.	PROPN
admet-3030	512	5	rathnayake	rathnayake	PROPN
admet-3030	512	6	,	,	PUNCT
admet-3030	512	7	r.	r.	PROPN
admet-3030	512	8	sinclair	sinclair	PROPN
admet-3030	512	9	.	.	PUNCT
admet-3030	513	1	male	male	ADJ
admet-3030	513	2	androgenetic	androgenetic	ADJ
admet-3030	513	3	alopecia	alopecia	NOUN
admet-3030	513	4	.	.	PUNCT
admet-3030	514	1	expert	expert	ADJ
admet-3030	514	2	opinion	opinion	NOUN
admet-3030	514	3	on	on	ADP
admet-3030	514	4	pharmacotherapy	pharmacotherapy	NOUN
admet-3030	514	5	11	11	NUM
admet-3030	514	6	(	(	PUNCT
admet-3030	514	7	2010	2010	NUM
admet-3030	514	8	)	)	PUNCT
admet-3030	514	9	1295	1295	NUM
admet-3030	514	10	-	-	SYM
admet-3030	514	11	1304	1304	NUM
admet-3030	514	12	.	.	PUNCT
admet-3030	515	1	https://dx.doi.org/10.1517/14656561003752730	https://dx.doi.org/10.1517/14656561003752730	PROPN
admet-3030	516	1	[	[	X
admet-3030	516	2	54	54	NUM
admet-3030	516	3	]	]	X
admet-3030	516	4	m.h	m.h	PROPN
admet-3030	516	5	.	.	PROPN
admet-3030	516	6	kwack	kwack	PROPN
admet-3030	516	7	,	,	PUNCT
admet-3030	516	8	m.k	m.k	PROPN
admet-3030	516	9	.	.	PUNCT
admet-3030	516	10	kim	kim	PROPN
admet-3030	516	11	,	,	PUNCT
admet-3030	516	12	j.c	j.c	PROPN
admet-3030	516	13	.	.	PROPN
admet-3030	516	14	kim	kim	PROPN
admet-3030	516	15	,	,	PUNCT
admet-3030	516	16	y.k	y.k	PROPN
admet-3030	516	17	.	.	PROPN
admet-3030	516	18	sung	sung	PROPN
admet-3030	516	19	.	.	PUNCT
admet-3030	517	1	dickkopf	dickkopf	VERB
admet-3030	517	2	1	1	NUM
admet-3030	517	3	promotes	promote	VERB
admet-3030	517	4	regression	regression	NOUN
admet-3030	517	5	of	of	ADP
admet-3030	517	6	hair	hair	NOUN
admet-3030	517	7	follicles	follicle	NOUN
admet-3030	517	8	.	.	PUNCT
admet-3030	518	1	journal	journal	NOUN
admet-3030	518	2	of	of	ADP
admet-3030	518	3	investigative	investigative	ADJ
admet-3030	518	4	dermatology	dermatology	NOUN
admet-3030	518	5	132	132	NUM
admet-3030	518	6	(	(	PUNCT
admet-3030	518	7	2012	2012	NUM
admet-3030	518	8	)	)	PUNCT
admet-3030	518	9	1554	1554	NUM
admet-3030	518	10	-	-	SYM
admet-3030	518	11	1560	1560	NUM
admet-3030	518	12	.	.	PUNCT
admet-3030	519	1	https://dx.doi.org/10.1038/jid.2012.24	https://dx.doi.org/10.1038/jid.2012.24	PRON
admet-3030	519	2	[	[	X
admet-3030	519	3	55	55	NUM
admet-3030	519	4	]	]	PUNCT
admet-3030	519	5	k.	k.	PROPN
admet-3030	519	6	lingappan	lingappan	PROPN
admet-3030	519	7	.	.	PUNCT
admet-3030	520	1	nf	nf	X
admet-3030	520	2	-	-	PUNCT
admet-3030	520	3	κb	κb	NOUN
admet-3030	520	4	in	in	ADP
admet-3030	520	5	oxidative	oxidative	ADJ
admet-3030	520	6	stress	stress	NOUN
admet-3030	520	7	.	.	PUNCT
admet-3030	521	1	current	current	ADJ
admet-3030	521	2	opinion	opinion	NOUN
admet-3030	521	3	in	in	ADP
admet-3030	521	4	toxicology	toxicology	NOUN
admet-3030	521	5	7	7	NUM
admet-3030	521	6	(	(	PUNCT
admet-3030	521	7	2018	2018	NUM
admet-3030	521	8	)	)	PUNCT
admet-3030	521	9	81	81	NUM
admet-3030	521	10	-	-	SYM
admet-3030	521	11	86	86	NUM
admet-3030	521	12	.	.	PUNCT
admet-3030	522	1	https://dx.doi.org/10.1016/j.cotox.2017.11.002	https://dx.doi.org/10.1016/j.cotox.2017.11.002	PROPN
admet-3030	523	1	[	[	X
admet-3030	523	2	56	56	NUM
admet-3030	523	3	]	]	PUNCT
admet-3030	523	4	z.	z.	PROPN
admet-3030	523	5	liu	liu	PROPN
admet-3030	523	6	,	,	PUNCT
admet-3030	523	7	x.	x.	PROPN
admet-3030	523	8	liu	liu	PROPN
admet-3030	523	9	.	.	PUNCT
admet-3030	524	1	gut	gut	VERB
admet-3030	524	2	microbiome	microbiome	NOUN
admet-3030	524	3	,	,	PUNCT
admet-3030	524	4	metabolome	metabolome	NOUN
admet-3030	524	5	and	and	CCONJ
admet-3030	524	6	alopecia	alopecia	NOUN
admet-3030	524	7	areata	areata	ADJ
admet-3030	524	8	.	.	PUNCT
admet-3030	525	1	frontiers	frontier	NOUN
admet-3030	525	2	in	in	ADP
admet-3030	525	3	microbiology	microbiology	NOUN
admet-3030	525	4	14	14	NUM
admet-3030	525	5	(	(	PUNCT
admet-3030	525	6	2023	2023	NUM
admet-3030	525	7	)	)	PUNCT
admet-3030	525	8	1281660	1281660	NUM
admet-3030	525	9	.	.	PUNCT
admet-3030	526	1	https://dx.doi.org/10.3389/fmicb.2023.1281660	https://dx.doi.org/10.3389/fmicb.2023.1281660	NOUN
admet-3030	527	1	[	[	X
admet-3030	527	2	57	57	NUM
admet-3030	527	3	]	]	PUNCT
admet-3030	527	4	b.	b.	PROPN
admet-3030	527	5	liu	liu	PROPN
admet-3030	527	6	,	,	PUNCT
admet-3030	527	7	a.	a.	PROPN
admet-3030	527	8	li	li	PROPN
admet-3030	527	9	,	,	PUNCT
admet-3030	527	10	y.	y.	PROPN
admet-3030	527	11	liu	liu	PROPN
admet-3030	527	12	,	,	PUNCT
admet-3030	527	13	x.	x.	PROPN
admet-3030	527	14	ke	ke	PROPN
admet-3030	527	15	,	,	PUNCT
admet-3030	527	16	q.	q.	PROPN
admet-3030	527	17	liu	liu	PROPN
admet-3030	527	18	,	,	PUNCT
admet-3030	527	19	x.	x.	PROPN
admet-3030	527	20	zuo	zuo	PROPN
admet-3030	527	21	,	,	PUNCT
admet-3030	527	22	j.	j.	PROPN
admet-3030	527	23	xu	xu	PROPN
admet-3030	527	24	,	,	PUNCT
admet-3030	527	25	y.	y.	PROPN
admet-3030	527	26	cui	cui	PROPN
admet-3030	527	27	.	.	PUNCT
admet-3030	528	1	identification	identification	NOUN
admet-3030	528	2	of	of	ADP
admet-3030	528	3	distinct	distinct	ADJ
admet-3030	528	4	immune	immune	ADJ
admet-3030	528	5	signatures	signature	NOUN
admet-3030	528	6	and	and	CCONJ
admet-3030	528	7	chemokine	chemokine	ADJ
admet-3030	528	8	networks	network	NOUN
admet-3030	528	9	in	in	ADP
admet-3030	528	10	scalp	scalp	NOUN
admet-3030	528	11	inflammatory	inflammatory	ADJ
admet-3030	528	12	diseases	disease	NOUN
admet-3030	528	13	.	.	PUNCT
admet-3030	529	1	research	research	NOUN
admet-3030	529	2	square	square	NOUN
admet-3030	529	3	(	(	PUNCT
admet-3030	529	4	2023	2023	NUM
admet-3030	529	5	)	)	PUNCT
admet-3030	529	6	.	.	PUNCT
admet-3030	530	1	https://doi.org/10.21203/rs.3.rs-3074741/v1	https://doi.org/10.21203/rs.3.rs-3074741/v1	X
admet-3030	531	1	[	[	X
admet-3030	531	2	58	58	NUM
admet-3030	531	3	]	]	SYM
admet-3030	531	4	a.b	a.b	PROPN
admet-3030	531	5	.	.	PROPN
admet-3030	531	6	coda	coda	NOUN
admet-3030	531	7	,	,	PUNCT
admet-3030	531	8	a.a	a.a	PROPN
admet-3030	531	9	.	.	PROPN
admet-3030	531	10	sinha	sinha	PROPN
admet-3030	531	11	.	.	PUNCT
admet-3030	532	1	integration	integration	NOUN
admet-3030	532	2	of	of	ADP
admet-3030	532	3	genome	genome	NOUN
admet-3030	532	4	-	-	PUNCT
admet-3030	532	5	wide	wide	ADJ
admet-3030	532	6	transcriptional	transcriptional	NOUN
admet-3030	532	7	and	and	CCONJ
admet-3030	532	8	genetic	genetic	ADJ
admet-3030	532	9	profiles	profile	NOUN
admet-3030	532	10	provides	provide	VERB
admet-3030	532	11	insights	insight	NOUN
admet-3030	532	12	into	into	ADP
admet-3030	532	13	disease	disease	NOUN
admet-3030	532	14	development	development	NOUN
admet-3030	532	15	and	and	CCONJ
admet-3030	532	16	clinical	clinical	ADJ
admet-3030	532	17	heterogeneity	heterogeneity	NOUN
admet-3030	532	18	in	in	ADP
admet-3030	532	19	alopecia	alopecia	NOUN
admet-3030	532	20	areata	areata	NOUN
admet-3030	532	21	.	.	PUNCT
admet-3030	533	1	genomics	genomic	NOUN
admet-3030	533	2	98	98	NUM
admet-3030	533	3	(	(	PUNCT
admet-3030	533	4	2011	2011	NUM
admet-3030	533	5	)	)	PUNCT
admet-3030	533	6	431	431	NUM
admet-3030	533	7	-	-	SYM
admet-3030	533	8	439	439	NUM
admet-3030	533	9	.	.	PUNCT
admet-3030	534	1	https://dx.doi.org/10.1016/j.ygeno.2011.08.009	https://dx.doi.org/10.1016/j.ygeno.2011.08.009	PROPN
admet-3030	534	2	https://doi.org/10.1007/s00439-006-0317-8	https://doi.org/10.1007/s00439-006-0317-8	NUM
admet-3030	534	3	https://doi.org/10.1038/jid.2008.60	https://doi.org/10.1038/jid.2008.60	PROPN
admet-3030	534	4	https://doi.org/10.21608/asmj.2024.299393.1282	https://doi.org/10.21608/asmj.2024.299393.1282	PROPN
admet-3030	534	5	https://doi.org/10.1038/nature08875	https://doi.org/10.1038/nature08875	PROPN
admet-3030	534	6	https://doi.org/10.1111/j.1365-2133.2012.10856.x	https://doi.org/10.1111/j.1365-2133.2012.10856.x	ADJ
admet-3030	534	7	https://doi.org/10.1111/bjd.13399	https://doi.org/10.1111/bjd.13399	NOUN
admet-3030	534	8	https://doi.org/10.1016/j.jdermsci.2004.05.001	https://doi.org/10.1016/j.jdermsci.2004.05.001	PROPN
admet-3030	534	9	https://doi.org/10.1126/scitranslmed.3003122	https://doi.org/10.1126/scitranslmed.3003122	VERB
admet-3030	534	10	https://doi.org/10.1038/jid.2013.43	https://doi.org/10.1038/jid.2013.43	ADJ
admet-3030	534	11	https://doi.org/10.1056/nejm199909233411307	https://doi.org/10.1056/nejm199909233411307	PROPN
admet-3030	534	12	https://doi.org/10.1517/14656561003752730	https://doi.org/10.1517/14656561003752730	PRON
admet-3030	534	13	https://doi.org/10.1038/jid.2012.24	https://doi.org/10.1038/jid.2012.24	NOUN
admet-3030	534	14	https://doi.org/10.1016/j.cotox.2017.11.002	https://doi.org/10.1016/j.cotox.2017.11.002	PROPN
admet-3030	534	15	https://doi.org/10.3389/fmicb.2023.1281660	https://doi.org/10.3389/fmicb.2023.1281660	PROPN
admet-3030	534	16	https://doi.org/10.21203/rs.3.rs-3074741/v1	https://doi.org/10.21203/rs.3.rs-3074741/v1	ADP
admet-3030	534	17	https://doi.org/10.1016/j.ygeno.2011.08.009	https://doi.org/10.1016/j.ygeno.2011.08.009	NUM
admet-3030	534	18	admet	admet	PROPN
admet-3030	534	19	&	&	CCONJ
admet-3030	534	20	dmpk	dmpk	PROPN
admet-3030	534	21	00(0	00(0	PROPN
admet-3030	534	22	)	)	PUNCT
admet-3030	534	23	(	(	PUNCT
admet-3030	534	24	2025	2025	NUM
admet-3030	534	25	)	)	PUNCT
admet-3030	534	26	3030	3030	NUM
admet-3030	534	27	precision	precision	NOUN
admet-3030	534	28	therapeutics	therapeutic	NOUN
admet-3030	534	29	in	in	ADP
admet-3030	534	30	non	non	ADJ
admet-3030	534	31	-	-	ADJ
admet-3030	534	32	scarring	scar	VERB
admet-3030	534	33	alopecia	alopecia	NOUN
admet-3030	534	34	doi	doi	NOUN
admet-3030	534	35	:	:	PUNCT
admet-3030	534	36	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	534	37	19	19	NUM
admet-3030	534	38	[	[	SYM
admet-3030	534	39	59	59	NUM
admet-3030	534	40	]	]	X
admet-3030	534	41	j.a	j.a	PROPN
admet-3030	534	42	.	.	PROPN
admet-3030	534	43	ellis	ellis	PROPN
admet-3030	534	44	,	,	PUNCT
admet-3030	534	45	m.	m.	NOUN
admet-3030	534	46	stebbing	stebbing	NOUN
admet-3030	534	47	,	,	PUNCT
admet-3030	534	48	s.b	s.b	PROPN
admet-3030	534	49	.	.	PROPN
admet-3030	534	50	harrap	harrap	PROPN
admet-3030	534	51	.	.	PUNCT
admet-3030	535	1	polymorphism	polymorphism	NOUN
admet-3030	535	2	of	of	ADP
admet-3030	535	3	the	the	DET
admet-3030	535	4	androgen	androgen	NOUN
admet-3030	535	5	receptor	receptor	NOUN
admet-3030	535	6	gene	gene	NOUN
admet-3030	535	7	is	be	AUX
admet-3030	535	8	associated	associate	VERB
admet-3030	535	9	with	with	ADP
admet-3030	535	10	male	male	ADJ
admet-3030	535	11	pattern	pattern	NOUN
admet-3030	535	12	baldness	baldness	NOUN
admet-3030	535	13	.	.	PUNCT
admet-3030	536	1	journal	journal	NOUN
admet-3030	536	2	of	of	ADP
admet-3030	536	3	investigative	investigative	ADJ
admet-3030	536	4	dermatology	dermatology	NOUN
admet-3030	536	5	116	116	NUM
admet-3030	536	6	(	(	PUNCT
admet-3030	536	7	2001	2001	NUM
admet-3030	536	8	)	)	PUNCT
admet-3030	536	9	452	452	NUM
admet-3030	536	10	-	-	SYM
admet-3030	536	11	455	455	NUM
admet-3030	536	12	.	.	PUNCT
admet-3030	537	1	https://dx.doi.org/10.1046/j.1523-1747.2001.01261.x	https://dx.doi.org/10.1046/j.1523-1747.2001.01261.x	NOUN
admet-3030	537	2	[	[	X
admet-3030	537	3	60	60	NUM
admet-3030	537	4	]	]	X
admet-3030	537	5	c.h	c.h	PROPN
admet-3030	537	6	.	.	PROPN
admet-3030	537	7	ho	ho	PROPN
admet-3030	537	8	,	,	PUNCT
admet-3030	537	9	t.	t.	PROPN
admet-3030	537	10	sood	sood	PROPN
admet-3030	537	11	,	,	PUNCT
admet-3030	537	12	p.m.	p.m.	PROPN
admet-3030	537	13	zito	zito	PROPN
admet-3030	537	14	.	.	PUNCT
admet-3030	538	1	androgenetic	androgenetic	ADJ
admet-3030	538	2	alopecia	alopecia	NOUN
admet-3030	538	3	,	,	PUNCT
admet-3030	538	4	in	in	ADP
admet-3030	538	5	statpearls	statpearl	NOUN
admet-3030	539	1	[	[	X
admet-3030	539	2	internet	internet	NOUN
admet-3030	539	3	]	]	PUNCT
admet-3030	539	4	,	,	PUNCT
admet-3030	539	5	statpearls	statpearls	PROPN
admet-3030	539	6	publishing	publishing	NOUN
admet-3030	539	7	,	,	PUNCT
admet-3030	539	8	treasure	treasure	NOUN
admet-3030	539	9	island	island	NOUN
admet-3030	539	10	,	,	PUNCT
admet-3030	539	11	florida	florida	PROPN
admet-3030	539	12	,	,	PUNCT
admet-3030	539	13	2024	2024	NUM
admet-3030	539	14	.	.	PUNCT
admet-3030	540	1	https://www.ncbi.nlm.nih.gov/books/nbk430924/	https://www.ncbi.nlm.nih.gov/books/nbk430924/	NOUN
admet-3030	541	1	[	[	X
admet-3030	541	2	61	61	NUM
admet-3030	541	3	]	]	X
admet-3030	541	4	d.	d.	PROPN
admet-3030	541	5	bellani	bellani	PROPN
admet-3030	541	6	,	,	PUNCT
admet-3030	541	7	r.	r.	PROPN
admet-3030	541	8	patil	patil	PROPN
admet-3030	541	9	,	,	PUNCT
admet-3030	541	10	a.	a.	NOUN
admet-3030	541	11	prabhughate	prabhughate	PROPN
admet-3030	541	12	,	,	PUNCT
admet-3030	541	13	r.	r.	PROPN
admet-3030	541	14	shahare	shahare	PROPN
admet-3030	541	15	,	,	PUNCT
admet-3030	541	16	m.	m.	NOUN
admet-3030	541	17	gold	gold	NOUN
admet-3030	541	18	,	,	PUNCT
admet-3030	541	19	r.	r.	PROPN
admet-3030	541	20	kapoor	kapoor	PROPN
admet-3030	541	21	,	,	PUNCT
admet-3030	541	22	d.	d.	PROPN
admet-3030	541	23	shome	shome	PROPN
admet-3030	541	24	.	.	PUNCT
admet-3030	542	1	pathophysiological	pathophysiological	ADJ
admet-3030	542	2	mechanisms	mechanism	NOUN
admet-3030	542	3	of	of	ADP
admet-3030	542	4	hair	hair	NOUN
admet-3030	542	5	follicle	follicle	NOUN
admet-3030	542	6	regeneration	regeneration	NOUN
admet-3030	542	7	and	and	CCONJ
admet-3030	542	8	potential	potential	ADJ
admet-3030	542	9	therapeutic	therapeutic	ADJ
admet-3030	542	10	strategies	strategy	NOUN
admet-3030	542	11	.	.	PUNCT
admet-3030	543	1	stem	stem	NOUN
admet-3030	543	2	cell	cell	NOUN
admet-3030	543	3	research	research	NOUN
admet-3030	543	4	&	&	CCONJ
admet-3030	543	5	therapy	therapy	PROPN
admet-3030	543	6	16	16	NUM
admet-3030	543	7	(	(	PUNCT
admet-3030	543	8	2025	2025	NUM
admet-3030	543	9	)	)	PUNCT
admet-3030	543	10	302	302	NUM
admet-3030	543	11	.	.	PUNCT
admet-3030	544	1	https://dx.doi.org/10.1186/s13287-025-04420-4	https://dx.doi.org/10.1186/s13287-025-04420-4	X
admet-3030	545	1	[	[	X
admet-3030	545	2	62	62	NUM
admet-3030	545	3	]	]	PUNCT
admet-3030	545	4	j.	j.	PROPN
admet-3030	545	5	kim	kim	PROPN
admet-3030	545	6	,	,	PUNCT
admet-3030	545	7	j.	j.	PROPN
admet-3030	545	8	an	an	PROPN
admet-3030	545	9	,	,	PUNCT
admet-3030	545	10	y.k	y.k	PROPN
admet-3030	545	11	.	.	PROPN
admet-3030	545	12	lee	lee	PROPN
admet-3030	545	13	,	,	PUNCT
admet-3030	545	14	g.	g.	PROPN
admet-3030	545	15	ha	ha	PROPN
admet-3030	545	16	,	,	PUNCT
admet-3030	545	17	h.	h.	PROPN
admet-3030	545	18	ban	ban	PROPN
admet-3030	545	19	,	,	PUNCT
admet-3030	545	20	h.	h.	PROPN
admet-3030	545	21	kong	kong	PROPN
admet-3030	545	22	,	,	PUNCT
admet-3030	545	23	h.	h.	PROPN
admet-3030	545	24	lee	lee	PROPN
admet-3030	545	25	,	,	PUNCT
admet-3030	545	26	y.	y.	PROPN
admet-3030	545	27	song	song	PROPN
admet-3030	545	28	,	,	PUNCT
admet-3030	545	29	c.k	c.k	PROPN
admet-3030	545	30	.	.	PROPN
admet-3030	545	31	lee	lee	PROPN
admet-3030	545	32	,	,	PUNCT
admet-3030	545	33	s.b	s.b	PROPN
admet-3030	545	34	.	.	PROPN
admet-3030	545	35	kim	kim	PROPN
admet-3030	545	36	,	,	PUNCT
admet-3030	545	37	k.	k.	PROPN
admet-3030	545	38	kim	kim	PROPN
admet-3030	545	39	.	.	PUNCT
admet-3030	545	40	hair	hair	NOUN
admet-3030	545	41	growth	growth	NOUN
admet-3030	545	42	promoting	promote	VERB
admet-3030	545	43	effects	effect	NOUN
admet-3030	545	44	of	of	ADP
admet-3030	545	45	solubilized	solubilize	VERB
admet-3030	545	46	sturgeon	sturgeon	NOUN
admet-3030	545	47	oil	oil	NOUN
admet-3030	545	48	and	and	CCONJ
admet-3030	545	49	its	its	PRON
admet-3030	545	50	correlation	correlation	NOUN
admet-3030	545	51	with	with	ADP
admet-3030	545	52	the	the	DET
admet-3030	545	53	gut	gut	NOUN
admet-3030	545	54	microbiome	microbiome	NOUN
admet-3030	545	55	.	.	PUNCT
admet-3030	546	1	pharmaceuticals	pharmaceutical	NOUN
admet-3030	546	2	(	(	PUNCT
admet-3030	546	3	basel	basel	PROPN
admet-3030	546	4	)	)	PUNCT
admet-3030	546	5	17	17	NUM
admet-3030	546	6	(	(	PUNCT
admet-3030	546	7	2024	2024	NUM
admet-3030	546	8	)	)	PUNCT
admet-3030	546	9	1112	1112	NUM
admet-3030	546	10	.	.	PUNCT
admet-3030	547	1	https://dx.doi.org/10.3390/ph17091112	https://dx.doi.org/10.3390/ph17091112	PROPN
admet-3030	547	2	[	[	X
admet-3030	547	3	63	63	NUM
admet-3030	547	4	]	]	PUNCT
admet-3030	547	5	j.	j.	PROPN
admet-3030	547	6	li	li	PROPN
admet-3030	547	7	,	,	PUNCT
admet-3030	547	8	x.	x.	PROPN
admet-3030	547	9	duan	duan	PROPN
admet-3030	547	10	,	,	PUNCT
admet-3030	547	11	f.	f.	PROPN
admet-3030	547	12	cheng	cheng	PROPN
admet-3030	547	13	,	,	PUNCT
admet-3030	547	14	g.	g.	PROPN
admet-3030	547	15	li	li	PROPN
admet-3030	547	16	,	,	PUNCT
admet-3030	547	17	z.-l	z.-l	PROPN
admet-3030	547	18	.	.	PUNCT
admet-3030	548	1	deng	deng	PROPN
admet-3030	548	2	,	,	PUNCT
admet-3030	548	3	l.	l.	PROPN
admet-3030	548	4	yang	yang	PROPN
admet-3030	548	5	,	,	PUNCT
admet-3030	548	6	j.	j.	PROPN
admet-3030	548	7	zhang	zhang	PROPN
admet-3030	548	8	,	,	PUNCT
admet-3030	548	9	f.	f.	PROPN
admet-3030	548	10	liu	liu	PROPN
admet-3030	548	11	,	,	PUNCT
admet-3030	548	12	y.	y.	PROPN
admet-3030	548	13	li	li	PROPN
admet-3030	548	14	,	,	PUNCT
admet-3030	548	15	z.	z.	PROPN
admet-3030	548	16	wu	wu	PROPN
admet-3030	548	17	,	,	PUNCT
admet-3030	548	18	t.	t.	PROPN
admet-3030	548	19	chen	chen	PROPN
admet-3030	548	20	,	,	PUNCT
admet-3030	548	21	b.	b.	PROPN
admet-3030	548	22	wang	wang	PROPN
admet-3030	548	23	,	,	PUNCT
admet-3030	548	24	x.	x.	PROPN
admet-3030	548	25	zhao	zhao	PROPN
admet-3030	548	26	,	,	PUNCT
admet-3030	548	27	w.	w.	PROPN
admet-3030	548	28	shi	shi	PROPN
admet-3030	548	29	,	,	PUNCT
admet-3030	548	30	f.	f.	PROPN
admet-3030	548	31	xie	xie	PROPN
admet-3030	548	32	,	,	PUNCT
admet-3030	548	33	y.	y.	PROPN
admet-3030	548	34	tang	tang	PROPN
admet-3030	548	35	.	.	PUNCT
admet-3030	549	1	impaired	impair	VERB
admet-3030	549	2	arginine	arginine	NOUN
admet-3030	549	3	metabolism	metabolism	NOUN
admet-3030	549	4	in	in	ADP
admet-3030	549	5	hair	hair	NOUN
admet-3030	549	6	follicles	follicle	NOUN
admet-3030	549	7	:	:	PUNCT
admet-3030	549	8	a	a	DET
admet-3030	549	9	potential	potential	ADJ
admet-3030	549	10	mechanism	mechanism	NOUN
admet-3030	549	11	in	in	ADP
admet-3030	549	12	androgenetic	androgenetic	ADJ
admet-3030	549	13	alopecia	alopecia	NOUN
admet-3030	549	14	,	,	PUNCT
admet-3030	549	15	research	research	NOUN
admet-3030	549	16	square	square	NOUN
admet-3030	549	17	(	(	PUNCT
admet-3030	549	18	2023	2023	NUM
admet-3030	549	19	)	)	PUNCT
admet-3030	549	20	.	.	PUNCT
admet-3030	550	1	https://dx.doi.org/10.21203/rs.3.rs-3629594/v1	https://dx.doi.org/10.21203/rs.3.rs-3629594/v1	X
admet-3030	551	1	[	[	X
admet-3030	551	2	64	64	NUM
admet-3030	551	3	]	]	PUNCT
admet-3030	551	4	l.b	l.b	PROPN
admet-3030	551	5	.	.	PROPN
admet-3030	551	6	zhou	zhou	PROPN
admet-3030	551	7	,	,	PUNCT
admet-3030	551	8	q.	q.	PROPN
admet-3030	551	9	cao	cao	PROPN
admet-3030	551	10	,	,	PUNCT
admet-3030	551	11	q.	q.	PROPN
admet-3030	551	12	ding	ding	PROPN
admet-3030	551	13	,	,	PUNCT
admet-3030	551	14	w.l	w.l	PROPN
admet-3030	551	15	.	.	PROPN
admet-3030	551	16	sun	sun	PROPN
admet-3030	551	17	,	,	PUNCT
admet-3030	551	18	z.y	z.y	PROPN
admet-3030	551	19	.	.	PROPN
admet-3030	551	20	li	li	PROPN
admet-3030	551	21	,	,	PUNCT
admet-3030	551	22	m.	m.	NOUN
admet-3030	551	23	zhao	zhao	PROPN
admet-3030	551	24	,	,	PUNCT
admet-3030	551	25	x.w	x.w	PROPN
admet-3030	551	26	.	.	PROPN
admet-3030	551	27	lin	lin	PROPN
admet-3030	551	28	,	,	PUNCT
admet-3030	551	29	g.p	g.p	PROPN
admet-3030	551	30	.	.	PROPN
admet-3030	551	31	zhou	zhou	PROPN
admet-3030	551	32	,	,	PUNCT
admet-3030	551	33	w.x	w.x	PROPN
admet-3030	551	34	.	.	PROPN
admet-3030	551	35	fan	fan	PROPN
admet-3030	551	36	.	.	PUNCT
admet-3030	552	1	transcription	transcription	NOUN
admet-3030	552	2	factor	factor	NOUN
admet-3030	552	3	foxc1	foxc1	PROPN
admet-3030	552	4	positively	positively	ADV
admet-3030	552	5	regulates	regulate	VERB
admet-3030	552	6	sfrp1	sfrp1	NOUN
admet-3030	552	7	expression	expression	NOUN
admet-3030	552	8	in	in	ADP
admet-3030	552	9	androgenetic	androgenetic	ADJ
admet-3030	552	10	alopecia	alopecia	NOUN
admet-3030	552	11	.	.	PUNCT
admet-3030	553	1	experimental	experimental	ADJ
admet-3030	553	2	cell	cell	NOUN
admet-3030	553	3	research	research	NOUN
admet-3030	553	4	404	404	NUM
admet-3030	553	5	(	(	PUNCT
admet-3030	553	6	2021	2021	NUM
admet-3030	553	7	)	)	PUNCT
admet-3030	553	8	112618	112618	NUM
admet-3030	553	9	.	.	PUNCT
admet-3030	554	1	https://dx.doi.org/10.1016/j.yexcr.2021.112618	https://dx.doi.org/10.1016/j.yexcr.2021.112618	PUNCT
admet-3030	555	1	[	[	X
admet-3030	555	2	65	65	NUM
admet-3030	555	3	]	]	X
admet-3030	555	4	y.	y.	PROPN
admet-3030	555	5	liu	liu	PROPN
admet-3030	555	6	,	,	PUNCT
admet-3030	555	7	s.	s.	PROPN
admet-3030	555	8	yang	yang	PROPN
admet-3030	555	9	,	,	PUNCT
admet-3030	555	10	y.	y.	PROPN
admet-3030	555	11	zeng	zeng	PROPN
admet-3030	555	12	,	,	PUNCT
admet-3030	555	13	z.	z.	PROPN
admet-3030	555	14	tang	tang	PROPN
admet-3030	555	15	,	,	PUNCT
admet-3030	555	16	x.	x.	PROPN
admet-3030	555	17	zong	zong	PROPN
admet-3030	555	18	,	,	PUNCT
admet-3030	555	19	x.	x.	PROPN
admet-3030	555	20	li	li	PROPN
admet-3030	555	21	,	,	PUNCT
admet-3030	555	22	c.	c.	PROPN
admet-3030	555	23	yang	yang	PROPN
admet-3030	555	24	,	,	PUNCT
admet-3030	555	25	l.	l.	PROPN
admet-3030	555	26	liu	liu	PROPN
admet-3030	555	27	,	,	PUNCT
admet-3030	555	28	x.	x.	PROPN
admet-3030	555	29	tong	tong	PROPN
admet-3030	555	30	,	,	PUNCT
admet-3030	555	31	l.	l.	PROPN
admet-3030	555	32	zhou	zhou	PROPN
admet-3030	555	33	,	,	PUNCT
admet-3030	555	34	d.	d.	PROPN
admet-3030	555	35	wang	wang	PROPN
admet-3030	555	36	.	.	PUNCT
admet-3030	556	1	dysregulated	dysregulated	ADJ
admet-3030	556	2	behaviour	behaviour	NOUN
admet-3030	556	3	of	of	ADP
admet-3030	556	4	hair	hair	NOUN
admet-3030	556	5	follicle	follicle	NOUN
admet-3030	556	6	stem	stem	NOUN
admet-3030	556	7	cells	cell	NOUN
admet-3030	556	8	triggers	trigger	VERB
admet-3030	556	9	alopecia	alopecia	NOUN
admet-3030	556	10	and	and	CCONJ
admet-3030	556	11	provides	provide	VERB
admet-3030	556	12	potential	potential	ADJ
admet-3030	556	13	therapeutic	therapeutic	ADJ
admet-3030	556	14	targets	target	NOUN
admet-3030	556	15	.	.	PUNCT
admet-3030	557	1	experimental	experimental	ADJ
admet-3030	557	2	dermatology	dermatology	NOUN
admet-3030	557	3	31	31	NUM
admet-3030	557	4	(	(	PUNCT
admet-3030	557	5	2022	2022	NUM
admet-3030	557	6	)	)	PUNCT
admet-3030	557	7	986	986	NUM
admet-3030	557	8	-	-	SYM
admet-3030	557	9	992	992	NUM
admet-3030	557	10	.	.	PUNCT
admet-3030	558	1	https://dx.doi.org/10.1111/exd.14600	https://dx.doi.org/10.1111/exd.14600	PROPN
admet-3030	558	2	[	[	X
admet-3030	558	3	66	66	NUM
admet-3030	558	4	]	]	PUNCT
admet-3030	558	5	w.	w.	PROPN
admet-3030	558	6	yu	yu	PROPN
admet-3030	558	7	,	,	PUNCT
admet-3030	558	8	y.	y.	PROPN
admet-3030	558	9	mei	mei	PROPN
admet-3030	558	10	,	,	PUNCT
admet-3030	558	11	z.	z.	PROPN
admet-3030	558	12	lu	lu	PROPN
admet-3030	558	13	,	,	PUNCT
admet-3030	558	14	l.	l.	PROPN
admet-3030	558	15	zhou	zhou	PROPN
admet-3030	558	16	,	,	PUNCT
admet-3030	558	17	f.	f.	PROPN
admet-3030	558	18	jia	jia	PROPN
admet-3030	558	19	,	,	PUNCT
admet-3030	558	20	s.	s.	PROPN
admet-3030	558	21	chen	chen	PROPN
admet-3030	558	22	,	,	PUNCT
admet-3030	558	23	z.	z.	PROPN
admet-3030	558	24	wang	wang	PROPN
admet-3030	558	25	.	.	PUNCT
admet-3030	559	1	the	the	DET
admet-3030	559	2	causal	causal	ADJ
admet-3030	559	3	relationship	relationship	NOUN
admet-3030	559	4	between	between	ADP
admet-3030	559	5	genetically	genetically	ADV
admet-3030	559	6	determined	determined	ADJ
admet-3030	559	7	telomere	telomere	NOUN
admet-3030	559	8	length	length	NOUN
admet-3030	559	9	and	and	CCONJ
admet-3030	559	10	meningiomas	meningiomas	PROPN
admet-3030	559	11	risk	risk	NOUN
admet-3030	559	12	.	.	PUNCT
admet-3030	560	1	frontiers	frontier	NOUN
admet-3030	560	2	in	in	ADP
admet-3030	560	3	neurology	neurology	NOUN
admet-3030	560	4	14	14	NUM
admet-3030	560	5	(	(	PUNCT
admet-3030	560	6	2023	2023	NUM
admet-3030	560	7	)	)	PUNCT
admet-3030	560	8	1178404	1178404	NUM
admet-3030	560	9	.	.	PUNCT
admet-3030	561	1	https://dx.doi.org/10.3389/fneur.2023.1178404	https://dx.doi.org/10.3389/fneur.2023.1178404	NOUN
admet-3030	562	1	[	[	X
admet-3030	562	2	67	67	NUM
admet-3030	562	3	]	]	X
admet-3030	562	4	j.	j.	PROPN
admet-3030	562	5	xiong	xiong	PROPN
admet-3030	562	6	,	,	PUNCT
admet-3030	562	7	b.	b.	PROPN
admet-3030	562	8	wu	wu	PROPN
admet-3030	562	9	,	,	PUNCT
admet-3030	562	10	q.	q.	PROPN
admet-3030	562	11	hou	hou	PROPN
admet-3030	562	12	,	,	PUNCT
admet-3030	562	13	x.	x.	PROPN
admet-3030	562	14	huang	huang	PROPN
admet-3030	562	15	,	,	PUNCT
admet-3030	562	16	l.	l.	PROPN
admet-3030	562	17	jia	jia	PROPN
admet-3030	562	18	,	,	PUNCT
admet-3030	562	19	y.	y.	PROPN
admet-3030	562	20	li	li	PROPN
admet-3030	562	21	,	,	PUNCT
admet-3030	562	22	h.	h.	PROPN
admet-3030	562	23	jiang	jiang	PROPN
admet-3030	562	24	.	.	PUNCT
admet-3030	563	1	comprehensive	comprehensive	ADJ
admet-3030	563	2	analysis	analysis	NOUN
admet-3030	563	3	of	of	ADP
admet-3030	563	4	lncrna	lncrna	NOUN
admet-3030	563	5	ac010789.1	ac010789.1	NOUN
admet-3030	563	6	delays	delay	VERB
admet-3030	563	7	androgenic	androgenic	ADJ
admet-3030	563	8	alopecia	alopecia	NOUN
admet-3030	563	9	progression	progression	NOUN
admet-3030	563	10	by	by	ADP
admet-3030	563	11	targeting	target	VERB
admet-3030	563	12	microrna-21	microrna-21	PROPN
admet-3030	563	13	and	and	CCONJ
admet-3030	563	14	the	the	DET
admet-3030	563	15	wnt	wnt	PROPN
admet-3030	563	16	/	/	SYM
admet-3030	563	17	βcatenin	βcatenin	NOUN
admet-3030	563	18	signaling	signal	VERB
admet-3030	563	19	pathway	pathway	NOUN
admet-3030	563	20	in	in	ADP
admet-3030	563	21	hair	hair	NOUN
admet-3030	563	22	follicle	follicle	NOUN
admet-3030	563	23	stem	stem	NOUN
admet-3030	563	24	cells	cell	NOUN
admet-3030	563	25	.	.	PUNCT
admet-3030	564	1	frontiers	frontier	NOUN
admet-3030	564	2	in	in	ADP
admet-3030	564	3	genetics	genetic	NOUN
admet-3030	564	4	13	13	NUM
admet-3030	564	5	(	(	PUNCT
admet-3030	564	6	2022	2022	NUM
admet-3030	564	7	)	)	PUNCT
admet-3030	564	8	782750	782750	NUM
admet-3030	564	9	.	.	PUNCT
admet-3030	565	1	https://dx.doi.org/10.3389/fgene.2022.782750	https://dx.doi.org/10.3389/fgene.2022.782750	VERB
admet-3030	566	1	[	[	X
admet-3030	566	2	68	68	NUM
admet-3030	566	3	]	]	PUNCT
admet-3030	566	4	p.	p.	NOUN
admet-3030	566	5	mohammadi	mohammadi	NOUN
admet-3030	566	6	,	,	PUNCT
admet-3030	566	7	m.a	m.a	PROPN
admet-3030	566	8	.	.	PROPN
admet-3030	566	9	nilforoushzadeh	nilforoushzadeh	PROPN
admet-3030	566	10	,	,	PUNCT
admet-3030	566	11	k.k	k.k	PROPN
admet-3030	566	12	.	.	PROPN
admet-3030	566	13	youssef	youssef	PROPN
admet-3030	566	14	,	,	PUNCT
admet-3030	566	15	a.	a.	PROPN
admet-3030	566	16	sharifi	sharifi	PROPN
admet-3030	566	17	-	-	PUNCT
admet-3030	566	18	zarchi	zarchi	PROPN
admet-3030	566	19	,	,	PUNCT
admet-3030	566	20	s.	s.	PROPN
admet-3030	566	21	moradi	moradi	PROPN
admet-3030	566	22	,	,	PUNCT
admet-3030	566	23	p.	p.	PROPN
admet-3030	566	24	khosravani	khosravani	PROPN
admet-3030	566	25	,	,	PUNCT
admet-3030	566	26	r.	r.	PROPN
admet-3030	566	27	aghdami	aghdami	PROPN
admet-3030	566	28	,	,	PUNCT
admet-3030	566	29	p.	p.	PROPN
admet-3030	566	30	taheri	taheri	NOUN
admet-3030	566	31	,	,	PUNCT
admet-3030	566	32	g.	g.	PROPN
admet-3030	566	33	hosseini	hosseini	PROPN
admet-3030	566	34	salekdeh	salekdeh	PROPN
admet-3030	566	35	,	,	PUNCT
admet-3030	566	36	h.	h.	PROPN
admet-3030	566	37	baharvand	baharvand	PROPN
admet-3030	566	38	,	,	PUNCT
admet-3030	566	39	n.	n.	PROPN
admet-3030	566	40	aghdami	aghdami	NOUN
admet-3030	566	41	.	.	PUNCT
admet-3030	567	1	defining	define	VERB
admet-3030	567	2	microrna	microrna	PROPN
admet-3030	567	3	signatures	signature	NOUN
admet-3030	567	4	of	of	ADP
admet-3030	567	5	hair	hair	NOUN
admet-3030	567	6	follicular	follicular	ADJ
admet-3030	567	7	stem	stem	NOUN
admet-3030	567	8	and	and	CCONJ
admet-3030	567	9	progenitor	progenitor	NOUN
admet-3030	567	10	cells	cell	NOUN
admet-3030	567	11	in	in	ADP
admet-3030	567	12	healthy	healthy	ADJ
admet-3030	567	13	and	and	CCONJ
admet-3030	567	14	androgenic	androgenic	ADJ
admet-3030	567	15	alopecia	alopecia	NOUN
admet-3030	567	16	patients	patient	NOUN
admet-3030	567	17	.	.	PUNCT
admet-3030	568	1	journal	journal	NOUN
admet-3030	568	2	of	of	ADP
admet-3030	568	3	dermatological	dermatological	ADJ
admet-3030	568	4	science	science	NOUN
admet-3030	568	5	101	101	NUM
admet-3030	568	6	(	(	PUNCT
admet-3030	568	7	2021	2021	NUM
admet-3030	568	8	)	)	PUNCT
admet-3030	568	9	49	49	NUM
admet-3030	568	10	-	-	SYM
admet-3030	568	11	57	57	NUM
admet-3030	568	12	.	.	PUNCT
admet-3030	569	1	https://dx.doi.org/10.1016/j.jdermsci.2020.11.002	https://dx.doi.org/10.1016/j.jdermsci.2020.11.002	PROPN
admet-3030	570	1	[	[	X
admet-3030	570	2	69	69	NUM
admet-3030	570	3	]	]	X
admet-3030	570	4	w.	w.	PROPN
admet-3030	570	5	deng	deng	PROPN
admet-3030	570	6	,	,	PUNCT
admet-3030	570	7	t.	t.	PROPN
admet-3030	570	8	hu	hu	PROPN
admet-3030	570	9	,	,	PUNCT
admet-3030	570	10	l.	l.	PROPN
admet-3030	570	11	han	han	PROPN
admet-3030	570	12	,	,	PUNCT
admet-3030	570	13	b.	b.	PROPN
admet-3030	570	14	liu	liu	PROPN
admet-3030	570	15	,	,	PUNCT
admet-3030	570	16	x.	x.	PROPN
admet-3030	570	17	tang	tang	PROPN
admet-3030	570	18	,	,	PUNCT
admet-3030	570	19	h.	h.	PROPN
admet-3030	570	20	chen	chen	PROPN
admet-3030	570	21	,	,	PUNCT
admet-3030	570	22	x.	x.	PROPN
admet-3030	570	23	chen	chen	PROPN
admet-3030	570	24	,	,	PUNCT
admet-3030	571	1	m.	m.	PROPN
admet-3030	571	2	wan	wan	PROPN
admet-3030	571	3	.	.	PROPN
admet-3030	571	4	mirna	mirna	PROPN
admet-3030	571	5	microarray	microarray	PROPN
admet-3030	571	6	profiling	profiling	NOUN
admet-3030	571	7	in	in	ADP
admet-3030	571	8	patients	patient	NOUN
admet-3030	571	9	with	with	ADP
admet-3030	571	10	androgenic	androgenic	ADJ
admet-3030	571	11	alopecia	alopecia	NOUN
admet-3030	571	12	and	and	CCONJ
admet-3030	571	13	the	the	DET
admet-3030	571	14	effects	effect	NOUN
admet-3030	571	15	of	of	ADP
admet-3030	571	16	mir-133b	mir-133b	NOUN
admet-3030	571	17	on	on	ADP
admet-3030	571	18	hair	hair	NOUN
admet-3030	571	19	growth	growth	NOUN
admet-3030	571	20	.	.	PUNCT
admet-3030	572	1	experimental	experimental	ADJ
admet-3030	572	2	and	and	CCONJ
admet-3030	572	3	molecular	molecular	ADJ
admet-3030	572	4	pathology	pathology	NOUN
admet-3030	572	5	118	118	NUM
admet-3030	572	6	(	(	PUNCT
admet-3030	572	7	2021	2021	NUM
admet-3030	572	8	)	)	PUNCT
admet-3030	572	9	104589	104589	NUM
admet-3030	572	10	.	.	PUNCT
admet-3030	572	11	https://dx.doi.org/10.1016/j.yexmp.2020.104589	https://dx.doi.org/10.1016/j.yexmp.2020.104589	PUNCT
admet-3030	573	1	[	[	X
admet-3030	573	2	70	70	NUM
admet-3030	573	3	]	]	X
admet-3030	573	4	s.w	s.w	PROPN
admet-3030	573	5	.	.	PROPN
admet-3030	573	6	choi	choi	PROPN
admet-3030	573	7	,	,	PUNCT
admet-3030	573	8	t.s	t.s	PROPN
admet-3030	573	9	.	.	PROPN
admet-3030	573	10	mak	mak	PROPN
admet-3030	573	11	,	,	PUNCT
admet-3030	573	12	p.f	p.f	PROPN
admet-3030	573	13	.	.	PROPN
admet-3030	573	14	o'reilly	o'reilly	PROPN
admet-3030	573	15	.	.	PUNCT
admet-3030	574	1	tutorial	tutorial	NOUN
admet-3030	574	2	:	:	PUNCT
admet-3030	574	3	a	a	DET
admet-3030	574	4	guide	guide	NOUN
admet-3030	574	5	to	to	ADP
admet-3030	574	6	performing	perform	VERB
admet-3030	574	7	polygenic	polygenic	ADJ
admet-3030	574	8	risk	risk	NOUN
admet-3030	574	9	score	score	NOUN
admet-3030	574	10	analyses	analysis	NOUN
admet-3030	574	11	.	.	PUNCT
admet-3030	575	1	nature	nature	NOUN
admet-3030	575	2	protocols	protocol	NOUN
admet-3030	575	3	15	15	NUM
admet-3030	575	4	(	(	PUNCT
admet-3030	575	5	2020	2020	NUM
admet-3030	575	6	)	)	PUNCT
admet-3030	575	7	2759	2759	NUM
admet-3030	575	8	-	-	SYM
admet-3030	575	9	2772	2772	NUM
admet-3030	575	10	.	.	PUNCT
admet-3030	575	11	https://dx.doi.org/10.1038/s41596-020-0353-1	https://dx.doi.org/10.1038/s41596-020-0353-1	PUNCT
admet-3030	576	1	[	[	X
admet-3030	576	2	71	71	NUM
admet-3030	576	3	]	]	X
admet-3030	576	4	h.	h.	PROPN
admet-3030	576	5	moravvej	moravvej	PROPN
admet-3030	576	6	,	,	PUNCT
admet-3030	576	7	m.r	m.r	PROPN
admet-3030	576	8	.	.	PROPN
admet-3030	576	9	pourani	pourani	PROPN
admet-3030	576	10	,	,	PUNCT
admet-3030	576	11	m.	m.	NOUN
admet-3030	576	12	baghani	baghani	PROPN
admet-3030	576	13	,	,	PUNCT
admet-3030	576	14	f.	f.	PROPN
admet-3030	576	15	abdollahimajd	abdollahimajd	PROPN
admet-3030	576	16	.	.	PUNCT
admet-3030	577	1	androgenetic	androgenetic	ADJ
admet-3030	577	2	alopecia	alopecia	NOUN
admet-3030	577	3	and	and	CCONJ
admet-3030	577	4	covid-19	covid-19	PROPN
admet-3030	577	5	:	:	PUNCT
admet-3030	577	6	a	a	DET
admet-3030	577	7	review	review	NOUN
admet-3030	577	8	of	of	ADP
admet-3030	577	9	the	the	DET
admet-3030	577	10	hypothetical	hypothetical	ADJ
admet-3030	577	11	role	role	NOUN
admet-3030	577	12	of	of	ADP
admet-3030	577	13	androgens	androgen	NOUN
admet-3030	577	14	.	.	PUNCT
admet-3030	578	1	dermatologic	dermatologic	ADJ
admet-3030	578	2	therapy	therapy	NOUN
admet-3030	578	3	34	34	NUM
admet-3030	578	4	(	(	PUNCT
admet-3030	578	5	2021	2021	NUM
admet-3030	578	6	)	)	PUNCT
admet-3030	578	7	e15004	e15004	PROPN
admet-3030	578	8	.	.	PUNCT
admet-3030	579	1	https://dx.doi.org/10.1111/dth.15004	https://dx.doi.org/10.1111/dth.15004	PROPN
admet-3030	579	2	[	[	X
admet-3030	579	3	72	72	NUM
admet-3030	579	4	]	]	X
admet-3030	579	5	j.	j.	PROPN
admet-3030	579	6	xiong	xiong	PROPN
admet-3030	579	7	,	,	PUNCT
admet-3030	579	8	g.	g.	PROPN
admet-3030	579	9	chen	chen	PROPN
admet-3030	579	10	,	,	PUNCT
admet-3030	579	11	z.	z.	PROPN
admet-3030	579	12	liu	liu	PROPN
admet-3030	579	13	,	,	PUNCT
admet-3030	579	14	x.	x.	PROPN
admet-3030	579	15	wu	wu	PROPN
admet-3030	579	16	,	,	PUNCT
admet-3030	579	17	s.	s.	PROPN
admet-3030	579	18	xu	xu	PROPN
admet-3030	579	19	,	,	PUNCT
admet-3030	579	20	j.	j.	PROPN
admet-3030	579	21	xiong	xiong	PROPN
admet-3030	579	22	,	,	PUNCT
admet-3030	579	23	s.	s.	PROPN
admet-3030	579	24	ji	ji	PROPN
admet-3030	579	25	,	,	PUNCT
admet-3030	579	26	m.	m.	PROPN
admet-3030	579	27	wu	wu	PROPN
admet-3030	579	28	.	.	PUNCT
admet-3030	580	1	construction	construction	NOUN
admet-3030	580	2	of	of	ADP
admet-3030	580	3	regulatory	regulatory	ADJ
admet-3030	580	4	network	network	NOUN
admet-3030	580	5	for	for	ADP
admet-3030	580	6	alopecia	alopecia	NOUN
admet-3030	580	7	areata	areata	ADJ
admet-3030	580	8	progression	progression	NOUN
admet-3030	580	9	and	and	CCONJ
admet-3030	580	10	identification	identification	NOUN
admet-3030	580	11	of	of	ADP
admet-3030	580	12	immune	immune	ADJ
admet-3030	580	13	monitoring	monitoring	NOUN
admet-3030	580	14	genes	gene	NOUN
admet-3030	580	15	based	base	VERB
admet-3030	580	16	on	on	ADP
admet-3030	580	17	multiple	multiple	ADJ
admet-3030	580	18	machine	machine	NOUN
admet-3030	580	19	-	-	PUNCT
admet-3030	580	20	learning	learn	VERB
admet-3030	580	21	algorithms	algorithm	NOUN
admet-3030	580	22	.	.	PUNCT
admet-3030	581	1	precision	precision	NOUN
admet-3030	581	2	clinical	clinical	ADJ
admet-3030	581	3	medicine	medicine	NOUN
admet-3030	581	4	6	6	NUM
admet-3030	581	5	(	(	PUNCT
admet-3030	581	6	2023	2023	NUM
admet-3030	581	7	)	)	PUNCT
admet-3030	581	8	pbad009	pbad009	PROPN
admet-3030	581	9	.	.	PUNCT
admet-3030	582	1	https://dx.doi.org/10.1093/pcmedi/pbad009	https://dx.doi.org/10.1093/pcmedi/pbad009	X
admet-3030	583	1	[	[	X
admet-3030	583	2	73	73	NUM
admet-3030	583	3	]	]	PUNCT
admet-3030	583	4	q.	q.	PROPN
admet-3030	583	5	zhou	zhou	PROPN
admet-3030	583	6	,	,	PUNCT
admet-3030	583	7	l.	l.	PROPN
admet-3030	583	8	lan	lan	PROPN
admet-3030	583	9	,	,	PUNCT
admet-3030	583	10	w.	w.	PROPN
admet-3030	583	11	wang	wang	PROPN
admet-3030	583	12	,	,	PUNCT
admet-3030	583	13	x.	x.	PROPN
admet-3030	583	14	xu	xu	PROPN
admet-3030	583	15	.	.	PUNCT
admet-3030	584	1	identifying	identify	VERB
admet-3030	584	2	effective	effective	ADJ
admet-3030	584	3	immune	immune	ADJ
admet-3030	584	4	biomarkers	biomarker	NOUN
admet-3030	584	5	in	in	ADP
admet-3030	584	6	alopecia	alopecia	NOUN
admet-3030	584	7	areata	areata	ADJ
admet-3030	584	8	diagnosis	diagnosis	NOUN
admet-3030	584	9	based	base	VERB
admet-3030	584	10	on	on	ADP
admet-3030	584	11	machine	machine	NOUN
admet-3030	584	12	learning	learning	NOUN
admet-3030	584	13	methods	method	NOUN
admet-3030	584	14	.	.	PUNCT
admet-3030	585	1	bmc	bmc	PROPN
admet-3030	585	2	medical	medical	ADJ
admet-3030	585	3	informatics	informatic	NOUN
admet-3030	585	4	and	and	CCONJ
admet-3030	585	5	decision	decision	NOUN
admet-3030	585	6	making	make	VERB
admet-3030	585	7	25	25	NUM
admet-3030	585	8	(	(	PUNCT
admet-3030	585	9	2025	2025	NUM
admet-3030	585	10	)	)	PUNCT
admet-3030	585	11	23	23	NUM
admet-3030	585	12	.	.	PUNCT
admet-3030	586	1	https://dx.doi.org/10.1186/s12911-025-02853-8	https://dx.doi.org/10.1186/s12911-025-02853-8	NUM
admet-3030	587	1	[	[	X
admet-3030	587	2	74	74	NUM
admet-3030	587	3	]	]	PUNCT
admet-3030	587	4	d.	d.	PROPN
admet-3030	587	5	ahn	ahn	PROPN
admet-3030	587	6	,	,	PUNCT
admet-3030	587	7	h.	h.	PROPN
admet-3030	587	8	kim	kim	PROPN
admet-3030	587	9	,	,	PUNCT
admet-3030	587	10	b.	b.	PROPN
admet-3030	587	11	lee	lee	PROPN
admet-3030	587	12	,	,	PUNCT
admet-3030	587	13	d.h	d.h	PROPN
admet-3030	587	14	.	.	PROPN
admet-3030	587	15	hahm	hahm	PROPN
admet-3030	587	16	.	.	PUNCT
admet-3030	588	1	psychological	psychological	ADJ
admet-3030	588	2	stress	stress	NOUN
admet-3030	588	3	-	-	PUNCT
admet-3030	588	4	induced	induce	VERB
admet-3030	588	5	pathogenesis	pathogenesis	NOUN
admet-3030	588	6	of	of	ADP
admet-3030	588	7	alopecia	alopecia	NOUN
admet-3030	588	8	areata	areata	NOUN
admet-3030	588	9	:	:	PUNCT
admet-3030	588	10	autoimmune	autoimmune	ADJ
admet-3030	588	11	and	and	CCONJ
admet-3030	588	12	apoptotic	apoptotic	ADJ
admet-3030	588	13	pathways	pathway	NOUN
admet-3030	588	14	.	.	PUNCT
admet-3030	589	1	international	international	ADJ
admet-3030	589	2	journal	journal	NOUN
admet-3030	589	3	of	of	ADP
admet-3030	589	4	molecular	molecular	ADJ
admet-3030	589	5	sciences	science	NOUN
admet-3030	589	6	24	24	NUM
admet-3030	589	7	(	(	PUNCT
admet-3030	589	8	2023	2023	NUM
admet-3030	589	9	)	)	PUNCT
admet-3030	589	10	11711	11711	NUM
admet-3030	589	11	.	.	PUNCT
admet-3030	590	1	https://dx.doi.org/10.3390/ijms241411711	https://dx.doi.org/10.3390/ijms241411711	NOUN
admet-3030	590	2	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	PROPN
admet-3030	590	3	https://doi.org/10.1046/j.1523-1747.2001.01261.x	https://doi.org/10.1046/j.1523-1747.2001.01261.x	VERB
admet-3030	590	4	https://www.ncbi.nlm.nih.gov/books/nbk430924/	https://www.ncbi.nlm.nih.gov/books/nbk430924/	PROPN
admet-3030	590	5	https://doi.org/10.1186/s13287-025-04420-4	https://doi.org/10.1186/s13287-025-04420-4	X
admet-3030	590	6	https://doi.org/10.3390/ph17091112	https://doi.org/10.3390/ph17091112	PROPN
admet-3030	590	7	https://doi.org/10.21203/rs.3.rs-3629594/v1	https://doi.org/10.21203/rs.3.rs-3629594/v1	PART
admet-3030	591	1	https://doi.org/10.1016/j.yexcr.2021.112618	https://doi.org/10.1016/j.yexcr.2021.112618	NOUN
admet-3030	591	2	https://doi.org/10.1111/exd.14600	https://doi.org/10.1111/exd.14600	ADP
admet-3030	591	3	https://doi.org/10.3389/fneur.2023.1178404	https://doi.org/10.3389/fneur.2023.1178404	PROPN
admet-3030	591	4	https://doi.org/10.3389/fgene.2022.782750	https://doi.org/10.3389/fgene.2022.782750	PROPN
admet-3030	591	5	https://doi.org/10.1016/j.jdermsci.2020.11.002	https://doi.org/10.1016/j.jdermsci.2020.11.002	NOUN
admet-3030	591	6	https://doi.org/10.1016/j.yexmp.2020.104589	https://doi.org/10.1016/j.yexmp.2020.104589	PROPN
admet-3030	591	7	https://doi.org/10.1038/s41596-020-0353-1	https://doi.org/10.1038/s41596-020-0353-1	PROPN
admet-3030	591	8	https://doi.org/10.1111/dth.15004	https://doi.org/10.1111/dth.15004	PROPN
admet-3030	591	9	https://doi.org/10.1093/pcmedi/pbad009	https://doi.org/10.1093/pcmedi/pbad009	PRON
admet-3030	591	10	https://doi.org/10.1186/s12911-025-02853-8	https://doi.org/10.1186/s12911-025-02853-8	PROPN
admet-3030	591	11	https://doi.org/10.3390/ijms241411711	https://doi.org/10.3390/ijms241411711	VERB
admet-3030	591	12	r.	r.	PROPN
admet-3030	591	13	kapoor	kapoor	PROPN
admet-3030	591	14	et	et	PROPN
admet-3030	591	15	al	al	PROPN
admet-3030	591	16	.	.	PROPN
admet-3030	591	17	admet	admet	PROPN
admet-3030	591	18	&	&	CCONJ
admet-3030	591	19	dmpk	dmpk	PROPN
admet-3030	591	20	00(0	00(0	PROPN
admet-3030	591	21	)	)	PUNCT
admet-3030	591	22	(	(	PUNCT
admet-3030	591	23	2025	2025	NUM
admet-3030	591	24	)	)	PUNCT
admet-3030	591	25	3030	3030	NUM
admet-3030	591	26	20	20	NUM
admet-3030	592	1	[	[	SYM
admet-3030	592	2	75	75	NUM
admet-3030	592	3	]	]	PUNCT
admet-3030	592	4	f.	f.	PROPN
admet-3030	592	5	lolli	lolli	PROPN
admet-3030	592	6	,	,	PUNCT
admet-3030	592	7	f.	f.	PROPN
admet-3030	592	8	pallotti	pallotti	PROPN
admet-3030	592	9	,	,	PUNCT
admet-3030	592	10	a.	a.	NOUN
admet-3030	592	11	rossi	rossi	PROPN
admet-3030	592	12	,	,	PUNCT
admet-3030	592	13	m.c	m.c	PROPN
admet-3030	592	14	.	.	PROPN
admet-3030	592	15	fortuna	fortuna	PROPN
admet-3030	592	16	,	,	PUNCT
admet-3030	592	17	g.	g.	PROPN
admet-3030	592	18	caro	caro	PROPN
admet-3030	592	19	,	,	PUNCT
admet-3030	592	20	a.	a.	PROPN
admet-3030	592	21	lenzi	lenzi	PROPN
admet-3030	592	22	,	,	PUNCT
admet-3030	592	23	a.	a.	NOUN
admet-3030	592	24	sansone	sansone	PROPN
admet-3030	592	25	,	,	PUNCT
admet-3030	592	26	f.	f.	PROPN
admet-3030	592	27	lombardo	lombardo	PROPN
admet-3030	592	28	.	.	PUNCT
admet-3030	593	1	androgenetic	androgenetic	ADJ
admet-3030	593	2	alopecia	alopecia	NOUN
admet-3030	593	3	:	:	PUNCT
admet-3030	593	4	a	a	DET
admet-3030	593	5	review	review	NOUN
admet-3030	593	6	.	.	PUNCT
admet-3030	594	1	endocrine	endocrine	PROPN
admet-3030	594	2	57	57	NUM
admet-3030	594	3	(	(	PUNCT
admet-3030	594	4	2017	2017	NUM
admet-3030	594	5	)	)	PUNCT
admet-3030	594	6	9	9	NUM
admet-3030	594	7	-	-	SYM
admet-3030	594	8	17	17	NUM
admet-3030	594	9	.	.	PUNCT
admet-3030	595	1	https://dx.doi.org/10.1007/s12020-017-1280-y	https://dx.doi.org/10.1007/s12020-017-1280-y	X
admet-3030	596	1	[	[	X
admet-3030	596	2	76	76	NUM
admet-3030	596	3	]	]	X
admet-3030	596	4	p.	p.	NOUN
admet-3030	596	5	suchonwanit	suchonwanit	PROPN
admet-3030	596	6	,	,	PUNCT
admet-3030	596	7	s.	s.	PROPN
admet-3030	596	8	thammarucha	thammarucha	PROPN
admet-3030	596	9	,	,	PUNCT
admet-3030	596	10	k.	k.	PROPN
admet-3030	596	11	leerunyakul	leerunyakul	PROPN
admet-3030	596	12	.	.	PUNCT
admet-3030	597	1	minoxidil	minoxidil	PROPN
admet-3030	597	2	and	and	CCONJ
admet-3030	597	3	its	its	PRON
admet-3030	597	4	use	use	NOUN
admet-3030	597	5	in	in	ADP
admet-3030	597	6	hair	hair	NOUN
admet-3030	597	7	disorders	disorder	NOUN
admet-3030	597	8	:	:	PUNCT
admet-3030	597	9	a	a	DET
admet-3030	597	10	review	review	NOUN
admet-3030	597	11	.	.	PUNCT
admet-3030	598	1	drug	drug	NOUN
admet-3030	598	2	design	design	NOUN
admet-3030	598	3	,	,	PUNCT
admet-3030	598	4	development	development	NOUN
admet-3030	598	5	and	and	CCONJ
admet-3030	598	6	therapy	therapy	NOUN
admet-3030	598	7	13	13	NUM
admet-3030	598	8	(	(	PUNCT
admet-3030	598	9	2019	2019	NUM
admet-3030	598	10	)	)	PUNCT
admet-3030	598	11	2777	2777	NUM
admet-3030	598	12	-	-	SYM
admet-3030	598	13	2786	2786	NUM
admet-3030	598	14	.	.	PUNCT
admet-3030	599	1	https://dx.doi.org/10.2147/dddt.s214907	https://dx.doi.org/10.2147/dddt.s214907	NOUN
admet-3030	600	1	[	[	X
admet-3030	600	2	77	77	NUM
admet-3030	600	3	]	]	X
admet-3030	600	4	a.k	a.k	PROPN
admet-3030	600	5	.	.	PROPN
admet-3030	600	6	gupta	gupta	PROPN
admet-3030	600	7	,	,	PUNCT
admet-3030	600	8	m.	m.	NOUN
admet-3030	600	9	venkataraman	venkataraman	NOUN
admet-3030	600	10	,	,	PUNCT
admet-3030	600	11	m.	m.	NOUN
admet-3030	600	12	talukder	talukder	NOUN
admet-3030	600	13	,	,	PUNCT
admet-3030	600	14	m.a	m.a	PROPN
admet-3030	600	15	.	.	PROPN
admet-3030	600	16	bamimore	bamimore	NOUN
admet-3030	600	17	.	.	PUNCT
admet-3030	601	1	finasteride	finasteride	ADJ
admet-3030	601	2	for	for	ADP
admet-3030	601	3	hair	hair	NOUN
admet-3030	601	4	loss	loss	NOUN
admet-3030	601	5	:	:	PUNCT
admet-3030	601	6	a	a	DET
admet-3030	601	7	review	review	NOUN
admet-3030	601	8	.	.	PUNCT
admet-3030	602	1	journal	journal	NOUN
admet-3030	602	2	of	of	ADP
admet-3030	602	3	dermatological	dermatological	ADJ
admet-3030	602	4	treatment	treatment	NOUN
admet-3030	602	5	33	33	NUM
admet-3030	602	6	(	(	PUNCT
admet-3030	602	7	2022	2022	NUM
admet-3030	602	8	)	)	PUNCT
admet-3030	602	9	1938	1938	NUM
admet-3030	602	10	-	-	SYM
admet-3030	602	11	1946	1946	NUM
admet-3030	602	12	.	.	PUNCT
admet-3030	603	1	https://dx.doi.org/10.1080/09546634.2021.1959506	https://dx.doi.org/10.1080/09546634.2021.1959506	X
admet-3030	604	1	[	[	X
admet-3030	604	2	78	78	NUM
admet-3030	604	3	]	]	X
admet-3030	604	4	v.w.y	v.w.y	PROPN
admet-3030	604	5	.	.	PUNCT
admet-3030	605	1	lai	lai	PROPN
admet-3030	605	2	,	,	PUNCT
admet-3030	605	3	r.	r.	PROPN
admet-3030	605	4	sinclair	sinclair	PROPN
admet-3030	605	5	.	.	PUNCT
admet-3030	606	1	utility	utility	NOUN
admet-3030	606	2	of	of	ADP
admet-3030	606	3	azathioprine	azathioprine	NOUN
admet-3030	606	4	,	,	PUNCT
admet-3030	606	5	methotrexate	methotrexate	NOUN
admet-3030	606	6	and	and	CCONJ
admet-3030	606	7	cyclosporine	cyclosporine	NOUN
admet-3030	606	8	as	as	ADP
admet-3030	606	9	steroid	steroid	NOUN
admet-3030	606	10	-	-	PUNCT
admet-3030	606	11	sparing	spare	VERB
admet-3030	606	12	agents	agent	NOUN
admet-3030	606	13	in	in	ADP
admet-3030	606	14	chronic	chronic	ADJ
admet-3030	606	15	alopecia	alopecia	NOUN
admet-3030	606	16	areata	areata	NOUN
admet-3030	606	17	:	:	PUNCT
admet-3030	606	18	a	a	DET
admet-3030	606	19	retrospective	retrospective	ADJ
admet-3030	606	20	study	study	NOUN
admet-3030	606	21	of	of	ADP
admet-3030	606	22	continuation	continuation	NOUN
admet-3030	606	23	rates	rate	NOUN
admet-3030	606	24	in	in	ADP
admet-3030	606	25	138	138	NUM
admet-3030	606	26	patients	patient	NOUN
admet-3030	606	27	.	.	PUNCT
admet-3030	607	1	journal	journal	NOUN
admet-3030	607	2	of	of	ADP
admet-3030	607	3	the	the	DET
admet-3030	607	4	european	european	PROPN
admet-3030	607	5	academy	academy	PROPN
admet-3030	607	6	of	of	ADP
admet-3030	607	7	dermatology	dermatology	NOUN
admet-3030	607	8	and	and	CCONJ
admet-3030	607	9	venereology	venereology	NOUN
admet-3030	607	10	34	34	NUM
admet-3030	607	11	(	(	PUNCT
admet-3030	607	12	2020	2020	NUM
admet-3030	607	13	)	)	PUNCT
admet-3030	607	14	2606	2606	NUM
admet-3030	607	15	-	-	SYM
admet-3030	607	16	2612	2612	NUM
admet-3030	607	17	.	.	PUNCT
admet-3030	608	1	https://dx.doi.org/10.1111/jdv.16858	https://dx.doi.org/10.1111/jdv.16858	PRON
admet-3030	609	1	[	[	X
admet-3030	609	2	79	79	NUM
admet-3030	609	3	]	]	X
admet-3030	609	4	m.	m.	NOUN
admet-3030	609	5	lensing	lensing	NOUN
admet-3030	609	6	,	,	PUNCT
admet-3030	609	7	a.	a.	NOUN
admet-3030	609	8	jabbari	jabbari	NOUN
admet-3030	609	9	.	.	PUNCT
admet-3030	610	1	an	an	DET
admet-3030	610	2	overview	overview	NOUN
admet-3030	610	3	of	of	ADP
admet-3030	610	4	jak	jak	PROPN
admet-3030	610	5	/	/	SYM
admet-3030	610	6	stat	stat	PROPN
admet-3030	610	7	pathways	pathway	NOUN
admet-3030	610	8	and	and	CCONJ
admet-3030	610	9	jak	jak	PROPN
admet-3030	610	10	inhibition	inhibition	NOUN
admet-3030	610	11	in	in	ADP
admet-3030	610	12	alopecia	alopecia	NOUN
admet-3030	610	13	areata	areata	NOUN
admet-3030	610	14	.	.	PUNCT
admet-3030	611	1	frontiers	frontier	NOUN
admet-3030	611	2	in	in	ADP
admet-3030	611	3	immunology	immunology	NOUN
admet-3030	611	4	13	13	NUM
admet-3030	611	5	(	(	PUNCT
admet-3030	611	6	2022	2022	NUM
admet-3030	611	7	)	)	PUNCT
admet-3030	611	8	955035	955035	NUM
admet-3030	611	9	.	.	PUNCT
admet-3030	612	1	https://dx.doi.org/10.3389/fimmu.2022.955035	https://dx.doi.org/10.3389/fimmu.2022.955035	PROPN
admet-3030	613	1	[	[	X
admet-3030	613	2	80	80	NUM
admet-3030	613	3	]	]	PUNCT
admet-3030	613	4	a.	a.	NOUN
admet-3030	613	5	samadi	samadi	NOUN
admet-3030	613	6	,	,	PUNCT
admet-3030	613	7	s.	s.	PROPN
admet-3030	613	8	ahmad	ahmad	PROPN
admet-3030	613	9	nasrollahi	nasrollahi	PROPN
admet-3030	613	10	,	,	PUNCT
admet-3030	613	11	a.	a.	NOUN
admet-3030	613	12	hashemi	hashemi	PROPN
admet-3030	613	13	,	,	PUNCT
admet-3030	613	14	m.	m.	NOUN
admet-3030	613	15	nassiri	nassiri	PROPN
admet-3030	613	16	kashani	kashani	PROPN
admet-3030	613	17	,	,	PUNCT
admet-3030	613	18	a.	a.	NOUN
admet-3030	613	19	firooz	firooz	PROPN
admet-3030	613	20	.	.	PUNCT
admet-3030	614	1	janus	janus	PROPN
admet-3030	614	2	kinase	kinase	PROPN
admet-3030	614	3	(	(	PUNCT
admet-3030	614	4	jak	jak	PROPN
admet-3030	614	5	)	)	PUNCT
admet-3030	614	6	inhibitors	inhibitor	NOUN
admet-3030	614	7	for	for	ADP
admet-3030	614	8	the	the	DET
admet-3030	614	9	treatment	treatment	NOUN
admet-3030	614	10	of	of	ADP
admet-3030	614	11	skin	skin	NOUN
admet-3030	614	12	and	and	CCONJ
admet-3030	614	13	hair	hair	NOUN
admet-3030	614	14	disorders	disorder	NOUN
admet-3030	614	15	:	:	PUNCT
admet-3030	614	16	a	a	DET
admet-3030	614	17	review	review	NOUN
admet-3030	614	18	of	of	ADP
admet-3030	614	19	literature	literature	NOUN
admet-3030	614	20	.	.	PUNCT
admet-3030	615	1	journal	journal	PROPN
admet-3030	615	2	of	of	ADP
admet-3030	615	3	dermatological	dermatological	ADJ
admet-3030	615	4	treatment	treatment	NOUN
admet-3030	615	5	28	28	NUM
admet-3030	615	6	(	(	PUNCT
admet-3030	615	7	2017	2017	NUM
admet-3030	615	8	)	)	PUNCT
admet-3030	615	9	476	476	NUM
admet-3030	615	10	-	-	SYM
admet-3030	615	11	483	483	NUM
admet-3030	615	12	.	.	PUNCT
admet-3030	616	1	https://dx.doi.org/10.1080/09546634.2016.1277179	https://dx.doi.org/10.1080/09546634.2016.1277179	NOUN
admet-3030	617	1	[	[	X
admet-3030	617	2	81	81	NUM
admet-3030	617	3	]	]	X
admet-3030	617	4	k.d	k.d	PROPN
admet-3030	617	5	.	.	PUNCT
admet-3030	617	6	kaufman	kaufman	PROPN
admet-3030	617	7	,	,	PUNCT
admet-3030	617	8	e.a	e.a	PROPN
admet-3030	617	9	.	.	PROPN
admet-3030	617	10	olsen	olsen	PROPN
admet-3030	617	11	,	,	PUNCT
admet-3030	617	12	d.	d.	PROPN
admet-3030	617	13	whiting	whiting	PROPN
admet-3030	617	14	,	,	PUNCT
admet-3030	617	15	r.	r.	PROPN
admet-3030	617	16	savin	savin	PROPN
admet-3030	617	17	,	,	PUNCT
admet-3030	617	18	r.	r.	PROPN
admet-3030	617	19	devillez	devillez	PROPN
admet-3030	617	20	,	,	PUNCT
admet-3030	617	21	w.	w.	PROPN
admet-3030	617	22	bergfeld	bergfeld	PROPN
admet-3030	617	23	,	,	PUNCT
admet-3030	617	24	v.h	v.h	PROPN
admet-3030	617	25	.	.	PROPN
admet-3030	617	26	price	price	NOUN
admet-3030	617	27	,	,	PUNCT
admet-3030	617	28	d.	d.	PROPN
admet-3030	617	29	van	van	PROPN
admet-3030	617	30	neste	neste	PROPN
admet-3030	617	31	,	,	PUNCT
admet-3030	617	32	j.l	j.l	PROPN
admet-3030	617	33	.	.	PROPN
admet-3030	617	34	roberts	roberts	PROPN
admet-3030	617	35	,	,	PUNCT
admet-3030	617	36	m.	m.	NOUN
admet-3030	617	37	hordinsky	hordinsky	PROPN
admet-3030	617	38	,	,	PUNCT
admet-3030	617	39	j.	j.	PROPN
admet-3030	617	40	shapiro	shapiro	PROPN
admet-3030	617	41	,	,	PUNCT
admet-3030	617	42	b.	b.	PROPN
admet-3030	617	43	binkowitz	binkowitz	PROPN
admet-3030	617	44	,	,	PUNCT
admet-3030	617	45	g.j	g.j	PROPN
admet-3030	617	46	.	.	PROPN
admet-3030	617	47	gormley	gormley	PROPN
admet-3030	617	48	.	.	PUNCT
admet-3030	618	1	finasteride	finasteride	ADV
admet-3030	618	2	in	in	ADP
admet-3030	618	3	the	the	DET
admet-3030	618	4	treatment	treatment	NOUN
admet-3030	618	5	of	of	ADP
admet-3030	618	6	men	man	NOUN
admet-3030	618	7	with	with	ADP
admet-3030	618	8	androgenetic	androgenetic	ADJ
admet-3030	618	9	alopecia	alopecia	NOUN
admet-3030	618	10	.	.	PUNCT
admet-3030	619	1	finasteride	finasteride	ADJ
admet-3030	619	2	male	male	ADJ
admet-3030	619	3	pattern	pattern	NOUN
admet-3030	619	4	hair	hair	NOUN
admet-3030	619	5	loss	loss	NOUN
admet-3030	619	6	study	study	NOUN
admet-3030	619	7	group	group	NOUN
admet-3030	619	8	.	.	PUNCT
admet-3030	620	1	journal	journal	PROPN
admet-3030	620	2	of	of	ADP
admet-3030	620	3	the	the	DET
admet-3030	620	4	american	american	PROPN
admet-3030	620	5	academy	academy	PROPN
admet-3030	620	6	of	of	ADP
admet-3030	620	7	dermatology	dermatology	NOUN
admet-3030	620	8	39	39	NUM
admet-3030	620	9	(	(	PUNCT
admet-3030	620	10	1998	1998	NUM
admet-3030	620	11	)	)	PUNCT
admet-3030	620	12	578	578	NUM
admet-3030	620	13	-	-	SYM
admet-3030	620	14	589	589	NUM
admet-3030	620	15	.	.	PUNCT
admet-3030	621	1	https://dx.doi.org/10.1016/s01909622(98)70007-6	https://dx.doi.org/10.1016/s01909622(98)70007-6	PROPN
admet-3030	621	2	[	[	X
admet-3030	621	3	82	82	NUM
admet-3030	621	4	]	]	X
admet-3030	621	5	r.m	r.m	PROPN
admet-3030	621	6	.	.	PROPN
admet-3030	621	7	trüeb	trüeb	PROPN
admet-3030	621	8	.	.	PUNCT
admet-3030	622	1	oxidative	oxidative	ADJ
admet-3030	622	2	stress	stress	NOUN
admet-3030	622	3	in	in	ADP
admet-3030	622	4	ageing	ageing	NOUN
admet-3030	622	5	of	of	ADP
admet-3030	622	6	hair	hair	NOUN
admet-3030	622	7	.	.	PUNCT
admet-3030	623	1	international	international	ADJ
admet-3030	623	2	journal	journal	NOUN
admet-3030	623	3	of	of	ADP
admet-3030	623	4	trichology	trichology	NOUN
admet-3030	623	5	1	1	NUM
admet-3030	623	6	(	(	PUNCT
admet-3030	623	7	2009	2009	NUM
admet-3030	623	8	)	)	PUNCT
admet-3030	623	9	6	6	NUM
admet-3030	623	10	-	-	SYM
admet-3030	623	11	14	14	NUM
admet-3030	623	12	.	.	PUNCT
admet-3030	624	1	https://dx.doi.org/10.4103/0974-7753.51923	https://dx.doi.org/10.4103/0974-7753.51923	PROPN
admet-3030	625	1	[	[	X
admet-3030	625	2	83	83	NUM
admet-3030	625	3	]	]	SYM
admet-3030	625	4	n.j	n.j	PROPN
admet-3030	625	5	.	.	PROPN
admet-3030	625	6	hawkshaw	hawkshaw	PROPN
admet-3030	625	7	,	,	PUNCT
admet-3030	625	8	j.a	j.a	PROPN
admet-3030	625	9	.	.	PROPN
admet-3030	625	10	hardman	hardman	PROPN
admet-3030	625	11	,	,	PUNCT
admet-3030	625	12	i.s	i.s	PROPN
admet-3030	625	13	.	.	PROPN
admet-3030	625	14	haslam	haslam	PROPN
admet-3030	625	15	,	,	PUNCT
admet-3030	625	16	a.	a.	PROPN
admet-3030	625	17	shahmalak	shahmalak	PROPN
admet-3030	625	18	,	,	PUNCT
admet-3030	625	19	a.	a.	NOUN
admet-3030	625	20	gilhar	gilhar	NOUN
admet-3030	625	21	,	,	PUNCT
admet-3030	625	22	x.	x.	PROPN
admet-3030	625	23	lim	lim	PROPN
admet-3030	625	24	,	,	PUNCT
admet-3030	625	25	r.	r.	PROPN
admet-3030	625	26	paus	paus	PROPN
admet-3030	625	27	.	.	PUNCT
admet-3030	626	1	identifying	identify	VERB
admet-3030	626	2	novel	novel	ADJ
admet-3030	626	3	strategies	strategy	NOUN
admet-3030	626	4	for	for	ADP
admet-3030	626	5	treating	treat	VERB
admet-3030	626	6	human	human	ADJ
admet-3030	626	7	hair	hair	NOUN
admet-3030	626	8	loss	loss	NOUN
admet-3030	626	9	disorders	disorder	NOUN
admet-3030	626	10	:	:	PUNCT
admet-3030	626	11	cyclosporine	cyclosporine	VERB
admet-3030	626	12	a	a	DET
admet-3030	626	13	suppresses	suppress	VERB
admet-3030	626	14	the	the	DET
admet-3030	626	15	wnt	wnt	PROPN
admet-3030	626	16	inhibitor	inhibitor	NOUN
admet-3030	626	17	,	,	PUNCT
admet-3030	626	18	sfrp1	sfrp1	NOUN
admet-3030	626	19	,	,	PUNCT
admet-3030	626	20	in	in	ADP
admet-3030	626	21	the	the	DET
admet-3030	626	22	dermal	dermal	ADJ
admet-3030	626	23	papilla	papilla	NOUN
admet-3030	626	24	of	of	ADP
admet-3030	626	25	human	human	ADJ
admet-3030	626	26	scalp	scalp	NOUN
admet-3030	626	27	hair	hair	NOUN
admet-3030	626	28	follicles	follicle	NOUN
admet-3030	626	29	.	.	PUNCT
admet-3030	627	1	plos	plos	PROPN
admet-3030	627	2	biology	biology	NOUN
admet-3030	627	3	16	16	NUM
admet-3030	627	4	(	(	PUNCT
admet-3030	627	5	2018	2018	NUM
admet-3030	627	6	)	)	PUNCT
admet-3030	627	7	e2003705	e2003705	NOUN
admet-3030	627	8	.	.	PUNCT
admet-3030	628	1	https://dx.doi.org/10.1371/journal.pbio.2003705	https://dx.doi.org/10.1371/journal.pbio.2003705	NOUN
admet-3030	629	1	[	[	X
admet-3030	629	2	84	84	NUM
admet-3030	629	3	]	]	X
admet-3030	629	4	d.h	d.h	PROPN
admet-3030	629	5	.	.	PROPN
admet-3030	629	6	bak	bak	PROPN
admet-3030	629	7	,	,	PUNCT
admet-3030	629	8	m.j	m.j	PROPN
admet-3030	629	9	.	.	PROPN
admet-3030	629	10	choi	choi	PROPN
admet-3030	629	11	,	,	PUNCT
admet-3030	629	12	s.r	s.r	PROPN
admet-3030	629	13	.	.	PROPN
admet-3030	629	14	kim	kim	PROPN
admet-3030	629	15	,	,	PUNCT
admet-3030	629	16	b.c	b.c	PROPN
admet-3030	629	17	.	.	PROPN
admet-3030	629	18	lee	lee	PROPN
admet-3030	629	19	,	,	PUNCT
admet-3030	629	20	j.m	j.m	PROPN
admet-3030	629	21	.	.	PROPN
admet-3030	629	22	kim	kim	PROPN
admet-3030	629	23	,	,	PUNCT
admet-3030	629	24	e.s	e.s	PROPN
admet-3030	629	25	.	.	PROPN
admet-3030	629	26	jeon	jeon	PROPN
admet-3030	629	27	,	,	PUNCT
admet-3030	629	28	w.	w.	PROPN
admet-3030	629	29	oh	oh	INTJ
admet-3030	629	30	,	,	PUNCT
admet-3030	629	31	e.s	e.s	PROPN
admet-3030	629	32	.	.	PROPN
admet-3030	629	33	lim	lim	PROPN
admet-3030	629	34	,	,	PUNCT
admet-3030	629	35	b.c	b.c	PROPN
admet-3030	629	36	.	.	PROPN
admet-3030	629	37	park	park	PROPN
admet-3030	629	38	,	,	PUNCT
admet-3030	629	39	m.j	m.j	PROPN
admet-3030	629	40	.	.	PROPN
admet-3030	629	41	kim	kim	PROPN
admet-3030	629	42	,	,	PUNCT
admet-3030	629	43	j.	j.	PROPN
admet-3030	629	44	na	na	PROPN
admet-3030	629	45	,	,	PUNCT
admet-3030	629	46	b.j	b.j	PROPN
admet-3030	629	47	.	.	PROPN
admet-3030	629	48	kim	kim	PROPN
admet-3030	629	49	.	.	PUNCT
admet-3030	630	1	human	human	ADJ
admet-3030	630	2	umbilical	umbilical	ADJ
admet-3030	630	3	cord	cord	NOUN
admet-3030	630	4	blood	blood	NOUN
admet-3030	630	5	mesenchymal	mesenchymal	NOUN
admet-3030	630	6	stem	stem	NOUN
admet-3030	630	7	cells	cell	NOUN
admet-3030	630	8	engineered	engineer	VERB
admet-3030	630	9	to	to	ADP
admet-3030	630	10	overexpress	overexpress	NOUN
admet-3030	630	11	growth	growth	NOUN
admet-3030	630	12	factors	factor	NOUN
admet-3030	630	13	accelerate	accelerate	VERB
admet-3030	630	14	outcomes	outcome	NOUN
admet-3030	630	15	in	in	ADP
admet-3030	630	16	hair	hair	NOUN
admet-3030	630	17	growth	growth	NOUN
admet-3030	630	18	.	.	PUNCT
admet-3030	631	1	korean	korean	ADJ
admet-3030	631	2	journal	journal	PROPN
admet-3030	631	3	of	of	ADP
admet-3030	631	4	physiology	physiology	NOUN
admet-3030	631	5	&	&	CCONJ
admet-3030	631	6	pharmacology	pharmacology	PROPN
admet-3030	631	7	22	22	NUM
admet-3030	631	8	(	(	PUNCT
admet-3030	631	9	2018	2018	NUM
admet-3030	631	10	)	)	PUNCT
admet-3030	631	11	555	555	NUM
admet-3030	631	12	-	-	SYM
admet-3030	631	13	566	566	NUM
admet-3030	631	14	.	.	PUNCT
admet-3030	632	1	https://dx.doi.org/10.4196/kjpp.2018.22.5.555	https://dx.doi.org/10.4196/kjpp.2018.22.5.555	NOUN
admet-3030	633	1	[	[	SYM
admet-3030	633	2	85	85	NUM
admet-3030	633	3	]	]	X
admet-3030	633	4	a.r	a.r	PROPN
admet-3030	633	5	.	.	PROPN
admet-3030	633	6	yuan	yuan	PROPN
admet-3030	633	7	,	,	PUNCT
admet-3030	633	8	q.	q.	PROPN
admet-3030	633	9	bian	bian	PROPN
admet-3030	633	10	,	,	PUNCT
admet-3030	633	11	j.q	j.q	PROPN
admet-3030	633	12	.	.	PROPN
admet-3030	633	13	gao	gao	PROPN
admet-3030	633	14	.	.	PUNCT
admet-3030	634	1	current	current	ADJ
admet-3030	634	2	advances	advance	NOUN
admet-3030	634	3	in	in	ADP
admet-3030	634	4	stem	stem	NOUN
admet-3030	634	5	cell	cell	NOUN
admet-3030	634	6	-	-	PUNCT
admet-3030	634	7	based	base	VERB
admet-3030	634	8	therapies	therapy	NOUN
admet-3030	634	9	for	for	ADP
admet-3030	634	10	hair	hair	NOUN
admet-3030	634	11	regeneration	regeneration	NOUN
admet-3030	634	12	.	.	PUNCT
admet-3030	635	1	european	european	PROPN
admet-3030	635	2	journal	journal	PROPN
admet-3030	635	3	of	of	ADP
admet-3030	635	4	pharmacology	pharmacology	NOUN
admet-3030	635	5	881	881	NUM
admet-3030	635	6	(	(	PUNCT
admet-3030	635	7	2020	2020	NUM
admet-3030	635	8	)	)	PUNCT
admet-3030	635	9	173197	173197	NUM
admet-3030	635	10	.	.	PUNCT
admet-3030	636	1	https://dx.doi.org/10.1016/j.ejphar.2020.173197	https://dx.doi.org/10.1016/j.ejphar.2020.173197	NUM
admet-3030	637	1	[	[	X
admet-3030	637	2	86	86	NUM
admet-3030	637	3	]	]	PUNCT
admet-3030	637	4	p.	p.	NOUN
admet-3030	637	5	gentile	gentile	NOUN
admet-3030	637	6	,	,	PUNCT
admet-3030	637	7	m.g	m.g	PROPN
admet-3030	637	8	.	.	PROPN
admet-3030	637	9	scioli	scioli	PROPN
admet-3030	637	10	,	,	PUNCT
admet-3030	637	11	a.	a.	NOUN
admet-3030	637	12	bielli	bielli	PROPN
admet-3030	637	13	,	,	PUNCT
admet-3030	637	14	b.	b.	PROPN
admet-3030	637	15	de	de	PROPN
admet-3030	637	16	angelis	angelis	PROPN
admet-3030	637	17	,	,	PUNCT
admet-3030	637	18	c.	c.	PROPN
admet-3030	637	19	de	de	PROPN
admet-3030	637	20	sio	sio	PROPN
admet-3030	637	21	,	,	PUNCT
admet-3030	637	22	d.	d.	PROPN
admet-3030	637	23	de	de	PROPN
admet-3030	637	24	fazio	fazio	PROPN
admet-3030	637	25	,	,	PUNCT
admet-3030	637	26	g.	g.	PROPN
admet-3030	637	27	ceccarelli	ceccarelli	PROPN
admet-3030	637	28	,	,	PUNCT
admet-3030	637	29	a.	a.	NOUN
admet-3030	637	30	trivisonno	trivisonno	NOUN
admet-3030	637	31	,	,	PUNCT
admet-3030	637	32	a.	a.	NOUN
admet-3030	637	33	orlandi	orlandi	PROPN
admet-3030	637	34	,	,	PUNCT
admet-3030	637	35	v.	v.	PROPN
admet-3030	637	36	cervelli	cervelli	PROPN
admet-3030	637	37	,	,	PUNCT
admet-3030	637	38	s.	s.	PROPN
admet-3030	637	39	garcovich	garcovich	PROPN
admet-3030	637	40	.	.	PUNCT
admet-3030	638	1	platelet	platelet	ADJ
admet-3030	638	2	-	-	PUNCT
admet-3030	638	3	rich	rich	ADJ
admet-3030	638	4	plasma	plasma	NOUN
admet-3030	638	5	and	and	CCONJ
admet-3030	638	6	micrografts	micrograft	NOUN
admet-3030	638	7	enriched	enrich	VERB
admet-3030	638	8	with	with	ADP
admet-3030	638	9	autologous	autologous	ADJ
admet-3030	638	10	human	human	ADJ
admet-3030	638	11	follicle	follicle	NOUN
admet-3030	638	12	mesenchymal	mesenchymal	NOUN
admet-3030	638	13	stem	stem	NOUN
admet-3030	638	14	cells	cell	NOUN
admet-3030	638	15	improve	improve	VERB
admet-3030	638	16	hair	hair	NOUN
admet-3030	638	17	re	re	NOUN
admet-3030	638	18	-	-	NOUN
admet-3030	638	19	growth	growth	NOUN
admet-3030	638	20	in	in	ADP
admet-3030	638	21	androgenetic	androgenetic	ADJ
admet-3030	638	22	alopecia	alopecia	NOUN
admet-3030	638	23	.	.	PUNCT
admet-3030	639	1	biomolecular	biomolecular	ADJ
admet-3030	639	2	pathway	pathway	NOUN
admet-3030	639	3	analysis	analysis	NOUN
admet-3030	639	4	and	and	CCONJ
admet-3030	639	5	clinical	clinical	ADJ
admet-3030	639	6	evaluation	evaluation	NOUN
admet-3030	639	7	.	.	PUNCT
admet-3030	640	1	biomedicines	biomedicine	VERB
admet-3030	640	2	7	7	NUM
admet-3030	640	3	(	(	PUNCT
admet-3030	640	4	2019	2019	NUM
admet-3030	640	5	)	)	PUNCT
admet-3030	640	6	27	27	NUM
admet-3030	640	7	.	.	PUNCT
admet-3030	641	1	https://dx.doi.org/10.3390/biomedicines7020027	https://dx.doi.org/10.3390/biomedicines7020027	PROPN
admet-3030	641	2	[	[	X
admet-3030	641	3	87	87	NUM
admet-3030	641	4	]	]	X
admet-3030	641	5	d.w	d.w	PROPN
admet-3030	641	6	.	.	PROPN
admet-3030	641	7	shin	shin	PROPN
admet-3030	641	8	.	.	PUNCT
admet-3030	642	1	the	the	DET
admet-3030	642	2	physiological	physiological	ADJ
admet-3030	642	3	and	and	CCONJ
admet-3030	642	4	pharmacological	pharmacological	ADJ
admet-3030	642	5	roles	role	NOUN
admet-3030	642	6	of	of	ADP
admet-3030	642	7	prostaglandins	prostaglandin	NOUN
admet-3030	642	8	in	in	ADP
admet-3030	642	9	hair	hair	NOUN
admet-3030	642	10	growth	growth	NOUN
admet-3030	642	11	.	.	PUNCT
admet-3030	643	1	korean	korean	ADJ
admet-3030	643	2	journal	journal	PROPN
admet-3030	643	3	of	of	ADP
admet-3030	643	4	physiology	physiology	NOUN
admet-3030	643	5	&	&	CCONJ
admet-3030	643	6	pharmacology	pharmacology	PROPN
admet-3030	643	7	26	26	NUM
admet-3030	643	8	(	(	PUNCT
admet-3030	643	9	2022	2022	NUM
admet-3030	643	10	)	)	PUNCT
admet-3030	643	11	405	405	NUM
admet-3030	643	12	-	-	SYM
admet-3030	643	13	413	413	NUM
admet-3030	643	14	.	.	PUNCT
admet-3030	644	1	https://dx.doi.org/10.4196/kjpp.2022.26.6.405	https://dx.doi.org/10.4196/kjpp.2022.26.6.405	NOUN
admet-3030	645	1	[	[	X
admet-3030	645	2	88	88	NUM
admet-3030	645	3	]	]	X
admet-3030	645	4	j.y	j.y	PROPN
admet-3030	645	5	.	.	PROPN
admet-3030	645	6	choi	choi	PROPN
admet-3030	645	7	,	,	PUNCT
admet-3030	645	8	m.y	m.y	PROPN
admet-3030	645	9	.	.	PROPN
admet-3030	645	10	boo	boo	PROPN
admet-3030	645	11	,	,	PUNCT
admet-3030	645	12	y.c	y.c	PROPN
admet-3030	645	13	.	.	PROPN
admet-3030	645	14	boo	boo	NOUN
admet-3030	645	15	.	.	PUNCT
admet-3030	646	1	can	can	AUX
admet-3030	646	2	plant	plant	VERB
admet-3030	646	3	extracts	extract	NOUN
admet-3030	646	4	help	help	NOUN
admet-3030	646	5	prevent	prevent	VERB
admet-3030	646	6	hair	hair	NOUN
admet-3030	646	7	loss	loss	NOUN
admet-3030	646	8	or	or	CCONJ
admet-3030	646	9	promote	promote	VERB
admet-3030	646	10	hair	hair	NOUN
admet-3030	646	11	growth	growth	NOUN
admet-3030	646	12	?	?	PUNCT
admet-3030	647	1	a	a	DET
admet-3030	647	2	review	review	NOUN
admet-3030	647	3	comparing	compare	VERB
admet-3030	647	4	their	their	PRON
admet-3030	647	5	therapeutic	therapeutic	ADJ
admet-3030	647	6	efficacies	efficacy	NOUN
admet-3030	647	7	,	,	PUNCT
admet-3030	647	8	phytochemical	phytochemical	ADJ
admet-3030	647	9	components	component	NOUN
admet-3030	647	10	,	,	PUNCT
admet-3030	647	11	and	and	CCONJ
admet-3030	647	12	modulatory	modulatory	ADJ
admet-3030	647	13	targets	target	NOUN
admet-3030	647	14	.	.	PUNCT
admet-3030	648	1	molecules	molecule	NOUN
admet-3030	648	2	29	29	NUM
admet-3030	648	3	(	(	PUNCT
admet-3030	648	4	2024	2024	NUM
admet-3030	648	5	)	)	PUNCT
admet-3030	648	6	2288	2288	NUM
admet-3030	648	7	.	.	PUNCT
admet-3030	649	1	https://dx.doi.org/10.3390/molecules29102288	https://dx.doi.org/10.3390/molecules29102288	PROPN
admet-3030	649	2	[	[	X
admet-3030	649	3	89	89	NUM
admet-3030	649	4	]	]	X
admet-3030	649	5	b.	b.	PROPN
admet-3030	649	6	rafidi	rafidi	PROPN
admet-3030	649	7	,	,	PUNCT
admet-3030	649	8	k.	k.	PROPN
admet-3030	649	9	kondapi	kondapi	PROPN
admet-3030	649	10	,	,	PUNCT
admet-3030	649	11	m.	m.	NOUN
admet-3030	649	12	beestrum	beestrum	PROPN
admet-3030	649	13	,	,	PUNCT
admet-3030	649	14	s.	s.	PROPN
admet-3030	649	15	basra	basra	PROPN
admet-3030	649	16	,	,	PUNCT
admet-3030	649	17	p.	p.	PROPN
admet-3030	649	18	lio	lio	PROPN
admet-3030	649	19	.	.	PUNCT
admet-3030	650	1	psychological	psychological	ADJ
admet-3030	650	2	therapies	therapy	NOUN
admet-3030	650	3	and	and	CCONJ
admet-3030	650	4	mind	mind	NOUN
admet-3030	650	5	-	-	PUNCT
admet-3030	650	6	body	body	NOUN
admet-3030	650	7	techniques	technique	NOUN
admet-3030	650	8	in	in	ADP
admet-3030	650	9	the	the	DET
admet-3030	650	10	management	management	NOUN
admet-3030	650	11	of	of	ADP
admet-3030	650	12	dermatologic	dermatologic	ADJ
admet-3030	650	13	diseases	disease	NOUN
admet-3030	650	14	:	:	PUNCT
admet-3030	650	15	a	a	DET
admet-3030	650	16	systematic	systematic	ADJ
admet-3030	650	17	review	review	NOUN
admet-3030	650	18	.	.	PUNCT
admet-3030	651	1	american	american	PROPN
admet-3030	651	2	journal	journal	PROPN
admet-3030	651	3	of	of	ADP
admet-3030	651	4	clinical	clinical	ADJ
admet-3030	651	5	dermatology	dermatology	NOUN
admet-3030	651	6	23	23	NUM
admet-3030	651	7	(	(	PUNCT
admet-3030	651	8	2022	2022	NUM
admet-3030	651	9	)	)	PUNCT
admet-3030	651	10	755	755	NUM
admet-3030	651	11	-	-	SYM
admet-3030	651	12	773	773	NUM
admet-3030	651	13	.	.	PUNCT
admet-3030	652	1	https://dx.doi.org/10.1007/s40257-022-00714-y	https://dx.doi.org/10.1007/s40257-022-00714-y	PROPN
admet-3030	652	2	https://doi.org/10.1007/s12020-017-1280-y	https://doi.org/10.1007/s12020-017-1280-y	PROPN
admet-3030	653	1	https://doi.org/10.2147/dddt.s214907	https://doi.org/10.2147/dddt.s214907	PROPN
admet-3030	653	2	https://doi.org/10.1080/09546634.2021.1959506	https://doi.org/10.1080/09546634.2021.1959506	PROPN
admet-3030	653	3	https://doi.org/10.1111/jdv.16858	https://doi.org/10.1111/jdv.16858	PROPN
admet-3030	653	4	https://doi.org/10.3389/fimmu.2022.955035	https://doi.org/10.3389/fimmu.2022.955035	PROPN
admet-3030	654	1	https://doi.org/10.1080/09546634.2016.1277179	https://doi.org/10.1080/09546634.2016.1277179	PROPN
admet-3030	654	2	https://doi.org/10.1016/s0190-9622(98)70007-6	https://doi.org/10.1016/s0190-9622(98)70007-6	PROPN
admet-3030	654	3	https://doi.org/10.1016/s0190-9622(98)70007-6	https://doi.org/10.1016/s0190-9622(98)70007-6	VERB
admet-3030	654	4	https://doi.org/10.4103/0974-7753.51923	https://doi.org/10.4103/0974-7753.51923	VERB
admet-3030	654	5	https://doi.org/10.1371/journal.pbio.2003705	https://doi.org/10.1371/journal.pbio.2003705	NOUN
admet-3030	654	6	https://doi.org/10.4196/kjpp.2018.22.5.555	https://doi.org/10.4196/kjpp.2018.22.5.555	NOUN
admet-3030	654	7	https://doi.org/10.1016/j.ejphar.2020.173197	https://doi.org/10.1016/j.ejphar.2020.173197	NOUN
admet-3030	654	8	https://dx.doi.org/10.3390/biomedicines7020027	https://dx.doi.org/10.3390/biomedicines7020027	NOUN
admet-3030	654	9	https://doi.org/10.4196/kjpp.2022.26.6.405	https://doi.org/10.4196/kjpp.2022.26.6.405	PROPN
admet-3030	654	10	https://doi.org/10.3390/molecules29102288	https://doi.org/10.3390/molecules29102288	NOUN
admet-3030	654	11	https://doi.org/10.1007/s40257-022-00714-y	https://doi.org/10.1007/s40257-022-00714-y	PROPN
admet-3030	654	12	admet	admet	PROPN
admet-3030	654	13	&	&	CCONJ
admet-3030	654	14	dmpk	dmpk	PROPN
admet-3030	654	15	00(0	00(0	PROPN
admet-3030	654	16	)	)	PUNCT
admet-3030	654	17	(	(	PUNCT
admet-3030	654	18	2025	2025	NUM
admet-3030	654	19	)	)	PUNCT
admet-3030	654	20	3030	3030	NUM
admet-3030	654	21	precision	precision	NOUN
admet-3030	654	22	therapeutics	therapeutic	NOUN
admet-3030	654	23	in	in	ADP
admet-3030	654	24	non	non	ADJ
admet-3030	654	25	-	-	ADJ
admet-3030	654	26	scarring	scar	VERB
admet-3030	654	27	alopecia	alopecia	NOUN
admet-3030	654	28	doi	doi	NOUN
admet-3030	654	29	:	:	PUNCT
admet-3030	654	30	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	X
admet-3030	654	31	21	21	NUM
admet-3030	654	32	[	[	X
admet-3030	654	33	90	90	NUM
admet-3030	654	34	]	]	X
admet-3030	654	35	y.	y.	PROPN
admet-3030	654	36	zou	zou	PROPN
admet-3030	654	37	,	,	PUNCT
admet-3030	654	38	f.	f.	PROPN
admet-3030	654	39	tang	tang	PROPN
admet-3030	654	40	,	,	PUNCT
admet-3030	654	41	p.	p.	PROPN
admet-3030	654	42	li	li	PROPN
admet-3030	654	43	,	,	PUNCT
admet-3030	654	44	w.	w.	PROPN
admet-3030	654	45	qiu	qiu	PROPN
admet-3030	654	46	,	,	PUNCT
admet-3030	654	47	m.	m.	PROPN
admet-3030	654	48	lei	lei	PROPN
admet-3030	654	49	.	.	PUNCT
admet-3030	654	50	wnt10b	wnt10b	PROPN
admet-3030	654	51	regulation	regulation	NOUN
admet-3030	654	52	of	of	ADP
admet-3030	654	53	hair	hair	NOUN
admet-3030	654	54	follicle	follicle	NOUN
admet-3030	654	55	development	development	NOUN
admet-3030	654	56	,	,	PUNCT
admet-3030	654	57	regeneration	regeneration	NOUN
admet-3030	654	58	,	,	PUNCT
admet-3030	654	59	and	and	CCONJ
admet-3030	654	60	skin	skin	NOUN
admet-3030	654	61	diseases	disease	NOUN
admet-3030	654	62	.	.	PUNCT
admet-3030	655	1	stem	stem	NOUN
admet-3030	655	2	cell	cell	NOUN
admet-3030	655	3	reviews	review	NOUN
admet-3030	655	4	and	and	CCONJ
admet-3030	655	5	reports	report	NOUN
admet-3030	655	6	21	21	NUM
admet-3030	655	7	(	(	PUNCT
admet-3030	655	8	2025	2025	NUM
admet-3030	655	9	)	)	PUNCT
admet-3030	655	10	1728	1728	NUM
admet-3030	655	11	-	-	SYM
admet-3030	655	12	1737	1737	NUM
admet-3030	655	13	.	.	PUNCT
admet-3030	656	1	https://dx.doi.org/10.1007/s12015-025-10898-5	https://dx.doi.org/10.1007/s12015-025-10898-5	PUNCT
admet-3030	657	1	[	[	X
admet-3030	657	2	91	91	NUM
admet-3030	657	3	]	]	X
admet-3030	657	4	r.	r.	PROPN
admet-3030	657	5	kapoor	kapoor	PROPN
admet-3030	657	6	,	,	PUNCT
admet-3030	657	7	d.	d.	PROPN
admet-3030	657	8	shome	shome	PROPN
admet-3030	657	9	,	,	PUNCT
admet-3030	657	10	s.	s.	PROPN
admet-3030	657	11	vadera	vadera	PROPN
admet-3030	657	12	,	,	PUNCT
admet-3030	657	13	v.	v.	PROPN
admet-3030	657	14	kumar	kumar	PROPN
admet-3030	657	15	,	,	PUNCT
admet-3030	657	16	m.s	m.s	PROPN
admet-3030	657	17	.	.	PROPN
admet-3030	657	18	ram	ram	PROPN
admet-3030	657	19	.	.	PUNCT
admet-3030	658	1	qr678	qr678	PROPN
admet-3030	658	2	&	&	CCONJ
admet-3030	658	3	qr678	qr678	PROPN
admet-3030	658	4	neo	neo	NOUN
admet-3030	658	5	hair	hair	NOUN
admet-3030	658	6	growth	growth	NOUN
admet-3030	658	7	formulations	formulation	NOUN
admet-3030	658	8	:	:	PUNCT
admet-3030	658	9	a	a	DET
admet-3030	658	10	cellular	cellular	ADJ
admet-3030	658	11	toxicity	toxicity	NOUN
admet-3030	658	12	&	&	CCONJ
admet-3030	658	13	animal	animal	PROPN
admet-3030	658	14	efficacy	efficacy	NOUN
admet-3030	658	15	study	study	NOUN
admet-3030	658	16	.	.	PUNCT
admet-3030	659	1	plastic	plastic	NOUN
admet-3030	659	2	and	and	CCONJ
admet-3030	659	3	reconstructive	reconstructive	ADJ
admet-3030	659	4	surgery	surgery	NOUN
admet-3030	659	5	global	global	ADJ
admet-3030	659	6	open	open	ADJ
admet-3030	659	7	8	8	NUM
admet-3030	659	8	(	(	PUNCT
admet-3030	659	9	2020	2020	NUM
admet-3030	659	10	)	)	PUNCT
admet-3030	659	11	e2843	e2843	NOUN
admet-3030	659	12	.	.	PUNCT
admet-3030	660	1	https://dx.doi.org/10.1097/gox.0000000000002843	https://dx.doi.org/10.1097/gox.0000000000002843	PROPN
admet-3030	660	2	[	[	X
admet-3030	660	3	92	92	NUM
admet-3030	660	4	]	]	PUNCT
admet-3030	660	5	biospace	biospace	NOUN
admet-3030	660	6	.	.	PUNCT
admet-3030	661	1	scientists	scientist	NOUN
admet-3030	661	2	decode	decode	VERB
admet-3030	661	3	hair	hair	NOUN
admet-3030	661	4	loss	loss	NOUN
admet-3030	661	5	at	at	ADP
admet-3030	661	6	the	the	DET
admet-3030	661	7	molecular	molecular	ADJ
admet-3030	661	8	level	level	NOUN
admet-3030	661	9	,	,	PUNCT
admet-3030	661	10	paving	pave	VERB
admet-3030	661	11	the	the	DET
admet-3030	661	12	way	way	NOUN
admet-3030	661	13	for	for	ADP
admet-3030	661	14	regrowth	regrowth	NOUN
admet-3030	661	15	without	without	ADP
admet-3030	661	16	transplants	transplant	NOUN
admet-3030	661	17	.	.	PUNCT
admet-3030	662	1	biospace	biospace	NOUN
admet-3030	662	2	(	(	PUNCT
admet-3030	662	3	2025	2025	NUM
admet-3030	662	4	)	)	PUNCT
admet-3030	662	5	.	.	PUNCT
admet-3030	663	1	https://www.biospace.com/press-releases/scientists-decode-hairloss-at-the-molecular-level-paving-the-way-for-regrowth-without-transplants	https://www.biospace.com/press-releases/scientists-decode-hairloss-at-the-molecular-level-paving-the-way-for-regrowth-without-transplant	NOUN
admet-3030	663	2	(	(	PUNCT
admet-3030	663	3	date	date	NOUN
admet-3030	663	4	accessed	access	VERB
admet-3030	663	5	on	on	ADP
admet-3030	663	6	30th	30th	ADJ
admet-3030	663	7	july	july	PROPN
admet-3030	663	8	2025	2025	NUM
admet-3030	663	9	)	)	PUNCT
admet-3030	664	1	[	[	X
admet-3030	664	2	93	93	NUM
admet-3030	664	3	]	]	PUNCT
admet-3030	664	4	d.	d.	PROPN
admet-3030	664	5	shome	shome	PROPN
admet-3030	664	6	,	,	PUNCT
admet-3030	664	7	r.	r.	PROPN
admet-3030	664	8	kapoor	kapoor	PROPN
admet-3030	664	9	,	,	PUNCT
admet-3030	664	10	k.	k.	PROPN
admet-3030	664	11	doshi	doshi	PROPN
admet-3030	664	12	,	,	PUNCT
admet-3030	664	13	g.	g.	PROPN
admet-3030	664	14	patel	patel	PROPN
admet-3030	664	15	,	,	PUNCT
admet-3030	664	16	s.	s.	PROPN
admet-3030	664	17	vadera	vadera	PROPN
admet-3030	664	18	,	,	PUNCT
admet-3030	664	19	v.	v.	PROPN
admet-3030	664	20	kumar	kumar	PROPN
admet-3030	664	21	.	.	PROPN
admet-3030	664	22	effectiveness	effectiveness	NOUN
admet-3030	664	23	of	of	ADP
admet-3030	664	24	qr678	qr678	PROPN
admet-3030	664	25	and	and	CCONJ
admet-3030	664	26	qr678	qr678	X
admet-3030	664	27	neo	neo	NOUN
admet-3030	664	28	(	(	PUNCT
admet-3030	664	29	®	®	NOUN
admet-3030	664	30	)	)	PUNCT
admet-3030	664	31	with	with	ADP
admet-3030	664	32	intralesional	intralesional	ADJ
admet-3030	664	33	corticosteroid	corticosteroid	ADJ
admet-3030	664	34	vs.	vs.	ADP
admet-3030	664	35	intralesional	intralesional	ADJ
admet-3030	664	36	corticosteroid	corticosteroid	NOUN
admet-3030	664	37	alone	alone	ADV
admet-3030	664	38	in	in	ADP
admet-3030	664	39	the	the	DET
admet-3030	664	40	treatment	treatment	NOUN
admet-3030	664	41	of	of	ADP
admet-3030	664	42	alopecia	alopecia	NOUN
admet-3030	664	43	areata	areata	VERB
admet-3030	664	44	a	a	DET
admet-3030	664	45	randomized	randomized	ADJ
admet-3030	664	46	,	,	PUNCT
admet-3030	664	47	comparative	comparative	ADJ
admet-3030	664	48	,	,	PUNCT
admet-3030	664	49	prospective	prospective	ADJ
admet-3030	664	50	study	study	NOUN
admet-3030	664	51	.	.	PUNCT
admet-3030	665	1	journal	journal	PROPN
admet-3030	665	2	of	of	ADP
admet-3030	665	3	cosmetic	cosmetic	ADJ
admet-3030	665	4	dermatology	dermatology	NOUN
admet-3030	665	5	21	21	NUM
admet-3030	665	6	(	(	PUNCT
admet-3030	665	7	2022	2022	NUM
admet-3030	665	8	)	)	PUNCT
admet-3030	665	9	358	358	NUM
admet-3030	665	10	-	-	SYM
admet-3030	665	11	367	367	NUM
admet-3030	665	12	.	.	PUNCT
admet-3030	666	1	https://dx.doi.org/10.1111/jocd.14630	https://dx.doi.org/10.1111/jocd.14630	PROPN
admet-3030	667	1	[	[	X
admet-3030	667	2	94	94	NUM
admet-3030	667	3	]	]	X
admet-3030	667	4	d.	d.	PROPN
admet-3030	667	5	shome	shome	PROPN
admet-3030	667	6	,	,	PUNCT
admet-3030	667	7	r.	r.	PROPN
admet-3030	667	8	kapoor	kapoor	PROPN
admet-3030	667	9	,	,	PUNCT
admet-3030	667	10	m.	m.	NOUN
admet-3030	667	11	surana	surana	PROPN
admet-3030	667	12	,	,	PUNCT
admet-3030	667	13	s.	s.	PROPN
admet-3030	667	14	vadera	vadera	PROPN
admet-3030	667	15	,	,	PUNCT
admet-3030	667	16	r.	r.	PROPN
admet-3030	667	17	shah	shah	PROPN
admet-3030	667	18	.	.	PUNCT
admet-3030	668	1	efficacy	efficacy	NOUN
admet-3030	668	2	of	of	ADP
admet-3030	668	3	qr678	qr678	PROPN
admet-3030	668	4	neo	neo	NOUN
admet-3030	668	5	(	(	PUNCT
admet-3030	668	6	®	®	NOUN
admet-3030	668	7	)	)	PUNCT
admet-3030	668	8	hair	hair	NOUN
admet-3030	668	9	growth	growth	NOUN
admet-3030	668	10	factor	factor	NOUN
admet-3030	668	11	formulation	formulation	NOUN
admet-3030	668	12	for	for	ADP
admet-3030	668	13	the	the	DET
admet-3030	668	14	treatment	treatment	NOUN
admet-3030	668	15	of	of	ADP
admet-3030	668	16	hair	hair	NOUN
admet-3030	668	17	loss	loss	NOUN
admet-3030	668	18	in	in	ADP
admet-3030	668	19	covid-19	covid-19	PROPN
admet-3030	668	20	-	-	PUNCT
admet-3030	668	21	induced	induce	VERB
admet-3030	668	22	persistent	persistent	ADJ
admet-3030	668	23	telogen	telogen	NOUN
admet-3030	668	24	effluvium	effluvium	NOUN
admet-3030	668	25	a	a	DET
admet-3030	668	26	prospective	prospective	ADJ
admet-3030	668	27	,	,	PUNCT
admet-3030	668	28	clinical	clinical	ADJ
admet-3030	668	29	,	,	PUNCT
admet-3030	668	30	single	single	ADJ
admet-3030	668	31	-	-	PUNCT
admet-3030	668	32	blind	blind	ADJ
admet-3030	668	33	study	study	NOUN
admet-3030	668	34	.	.	PUNCT
admet-3030	669	1	journal	journal	NOUN
admet-3030	669	2	of	of	ADP
admet-3030	669	3	cosmetic	cosmetic	ADJ
admet-3030	669	4	dermatology	dermatology	NOUN
admet-3030	669	5	21	21	NUM
admet-3030	669	6	(	(	PUNCT
admet-3030	669	7	2022	2022	NUM
admet-3030	669	8	)	)	PUNCT
admet-3030	669	9	16	16	NUM
admet-3030	669	10	-	-	SYM
admet-3030	669	11	23	23	NUM
admet-3030	669	12	.	.	PUNCT
admet-3030	670	1	https://dx.doi.org/10.1111/jocd.14626	https://dx.doi.org/10.1111/jocd.14626	X
admet-3030	671	1	[	[	X
admet-3030	671	2	95	95	NUM
admet-3030	671	3	]	]	PUNCT
admet-3030	671	4	a.	a.	NOUN
admet-3030	671	5	clinic	clinic	PROPN
admet-3030	671	6	,	,	PUNCT
admet-3030	671	7	a.	a.	NOUN
admet-3030	671	8	asper	asper	NOUN
admet-3030	671	9	,	,	PUNCT
admet-3030	671	10	a.	a.	NOUN
admet-3030	671	11	mittal	mittal	PROPN
admet-3030	671	12	,	,	PUNCT
admet-3030	671	13	d.	d.	PROPN
admet-3030	671	14	shome	shome	PROPN
admet-3030	671	15	,	,	PUNCT
admet-3030	671	16	d.	d.	PROPN
admet-3030	671	17	parbhoo	parbhoo	PROPN
admet-3030	671	18	,	,	PUNCT
admet-3030	671	19	j.	j.	PROPN
admet-3030	671	20	thanzama	thanzama	PROPN
admet-3030	671	21	,	,	PUNCT
admet-3030	671	22	k.	k.	PROPN
admet-3030	671	23	doshi	doshi	PROPN
admet-3030	671	24	,	,	PUNCT
admet-3030	671	25	n.	n.	PROPN
admet-3030	671	26	sachde	sachde	PROPN
admet-3030	671	27	,	,	PUNCT
admet-3030	671	28	r.	r.	PROPN
admet-3030	671	29	gaunkar	gaunkar	PROPN
admet-3030	671	30	,	,	PUNCT
admet-3030	671	31	r.	r.	PROPN
admet-3030	671	32	kapoor	kapoor	PROPN
admet-3030	671	33	,	,	PUNCT
admet-3030	671	34	r.	r.	PROPN
admet-3030	671	35	thakkar	thakkar	PROPN
admet-3030	671	36	,	,	PUNCT
admet-3030	671	37	s.	s.	PROPN
admet-3030	671	38	sion	sion	PROPN
admet-3030	671	39	,	,	PUNCT
admet-3030	671	40	s.	s.	PROPN
admet-3030	671	41	shetty	shetty	PROPN
admet-3030	671	42	,	,	PUNCT
admet-3030	671	43	v.	v.	PROPN
admet-3030	671	44	kumar	kumar	PROPN
admet-3030	671	45	,	,	PUNCT
admet-3030	671	46	v.	v.	PROPN
admet-3030	671	47	parveen	parveen	PROPN
admet-3030	671	48	,	,	PUNCT
admet-3030	671	49	v.	v.	ADP
admet-3030	671	50	singhal	singhal	PROPN
admet-3030	671	51	.	.	PUNCT
admet-3030	672	1	evaluation	evaluation	NOUN
admet-3030	672	2	of	of	ADP
admet-3030	672	3	the	the	DET
admet-3030	672	4	safety	safety	NOUN
admet-3030	672	5	and	and	CCONJ
admet-3030	672	6	effectiveness	effectiveness	NOUN
admet-3030	672	7	of	of	ADP
admet-3030	672	8	intradermal	intradermal	ADJ
admet-3030	672	9	administration	administration	NOUN
admet-3030	672	10	of	of	ADP
admet-3030	672	11	qr678	qr678	PROPN
admet-3030	672	12	neo	neo	PROPN
admet-3030	672	13	(	(	PUNCT
admet-3030	672	14	®	®	NOUN
admet-3030	672	15	)	)	PUNCT
admet-3030	672	16	hair	hair	NOUN
admet-3030	672	17	growth	growth	NOUN
admet-3030	672	18	factor	factor	NOUN
admet-3030	672	19	formulation	formulation	NOUN
admet-3030	672	20	:	:	PUNCT
admet-3030	672	21	a	a	DET
admet-3030	672	22	phase	phase	NOUN
admet-3030	672	23	-	-	PUNCT
admet-3030	672	24	iv	iv	NOUN
admet-3030	672	25	,	,	PUNCT
admet-3030	672	26	open	open	ADJ
admet-3030	672	27	-	-	PUNCT
admet-3030	672	28	label	label	NOUN
admet-3030	672	29	,	,	PUNCT
admet-3030	672	30	single	single	ADJ
admet-3030	672	31	-	-	PUNCT
admet-3030	672	32	arm	arm	NOUN
admet-3030	672	33	multi	multi	ADJ
admet-3030	672	34	-	-	ADJ
admet-3030	672	35	ethnicity	ethnicity	ADJ
admet-3030	672	36	clinical	clinical	ADJ
admet-3030	672	37	trial	trial	NOUN
admet-3030	672	38	.	.	PUNCT
admet-3030	673	1	journal	journal	NOUN
admet-3030	673	2	of	of	ADP
admet-3030	673	3	cosmetic	cosmetic	ADJ
admet-3030	673	4	dermatology	dermatology	NOUN
admet-3030	673	5	21	21	NUM
admet-3030	673	6	(	(	PUNCT
admet-3030	673	7	2022	2022	NUM
admet-3030	673	8	)	)	PUNCT
admet-3030	673	9	580	580	NUM
admet-3030	673	10	-	-	SYM
admet-3030	673	11	589	589	NUM
admet-3030	673	12	.	.	PUNCT
admet-3030	674	1	https://dx.doi.org/10.1111/jocd.14715	https://dx.doi.org/10.1111/jocd.14715	NOUN
admet-3030	675	1	[	[	X
admet-3030	675	2	96	96	NUM
admet-3030	675	3	]	]	X
admet-3030	675	4	r.	r.	PROPN
admet-3030	675	5	kapoor	kapoor	PROPN
admet-3030	675	6	,	,	PUNCT
admet-3030	675	7	d.	d.	PROPN
admet-3030	675	8	shome	shome	PROPN
admet-3030	675	9	,	,	PUNCT
admet-3030	675	10	k.	k.	PROPN
admet-3030	675	11	doshi	doshi	PROPN
admet-3030	675	12	,	,	PUNCT
admet-3030	675	13	g.	g.	PROPN
admet-3030	675	14	patel	patel	PROPN
admet-3030	675	15	,	,	PUNCT
admet-3030	675	16	s.	s.	PROPN
admet-3030	675	17	vadera	vadera	PROPN
admet-3030	675	18	.	.	PUNCT
admet-3030	676	1	evaluation	evaluation	NOUN
admet-3030	676	2	of	of	ADP
admet-3030	676	3	efficacy	efficacy	NOUN
admet-3030	676	4	of	of	ADP
admet-3030	676	5	qr	qr	PROPN
admet-3030	676	6	678	678	NUM
admet-3030	676	7	and	and	CCONJ
admet-3030	676	8	qr678	qr678	X
admet-3030	676	9	neo	neo	NOUN
admet-3030	676	10	hair	hair	NOUN
admet-3030	676	11	growth	growth	NOUN
admet-3030	676	12	factor	factor	NOUN
admet-3030	676	13	formulation	formulation	NOUN
admet-3030	676	14	for	for	ADP
admet-3030	676	15	the	the	DET
admet-3030	676	16	treatment	treatment	NOUN
admet-3030	676	17	of	of	ADP
admet-3030	676	18	female	female	ADJ
admet-3030	676	19	pattern	pattern	NOUN
admet-3030	676	20	alopecia	alopecia	NOUN
admet-3030	676	21	in	in	ADP
admet-3030	676	22	patients	patient	NOUN
admet-3030	676	23	with	with	ADP
admet-3030	676	24	pcos	pcos	PROPN
admet-3030	676	25	a	a	DET
admet-3030	676	26	prospective	prospective	ADJ
admet-3030	676	27	study	study	NOUN
admet-3030	676	28	.	.	PUNCT
admet-3030	677	1	journal	journal	PROPN
admet-3030	677	2	of	of	ADP
admet-3030	677	3	cosmetic	cosmetic	ADJ
admet-3030	677	4	dermatology	dermatology	NOUN
admet-3030	677	5	19	19	NUM
admet-3030	677	6	(	(	PUNCT
admet-3030	677	7	2020	2020	NUM
admet-3030	677	8	)	)	PUNCT
admet-3030	677	9	2637	2637	NUM
admet-3030	677	10	-	-	SYM
admet-3030	677	11	2646	2646	NUM
admet-3030	677	12	.	.	PUNCT
admet-3030	678	1	https://dx.doi.org/10.1111/jocd.13673	https://dx.doi.org/10.1111/jocd.13673	PUNCT
admet-3030	679	1	[	[	X
admet-3030	679	2	97	97	NUM
admet-3030	679	3	]	]	X
admet-3030	679	4	r.	r.	PROPN
admet-3030	679	5	kapoor	kapoor	PROPN
admet-3030	679	6	,	,	PUNCT
admet-3030	679	7	d.	d.	PROPN
admet-3030	679	8	shome	shome	PROPN
admet-3030	679	9	,	,	PUNCT
admet-3030	679	10	s.	s.	PROPN
admet-3030	679	11	vadera	vadera	PROPN
admet-3030	679	12	,	,	PUNCT
admet-3030	679	13	m.s	m.s	PROPN
admet-3030	679	14	.	.	PROPN
admet-3030	679	15	ram	ram	PROPN
admet-3030	679	16	.	.	PUNCT
admet-3030	680	1	qr	qr	PROPN
admet-3030	680	2	678	678	NUM
admet-3030	680	3	&	&	CCONJ
admet-3030	680	4	qr678	qr678	PROPN
admet-3030	680	5	neo	neo	NOUN
admet-3030	680	6	vs	vs	ADP
admet-3030	680	7	prp	prp	PROPN
admet-3030	680	8	a	a	DET
admet-3030	680	9	randomised	randomised	ADJ
admet-3030	680	10	,	,	PUNCT
admet-3030	680	11	comparative	comparative	ADJ
admet-3030	680	12	,	,	PUNCT
admet-3030	680	13	prospective	prospective	ADJ
admet-3030	680	14	study	study	NOUN
admet-3030	680	15	.	.	PUNCT
admet-3030	681	1	journal	journal	PROPN
admet-3030	681	2	of	of	ADP
admet-3030	681	3	cosmetic	cosmetic	ADJ
admet-3030	681	4	dermatology	dermatology	NOUN
admet-3030	681	5	19	19	NUM
admet-3030	681	6	(	(	PUNCT
admet-3030	681	7	2020	2020	NUM
admet-3030	681	8	)	)	PUNCT
admet-3030	681	9	2877	2877	NUM
admet-3030	681	10	-	-	SYM
admet-3030	681	11	2885	2885	NUM
admet-3030	681	12	.	.	PUNCT
admet-3030	682	1	https://dx.doi.org/10.1111/jocd.13398	https://dx.doi.org/10.1111/jocd.13398	X
admet-3030	683	1	[	[	X
admet-3030	683	2	98	98	NUM
admet-3030	683	3	]	]	X
admet-3030	683	4	v.	v.	CCONJ
admet-3030	683	5	kumar	kumar	PROPN
admet-3030	683	6	,	,	PUNCT
admet-3030	683	7	d.	d.	PROPN
admet-3030	683	8	shome	shome	PROPN
admet-3030	683	9	,	,	PUNCT
admet-3030	683	10	s.	s.	PROPN
admet-3030	683	11	atre	atre	PROPN
admet-3030	683	12	,	,	PUNCT
admet-3030	683	13	a.	a.	NOUN
admet-3030	683	14	nagarsekar	nagarsekar	PROPN
admet-3030	683	15	,	,	PUNCT
admet-3030	683	16	r.	r.	PROPN
admet-3030	683	17	gaunkar	gaunkar	PROPN
admet-3030	683	18	,	,	PUNCT
admet-3030	683	19	r.	r.	PROPN
admet-3030	683	20	kapoor	kapoor	PROPN
admet-3030	683	21	,	,	PUNCT
admet-3030	683	22	k.	k.	PROPN
admet-3030	683	23	doshi	doshi	PROPN
admet-3030	683	24	.	.	PUNCT
admet-3030	684	1	the	the	DET
admet-3030	684	2	iceberg	iceberg	NOUN
admet-3030	684	3	phenomenon	phenomenon	NOUN
admet-3030	684	4	of	of	ADP
admet-3030	684	5	alopecia	alopecia	NOUN
admet-3030	684	6	associated	associate	VERB
admet-3030	684	7	public	public	ADJ
admet-3030	684	8	health	health	NOUN
admet-3030	684	9	ramifications	ramification	NOUN
admet-3030	684	10	on	on	ADP
admet-3030	684	11	the	the	DET
admet-3030	684	12	quality	quality	NOUN
admet-3030	684	13	of	of	ADP
admet-3030	684	14	life	life	NOUN
admet-3030	684	15	among	among	ADP
admet-3030	684	16	adults	adult	NOUN
admet-3030	684	17	in	in	ADP
admet-3030	684	18	india	india	PROPN
admet-3030	684	19	.	.	PUNCT
admet-3030	685	1	dermatological	dermatological	ADJ
admet-3030	685	2	reviews	review	NOUN
admet-3030	685	3	(	(	PUNCT
admet-3030	685	4	2022	2022	NUM
admet-3030	685	5	)	)	PUNCT
admet-3030	685	6	.	.	PUNCT
admet-3030	686	1	https://dx.doi.org/10.1002/der2.109	https://dx.doi.org/10.1002/der2.109	PROPN
admet-3030	687	1	[	[	X
admet-3030	687	2	99	99	NUM
admet-3030	687	3	]	]	PUNCT
admet-3030	687	4	v.	v.	PROPN
admet-3030	687	5	kumar	kumar	PROPN
admet-3030	687	6	,	,	PUNCT
admet-3030	687	7	m.	m.	NOUN
admet-3030	687	8	gold	gold	NOUN
admet-3030	687	9	,	,	PUNCT
admet-3030	687	10	a.	a.	NOUN
admet-3030	687	11	jain	jain	PROPN
admet-3030	687	12	,	,	PUNCT
admet-3030	687	13	p.	p.	NOUN
admet-3030	687	14	mhatre	mhatre	PROPN
admet-3030	687	15	,	,	PUNCT
admet-3030	687	16	u.	u.	PROPN
admet-3030	687	17	zaman	zaman	PROPN
admet-3030	687	18	,	,	PUNCT
admet-3030	687	19	r.	r.	PROPN
admet-3030	687	20	kapoor	kapoor	PROPN
admet-3030	687	21	,	,	PUNCT
admet-3030	687	22	d.	d.	PROPN
admet-3030	687	23	shome	shome	PROPN
admet-3030	687	24	.	.	PUNCT
admet-3030	687	25	effectiveness	effectiveness	NOUN
admet-3030	687	26	of	of	ADP
admet-3030	687	27	minimally	minimally	ADV
admet-3030	687	28	invasive	invasive	ADJ
admet-3030	687	29	injectable	injectable	ADJ
admet-3030	687	30	modalities	modality	NOUN
admet-3030	687	31	in	in	ADP
admet-3030	687	32	the	the	DET
admet-3030	687	33	management	management	NOUN
admet-3030	687	34	of	of	ADP
admet-3030	687	35	androgenetic	androgenetic	ADJ
admet-3030	687	36	alopecia	alopecia	NOUN
admet-3030	687	37	among	among	ADP
admet-3030	687	38	adults	adult	NOUN
admet-3030	687	39	a	a	DET
admet-3030	687	40	systematic	systematic	ADJ
admet-3030	687	41	review	review	NOUN
admet-3030	687	42	.	.	PUNCT
admet-3030	688	1	journal	journal	PROPN
admet-3030	688	2	of	of	ADP
admet-3030	688	3	cosmetic	cosmetic	ADJ
admet-3030	688	4	dermatology	dermatology	NOUN
admet-3030	688	5	23	23	NUM
admet-3030	688	6	(	(	PUNCT
admet-3030	688	7	2024	2024	NUM
admet-3030	688	8	)	)	PUNCT
admet-3030	688	9	3144	3144	NUM
admet-3030	688	10	-	-	SYM
admet-3030	688	11	3157	3157	NUM
admet-3030	688	12	.	.	PUNCT
admet-3030	689	1	https://dx.doi.org/10.1111/jocd.16493	https://dx.doi.org/10.1111/jocd.16493	PUNCT
admet-3030	690	1	[	[	X
admet-3030	690	2	100	100	NUM
admet-3030	690	3	]	]	X
admet-3030	690	4	r.	r.	PROPN
admet-3030	690	5	kapoor	kapoor	PROPN
admet-3030	690	6	,	,	PUNCT
admet-3030	690	7	d.	d.	PROPN
admet-3030	690	8	shome	shome	PROPN
admet-3030	690	9	,	,	PUNCT
admet-3030	690	10	k.	k.	PROPN
admet-3030	690	11	doshi	doshi	PROPN
admet-3030	690	12	,	,	PUNCT
admet-3030	690	13	g.	g.	PROPN
admet-3030	690	14	patel	patel	PROPN
admet-3030	690	15	,	,	PUNCT
admet-3030	690	16	h.	h.	PROPN
admet-3030	690	17	tandel	tandel	PROPN
admet-3030	690	18	,	,	PUNCT
admet-3030	690	19	v.	v.	PROPN
admet-3030	690	20	kumar	kumar	PROPN
admet-3030	690	21	.	.	PUNCT
admet-3030	691	1	a	a	DET
admet-3030	691	2	newer	new	ADJ
admet-3030	691	3	approach	approach	NOUN
admet-3030	691	4	in	in	ADP
admet-3030	691	5	the	the	DET
admet-3030	691	6	treatment	treatment	NOUN
admet-3030	691	7	of	of	ADP
admet-3030	691	8	seborrheic	seborrheic	PROPN
admet-3030	691	9	dermatitis	dermatitis	NOUN
admet-3030	691	10	with	with	ADP
admet-3030	691	11	qr678	qr678	PROPN
admet-3030	691	12	®	®	NOUN
admet-3030	691	13	and	and	CCONJ
admet-3030	691	14	qr678	qr678	PROPN
admet-3030	691	15	neo	neo	NOUN
admet-3030	691	16	®	®	VERB
admet-3030	691	17	a	a	DET
admet-3030	691	18	prospective	prospective	ADJ
admet-3030	691	19	pilot	pilot	NOUN
admet-3030	691	20	study	study	NOUN
admet-3030	691	21	.	.	PUNCT
admet-3030	692	1	journal	journal	PROPN
admet-3030	692	2	of	of	ADP
admet-3030	692	3	cosmetic	cosmetic	ADJ
admet-3030	692	4	dermatology	dermatology	NOUN
admet-3030	692	5	22	22	NUM
admet-3030	692	6	(	(	PUNCT
admet-3030	692	7	2023	2023	NUM
admet-3030	692	8	)	)	PUNCT
admet-3030	692	9	3078	3078	NUM
admet-3030	692	10	-	-	SYM
admet-3030	692	11	3087	3087	NUM
admet-3030	692	12	.	.	PUNCT
admet-3030	693	1	https://dx.doi.org/10.1111/jocd.15957	https://dx.doi.org/10.1111/jocd.15957	PUNCT
admet-3030	693	2	[	[	X
admet-3030	693	3	101	101	NUM
admet-3030	693	4	]	]	PUNCT
admet-3030	693	5	r.	r.	PROPN
admet-3030	693	6	kapoor	kapoor	PROPN
admet-3030	693	7	,	,	PUNCT
admet-3030	693	8	d.	d.	PROPN
admet-3030	693	9	shome	shome	PROPN
admet-3030	693	10	,	,	PUNCT
admet-3030	693	11	k.	k.	PROPN
admet-3030	693	12	doshi	doshi	PROPN
admet-3030	693	13	,	,	PUNCT
admet-3030	693	14	s.	s.	PROPN
admet-3030	693	15	vadera	vadera	PROPN
admet-3030	693	16	,	,	PUNCT
admet-3030	693	17	g.	g.	PROPN
admet-3030	693	18	patel	patel	PROPN
admet-3030	693	19	,	,	PUNCT
admet-3030	693	20	v.	v.	PROPN
admet-3030	693	21	kumar	kumar	PROPN
admet-3030	693	22	.	.	PUNCT
admet-3030	694	1	evaluation	evaluation	NOUN
admet-3030	694	2	of	of	ADP
admet-3030	694	3	efficacy	efficacy	NOUN
admet-3030	694	4	of	of	ADP
admet-3030	694	5	qr678	qr678	PROPN
admet-3030	694	6	®	®	NOUN
admet-3030	694	7	and	and	CCONJ
admet-3030	694	8	qr678	qr678	PROPN
admet-3030	694	9	®	®	NOUN
admet-3030	694	10	neo	neo	NOUN
admet-3030	694	11	hair	hair	NOUN
admet-3030	694	12	growth	growth	NOUN
admet-3030	694	13	factor	factor	NOUN
admet-3030	694	14	formulation	formulation	NOUN
admet-3030	694	15	in	in	ADP
admet-3030	694	16	the	the	DET
admet-3030	694	17	treatment	treatment	NOUN
admet-3030	694	18	of	of	ADP
admet-3030	694	19	persistent	persistent	ADJ
admet-3030	694	20	chemotherapy‐induced	chemotherapy‐induced	ADJ
admet-3030	694	21	alopecia	alopecia	NOUN
admet-3030	694	22	caused	cause	VERB
admet-3030	694	23	due	due	ADJ
admet-3030	694	24	to	to	ADP
admet-3030	694	25	cytotoxic	cytotoxic	ADJ
admet-3030	694	26	chemotherapy	chemotherapy	NOUN
admet-3030	694	27	—	—	PUNCT
admet-3030	694	28	a	a	DET
admet-3030	694	29	prospective	prospective	ADJ
admet-3030	694	30	pilot	pilot	NOUN
admet-3030	694	31	study	study	NOUN
admet-3030	694	32	.	.	PUNCT
admet-3030	695	1	journal	journal	PROPN
admet-3030	695	2	of	of	ADP
admet-3030	695	3	cosmetic	cosmetic	ADJ
admet-3030	695	4	dermatology	dermatology	NOUN
admet-3030	695	5	19	19	NUM
admet-3030	695	6	(	(	PUNCT
admet-3030	695	7	2020	2020	NUM
admet-3030	695	8	)	)	PUNCT
admet-3030	695	9	3270	3270	NUM
admet-3030	695	10	-	-	SYM
admet-3030	695	11	3279	3279	NUM
admet-3030	695	12	.	.	PUNCT
admet-3030	696	1	https://dx.doi	https://dx.doi	NOUN
admet-3030	696	2	:	:	PUNCT
admet-3030	696	3	10.1111	10.1111	NUM
admet-3030	696	4	/	/	SYM
admet-3030	697	1	jocd.13759	jocd.13759	PROPN
admet-3030	697	2	[	[	X
admet-3030	697	3	102	102	NUM
admet-3030	697	4	]	]	X
admet-3030	697	5	d.	d.	PROPN
admet-3030	697	6	shome	shome	PROPN
admet-3030	697	7	,	,	PUNCT
admet-3030	697	8	r.	r.	PROPN
admet-3030	697	9	kapoor	kapoor	PROPN
admet-3030	697	10	,	,	PUNCT
admet-3030	697	11	s.	s.	PROPN
admet-3030	697	12	vadera	vadera	PROPN
admet-3030	697	13	,	,	PUNCT
admet-3030	697	14	k.	k.	PROPN
admet-3030	697	15	doshi	doshi	PROPN
admet-3030	697	16	,	,	PUNCT
admet-3030	697	17	g.	g.	PROPN
admet-3030	697	18	patel	patel	PROPN
admet-3030	697	19	,	,	PUNCT
admet-3030	697	20	t.	t.	PROPN
admet-3030	697	21	mohammad	mohammad	PROPN
admet-3030	697	22	khan	khan	PROPN
admet-3030	697	23	.	.	PUNCT
admet-3030	698	1	evaluation	evaluation	NOUN
admet-3030	698	2	of	of	ADP
admet-3030	698	3	efficacy	efficacy	NOUN
admet-3030	698	4	of	of	ADP
admet-3030	698	5	intradermal	intradermal	ADJ
admet-3030	698	6	injection	injection	NOUN
admet-3030	698	7	therapy	therapy	NOUN
admet-3030	698	8	vs	vs	ADP
admet-3030	698	9	derma	derma	NOUN
admet-3030	698	10	roller	roller	NOUN
admet-3030	698	11	application	application	NOUN
admet-3030	698	12	for	for	ADP
admet-3030	698	13	administration	administration	NOUN
admet-3030	698	14	of	of	ADP
admet-3030	698	15	qr678	qr678	PROPN
admet-3030	698	16	neo	neo	PROPN
admet-3030	698	17	(	(	PUNCT
admet-3030	698	18	®	®	NOUN
admet-3030	698	19	)	)	PUNCT
admet-3030	698	20	hair	hair	NOUN
admet-3030	698	21	regrowth	regrowth	NOUN
admet-3030	698	22	formulation	formulation	NOUN
admet-3030	698	23	for	for	ADP
admet-3030	698	24	the	the	DET
admet-3030	698	25	treatment	treatment	NOUN
admet-3030	698	26	of	of	ADP
admet-3030	698	27	androgenetic	androgenetic	ADJ
admet-3030	698	28	alopecia	alopecia	NOUN
admet-3030	698	29	a	a	DET
admet-3030	698	30	prospective	prospective	ADJ
admet-3030	698	31	study	study	NOUN
admet-3030	698	32	.	.	PUNCT
admet-3030	699	1	journal	journal	PROPN
admet-3030	699	2	of	of	ADP
admet-3030	699	3	cosmetic	cosmetic	ADJ
admet-3030	699	4	dermatology	dermatology	NOUN
admet-3030	699	5	20	20	NUM
admet-3030	699	6	(	(	PUNCT
admet-3030	699	7	2021	2021	NUM
admet-3030	699	8	)	)	PUNCT
admet-3030	699	9	3299	3299	NUM
admet-3030	699	10	-	-	SYM
admet-3030	699	11	3307	3307	NUM
admet-3030	699	12	.	.	PUNCT
admet-3030	700	1	https://dx.doi.org/10.1111/jocd.14139	https://dx.doi.org/10.1111/jocd.14139	PUNCT
admet-3030	701	1	[	[	X
admet-3030	701	2	103	103	NUM
admet-3030	701	3	]	]	X
admet-3030	701	4	d.	d.	PROPN
admet-3030	701	5	shome	shome	PROPN
admet-3030	701	6	,	,	PUNCT
admet-3030	701	7	h.	h.	PROPN
admet-3030	701	8	tandel	tandel	PROPN
admet-3030	701	9	,	,	PUNCT
admet-3030	701	10	v.	v.	PROPN
admet-3030	701	11	kumar	kumar	PROPN
admet-3030	701	12	,	,	PUNCT
admet-3030	701	13	r.	r.	PROPN
admet-3030	701	14	kapoor	kapoor	PROPN
admet-3030	701	15	.	.	PUNCT
admet-3030	702	1	evaluation	evaluation	NOUN
admet-3030	702	2	of	of	ADP
admet-3030	702	3	efficacy	efficacy	NOUN
admet-3030	702	4	of	of	ADP
admet-3030	702	5	derma	derma	NOUN
admet-3030	702	6	roller	roller	NOUN
admet-3030	702	7	sizes	size	NOUN
admet-3030	702	8	vs	vs	ADP
admet-3030	702	9	topical	topical	ADJ
admet-3030	702	10	application	application	NOUN
admet-3030	702	11	for	for	ADP
admet-3030	702	12	administration	administration	NOUN
admet-3030	702	13	of	of	ADP
admet-3030	702	14	qr678	qr678	PROPN
admet-3030	702	15	neo	neo	NOUN
admet-3030	702	16	®	®	NOUN
admet-3030	702	17	hair	hair	NOUN
admet-3030	702	18	regrowth	regrowth	NOUN
admet-3030	702	19	formulation	formulation	NOUN
admet-3030	702	20	in	in	ADP
admet-3030	702	21	the	the	DET
admet-3030	702	22	treatment	treatment	NOUN
admet-3030	702	23	of	of	ADP
admet-3030	702	24	https://doi.org/10.5599/admet.3030	https://doi.org/10.5599/admet.3030	NOUN
admet-3030	702	25	https://doi.org/10.1007/s12015-025-10898-5	https://doi.org/10.1007/s12015-025-10898-5	PROPN
admet-3030	703	1	https://doi.org/10.1097/gox.0000000000002843	https://doi.org/10.1097/gox.0000000000002843	NOUN
admet-3030	703	2	https://www.biospace.com/press-releases/scientists-decode-hair-loss-at-the-molecular-level-paving-the-way-for-regrowth-without-transplants	https://www.biospace.com/press-releases/scientists-decode-hair-loss-at-the-molecular-level-paving-the-way-for-regrowth-without-transplant	VERB
admet-3030	703	3	https://www.biospace.com/press-releases/scientists-decode-hair-loss-at-the-molecular-level-paving-the-way-for-regrowth-without-transplants	https://www.biospace.com/press-releases/scientists-decode-hair-loss-at-the-molecular-level-paving-the-way-for-regrowth-without-transplant	NOUN
admet-3030	703	4	https://doi.org/10.1111/jocd.14630	https://doi.org/10.1111/jocd.14630	PROPN
admet-3030	703	5	https://doi.org/10.1111/jocd.14626	https://doi.org/10.1111/jocd.14626	ADJ
admet-3030	703	6	https://doi.org/10.1111/jocd.14715	https://doi.org/10.1111/jocd.14715	NOUN
admet-3030	703	7	https://doi.org/10.1111/jocd.13673	https://doi.org/10.1111/jocd.13673	PROPN
admet-3030	703	8	https://doi.org/10.1111/jocd.13398	https://doi.org/10.1111/jocd.13398	PROPN
admet-3030	704	1	https://doi.org/10.1002/der2.109	https://doi.org/10.1002/der2.109	VERB
admet-3030	704	2	https://doi.org/10.1111/jocd.16493	https://doi.org/10.1111/jocd.16493	ADJ
admet-3030	704	3	https://doi.org/10.1111/jocd.15957	https://doi.org/10.1111/jocd.15957	NOUN
admet-3030	704	4	https://doi.org/10.1111/jocd.14139	https://doi.org/10.1111/jocd.14139	PROPN
admet-3030	704	5	r.	r.	PROPN
admet-3030	704	6	kapoor	kapoor	PROPN
admet-3030	704	7	et	et	PROPN
admet-3030	704	8	al	al	PROPN
admet-3030	704	9	.	.	PROPN
admet-3030	704	10	admet	admet	PROPN
admet-3030	704	11	&	&	CCONJ
admet-3030	704	12	dmpk	dmpk	PROPN
admet-3030	704	13	00(0	00(0	PROPN
admet-3030	704	14	)	)	PUNCT
admet-3030	704	15	(	(	PUNCT
admet-3030	704	16	2025	2025	NUM
admet-3030	704	17	)	)	PUNCT
admet-3030	704	18	3030	3030	NUM
admet-3030	704	19	22	22	NUM
admet-3030	704	20	androgenetic	androgenetic	ADJ
admet-3030	704	21	alopecia	alopecia	NOUN
admet-3030	704	22	.	.	PUNCT
admet-3030	705	1	journal	journal	PROPN
admet-3030	705	2	of	of	ADP
admet-3030	705	3	cosmetic	cosmetic	ADJ
admet-3030	705	4	dermatology	dermatology	NOUN
admet-3030	705	5	21	21	NUM
admet-3030	705	6	(	(	PUNCT
admet-3030	705	7	2022	2022	NUM
admet-3030	705	8	)	)	PUNCT
admet-3030	705	9	6528	6528	NUM
admet-3030	705	10	-	-	SYM
admet-3030	705	11	6530	6530	NUM
admet-3030	705	12	.	.	PUNCT
admet-3030	706	1	https://dx.doi.org/10.1111/jocd.15336	https://dx.doi.org/10.1111/jocd.15336	PUNCT
admet-3030	707	1	[	[	X
admet-3030	707	2	104	104	X
admet-3030	707	3	]	]	X
admet-3030	707	4	r.	r.	PROPN
admet-3030	707	5	kapoor	kapoor	PROPN
admet-3030	707	6	,	,	PUNCT
admet-3030	707	7	d.	d.	PROPN
admet-3030	707	8	shome	shome	PROPN
admet-3030	707	9	.	.	PUNCT
admet-3030	708	1	intradermal	intradermal	ADJ
admet-3030	708	2	injections	injection	NOUN
admet-3030	708	3	of	of	ADP
admet-3030	708	4	a	a	DET
admet-3030	708	5	hair	hair	NOUN
admet-3030	708	6	growth	growth	NOUN
admet-3030	708	7	factor	factor	NOUN
admet-3030	708	8	formulation	formulation	NOUN
admet-3030	708	9	for	for	ADP
admet-3030	708	10	enhancement	enhancement	NOUN
admet-3030	708	11	of	of	ADP
admet-3030	708	12	human	human	ADJ
admet-3030	708	13	hair	hair	NOUN
admet-3030	708	14	regrowth	regrowth	NOUN
admet-3030	708	15	safety	safety	NOUN
admet-3030	708	16	and	and	CCONJ
admet-3030	708	17	efficacy	efficacy	NOUN
admet-3030	708	18	evaluation	evaluation	NOUN
admet-3030	708	19	in	in	ADP
admet-3030	708	20	a	a	DET
admet-3030	708	21	first	first	ADJ
admet-3030	708	22	-	-	PUNCT
admet-3030	708	23	in	in	ADP
admet-3030	708	24	-	-	PUNCT
admet-3030	708	25	man	man	NOUN
admet-3030	708	26	pilot	pilot	NOUN
admet-3030	708	27	clinical	clinical	ADJ
admet-3030	708	28	study	study	NOUN
admet-3030	708	29	.	.	PUNCT
admet-3030	709	1	journal	journal	PROPN
admet-3030	709	2	of	of	ADP
admet-3030	709	3	cosmetic	cosmetic	ADJ
admet-3030	709	4	and	and	CCONJ
admet-3030	709	5	laser	laser	NOUN
admet-3030	709	6	therapy	therapy	NOUN
admet-3030	709	7	20	20	NUM
admet-3030	709	8	(	(	PUNCT
admet-3030	709	9	2018	2018	NUM
admet-3030	709	10	)	)	PUNCT
admet-3030	709	11	369	369	NUM
admet-3030	709	12	-	-	SYM
admet-3030	709	13	379	379	NUM
admet-3030	709	14	.	.	PUNCT
admet-3030	710	1	https://dx.doi.org/10.1080/14764172.2018.1439965	https://dx.doi.org/10.1080/14764172.2018.1439965	NOUN
admet-3030	711	1	[	[	X
admet-3030	711	2	105	105	NUM
admet-3030	711	3	]	]	X
admet-3030	711	4	d.	d.	PROPN
admet-3030	711	5	shome	shome	PROPN
admet-3030	711	6	,	,	PUNCT
admet-3030	711	7	r.	r.	PROPN
admet-3030	711	8	kapoor	kapoor	PROPN
admet-3030	711	9	,	,	PUNCT
admet-3030	711	10	k.	k.	PROPN
admet-3030	711	11	doshi	doshi	PROPN
admet-3030	711	12	,	,	PUNCT
admet-3030	711	13	g.	g.	PROPN
admet-3030	711	14	patel	patel	PROPN
admet-3030	711	15	,	,	PUNCT
admet-3030	711	16	s.	s.	PROPN
admet-3030	711	17	vadera	vadera	PROPN
admet-3030	711	18	,	,	PUNCT
admet-3030	711	19	v.	v.	PROPN
admet-3030	711	20	kumar	kumar	PROPN
admet-3030	711	21	.	.	PROPN
admet-3030	712	1	comparison	comparison	NOUN
admet-3030	712	2	of	of	ADP
admet-3030	712	3	qr	qr	PROPN
admet-3030	712	4	678	678	NUM
admet-3030	712	5	(	(	PUNCT
admet-3030	712	6	®	®	NOUN
admet-3030	712	7	)	)	PUNCT
admet-3030	712	8	&	&	CCONJ
admet-3030	712	9	qr678	qr678	PROPN
admet-3030	712	10	(	(	PUNCT
admet-3030	712	11	®	®	NOUN
admet-3030	712	12	)	)	PUNCT
admet-3030	712	13	neo	neo	NOUN
admet-3030	712	14	as	as	ADP
admet-3030	712	15	monotherapy	monotherapy	NOUN
admet-3030	712	16	and	and	CCONJ
admet-3030	712	17	as	as	ADP
admet-3030	712	18	combination	combination	NOUN
admet-3030	712	19	therapy	therapy	NOUN
admet-3030	712	20	with	with	ADP
admet-3030	712	21	5	5	NUM
admet-3030	712	22	%	%	NOUN
admet-3030	712	23	minoxidil	minoxidil	ADJ
admet-3030	712	24	solution	solution	NOUN
admet-3030	712	25	and	and	CCONJ
admet-3030	712	26	oral	oral	ADJ
admet-3030	712	27	finasteride	finasteride	ADV
admet-3030	712	28	in	in	ADP
admet-3030	712	29	the	the	DET
admet-3030	712	30	treatment	treatment	NOUN
admet-3030	712	31	of	of	ADP
admet-3030	712	32	male	male	ADJ
admet-3030	712	33	androgenetic	androgenetic	ADJ
admet-3030	712	34	alopecia	alopecia	NOUN
admet-3030	712	35	which	which	PRON
admet-3030	712	36	is	be	AUX
admet-3030	712	37	better	well	ADJ
admet-3030	712	38	?	?	PUNCT
admet-3030	713	1	journal	journal	NOUN
admet-3030	713	2	of	of	ADP
admet-3030	713	3	cosmetic	cosmetic	ADJ
admet-3030	713	4	dermatology	dermatology	NOUN
admet-3030	713	5	20	20	NUM
admet-3030	713	6	(	(	PUNCT
admet-3030	713	7	2021	2021	NUM
admet-3030	713	8	)	)	PUNCT
admet-3030	713	9	1763	1763	NUM
admet-3030	713	10	-	-	SYM
admet-3030	713	11	1765	1765	NUM
admet-3030	713	12	.	.	PUNCT
admet-3030	714	1	https://dx.doi.org/10.1111/jocd.14154	https://dx.doi.org/10.1111/jocd.14154	X
admet-3030	715	1	[	[	X
admet-3030	715	2	106	106	NUM
admet-3030	715	3	]	]	PUNCT
admet-3030	715	4	m.	m.	NOUN
admet-3030	715	5	gold	gold	NOUN
admet-3030	715	6	,	,	PUNCT
admet-3030	715	7	u.	u.	PROPN
admet-3030	715	8	zaman	zaman	PROPN
admet-3030	715	9	,	,	PUNCT
admet-3030	715	10	v.	v.	ADP
admet-3030	715	11	chouksey	chouksey	ADJ
admet-3030	715	12	,	,	PUNCT
admet-3030	715	13	m.	m.	NOUN
admet-3030	715	14	gosavi	gosavi	NOUN
admet-3030	715	15	.	.	PUNCT
admet-3030	716	1	evaluation	evaluation	NOUN
admet-3030	716	2	of	of	ADP
admet-3030	716	3	the	the	DET
admet-3030	716	4	efficacy	efficacy	NOUN
admet-3030	716	5	of	of	ADP
admet-3030	716	6	a	a	DET
admet-3030	716	7	biomimetic	biomimetic	ADJ
admet-3030	716	8	peptide	peptide	NOUN
admet-3030	716	9	solution	solution	NOUN
admet-3030	716	10	for	for	ADP
admet-3030	716	11	rejuvenation	rejuvenation	NOUN
admet-3030	716	12	of	of	ADP
admet-3030	716	13	donor	donor	NOUN
admet-3030	716	14	scalp	scalp	NOUN
admet-3030	716	15	and	and	CCONJ
admet-3030	716	16	as	as	ADP
admet-3030	716	17	storage	storage	NOUN
admet-3030	716	18	media	medium	NOUN
admet-3030	716	19	for	for	ADP
admet-3030	716	20	hair	hair	NOUN
admet-3030	716	21	follicle	follicle	NOUN
admet-3030	716	22	grafts	graft	NOUN
admet-3030	716	23	during	during	ADP
admet-3030	716	24	fue	fue	PROPN
admet-3030	716	25	hair	hair	NOUN
admet-3030	716	26	transplantation	transplantation	NOUN
admet-3030	716	27	.	.	PUNCT
admet-3030	717	1	journal	journal	NOUN
admet-3030	717	2	of	of	ADP
admet-3030	717	3	cosmetic	cosmetic	ADJ
admet-3030	717	4	and	and	CCONJ
admet-3030	717	5	laser	laser	NOUN
admet-3030	717	6	therapy	therapy	NOUN
admet-3030	717	7	27	27	NUM
admet-3030	717	8	(	(	PUNCT
admet-3030	717	9	2025	2025	NUM
admet-3030	717	10	)	)	PUNCT
admet-3030	717	11	64	64	NUM
admet-3030	717	12	-	-	SYM
admet-3030	717	13	70	70	NUM
admet-3030	717	14	.	.	PUNCT
admet-3030	718	1	https://dx.doi.org/10.1080/14764172.2025.2468499	https://dx.doi.org/10.1080/14764172.2025.2468499	ADJ
admet-3030	718	2	©	©	PROPN
admet-3030	718	3	2025	2025	NUM
admet-3030	718	4	by	by	ADP
admet-3030	718	5	the	the	DET
admet-3030	718	6	authors	author	NOUN
admet-3030	718	7	;	;	PUNCT
admet-3030	719	1	licensee	licensee	PROPN
admet-3030	719	2	iapc	iapc	PROPN
admet-3030	719	3	,	,	PUNCT
admet-3030	719	4	zagreb	zagreb	PROPN
admet-3030	719	5	,	,	PUNCT
admet-3030	719	6	croatia	croatia	PROPN
admet-3030	719	7	.	.	PUNCT
admet-3030	720	1	this	this	DET
admet-3030	720	2	article	article	NOUN
admet-3030	720	3	is	be	AUX
admet-3030	720	4	an	an	DET
admet-3030	720	5	open	open	ADJ
admet-3030	720	6	-	-	PUNCT
admet-3030	720	7	access	access	NOUN
admet-3030	720	8	article	article	NOUN
admet-3030	720	9	distributed	distribute	VERB
admet-3030	720	10	under	under	ADP
admet-3030	720	11	the	the	DET
admet-3030	720	12	terms	term	NOUN
admet-3030	720	13	and	and	CCONJ
admet-3030	720	14	conditions	condition	NOUN
admet-3030	720	15	of	of	ADP
admet-3030	720	16	the	the	DET
admet-3030	720	17	creative	creative	ADJ
admet-3030	720	18	commons	common	NOUN
admet-3030	720	19	attribution	attribution	NOUN
admet-3030	720	20	license	license	NOUN
admet-3030	720	21	(	(	PUNCT
admet-3030	720	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-3030	720	23	)	)	PUNCT
admet-3030	720	24	https://doi.org/10.1111/jocd.15336	https://doi.org/10.1111/jocd.15336	NOUN
admet-3030	720	25	https://doi.org/10.1080/14764172.2018.1439965	https://doi.org/10.1080/14764172.2018.1439965	VERB
admet-3030	720	26	https://doi.org/10.1111/jocd.14154	https://doi.org/10.1111/jocd.14154	PROPN
admet-3030	720	27	https://doi.org/10.1080/14764172.2025.2468499	https://doi.org/10.1080/14764172.2025.2468499	PROPN
admet-3030	721	1	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN